<script data-pm-proxy="intercept"></script><?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"><channel><title><![CDATA[OutraMedicina2024]]></title><description><![CDATA[Medicina humanizada, não tóxica e não invasiva versus medicina formatada pelo mercado]]></description><link>https://outramedicina2024.substack.com</link><image><url>https://substackcdn.com/image/fetch/$s_!U70D!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc1699f59-5c21-4330-b9a8-0369681ff305_336x336.png</url><title>OutraMedicina2024</title><link>https://outramedicina2024.substack.com</link></image><generator>Substack</generator><lastBuildDate>Fri, 04 Sep 2026 11:52:40 GMT</lastBuildDate><atom:link href="/__u/outramedicina2024.substack.com/feed" rel="self" type="application/rss+xml"/><copyright><![CDATA[gilson dantas]]></copyright><language><![CDATA[pt]]></language><webMaster><![CDATA[outramedicina2024@substack.com]]></webMaster><itunes:owner><itunes:email><![CDATA[outramedicina2024@substack.com]]></itunes:email><itunes:name><![CDATA[dantas2021]]></itunes:name></itunes:owner><itunes:author><![CDATA[dantas2021]]></itunes:author><googleplay:owner><![CDATA[outramedicina2024@substack.com]]></googleplay:owner><googleplay:email><![CDATA[outramedicina2024@substack.com]]></googleplay:email><googleplay:author><![CDATA[dantas2021]]></googleplay:author><itunes:block><![CDATA[Yes]]></itunes:block><item><title><![CDATA[CO2, exercício e ácido lático – nem sempre o exercício significa saúde [Parte 2 de 3]]]></title><description><![CDATA[Aumento de massa muscular pode n&#227;o ser exatamente sa&#250;de; e o tipo e o tempo do exerc&#237;cio importam &#8211; sendo que tudo isso pode ser entendido a partir do CO2 e &#225;cido l&#225;tico [lactato]]]></description><link>https://outramedicina2024.substack.com/p/co2-exercicio-e-acido-latico-nem-97c</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/co2-exercicio-e-acido-latico-nem-97c</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Thu, 03 Sep 2026 17:53:43 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!Soob!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!Soob!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!Soob!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg" width="480" height="360" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:360,&quot;width&quot;:480,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:43891,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/214044657?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!Soob!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F662b3557-24ed-4877-b1f9-073301470242_480x360.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>O paradoxo e a pergunta a ser feita: o tipo de treinamento f&#237;sico est&#225; aumentando a capacidade respirat&#243;ria ou est&#225; impondo repetidamente um estado de estresse que ultrapassa a capacidade de recupera&#231;&#227;o?</p><p><em>&#8220;O exerc&#237;cio exaustivo eleva o cortisol, a prolactina e o estrog&#234;nio, enquanto reduz o T3 ativado e os horm&#244;nios protetores. O h&#225;bito de se exercitar at&#233; a exaust&#227;o imita os efeitos fisiol&#243;gicos do envelhecimento e do estresse cr&#244;nico&#8221;</em> [Ray Peat, <em>Exercise and Aging</em>]</p><p>O que &#233; importante entender na dire&#231;&#227;o contr&#225;ria: que uma atividade f&#237;sica ser&#225; positiva se for prazerosa, n&#227;o compulsiva e predominantemente conc&#234;ntrica [aplicar carga no m&#250;sculo contra&#237;do, n&#227;o relaxando]; e que, por outro lado, ser&#225; um problema, ser&#225; estressante por natureza, se for prolongada, muito exc&#234;ntrica, associada a hiperventila&#231;&#227;o [anaer&#243;bica] e se for em jejum. Nesse &#250;ltimo caso aumentar&#225; muito mais o lactato, que se traduzir&#225; em redu&#231;&#227;o efetiva de CO2, aumento da adrenalina, cortisol, maior dificuldade para a queima oxidativa do a&#231;&#250;car, da&#237; maior tend&#234;ncia &#224; produ&#231;&#227;o de lactato.</p><p>O di&#243;xido de carbono &#233; central, nisso tudo. Peat chegou a argumentar que a defici&#234;ncia de CO&#8322; induzida pela hiperventila&#231;&#227;o favorece a produ&#231;&#227;o de &#225;cido l&#225;tico e que o CO&#8322;, em sentido oposto, limita a forma&#231;&#227;o de lactato e ajuda a sustentar o metabolismo oxidativo.</p><p>Sua preocupa&#231;&#227;o &#233; que o treinamento extenuante repetido possa deixar o organismo em um estado persistente de maior produ&#231;&#227;o de lactato e menor efici&#234;ncia respirat&#243;ria, de modo que lactato elevado possa reaparecer ou permanecer anormalmente alto durante a recupera&#231;&#227;o.</p><p>Para Peat, portanto, um atleta pode parecer extremamente apto &#8212; correr muito, ter grande resist&#234;ncia, tolerar sofrimento &#8212; e, ainda assim, estar produzindo um padr&#227;o metab&#243;lico que ele consideraria progressivamente estressante.</p><p>Como saber se est&#225; sendo a atividade f&#237;sica inadequada? Se ap&#243;s o exerc&#237;cio, a pessoa retorna rapidamente a um estado de alta produ&#231;&#227;o de CO&#8322; e boa oxida&#231;&#227;o da glicose &#8212; ou se permanece por dias em um estado de lactato, cortisol, lip&#243;lise, edema, hiperventila&#231;&#227;o e recupera&#231;&#227;o incompleta. [Mesmo que costume dizer &#8220;eu estou &#243;timo&#8221;].</p><p>Para Peat, o ponto importante &#233; que CO&#8322; n&#227;o &#233; apenas um res&#237;duo: sua presen&#231;a &#233; express&#227;o da oxida&#231;&#227;o e tamb&#233;m exerce efeitos protetores sobre os tecidos. E o exerc&#237;cio inadequado acelera a utiliza&#231;&#227;o da glicose e a ventila&#231;&#227;o [podendo aparecer a &#8220;falta de ar&#8221;], da&#237; atinge a glic&#243;lise acelerada e a produ&#231;&#227;o de lactato.</p><p>Sempre lembrar um ponto cr&#237;tico:<span> </span>respira&#231;&#227;o excessiva significar&#225; elimina&#231;&#227;o aumentada de CO&#8322; pelos pulm&#245;es e diminui&#231;&#227;o do CO2 dispon&#237;vel para o organismo. Pode at&#233; ser que em determinadas condi&#231;&#245;es um corredor esteja metabolicamente produzindo muito CO&#8322; mas acontece que, ao mesmo tempo, pode estar expelindo-o excessivamente atrav&#233;s da hiperventila&#231;&#227;o. O balan&#231;o ser&#225; negativo.</p><p>E aqui o exerc&#237;cio deixa de ser simplesmente uma atividade que aumenta o metabolismo e pode transformar-se, segundo Peat, lamentavelmente, em um estado de estresse metab&#243;lico. Nesta condi&#231;&#227;o, estar&#225; aumentada a mobiliza&#231;&#227;o de gorduras, queima de &#225;cidos graxos livres; sendo que ser&#225; especialmente ruim a queima de &#243;leos poli-insaturados agora liberados no exerc&#237;cio extenuante, anaer&#243;bico. Esses &#225;cidos graxos comprometem a oxida&#231;&#227;o da glicose, aumentando produ&#231;&#227;o de lactato.</p><p>De forma que o atleta pode estar gastando enormes quantidades de energia sem que isso signifique, para Peat, que sua respira&#231;&#227;o celular esteja funcionando idealmente. Ao contr&#225;rio estar&#225; com metabolismo inibido enquanto gasta energia.</p><p>Muito lactato produzido naquele esfor&#231;o f&#237;sico pode at&#233; ir desaparecendo do sangue mas ao mesmo tempo em que os sintomas ruins persistam:  edema; dano muscular; ativa&#231;&#227;o simp&#225;tica; maior mobiliza&#231;&#227;o de &#225;cidos graxos; redu&#231;&#227;o transit&#243;ria da capacidade oxidativa. O lactato pode cair, pode at&#233; normalizar, mas esses efeitos ruins continuam no tempo.</p><p>Da&#237; que atletas muito treinados possam apresentar um padr&#227;o persistentemente anormal de lactato. N&#227;o &#233; tanto a persist&#234;ncia do lactato formado naquele esfor&#231;o extenuante. Mas sim que o sistema pode ter sido deslocado para um estado que volta a produzir lactato com mais facilidade.</p><p>Ainda mais, como foi dito, com exerc&#237;cio que hiperventila, feito em jejum ou por muito tempo.</p><p>Na perspectiva de Peat, uma respira&#231;&#227;o oxidativa eficiente tende a produzir CO&#8322;, enquanto o desvio para uma glic&#243;lise predominantemente anaer&#243;bica produz mais lactato relativamente ao CO&#8322;.</p><p>Um m&#250;sculo maior, ou seja, ganho muscular, pode resultar de adapta&#231;&#227;o estrutural, mas tamb&#233;m pode estar temporariamente aumentado por edema decorrente de estresse e dano. Isto &#233;, o m&#250;sculo pode ficar mensuravelmente maior sem que todo esse aumento corresponda a novo tecido muscular contr&#225;til [B].</p><p>Se o exerc&#237;cio excessivo produz lactato, hiperventila&#231;&#227;o, perda de CO&#8322;, mobiliza&#231;&#227;o de &#225;cidos graxos e dano celular, um aumento de volume muscular pode ser, pelo menos inicialmente, parte da resposta ao estresse e ao edema, e n&#227;o necessariamente um sinal de adapta&#231;&#227;o ben&#233;fica.</p><p>Um aumento do volume muscular observado ap&#243;s o in&#237;cio ou a intensifica&#231;&#227;o de exerc&#237;cios resistidos n&#227;o demonstra, por si s&#243;, hipertrofia verdadeira. Parte &#8212; e em determinadas circunst&#226;ncias, uma parte substancial &#8212; do aumento da &#225;rea ou espessura muscular pode representar edema e incha&#231;o induzidos por dano muscular.</p><p>E isso abre uma pergunta muito boa para o nosso eixo CO&#8322;&#8211;lactato&#8211;exerc&#237;cio: se o m&#250;sculo aumentado ap&#243;s treinamento pode conter uma quantidade significativa de &#225;gua associada ao dano, at&#233; que ponto a &#8220;hipertrofia&#8221; inicial &#233; uma adapta&#231;&#227;o ou simplesmente a sequ&#234;ncia edema-reparo-remodela&#231;&#227;o? [C]</p><p>De tudo isso se pode concluir, provisoriamente, que h&#225; exerc&#237;cio e exerc&#237;cio. Existem aqueles adequados, que agregam apenas qualidade ao metabolismo [e criam m&#250;sculos, importantes para a sa&#250;de sist&#234;mica]. N&#227;o promovem n&#237;veis altos de lactato e cortisol continuados.</p><p>Pensar apenas em ser atleta, em &#8220;fazer academia&#8221; para ter sa&#250;de, e tomando o  exerc&#237;cio como uma coisa em si ou do mundo das apar&#234;ncias [homem ou mulher &#8220;tanquinho&#8221; e coisas no estilo] pode ser uma grande ilus&#227;o. Ilus&#227;o que cobra seu pre&#231;o mais adiante, na doen&#231;a ou na forma de envelhecimento.</p><p>G Dantas, 3-9-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong>Notas</strong> ________</p><p>[A]<span> </span>R. Peat, 2010. <em>Altitude and CO2</em>,<span> </span>2010</p><p>[B]<span> </span>DAMAS f, 2016. &#8220;Early resistance training-induced increases in muscle cross-sectional area are concomitant with edema-induced muscle swelling <em>European Journal of Applied Physiology</em>, 2016. <a href="https://pubmed.ncbi.nlm.nih.gov/26280652/?utm_source=chatgpt.com">Abrir no PubMed</a></p><p>O pr&#243;prio t&#237;tulo j&#225; aponta que &#8220;os aumentos precoces da &#225;rea de sec&#231;&#227;o transversal muscular induzidos pelo treinamento de resist&#234;ncia ocorrem concomitantemente com aumento do volume muscular induzido por edema.&#8221;</p><p>O que eles fizeram</p><p>Acompanharam homens jovens n&#227;o treinados durante 10 semanas de muscula&#231;&#227;o, medindo:</p><p><span>&#183; </span>&#225;rea de sec&#231;&#227;o transversal do m&#250;sculo vasto lateral;</p><p><span>&#183; </span>intensidade do sinal de ultrassom, usada como indicador indireto de edema;</p><p><span>&#183; </span>marcadores de dano muscular;</p><p><span>&#183; </span>for&#231;a;</p><p><span>&#183; </span>volume de treinamento.</p><p>O resultado &#233; muito interessante</p><p>Ap&#243;s 3 semanas, a &#225;rea muscular havia aumentado cerca de 2,7%.</p><p>Por&#233;m, nesse mesmo momento, os indicadores de edema por ultrassom aumentaram cerca de 17,2%. Al&#233;m disso, marcadores de dano muscular e interleucina-6 estavam elevados. A for&#231;a m&#225;xima volunt&#225;ria, por outro lado, ainda n&#227;o havia aumentado significativamente.</p><p>Os autores conclu&#237;ram que o aumento precoce da &#225;rea muscular n&#227;o era <em>puramente hipertrofia</em>, pois havia edema concomitante e esse edema provavelmente explicava uma propor&#231;&#227;o substancial do aumento aparente de tamanho. Eles chegam a dizer que aumentos precoces da &#225;rea muscular n&#227;o deveriam ser chamados simplesmente de hipertrofia sem alguma medida concomitante de edema ou dano muscular.</p><p>[C]<span> </span>NOSAKA K CLARKSON P M, 1996. <em>Changes in indicators of inflammation after eccentric exercise of the elbow flexors</em>. Med Sci Sports Exerc. 1996 Aug;28(8):953-61. doi: 10.1097/00005768-199608000-00003.  PMID: 8871903<span> </span>DOI: <a href="https://doi.org/10.1097/00005768-199608000-00003">10.1097/00005768-199608000-00003</a></p><p>Abstract</p><p>This study examined muscle swelling and changes in inflammatory markers in the blood following eccentric exercise-induced muscle damage. Subjects (N = 14) who had not been involved in a resistance training program performed 24 maximal eccentric actions of the elbow flexors. Muscle swelling was assessed by measures of the upper arm circumference (CIR), ultrasonography (USG), and magnetic resonance imaging (MRI). Plasma concentrations of interleukin-1 alpha, interleukin-1 beta, interleukin-2, interleukin-6, tumor necrosis factor-alpha, and plasma levels of C-reactive protein, cortisol, and zinc were analyzed. Established indicators of muscle damage (maximal isometric force, range of motion, muscle soreness, and plasma creatine kinase, aspartate aminotransferase, and lactate dehydrogenase activities) were also measured. All measures, including CIR and USG, except for MRI, were assessed immediately before and after and for 5 d post-exercise. MRI was taken at pre- and 1, 3, 6, 10, 23, 31, and 58 d post-exercise. All muscle damage indicators changed significantly after exercise. A large increase in CIR (&gt; 20 mm) was found 4-5 d after exercise, and this coincided with USG, showing an increase in muscle thickness. The echointensity of USG increased with the enlargement of the elbow flexors. MRI displayed enlargement of the biceps brachii and brachialis cross-sectional area that started at 1 d, and lasted until 23 d, post-exercise. The most profound increase in the enlargement and signal intensity of the MRI was found 3 or 6 d after exercise. However, none of the plasma levels of inflammatory makers showed significant muscle swelling, which is indicative of muscle edema, but the inflammatory responses after exercise appear to be different from those accompanying infection or tissue injury.</p><p>Esse estudo mostrou que ap&#243;s uma &#250;nica sess&#227;o de contra&#231;&#245;es exc&#234;ntricas m&#225;ximas, houve aumento do tamanho muscular por resson&#226;ncia magn&#233;tica que come&#231;ou ap&#243;s 1 dia e persistiu at&#233; 23 dias. O maior aumento de volume e sinal compat&#237;vel com edema ocorreu por volta de 3 a 6 dias ap&#243;s o exerc&#237;cio. Particularmente importante para a argumenta&#231;&#227;o acima: um m&#250;sculo pode permanecer maior durante dias ou at&#233; semanas como consequ&#234;ncia de edema p&#243;s-les&#227;o, e uma simples medida de circunfer&#234;ncia ou &#225;rea transversal pode confundir esse aumento com &#8220;crescimento muscular&#8221;.</p><p>E mais: uma revis&#227;o posterior do mesmo grupo prop&#244;s, para a fase inicial do treinamento, algo aproximadamente assim:  primeiras sess&#245;es de muscula&#231;&#227;o, dano muscular e incha&#231;o predominam; depois de cerca de 10 sess&#245;es<span> </span>come&#231;a a surgir hipertrofia modesta; numa fase posterior, por volta de 18 sess&#245;es<br><span> </span>torna-se mais evidente a hipertrofia verdadeira.  Os pr&#243;prios autores ressaltam que <em>a interpreta&#231;&#227;o da hipertrofia nas primeiras semanas &#233; fortemente confundida pelo edema</em>.</p><p>[D]<span> </span>JEUKENDRUP A E VET-JOOP K STEGEN J H, 2000. <em>Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men.</em><strong> </strong>Clin Sci (Lond). 2000 Jan;98(1):47-55. PMID: 10600658 &#8220;The aim of the present study was to establish whether gastro-intestinal (GI) complaints observed during and after ultra-endurance exercise are related to gut ischaemia-associated leakage of endotoxins [lipopolysaccharide (LPS)] into the circulation and associated cytokine production. Therefore we collected blood samples from 29 athletes before, immediately after, and 1, 2 and 16 h after a long-distance triathlon for measurement of LPS, tumour necrosis factor-alpha and interleukin-6 (IL-6). As the cytokine response would trigger an acute-phase response, characteristic variables of these responses were also measured, along with creatine kinase (CK) to obtain an indicator of muscle damage. There was a high incidence (93% of all participants) of GI symptoms; 45% reported severe complaints and 7% of the participants abandoned the race because of severe GI distress. Mild endotoxaemia (5-15 pg/ml) was evident in 68% of the athletes immediately after the race, as also indicated by a reduction in IgG anti-LPS levels. In addition, we observed production of IL-6 (27-fold increase immediately after the race), leading to an acute-phase response (20-fold increase in C-reactive protein and 12% decrease in pre-albumin 16 h after the race). The extent of endotoxaemia was not correlated with the GI complaints or the IL-6 response, but did show a correlation with the elevation in C-reactive protein (r(s) 0.389; P=0.037). Creatine kinase levels were increased significantly immediately post-race, and increased further in the follow-up period. Creatine kinase levels did not correlate with those of either IL-6 or C-reactive protein. It is therefore concluded that LPS does enter the circulation after ultra-endurance exercise and may, together with muscle damage, be responsible for the increased cytokine response and hence GI complaints in these athletes&#8221;.</p><p>[E] PEDERSEN B K STEENSBERG A FISCHER C, 2001.<em> Exercise and cytokines with particular focus on muscle-derived IL-6</em><strong>. </strong>Exerc Immunol Rev. 2001:7:18-31.<strong> </strong>PMID: 11579746<strong> &#8220;</strong>Exercise induces increased circulating levels of a number of cytokines. Thus, increased plasma levels of tumour necrosis factor (TNF)-alpha, interleukin (IL-1) beta, IL-1 receptor antagonist (IL-1ra), TNF-receptors (TNF-R), IL-10, IL-8, and macrophage inflammatory protein (MIP)-1 are found after strenuous exercise. The concentration of IL-6 increases up to 100 fold after a marathon race. Recently, it has been demonstrated that IL-6 is produced locally in contracting skeletal muscles and that the net release from the muscle can account for the exercise-induced increase in arterial IL-6 concentration. IL-6 more than any other cytokine is produced in large amounts in response to exercise. It is produced locally in the skeletal muscle in response to exercise, and IL-6 is known to induce hepatic glucose-output and to induce lipolysis. This indicates that IL-6 may represent an important link between contracting skeletal muscles and exercise-related metabolic changes&#8221;.</p><p>[F] SUZUKI K NATAJI S YAMADA M, 2002. <em>Systemic inflammatory response to exhaustive exercise. Cytokine kinetics</em><strong>. </strong>Exerc Immunol Rev. 2002:8:6-48.<strong> </strong>PMID: 12690937<strong> &#8220;</strong>It has been documented that strenuous exercise not only <strong>induces pyrogenesis but also elicits mobilization and functional augmentation of neutrophils and monocytes whereas it suppresses cellular immunity leading to increased susceptibility to infections</strong>. As mediators of these phenomena, cytokines released into the circulation have been a recent focus of attention. Indeed, there are as many as one hundred original reports concerning exercise and cytokines, and half of them have been published in rapid succession from 2000, resulting in a tremendous accumulation of new knowledge within such a short term. The first aim of this review is to comprehensively summarize previous studies on systemic cytokine kinetics following exercise, with a special focus on reproducibility and quantitative comparison in human studies using specific immunoassays. Although tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta have traditionally been understood to be the main inducer cytokines of acute phase reactions, the majority of studies have shown that the circulating concentration of these cytokines is either unchanged following exercise, or exhibits relatively small, delayed increments. Plasma interferon (IFN)-alpha and IFN-gamma do not appear to change following exercise, whereas IL-2 decreases after endurance exercise. The small changes of these proinflammatory and immunomodulatory cytokines could well be mediated by anti-inflammatory cytokines such as IL-1 receptor antagonist (IL-1ra), IL-6 and IL-10 and cytokine inhibitors (cortisol, prostaglandin E2 and soluble receptors against TNF and IL-2), which are known to increase markedly in the circulation following endurance exercise. Moreover, it has been recently demonstrated that endurance exercise induces systemic release of granulocyte colony-stimulating factor (G-CSF), macrophage CSF (M-CSF), IL-8 and monocyte chemotactic protein 1 (MCP-1). Although the majority of available data have been obtained following prolonged exercise, it remains to be elucidated whether short-duration intensive exercise also causes rapid systemic cytokine release. In addition, there have been few studies that have simultaneously compared the extent of each cytokine response to exercise from a wider perspective. The second aim of this study was to examine possible changes of not only plasma but also urine concentrations of a broad spectrum of cytokines (16 kinds) following maximal exercise, including the time course of recovery. Although plasma TNF-alpha could not be detected throughout, it was present in urine 2 h after exercise. Plasma IL-1 beta rose significantly 2 h after exercise, but plasma IL-1 ra increased more rapidly and markedly than IL-1 beta, thus IL-1 bioactivity should be blocked at least in the circulation. Although there was only a trend toward increased plasma IL-6 concentrations after exercise, urine IL-6 rose significantly 1 h after exercise, indicating that IL-6 was released systemically but eliminated rapidly into the urine. Furthermore, it is shown for the first time that plasma and urine IL-4 concentrations were significantly elevated 2 h after exercise. Therefore, it is possible that anti-inflammatory cytokines might be released into the circulation as a regulatory mode of the cytokine network for adaptation against systemic inflammatory stress. Additionally, we have demonstrated that plasma concentrations of G-CSF, granulocytemacrophage CSF (GM-CSF), M-CSF, IL-8 and MCP-1 increased immediately after short-duration exercise and that the urine concentrations of these cytokines were much more pronounced than the changes observed in plasma. In conclusion, cytokines that are considered to induce systemic bioactivity following exercise are not only anti-inflammatory cytokines but also colony-stimulating factors and chemokines, which were secreted in an earlier phase of exercise without the kinetic involvement of traditional proinflammatory cytokines. Although the wider physiological and pathological implications are still not clearly understood, these cytokine kinetics may partly explain suppressed cell-mediated immunity and increased allergic reactions derived from a lower type-1 to type-2 cytokine ratio, along with mobilization and functional augmentation of neutrophils and monocytes. The sources and stimuli of cytokine production are not fully elucidated at present, but several hypotheses based on recent experimental evidence are discussed in this review herein&#8221;.</p><p>[G] CAVAILLON J M 1995. <strong>[</strong><em>Cytokines in inflammation</em><strong>]. </strong>C R Seances Soc Biol Fil. 1995;189(4):531-44. [Article in French] PMID: 8564567 &#8220;Numerous cytokines are present within inflammatory foci. Interleukin-1 (IL-1) and tumour necrosis factor (TNF) play a major role in coordinating mechanisms which command inflammation. Upon their action, many different cells produce lipidic mediators, proteolytic enzymes, and free radicals, all directly responsible for the noxious effects observed. IL-1 and TNF exert cytotoxic effects on vascular endothelium, cartilage, bone and muscle. Such cytokines as interferon-gamma, IL-3 or granulocyte-macrophage colony stimulating factor amplify the inflammatory response by increasing the production of IL-1 and TNF. The latest trigger the release of chemokines such as IL-8 and macrophage chemoattractant protein-1, the chemotactic activity of which participates in the recruitment of leukocytes within the foci of inflammation. IL-6, abounds in inflammatory processes and induces the production by hepatocytes of acute phase proteins. The same applies to IL-1, TNF, IL-11, the leucocyte inhibitory factor, and the transforming growth factor-beta. The later also processes a number of anti-inflammatory activities and, like IL-4, IL-10 and IL-13, can inhibit IL-1 and TNF production. Such property has also been mentioned for interferon-alpha. These anti-inflammatory cytokines can also counteract some of the IL-1 and TNF activities such as those reported during the coagulation process. Furthermore, these anti-inflammatory cytokines can induce the production of the IL-1 receptor antagonist which prevents the activities initiated by IL-1. Soluble TNF receptors, released during inflammation, are the direct inhibitors for TNF. Glucocorticoids, produced following a cascade of events initiated by IL-1, TNF and IL-6, involving the neuroendocrine axis, also inhibit proinflammatory cytokine productions. The concept of &#8220;cytokine network&#8221; therefore, perfectly illustrates the participation of these mediators in inflammation mechanisms&#8221;.</p><p>[H] PEDERSEN B K STEENSBERG A FISCHER C, 2004. <em>The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?</em><strong> </strong>Proc Nutr Soc. 2004 May;63(2):263-7. doi: 10.1079/PNS2004338. PMID: 15294041 DOI: <a href="https://doi.org/10.1079/pns2004338">10.1079/PNS2004338</a> &#8220;For most of the last century, researchers have searched for a muscle contraction-induced factor that mediates some of the exercise effects in other tissues such as the liver and the adipose tissue. It has been called the &#8216;work stimulus&#8217;, the &#8216;work factor&#8217; or the &#8216;exercise factor&#8217;. In the search for such a factor, a cytokine, IL-6, was found to be produced by contracting muscles and released into the blood. It has been demonstrated that IL-6 has many biological roles such as: (1) induction of lipolysis; (2) suppression of TNF production; (3) stimulation of cortisol production. The IL-6 gene is rapidly activated during exercise, and the activation of this gene is further enhanced when muscle glycogen content is low. In addition, carbohydrate supplementation during exercise has been shown to inhibit the release of IL-6 from contracting muscle. Thus, it is suggested that muscle-derived IL-6 fulfils the criteria of an exercise factor and that such classes of cytokines could be termed &#8216;myokines&#8221;.</p><p>[I] BONSIGNORE M R MORICI G RICCOBONO L, 2001. <em>Airway inflammation in nonasthmatic amateur runners. </em>Am J Physiol Lung Cell Mol Physiol. 2001 Sep;281(3):L668-76. doi: 10.1152/ajplung.2001.281.3.L668.<strong> </strong>PMID: 11504695<strong> </strong>DOI: <a href="https://doi.org/10.1152/ajplung.2001.281.3.l668">10.1152/ajplung.2001.281.3.L668</a> &#8220;Elite athletes show a high prevalence of symptoms and signs of asthma, but no study has assessed the acute effects of endurance exercise on airway cells in nonasthmatic athletes. We measured exhaled nitric oxide (NO) and collected samples of induced sputum after 3% NaCl aerosol administration for 20 min in nonasthmatic middle-aged amateur runners after the Fourth Palermo International Marathon and 6--9 wk later (habitual training period) at baseline. After the marathon, exhaled NO (n = 9 subjects) was higher [27 +/- 9 parts/billion (ppb)] than at baseline (12 +/- 4 ppb; P &lt; 0.0005). Polymorphonuclear neutrophil (PMN) counts in induced sputum were much higher in runners (91.2 +/- 3.6% of total cells postmarathon and 78.7 +/- 9.1% at baseline) than in sedentary control subjects (9.9 +/- 5.9%; P &lt; 0.001). Expression of L-selectin and CD11b/CD18 in sputum PMNs was lower after the race than at baseline and inversely related to the amount of exhaled NO (r = -0.66 and -0.69, respectively; P &lt; 0.05). Our data indicate that sputum PMNs are increased in nonasthmatic runners both after a marathon and at baseline and suggest that NO may modulate exercise-associated inflammatory airway changes&#8221;.</p><p>[J] HELENIUS I HAAHTELA T, 2000. <em>Allergy and asthma in elite summer sport athletes.</em><strong> </strong>J Allergy Clin Immunol. 2000 Sep;106(3):444-52. doi: 10.1067/mai.2000.107749. PMID: 10984362 DOI: <a href="https://doi.org/10.1067/mai.2000.107749">10.1067/mai.2000.107749</a> &#8220;Exercise may increase ventilation up to 200 L/min for short periods of time in speed and power athletes, and for longer periods in endurance athletes, such as long-distance runners and swimmers. Therefore highly trained athletes are repeatedly and strongly exposed to cold air during winter training and to many pollen allergens in spring and summer. <strong>Competitive swimmers inhale and microaspirate large amounts of air that floats above the water surface, which means exposure to chlorine derivatives from swimming pool disinfectants. In the summer Olympic Games, 4% to 15% of the athletes showed evidence of asthma or used antiasthmatic medication. Asthma is most commonly found in endurance events, such as cycling, swimming, or long-distance running. The risk of asthma is especially increased among competitive swimmers, of which 36% to 79% show bronchial hyperresponsiveness to methacholine or histamine. The risk of asthma is closely associated with atopy and its severity among athletes.</strong> A few studies have investigated occurrence of exercise-induced bronchospasm among highly trained athletes. The occurrences of exercise-induced bronchospasm vary from 3% to 35% and depend on testing environment, type of exercise used, and athlete population tested. Mild eosinophilic airway inflammation has been shown to affect elite swimmers and cross-country skiers. This eosinophilic inflammation correlates with clinical parameters (ie, exercise-induced bronchial symptoms and bronchial hyperresponsiveness). Athletes commonly use antiasthmatic medication to treat their exercise-induced bronchial symptoms. However, controlled studies on their long-term effects on bronchial hyperresponsiveness and airway inflammation in the athletes are lacking. Follow-up studies on asthma in athletes are also lacking. What will happen to bronchial hyperresponsiveness and airway inflammation after discontinuation of competitional career is unclear. In the future, follow-up studies on bronchial responsiveness and airway inflammation, as well as controlled studies on both short- and long-term effects of antiasthmatic drugs in the athletes are needed&#8221;.</p><p>[K] PEAT R, 2005. <em>Contexts for asthma</em>. R P&#180;s Newsletter, march 2005</p><p>***</p>]]></content:encoded></item><item><title><![CDATA[Como vive o cristalino do olho, sem qualquer vascularização? [O cristalino e a “transparência da vida”] [Parte 3 de 3]]]></title><description><![CDATA[NOTAS sobre catarata-glaucoma-fisiologia do olho [Nota 1 de 8 ].]]></description><link>https://outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-sem</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-sem</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sun, 30 Aug 2026 20:31:37 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!aXfe!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!aXfe!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!aXfe!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg" width="509" height="320" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:320,&quot;width&quot;:509,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:20930,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/213451694?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!aXfe!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32c95749-1ef2-43f6-94c5-9fbf7ea7837c_509x320.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p></p><p>Parte 3 de 3<span> </span>[Continua&#231;&#227;o da P<a href="/__u/outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-se-d8b">arte 2</a>]</p><p>J&#225; foi explicado que o cristalino &#233; formado por milhares de c&#233;lulas altamente alongadas, chamadas <em>fibras</em> do cristalino, organizadas em camadas conc&#234;ntricas como as de uma cebola.</p><p>Cada nova camada de fibras &#233; produzida ao longo da vida. As fibras mais novas ficam na periferia (c&#243;rtex), enquanto as mais antigas s&#227;o empurradas para o centro, formando o n&#250;cleo do cristalino. Como as fibras antigas permanecem no interior por d&#233;cadas, o cristalino nunca &#8220;descarta&#8221; suas c&#233;lulas antigas; ele cresce continuamente.</p><p>As fibras maduras t&#234;m capacidade metab&#243;lica muito limitada porque perderam suas organelas. Assim, <em>quem mant&#233;m o ambiente adequado</em> para que essas fibras permane&#231;am transparentes &#233; principalmente o epit&#233;lio do cristalino.</p><p style="text-align: right;"><em>Em outras palavras, as fibras s&#227;o a estrutura &#243;ptica, enquanto o epit&#233;lio &#233; o centro de manuten&#231;&#227;o metab&#243;lica que preserva essa estrutura ao longo da vida. Ou: as fibras constituem a lente &#243;ptica; o epit&#233;lio constitui o sistema metab&#243;lico que mant&#233;m essa lente transparente durante toda a vida</em></p><p>Eis a extraordin&#225;ria transpar&#234;ncia da vida: o cristalino &#233; constitu&#237;do quase inteiramente por c&#233;lulas vivas altamente especializadas, transformadas em uma lente biol&#243;gica de impressionante transpar&#234;ncia.</p><p>De alguma maneira pode-se dizer que existem dois &#8220;mundos&#8221; no cristalino, o mundo &#243;ptico: formado pelas fibras, cuja fun&#231;&#227;o &#233; apenas transmitir e focalizar a luz e o mundo metab&#243;lico: formado pelo epit&#233;lio, cuja fun&#231;&#227;o &#233; produzir energia, sintetizar novas prote&#237;nas, controlar a composi&#231;&#227;o i&#244;nica, combater a oxida&#231;&#227;o e preservar a organiza&#231;&#227;o das fibras.</p><p>Uma fascinante divis&#227;o do trabalho.</p><p>E mais uma vez Peat: uma estrutura que n&#227;o se mant&#233;m sozinha; ela &#233; continuamente <em>sustentada pelo metabolismo</em>. A energia n&#227;o apenas faz a c&#233;lula funcionar; ela mant&#233;m a c&#233;lula existindo como uma estrutura organizada.</p><p>No cristalino, isso fica quase did&#225;tico. As fibras praticamente n&#227;o conseguem mais se manter sozinhas porque perderam n&#250;cleo e organelas. Elas dependem daquele j&#225; citado epit&#233;lio para conservar a ordem molecular que lhes d&#225; transpar&#234;ncia. A forma depende da energia. A estrutura n&#227;o &#233; o oposto do metabolismo; ela &#233; a <em>sua express&#227;o cont&#237;nua</em>. Quando o metabolismo declina, a estrutura deixa de conseguir preservar sua organiza&#231;&#227;o e come&#231;a a se degradar.</p><p>Eis aqui uma das ideias mais caracter&#237;sticas da vis&#227;o de Peat sobre biologia. E evidentemente n&#227;o &#233; o que se ensina nas faculdades; aqui o pensamento &#233; de que a estrutura vem primeiro e o metabolismo apenas a utiliza. Para Peat, a estrutura &#233; um estado de <em>equil&#237;brio din&#226;mico sustentado continuamente pela energia. </em>S&#227;o concep&#231;&#245;es diferentes, como se v&#234;.</p><p>A lente n&#227;o continua transparente porque foi &#8220;bem constru&#237;da&#8221; e se tornou uma estrutura acabada d&#233;cadas atr&#225;s. Ela continua transparente porque, <strong>a cada instante</strong>, o epit&#233;lio mant&#233;m as condi&#231;&#245;es para que as prote&#237;nas e a &#225;gua interna permane&#231;am organizadas.</p><p>Peat se referencia, nesse item, por Gilbert Ling. Ling tamb&#233;m argumentava que a organiza&#231;&#227;o celular n&#227;o depende principalmente de bombas trabalhando contra o caos, mas do estado f&#237;sico-qu&#237;mico da c&#233;lula, mantido por um metabolismo adequado. E a vida &#233; um estado organizado que precisa ser continuamente sustentado pela energia, e n&#227;o uma m&#225;quina que apenas <em>consome ATP para mover pe&#231;as</em>. N&#227;o &#233; um autom&#243;vel que o combust&#237;vel apenas o faz andar.</p><p>A energia &#233; como a tens&#227;o que mant&#233;m uma tenda armada.</p><p>Enquanto a tens&#227;o existe, a tenda permanece de p&#233;. Quando ela desaparece, n&#227;o &#233; apenas o movimento que cessa; a pr&#243;pria estrutura colapsa.</p><p>E para reiterar o pensamento, j&#225; que se trata de uma nova maneira de ver a biologia da c&#233;lula e do cristalino:<span> </span>a energia mant&#233;m a organiza&#231;&#227;o das prote&#237;nas; a energia mant&#233;m a seletividade da c&#233;lula; a energia mant&#233;m a transpar&#234;ncia do cristalino; a energia mant&#233;m a diferencia&#231;&#227;o celular; <em>quando a energia cai, o organismo entra em um modo de emerg&#234;ncia, sacrificando organiza&#231;&#227;o para sobreviver.</em></p><p>Eis uma esp&#233;cie de princ&#237;pio unificador [a vida &#233; a manuten&#231;&#227;o ativa da ordem]. Princ&#237;pio que n&#227;o se prende a fatos isolados, mas explica-os.</p><p>Aquela ordem precisa ser renovada continuamente pelo metabolismo. A constante oferta de energia mant&#233;m a estrutura.</p><p style="text-align: right;"><em>&#201; por isso que Peat via a restaura&#231;&#227;o da produ&#231;&#227;o de energia como o objetivo central da fisiologia e da terap&#234;utica. Quando o metabolismo melhora, o organismo frequentemente recupera espontaneamente estruturas e fun&#231;&#245;es que pareciam perdidas. &#201; uma maneira muito profunda de enxergar a biologia como um processo, e n&#227;o como um conjunto de pe&#231;as independentes.</em></p><p>As fibras do cristalino (c&#233;lulas longas e sem n&#250;cleo) praticamente n&#227;o s&#227;o substitu&#237;das depois que se formam. &#192; medida que novas fibras s&#227;o adicionadas, as antigas s&#227;o empurradas para o centro. As fibras centrais, que formam o n&#250;cleo do cristalino, podem permanecer ali por toda a vida.</p><p>Ou seja, em uma pessoa de 70 anos, algumas das fibras localizadas no centro do cristalino podem ter sido produzidas ainda durante a vida fetal ou nos primeiros anos de vida. Elas n&#227;o foram renovadas; apenas permaneceram preservadas. O que torna o cristalino um verdadeiro &#8220;arquivo biol&#243;gico&#8221; da hist&#243;ria metab&#243;lica do indiv&#237;duo.</p><p>Na perspectiva do Ray Peat, se uma fibra precisa permanecer transparente por tantas d&#233;cadas, por exemplo, oito d&#233;cadas, ela depende de um ambiente metab&#243;lico <em>extraordinariamente est&#225;vel</em>. Como ela perdeu o n&#250;cleo e as organelas, ela praticamente n&#227;o consegue reparar danos <em>por conta pr&#243;pria</em>. Sua integridade depende do epit&#233;lio e do ambiente bioqu&#237;mico ao seu redor.</p><p>&#201; por isso que Peat insistia tanto na import&#226;ncia da energia e da prote&#231;&#227;o contra processos oxidativos: n&#227;o porque essas fibras sejam constantemente substitu&#237;das, mas justamente porque elas <em>precisam ser preservadas por d&#233;cadas</em>.</p><p>E mais.</p><p>Embora as fibras antigas n&#227;o sejam renovadas, elas tamb&#233;m n&#227;o est&#227;o completamente &#8220;mortas&#8221;. Elas continuam sendo c&#233;lulas vivas em um sentido estrutural: mant&#234;m sua membrana, seu conte&#250;do proteico e trocam pequenas mol&#233;culas com as fibras vizinhas por meio de jun&#231;&#245;es comunicantes (<em>gap junctions</em>). Assim, glicose, antioxidantes como a glutationa e outros metab&#243;litos podem difundir-se do epit&#233;lio e das fibras mais superficiais para as fibras mais profundas.</p><p>De forma que seria mais correto dizer que novas fibras s&#227;o produzidas continuamente na periferia do cristalino; e as fibras antigas, especialmente as centrais, podem permanecer por toda a vida, sendo mantidas metabolicamente em vez de substitu&#237;das.</p><p>Esse &#233; mais um motivo pelo qual o cristalino &#233; um exemplo t&#227;o marcante da ideia que discutimos: a estrutura &#233; mantida ao longo do tempo por um metabolismo que a sustenta continuamente.</p><p>Todas as c&#233;lulas vivas possuem &#225;gua organizada, n&#227;o apenas o cristalino.</p><p>Gilbert Ling defendia que a maior parte da &#225;gua intracelular n&#227;o &#233; uma &#225;gua &#8220;livre&#8221;, como a &#225;gua de um copo. Ela est&#225; organizada pelas prote&#237;nas, formando um estado f&#237;sico diferente da &#225;gua comum. Para Ling, essa organiza&#231;&#227;o &#233; um aspecto fundamental da vida.</p><p>Pollack desenvolveu uma linha de pesquisa diferente mas congruente, mostrando experimentalmente que, junto a superf&#237;cies hidrof&#237;licas, a &#225;gua pode formar uma regi&#227;o altamente organizada, que ele chamou de &#8220;zona de exclus&#227;o&#8221; (Exclusion Zone, EZ). Embora a teoria completa de Pollack seja debatida e nem todas as suas interpreta&#231;&#245;es sejam amplamente aceitas, seus experimentos refor&#231;aram a ideia de que a &#225;gua pr&#243;xima a certas superf&#237;cies pode apresentar propriedades distintas da &#225;gua a granel.</p><p>Agora vem a diferen&#231;a do cristalino.</p><p>No cristalino, essa organiza&#231;&#227;o precisa atingir um grau extraordin&#225;rio.</p><p>Imagine dois tecidos:</p><p>No f&#237;gado, por exemplo, uma pequena desorganiza&#231;&#227;o molecular pode reduzir a efici&#234;ncia da c&#233;lula, mas a luz n&#227;o atravessa o &#243;rg&#227;o. No cristalino, qualquer pequena desorganiza&#231;&#227;o das prote&#237;nas ou da &#225;gua ao redor delas faz a luz se espalhar (dispers&#227;o da luz). O resultado &#233; perda de transpar&#234;ncia.</p><p>Ou seja, a &#225;gua estruturada existe em praticamente todas as c&#233;lulas, mas no cristalino <em>ela precisa permanecer uniformemente organizada em toda a lente</em>, porque sua fun&#231;&#227;o &#233; &#243;ptica.</p><p>Na perspectiva de Ray Peat, isso &#233; coerente com a ideia de que a energia mant&#233;m a organiza&#231;&#227;o molecular. Se o metabolismo diminui: as prote&#237;nas tendem a perder sua organiza&#231;&#227;o; a &#225;gua associada a elas tamb&#233;m perde parte de sua organiza&#231;&#227;o; a luz deixa de atravessar o cristalino de maneira uniforme; surge a catarata.</p><p>&#201; interessante notar que, embora Peat n&#227;o adotasse formalmente toda a teoria da <em>&#225;gua de exclus&#227;o</em> de Pollack, ele demonstrava grande interesse por trabalhos como os de Gilbert Ling e de Pollack porque todos apontavam para uma mesma dire&#231;&#227;o: a &#225;gua dentro dos tecidos vivos n&#227;o &#233; um solvente passivo; ela participa da organiza&#231;&#227;o da mat&#233;ria viva.</p><p>E uma s&#237;ntese disso tudo poderia ser: em todas as c&#233;lulas existe &#225;gua organizada. No cristalino, por&#233;m, essa organiza&#231;&#227;o precisa ser extraordinariamente uniforme e est&#225;vel, porque dela depende diretamente a transpar&#234;ncia da lente.</p><p>Qualquer perda significativa dessa organiza&#231;&#227;o torna-se imediatamente vis&#237;vel como opacifica&#231;&#227;o. Isso faz do cristalino um dos melhores exemplos de como a organiza&#231;&#227;o molecular e a fun&#231;&#227;o biol&#243;gica est&#227;o intimamente ligadas.</p><p>Foi explicado que as prote&#237;nas chamadas cristalinas permanecem ali durante d&#233;cadas. Muitas cristalinas do n&#250;cleo do cristalino s&#227;o consideradas algumas das prote&#237;nas mais longevas do organismo humano.</p><p>Isso explica por que a catarata &#233; t&#227;o dif&#237;cil de reverter: quando uma cristalina perde sua transpar&#234;ncia, n&#227;o existe uma renova&#231;&#227;o r&#225;pida dessas prote&#237;nas. O organismo depende principalmente de sistemas de prote&#231;&#227;o (como glutationa, NADPH, vitamina E, metabolismo energ&#233;tico adequado e manuten&#231;&#227;o do estado redox) para evitar que essas prote&#237;nas se danifiquem.</p><p>De tal forma, para Peat, que a catarata n&#227;o seria simplesmente um &#8220;envelhecimento inevit&#225;vel&#8221;, mas uma consequ&#234;ncia de anos de estresse metab&#243;lico, baixa produ&#231;&#227;o de energia, excesso de oxida&#231;&#227;o e perda da capacidade de manter aquelas prote&#237;nas antigas em seu estado corretamente dobrado e transparente. E &#233; justamente essa longevidade que torna a transpar&#234;ncia do cristalino um feito biol&#243;gico t&#227;o impressionante.</p><p>E sobre a reversibilidade. Para Peat, provavelmente imaginava que enquanto a prote&#237;na n&#227;o foi destru&#237;da de forma irrevers&#237;vel, o metabolismo poderia restaurar sua organiza&#231;&#227;o.</p><p>Uma prote&#237;na n&#227;o &#233; uma estrutura r&#237;gida e morta e sempre existe em um estado din&#226;mico, dependente de energia. E esse estado depende ou &#233; mantido continuamente por alta produ&#231;&#227;o de CO&#8322;; estado redutor (NADH/NADPH); glutationa reduzida; boa fun&#231;&#227;o mitocondrial; temperatura adequada; horm&#244;nios pr&#243;-metab&#243;licos, especialmente tireoide e progesterona em bons n&#237;veis.</p><p>Quando esse ambiente melhora, algumas prote&#237;nas parcialmente desnaturadas podem recuperar parte de sua conforma&#231;&#227;o normal. &#201; semelhante ao que acontece com outras prote&#237;nas celulares: nem toda desnatura&#231;&#227;o &#233; definitiva.</p><p>No caso da catarata depende de que a que ponto se chegou na desnatura&#231;&#227;o das prote&#237;nas cristalinas da regi&#227;o central do cristalino.</p><p>Haveria uma janela terap&#234;utica, por assim dizer.<span> </span>Nas fases iniciais da desnatura&#231;&#227;o uma melhora metab&#243;lica sustentada pode ter efeito positivo, de reverter o estrago. Sempre entendendo, na sua perspectiva, que <em>o CO2 &#233; o mais importante estabilizador das prote&#237;nas;</em> CO2 e progesterona.</p><p>De que forma se dariam tais interven&#231;&#245;es metab&#243;licas? Pela via da restaura&#231;&#227;o da fun&#231;&#227;o tireoidiana [suprimento de T3], boa oxida&#231;&#227;o da glicose, redu&#231;&#227;o do excesso de serotonina, de melatonina, de estrog&#234;nio, de &#243;leos poli-insaturados e recorrendo &#224; vitamina E, progesterona, da forma adequada e tamb&#233;m a outros fatores que diminuem o estresse oxidativo; talvez, especialmente nas fases iniciais, essa estrat&#233;gia poderia n&#227;o apenas retardar, mas em alguns casos produzir uma estabiliza&#231;&#227;o ou melhora parcial da transpar&#234;ncia do cristalino. Talvez esse seja o mais pr&#243;ximo do pensamento de R. Peat.</p><p>Certamente, para Peat, o cristalino n&#227;o &#233; um vidro inerte que vai &#8220;arranhando&#8221; com o tempo. E nem pode ser simplesmente definido com o r&#243;tulo de &#8220;envelhecimento&#8221; [embora seja, claro, uma <em>doen&#231;a ligada &#224; idade</em>].</p><p>Trata-se de um tecido vivo, embora extraordinariamente longevo, cuja transpar&#234;ncia depende da capacidade do organismo de fornecer energia <strong>continuamente</strong> para preservar a organiza&#231;&#227;o de prote&#237;nas que, em muitos casos, acompanham a pessoa por toda a vida. Assim como, por sua vez, a catarata &#233; uma doen&#231;a de natureza metab&#243;lica.</p><p>G Dantas, SP, 30-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><h6>Imagem:</h6><p></p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!D0BE!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!D0BE!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg" width="567" height="331" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:331,&quot;width&quot;:567,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:44585,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/213451694?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!D0BE!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6e7eb99b-bdeb-46ad-82da-46ceef68b5bb_567x331.jpeg 1456w" sizes="100vw" loading="lazy"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p></p><p><strong>Refer&#234;ncias:</strong></p><p>[A]<span> </span>PEAT, Ray, <span>Cataracts: water, energy, light, and aging <br></span><a href="https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml"><span>https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml</span></a></p><p>[B]<span> </span>PEAT Ray: <a href="https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml"><span>https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml</span></a></p><p>[C]<span> </span>Sobre anatomia do olho, v&#237;deo de uma oftalmologista &#8211; </p><div id="youtube2-mztpNNWZoh4" class="youtube-wrap" data-attrs="{&quot;videoId&quot;:&quot;mztpNNWZoh4&quot;,&quot;startTime&quot;:null,&quot;endTime&quot;:null}" data-component-name="Youtube2ToDOM"><div class="youtube-inner"><iframe src="https://www.youtube-nocookie.com/embed/mztpNNWZoh4?rel=0&amp;autoplay=0&amp;showinfo=0&amp;enablejsapi=0" frameborder="0" loading="lazy" gesture="media" allow="autoplay; fullscreen" allowautoplay="true" allowfullscreen="true" width="728" height="409"></iframe></div></div><p>[D]<span> </span>Outro v&#237;deo, mais curto, sobre anatomia do olho: </p><div id="youtube2-SiGLUvppKuI" class="youtube-wrap" data-attrs="{&quot;videoId&quot;:&quot;SiGLUvppKuI&quot;,&quot;startTime&quot;:null,&quot;endTime&quot;:null}" data-component-name="Youtube2ToDOM"><div class="youtube-inner"><iframe src="https://www.youtube-nocookie.com/embed/SiGLUvppKuI?rel=0&amp;autoplay=0&amp;showinfo=0&amp;enablejsapi=0" frameborder="0" loading="lazy" gesture="media" allow="autoplay; fullscreen" allowautoplay="true" allowfullscreen="true" width="728" height="409"></iframe></div></div><p>[E]<span> </span>LINHARES, S.; GEWANDSZNAJDER, F. <em>Biologia hoje</em>. Editora &#193;tica, S&#227;o Paulo, 2014.</p><p>[F]<span> </span>TORTORA, G. J.; GRABOWSKI, S. R. <em>Corpo humano: fundamentos de Anatomia e Fisiologia</em>. 6. Ed. Porto alegre: Artmed, 2006.</p><p>***</p>]]></content:encoded></item><item><title><![CDATA[CO2, exercício e ácido lático – nem sempre o exercício significa saúde [Parte 1 de 3]]]></title><description><![CDATA[Aumento de massa muscular pode n&#227;o ser exatamente sa&#250;de; e o tipo e o tempo do exerc&#237;cio importam &#8211; sendo que tudo isso pode ser entendido a partir do CO2 e &#225;cido l&#225;tico [lactato].]]></description><link>https://outramedicina2024.substack.com/p/co2-exercicio-e-acido-latico-nem</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/co2-exercicio-e-acido-latico-nem</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sat, 29 Aug 2026 19:42:43 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!fs8k!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!fs8k!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!fs8k!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg" width="507" height="380" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:380,&quot;width&quot;:507,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:28176,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/213321005?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!fs8k!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F14d71594-4a2f-4506-98a8-b80c3e7f3425_507x380.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>O nosso organismo fabrica g&#225;s carb&#244;nico todo o tempo.</p><p>Por conta de queimar o a&#231;&#250;car ininterruptamente, ao final deste processo &#233; sintetizado CO2. De tal forma que uma pessoa com boa sa&#250;de tem n&#237;veis altos, &#243;timos de CO2 no sistema, no plasma, nas c&#233;lulas e assim por diante.</p><p>E esse &#233; o estado esperado de bem-estar e de sa&#250;de.</p><p>Nesse contexto vejamos a quest&#227;o do exerc&#237;cio.</p><p>Quando a pessoa faz um exerc&#237;cio muscular, ela pode optar por fazer de uma forma que n&#227;o precise entrar em anaerobiose ou n&#227;o.</p><p>Ou seja, se ela fizer um exerc&#237;cio exaustivo, chegar&#225; um momento em que ela n&#227;o tem mais oxig&#234;nio para queimar plenamente o a&#231;&#250;car. Come&#231;a a &#8220;faltar ar&#8221;. Daquele ponto em diante, continuar com o exerc&#237;cio vai produzir &#225;cido l&#225;tico, ou seja, o corpo n&#227;o consegue, num exerc&#237;cio intenso e de longa dura&#231;&#227;o, manter a produ&#231;&#227;o &#243;tima de g&#225;s carb&#244;nico. Vai a lactato.</p><p>Em outras palavras: aqui faltou oxig&#234;nio e, automaticamente, o exerc&#237;cio se tornou <strong>anaer&#243;bico</strong>, e em consequ&#234;ncia o organismo come&#231;a a produzir &#8211; em certa medida - &#225;cido l&#225;tico, em vez de CO2.</p><p>Ent&#227;o a presen&#231;a de &#225;cido l&#225;tico &#233; inversamente proporcional &#224; exist&#234;ncia/s&#237;ntese do CO2.</p><p>&#8220;O &#225;cido l&#225;ctico na circula&#231;&#227;o &#233; um sinal de que a oxida&#231;&#227;o mitocondrial de glicose foi interrompida. O excesso de lactato promove inflama&#231;&#227;o, incha&#231;o celular, vasodilata&#231;&#227;o patol&#243;gica e inibe a fun&#231;&#227;o da tireoide. O exerc&#237;cio que produz &#225;cido l&#225;ctico &#233; um estressor que degrada a capacidade metab&#243;lica&#8221; [Ray Peat, <em>Lactic Acid vs. Carbon Dioxide</em>].</p><p>Isto &#233;, quanto mais o corpo durante o exerc&#237;cio come&#231;a a produzir &#225;cido l&#225;tico, isto &#233;, queimar o a&#231;&#250;car <em>apenas</em> at&#233; &#225;cido l&#225;tico, mais este se acumula e menos CO2 haver&#225; no sistema. Esse <em>status</em> &#233; perfeitamente aceit&#225;vel quando ele &#233; revertido rapidamente. Ou seja, num momento de fuga, de ataque ou de um exerc&#237;cio intenso que vai at&#233; determinado ponto e que cessa. Tudo isso depois pode ser perfeitamente revertido e o corpo volta ao estado inicial de produ&#231;&#227;o &#243;tima de CO2.</p><p>Tudo ter&#225; sido bem resolvido e equilibrado. Mas se a pessoa, [1&#186; ], faz corrida, exerc&#237;cios de longa dura&#231;&#227;o [anaer&#243;bicos, portanto]; ou [2&#186; ] ela faz exerc&#237;cios &#8211; academia, em modo anaer&#243;bico, por exemplo, com muita frequ&#234;ncia durante a semana, nos dois casos ela estar&#225; engajada em uma atividade [academia ou na corrida] que produz &#225;cido l&#225;tico, ou seja, ter&#225; feito exerc&#237;cio anaer&#243;bico por um tempo abusivo, e entrando nesse regime de produ&#231;&#227;o de &#225;cido l&#225;tico, a pessoa vai ficar com o metabolismo em alguma medida, comprometido.</p><p>Isso significa que depois daquele ponto em que em lugar do CO2, estar&#225; &#8211; em certa medida - sendo produzido &#225;cido l&#225;tico em alguma quantidade, essa pessoa n&#227;o ter&#225; <em>ganho metab&#243;lico</em>. Ela pode ter ganho muscular, pode ter ganho em condicionamento f&#237;sico, mas ter&#225; preju&#237;zo em termos de sa&#250;de metab&#243;lica. [Existem muitas doen&#231;as que s&#227;o mais comuns em atletas, por exemplo, como veremos na nota 3].</p><p>Ou seja, ela vai ter, se faz isso com frequ&#234;ncia ou continuamente, um n&#237;vel determinado de &#225;cido l&#225;tico presente no sangue. E a pessoa pode ter ainda dificuldade, de elimina&#231;&#227;o [<em>detox</em>] do &#225;cido l&#225;tico pelo f&#237;gado. Em outras palavras, ela vai entrar num estado de acidose, de produ&#231;&#227;o de &#225;cido l&#225;tico, que ser&#225; a <em>contraface</em> da falta de CO2. Isto &#233;, falta de CO2 se traduzir&#225; em produ&#231;&#227;o de &#225;cido l&#225;tico.</p><p>Em outras palavras, ela tem n&#237;veis de &#225;cido l&#225;tico no sangue porque <em>falta</em> CO2 no sistema. Ela n&#227;o tem um metabolismo &#243;timo, acabou de perder essa condi&#231;&#227;o.</p><p>Esta particular pessoa pode ser um atleta, pode ser uma pessoa que tem o h&#225;bito costumeiro da corrida, v&#225;rias vezes por semana e assim por diante; ou essa pessoa pode estar fazendo academia, muscula&#231;&#227;o exc&#234;ntrica por muito tempo, muitos minutos, para al&#233;m da aerobiose. [Exc&#234;ntrico &#233; o exerc&#237;cio que p&#245;e carga no m&#250;sculo em relaxamento].</p><p>E aqui ela tamb&#233;m ter&#225; um problema adicional [al&#233;m da produ&#231;&#227;o recorrente de &#225;cido l&#225;tico], que &#233;: o crescimento muscular provis&#243;rio, que ela ganha no exerc&#237;cio, pode ser doentio, pode ser apenas ac&#250;mulo de &#225;gua, inflama&#231;&#227;o.</p><p>S&#227;o duas situa&#231;&#245;es. Uma situa&#231;&#227;o em que o m&#250;sculo se constr&#243;i com exerc&#237;cio conc&#234;ntrico [e tamb&#233;m que n&#227;o v&#225; &#224; anaerobiose][L], uma boa situa&#231;&#227;o; mas tem outra situa&#231;&#227;o na qual o crescimento muscular n&#227;o &#233; sinal de sa&#250;de e sim, por exemplo, de edema. &#201; disso que n&#243;s vamos falar um pouco nesse artigo.</p><p>O pensamento de Peat &#233; de que &#8220;aquele mito comum de que, quando os m&#250;sculos doem, significa que est&#227;o crescendo e ficando mais fortes &#8212; essa cren&#231;a comum, na verdade, em geral, &#233; um mito&#8221; [Peat]</p><p>Aquelas dores podem ser do &#225;cido l&#225;tico, que at&#233; j&#225; pode ter desaparecido do sistema &#8211; eliminado pelo f&#237;gado &#8211; mas ficou edema, uma relativa les&#227;o, o dano persiste. &#8220;Esse dano envolve a perda de CO2, o que provoca a absor&#231;&#227;o de &#225;gua, o incha&#231;o e assim por diante; tanto o incha&#231;o quanto a les&#227;o fazem com que o m&#250;sculo aumente de tamanho, mas n&#227;o que se torne mais saud&#225;vel.</p><p>Esse &#233;, ali&#225;s, mais um equ&#237;voco comum. N&#243;s olhamos para os atletas ol&#237;mpicos e os imaginamos como os seres humanos com o melhor condicionamento f&#237;sico que existe, mas, na verdade, eles est&#227;o sob um estresse enorme ao realizar suas atividades.</p><p>Existem estudos mostrando que atletas muito bem treinados geralmente apresentam n&#237;veis elevados de &#225;cido l&#225;tico no sangue, mesmo dias <em>ap&#243;s</em> o &#250;ltimo treino. Eles acabam reduzindo seus n&#237;veis de di&#243;xido de carbono e se habituando a uma concentra&#231;&#227;o mais alta de &#225;cido l&#225;tico, o que traz efeitos nocivos a longo prazo&#8221; [A].</p><p>Com o tempo e com o h&#225;bito do exerc&#237;cio [do tipo inadequado] o &#225;cido l&#225;tico formado no esfor&#231;o muscular intenso impacta negativamente e, ainda por cima, condiciona o organismo a continuar produzindo lactato mesmo <em>depois</em> da atividade f&#237;sica.</p><p>Para Peat, o ponto n&#227;o &#233; simplesmente que o lactato permane&#231;a elevado no sangue por v&#225;rios dias ap&#243;s um treino isolado. O que ele enfatiza &#233; algo mais interessante: o treinamento extenuante repetido pode produzir uma altera&#231;&#227;o metab&#243;lica <em>persistente</em>, de modo que atletas muito treinados continuem produzindo lactato excessivamente &#8212; inclusive em repouso ou em exerc&#237;cios subsequentes &#8212; porque a pr&#243;pria capacidade respirat&#243;ria/oxidativa foi prejudicada.</p><p>Existe uma oposi&#231;&#227;o funcional e fisiol&#243;gica CO2-&#225;cido l&#225;tico. Seus efeitos s&#227;o opostos.</p><p>Metabolismo estressado [por exerc&#237;cio anaer&#243;bico ou estressante] leva a aumento de lactato, a inibi&#231;&#227;o da respira&#231;&#227;o oxidativa, mitocondrial.</p><p>Exerc&#237;cio intenso &#8211; anaer&#243;bico &#8211; est&#225; vinculado &#224; produ&#231;&#227;o de lactato e ao dano cumulativo da capacidade metab&#243;lica: &#8220;O exerc&#237;cio intenso danifica as c&#233;lulas de maneiras que prejudica o metabolismo de forma cumulativa&#8221; [Peat].</p><p>Para Peat, poucos minutos de exerc&#237;cio intenso [que chegue &#224; anaerobiose], pode levar &#224; redu&#231;&#227;o da atividade das enzimas envolvidas na oxida&#231;&#227;o da glicose.</p><p>E a longo prazo se instalar&#225; menor capacidade de restaurar plenamente o metabolismo; consequ&#234;ncia:<span> </span>no treino seguinte, ou mesmo em repouso, maior propens&#227;o a produzir lactato novamente.</p><p>Ou seja, n&#227;o seria necess&#225;rio imaginar que as mesmas mol&#233;culas de lactato produzidas na segunda-feira ainda estejam literalmente circulando na quinta-feira. O lactato sangu&#237;neo pode ser removido relativamente depressa. O problema, na interpreta&#231;&#227;o peatiana, &#233; que <em>o estado que o produziu</em> pode persistir.</p><p>&#201; diferente, portanto, a lactatemia transit&#243;ria do exerc&#237;cio da altera&#231;&#227;o persistente da capacidade metab&#243;lica. Peat observava que a atividade intensa pode levar a edema muscular: o m&#250;sculo fatigado pode reter muita &#225;gua e permanecer inchado mesmo <em>depois</em> de o f&#237;gado ter removido o lactato do sangue.</p><p>Em outras palavras</p><p>H&#225; duas coisas diferentes: uma &#233; o lactato circulante produzido pelo esfor&#231;o e que pode cair em horas. A outra &#233; que as consequ&#234;ncias celulares e metab&#243;licas do esfor&#231;o excessivo, anaer&#243;bico, podem persistir por muito mais tempo.</p><p>Esse ser&#225; o problema de atletas submetidos repetidamente a treinamento extenuante. Portanto, a atividade f&#237;sica anaer&#243;bica. [CONTINUA NA NOTA 2 DE 3]</p><p>G Dantas, SP, 29-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong>Notas</strong> ________</p><p>[A]<span> </span>R. Peat, 2010. <em>Altitude and CO2</em>,<span> </span>2010</p><p>[B]<span> </span>DAMAS f, 2016. &#8220;Early resistance training-induced increases in muscle cross-sectional area are concomitant with edema-induced muscle swelling <em>European Journal of Applied Physiology</em>, 2016. <a href="https://pubmed.ncbi.nlm.nih.gov/26280652/?utm_source=chatgpt.com">Abrir no PubMed</a></p><p>O pr&#243;prio t&#237;tulo j&#225; aponta que &#8220;os aumentos precoces da &#225;rea de sec&#231;&#227;o transversal muscular induzidos pelo treinamento de resist&#234;ncia ocorrem concomitantemente com aumento do volume muscular induzido por edema.&#8221;</p><p>O que eles fizeram</p><p>Acompanharam homens jovens n&#227;o treinados durante 10 semanas de muscula&#231;&#227;o, medindo:  <span>&#183; </span>&#225;rea de sec&#231;&#227;o transversal do m&#250;sculo vasto lateral; <span>&#183; </span>intensidade do sinal de ultrassom, usada como indicador indireto de edema; <span>&#183; </span>marcadores de dano muscular; <span>&#183; </span>for&#231;a; <span>&#183; </span>volume de treinamento.</p><p>O resultado &#233; muito interessante</p><p>Ap&#243;s 3 semanas, a &#225;rea muscular havia aumentado cerca de 2,7%.</p><p>Por&#233;m, nesse mesmo momento, os indicadores de edema por ultrassom aumentaram cerca de 17,2%. Al&#233;m disso, marcadores de dano muscular e interleucina-6 estavam elevados. A for&#231;a m&#225;xima volunt&#225;ria, por outro lado, ainda n&#227;o havia aumentado significativamente.</p><p>Os autores conclu&#237;ram que o aumento precoce da &#225;rea muscular n&#227;o era <em>puramente hipertrofia</em>, pois havia edema concomitante e esse edema provavelmente explicava uma propor&#231;&#227;o substancial do aumento aparente de tamanho. Eles chegam a dizer que aumentos precoces da &#225;rea muscular n&#227;o deveriam ser chamados simplesmente de hipertrofia sem alguma medida concomitante de edema ou dano muscular.</p><p>[C]<span> </span>NOSAKA K CLARKSON P M, 1996. <em>Changes in indicators of inflammation after eccentric exercise of the elbow flexors</em>. Med Sci Sports Exerc. 1996 Aug;28(8):953-61. doi: 10.1097/00005768-199608000-00003.  PMID: 8871903<span> </span>DOI: <a href="https://doi.org/10.1097/00005768-199608000-00003">10.1097/00005768-199608000-00003</a></p><p>Abstract</p><p>This study examined muscle swelling and changes in inflammatory markers in the blood following eccentric exercise-induced muscle damage. Subjects (N = 14) who had not been involved in a resistance training program performed 24 maximal eccentric actions of the elbow flexors. Muscle swelling was assessed by measures of the upper arm circumference (CIR), ultrasonography (USG), and magnetic resonance imaging (MRI). Plasma concentrations of interleukin-1 alpha, interleukin-1 beta, interleukin-2, interleukin-6, tumor necrosis factor-alpha, and plasma levels of C-reactive protein, cortisol, and zinc were analyzed. Established indicators of muscle damage (maximal isometric force, range of motion, muscle soreness, and plasma creatine kinase, aspartate aminotransferase, and lactate dehydrogenase activities) were also measured. All measures, including CIR and USG, except for MRI, were assessed immediately before and after and for 5 d post-exercise. MRI was taken at pre- and 1, 3, 6, 10, 23, 31, and 58 d post-exercise. All muscle damage indicators changed significantly after exercise. A large increase in CIR (&gt; 20 mm) was found 4-5 d after exercise, and this coincided with USG, showing an increase in muscle thickness. The echointensity of USG increased with the enlargement of the elbow flexors. MRI displayed enlargement of the biceps brachii and brachialis cross-sectional area that started at 1 d, and lasted until 23 d, post-exercise. The most profound increase in the enlargement and signal intensity of the MRI was found 3 or 6 d after exercise. However, none of the plasma levels of inflammatory makers showed significant muscle swelling, which is indicative of muscle edema, but the inflammatory responses after exercise appear to be different from those accompanying infection or tissue injury.</p><p>Esse estudo mostrou que ap&#243;s uma &#250;nica sess&#227;o de contra&#231;&#245;es exc&#234;ntricas m&#225;ximas, houve aumento do tamanho muscular por resson&#226;ncia magn&#233;tica que come&#231;ou ap&#243;s 1 dia e persistiu at&#233; 23 dias. O maior aumento de volume e sinal compat&#237;vel com edema ocorreu por volta de 3 a 6 dias ap&#243;s o exerc&#237;cio. Particularmente importante para a argumenta&#231;&#227;o acima: um m&#250;sculo pode permanecer maior durante dias ou at&#233; semanas como consequ&#234;ncia de edema p&#243;s-les&#227;o, e uma simples medida de circunfer&#234;ncia ou &#225;rea transversal pode confundir esse aumento com &#8220;crescimento muscular&#8221;.</p><p>E mais: uma revis&#227;o posterior do mesmo grupo prop&#244;s, para a fase inicial do treinamento, algo aproximadamente assim:</p><p>primeiras sess&#245;es de muscula&#231;&#227;o, dano muscular e incha&#231;o predominam;</p><p>depois de cerca de 10 sess&#245;es<br><span> </span>come&#231;a a surgir hipertrofia modesta; numa fase posterior, por volta de 18 sess&#245;es<br><span> </span>torna-se mais evidente a hipertrofia verdadeira.</p><p>Os pr&#243;prios autores ressaltam que <em>a interpreta&#231;&#227;o da hipertrofia nas primeiras semanas &#233; fortemente confundida pelo edema</em>.</p><p>[D]<span> </span>JEUKENDRUP A E VET-JOOP K STEGEN J H, 2000. <em>Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men.</em><strong> </strong>Clin Sci (Lond). 2000 Jan;98(1):47-55. PMID: 10600658 &#8220;The aim of the present study was to establish whether gastro-intestinal (GI) complaints observed during and after ultra-endurance exercise are related to gut ischaemia-associated leakage of endotoxins [lipopolysaccharide (LPS)] into the circulation and associated cytokine production. Therefore we collected blood samples from 29 athletes before, immediately after, and 1, 2 and 16 h after a long-distance triathlon for measurement of LPS, tumour necrosis factor-alpha and interleukin-6 (IL-6). As the cytokine response would trigger an acute-phase response, characteristic variables of these responses were also measured, along with creatine kinase (CK) to obtain an indicator of muscle damage. There was a high incidence (93% of all participants) of GI symptoms; 45% reported severe complaints and 7% of the participants abandoned the race because of severe GI distress. Mild endotoxaemia (5-15 pg/ml) was evident in 68% of the athletes immediately after the race, as also indicated by a reduction in IgG anti-LPS levels. In addition, we observed production of IL-6 (27-fold increase immediately after the race), leading to an acute-phase response (20-fold increase in C-reactive protein and 12% decrease in pre-albumin 16 h after the race). The extent of endotoxaemia was not correlated with the GI complaints or the IL-6 response, but did show a correlation with the elevation in C-reactive protein (r(s) 0.389; P=0.037). Creatine kinase levels were increased significantly immediately post-race, and increased further in the follow-up period. Creatine kinase levels did not correlate with those of either IL-6 or C-reactive protein. It is therefore concluded that LPS does enter the circulation after ultra-endurance exercise and may, together with muscle damage, be responsible for the increased cytokine response and hence GI complaints in these athletes&#8221;.</p><p>[E] PEDERSEN B K STEENSBERG A FISCHER C, 2001.<em> Exercise and cytokines with particular focus on muscle-derived IL-6</em><strong>. </strong>Exerc Immunol Rev. 2001:7:18-31.<strong> </strong>PMID: 11579746<strong> &#8220;</strong>Exercise induces increased circulating levels of a number of cytokines. Thus, increased plasma levels of tumour necrosis factor (TNF)-alpha, interleukin (IL-1) beta, IL-1 receptor antagonist (IL-1ra), TNF-receptors (TNF-R), IL-10, IL-8, and macrophage inflammatory protein (MIP)-1 are found after strenuous exercise. The concentration of IL-6 increases up to 100 fold after a marathon race. Recently, it has been demonstrated that IL-6 is produced locally in contracting skeletal muscles and that the net release from the muscle can account for the exercise-induced increase in arterial IL-6 concentration. IL-6 more than any other cytokine is produced in large amounts in response to exercise. It is produced locally in the skeletal muscle in response to exercise, and IL-6 is known to induce hepatic glucose-output and to induce lipolysis. This indicates that IL-6 may represent an important link between contracting skeletal muscles and exercise-related metabolic changes&#8221;.</p><p>[F] SUZUKI K NATAJI S YAMADA M, 2002. <em>Systemic inflammatory response to exhaustive exercise. Cytokine kinetics</em><strong>. </strong>Exerc Immunol Rev. 2002:8:6-48.<strong> </strong>PMID: 12690937<strong> &#8220;</strong>It has been documented that strenuous exercise not only <strong>induces pyrogenesis but also elicits mobilization and functional augmentation of neutrophils and monocytes whereas it suppresses cellular immunity leading to increased susceptibility to infections</strong>. As mediators of these phenomena, cytokines released into the circulation have been a recent focus of attention. Indeed, there are as many as one hundred original reports concerning exercise and cytokines, and half of them have been published in rapid succession from 2000, resulting in a tremendous accumulation of new knowledge within such a short term. The first aim of this review is to comprehensively summarize previous studies on systemic cytokine kinetics following exercise, with a special focus on reproducibility and quantitative comparison in human studies using specific immunoassays. Although tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta have traditionally been understood to be the main inducer cytokines of acute phase reactions, the majority of studies have shown that the circulating concentration of these cytokines is either unchanged following exercise, or exhibits relatively small, delayed increments. Plasma interferon (IFN)-alpha and IFN-gamma do not appear to change following exercise, whereas IL-2 decreases after endurance exercise. The small changes of these proinflammatory and immunomodulatory cytokines could well be mediated by anti-inflammatory cytokines such as IL-1 receptor antagonist (IL-1ra), IL-6 and IL-10 and cytokine inhibitors (cortisol, prostaglandin E2 and soluble receptors against TNF and IL-2), which are known to increase markedly in the circulation following endurance exercise. Moreover, it has been recently demonstrated that endurance exercise induces systemic release of granulocyte colony-stimulating factor (G-CSF), macrophage CSF (M-CSF), IL-8 and monocyte chemotactic protein 1 (MCP-1). Although the majority of available data have been obtained following prolonged exercise, it remains to be elucidated whether short-duration intensive exercise also causes rapid systemic cytokine release. In addition, there have been few studies that have simultaneously compared the extent of each cytokine response to exercise from a wider perspective. The second aim of this study was to examine possible changes of not only plasma but also urine concentrations of a broad spectrum of cytokines (16 kinds) following maximal exercise, including the time course of recovery. Although plasma TNF-alpha could not be detected throughout, it was present in urine 2 h after exercise. Plasma IL-1 beta rose significantly 2 h after exercise, but plasma IL-1 ra increased more rapidly and markedly than IL-1 beta, thus IL-1 bioactivity should be blocked at least in the circulation. Although there was only a trend toward increased plasma IL-6 concentrations after exercise, urine IL-6 rose significantly 1 h after exercise, indicating that IL-6 was released systemically but eliminated rapidly into the urine. Furthermore, it is shown for the first time that plasma and urine IL-4 concentrations were significantly elevated 2 h after exercise. Therefore, it is possible that anti-inflammatory cytokines might be released into the circulation as a regulatory mode of the cytokine network for adaptation against systemic inflammatory stress. Additionally, we have demonstrated that plasma concentrations of G-CSF, granulocytemacrophage CSF (GM-CSF), M-CSF, IL-8 and MCP-1 increased immediately after short-duration exercise and that the urine concentrations of these cytokines were much more pronounced than the changes observed in plasma. In conclusion, cytokines that are considered to induce systemic bioactivity following exercise are not only anti-inflammatory cytokines but also colony-stimulating factors and chemokines, which were secreted in an earlier phase of exercise without the kinetic involvement of traditional proinflammatory cytokines. Although the wider physiological and pathological implications are still not clearly understood, these cytokine kinetics may partly explain suppressed cell-mediated immunity and increased allergic reactions derived from a lower type-1 to type-2 cytokine ratio, along with mobilization and functional augmentation of neutrophils and monocytes. The sources and stimuli of cytokine production are not fully elucidated at present, but several hypotheses based on recent experimental evidence are discussed in this review herein&#8221;.</p><p>[G] CAVAILLON J M 1995. <strong>[</strong><em>Cytokines in inflammation</em><strong>]. </strong>C R Seances Soc Biol Fil. 1995;189(4):531-44. [Article in French] PMID: 8564567 &#8220;Numerous cytokines are present within inflammatory foci. Interleukin-1 (IL-1) and tumour necrosis factor (TNF) play a major role in coordinating mechanisms which command inflammation. Upon their action, many different cells produce lipidic mediators, proteolytic enzymes, and free radicals, all directly responsible for the noxious effects observed. IL-1 and TNF exert cytotoxic effects on vascular endothelium, cartilage, bone and muscle. Such cytokines as interferon-gamma, IL-3 or granulocyte-macrophage colony stimulating factor amplify the inflammatory response by increasing the production of IL-1 and TNF. The latest trigger the release of chemokines such as IL-8 and macrophage chemoattractant protein-1, the chemotactic activity of which participates in the recruitment of leukocytes within the foci of inflammation. IL-6, abounds in inflammatory processes and induces the production by hepatocytes of acute phase proteins. The same applies to IL-1, TNF, IL-11, the leucocyte inhibitory factor, and the transforming growth factor-beta. The later also processes a number of anti-inflammatory activities and, like IL-4, IL-10 and IL-13, can inhibit IL-1 and TNF production. Such property has also been mentioned for interferon-alpha. These anti-inflammatory cytokines can also counteract some of the IL-1 and TNF activities such as those reported during the coagulation process. Furthermore, these anti-inflammatory cytokines can induce the production of the IL-1 receptor antagonist which prevents the activities initiated by IL-1. Soluble TNF receptors, released during inflammation, are the direct inhibitors for TNF. Glucocorticoids, produced following a cascade of events initiated by IL-1, TNF and IL-6, involving the neuroendocrine axis, also inhibit proinflammatory cytokine productions. The concept of &#8220;cytokine network&#8221; therefore, perfectly illustrates the participation of these mediators in inflammation mechanisms&#8221;.</p><p>[H] PEDERSEN B K STEENSBERG A FISCHER C, 2004. <em>The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?</em><strong> </strong>Proc Nutr Soc. 2004 May;63(2):263-7. doi: 10.1079/PNS2004338. PMID: 15294041 DOI: <a href="https://doi.org/10.1079/pns2004338">10.1079/PNS2004338</a> &#8220;For most of the last century, researchers have searched for a muscle contraction-induced factor that mediates some of the exercise effects in other tissues such as the liver and the adipose tissue. It has been called the &#8216;work stimulus&#8217;, the &#8216;work factor&#8217; or the &#8216;exercise factor&#8217;. In the search for such a factor, a cytokine, IL-6, was found to be produced by contracting muscles and released into the blood. It has been demonstrated that IL-6 has many biological roles such as: (1) induction of lipolysis; (2) suppression of TNF production; (3) stimulation of cortisol production. The IL-6 gene is rapidly activated during exercise, and the activation of this gene is further enhanced when muscle glycogen content is low. In addition, carbohydrate supplementation during exercise has been shown to inhibit the release of IL-6 from contracting muscle. Thus, it is suggested that muscle-derived IL-6 fulfils the criteria of an exercise factor and that such classes of cytokines could be termed &#8216;myokines&#8221;.</p><p>[I] BONSIGNORE M R MORICI G RICCOBONO L, 2001. <em>Airway inflammation in nonasthmatic amateur runners. </em>Am J Physiol Lung Cell Mol Physiol. 2001 Sep;281(3):L668-76. doi: 10.1152/ajplung.2001.281.3.L668.<strong> </strong>PMID: 11504695<strong> </strong>DOI: <a href="https://doi.org/10.1152/ajplung.2001.281.3.l668">10.1152/ajplung.2001.281.3.L668</a> &#8220;Elite athletes show a high prevalence of symptoms and signs of asthma, but no study has assessed the acute effects of endurance exercise on airway cells in nonasthmatic athletes. We measured exhaled nitric oxide (NO) and collected samples of induced sputum after 3% NaCl aerosol administration for 20 min in nonasthmatic middle-aged amateur runners after the Fourth Palermo International Marathon and 6--9 wk later (habitual training period) at baseline. After the marathon, exhaled NO (n = 9 subjects) was higher [27 +/- 9 parts/billion (ppb)] than at baseline (12 +/- 4 ppb; P &lt; 0.0005). Polymorphonuclear neutrophil (PMN) counts in induced sputum were much higher in runners (91.2 +/- 3.6% of total cells postmarathon and 78.7 +/- 9.1% at baseline) than in sedentary control subjects (9.9 +/- 5.9%; P &lt; 0.001). Expression of L-selectin and CD11b/CD18 in sputum PMNs was lower after the race than at baseline and inversely related to the amount of exhaled NO (r = -0.66 and -0.69, respectively; P &lt; 0.05). Our data indicate that sputum PMNs are increased in nonasthmatic runners both after a marathon and at baseline and suggest that NO may modulate exercise-associated inflammatory airway changes&#8221;.</p><p>[J] HELENIUS I HAAHTELA T, 2000. <em>Allergy and asthma in elite summer sport athletes.</em><strong> </strong>J Allergy Clin Immunol. 2000 Sep;106(3):444-52. doi: 10.1067/mai.2000.107749. PMID: 10984362 DOI: <a href="https://doi.org/10.1067/mai.2000.107749">10.1067/mai.2000.107749</a> &#8220;Exercise may increase ventilation up to 200 L/min for short periods of time in speed and power athletes, and for longer periods in endurance athletes, such as long-distance runners and swimmers. Therefore highly trained athletes are repeatedly and strongly exposed to cold air during winter training and to many pollen allergens in spring and summer. <strong>Competitive swimmers inhale and microaspirate large amounts of air that floats above the water surface, which means exposure to chlorine derivatives from swimming pool disinfectants. In the summer Olympic Games, 4% to 15% of the athletes showed evidence of asthma or used antiasthmatic medication. Asthma is most commonly found in endurance events, such as cycling, swimming, or long-distance running. The risk of asthma is especially increased among competitive swimmers, of which 36% to 79% show bronchial hyperresponsiveness to methacholine or histamine. The risk of asthma is closely associated with atopy and its severity among athletes.</strong> A few studies have investigated occurrence of exercise-induced bronchospasm among highly trained athletes. The occurrences of exercise-induced bronchospasm vary from 3% to 35% and depend on testing environment, type of exercise used, and athlete population tested. Mild eosinophilic airway inflammation has been shown to affect elite swimmers and cross-country skiers. This eosinophilic inflammation correlates with clinical parameters (ie, exercise-induced bronchial symptoms and bronchial hyperresponsiveness). Athletes commonly use antiasthmatic medication to treat their exercise-induced bronchial symptoms. However, controlled studies on their long-term effects on bronchial hyperresponsiveness and airway inflammation in the athletes are lacking. Follow-up studies on asthma in athletes are also lacking. What will happen to bronchial hyperresponsiveness and airway inflammation after discontinuation of competitional career is unclear. In the future, follow-up studies on bronchial responsiveness and airway inflammation, as well as controlled studies on both short- and long-term effects of antiasthmatic drugs in the athletes are needed&#8221;.</p><p>[K] PEAT R, 2005. <em>Contexts for asthma</em>. R P&#180;s Newsletter, march 2005</p><p>[L]<span> </span>Exerc&#237;cio conc&#234;ntrico &#233; o que se faz colocando carga enqto se contrai o m&#250;sculo</p><p>***</p>]]></content:encoded></item><item><title><![CDATA[Como vive o cristalino do olho, se não tem vascularização? O cristalino e a “transparência da vida”. [Parte 2 de 3]]]></title><description><![CDATA[S&#201;RIE DE NOTAS sobre catarata-glaucoma-fisiologia do olho [Nota 1 de 8 ].]]></description><link>https://outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-se-d8b</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-se-d8b</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Thu, 27 Aug 2026 15:26:03 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!apWY!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<p>Parte 2 de 3<span> </span>[Continua&#231;&#227;o da <a href="/__u/outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-se">Parte 1</a>]</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!apWY!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!apWY!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg" width="509" height="320" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:320,&quot;width&quot;:509,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:20710,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/213002297?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!apWY!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F92e662df-15d5-484f-8847-724b7cad9879_509x320.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>A energia mant&#233;m a c&#233;lula existindo na condi&#231;&#227;o de estrutura organizada. Isso &#233; bem diferente, sutilmente diferente, da vis&#227;o comum, de que a estrutura <em>gera</em> o metabolismo, como se a estrutura viesse <em>primeiro</em> e o metabolismo a utilizasse. Explicamos isso em outra nota: n&#227;o se trata da mesma rela&#231;&#227;o combust&#237;vel-autom&#243;vel.</p><p>Em Peat, o metabolismo <em>mant&#233;m</em> a estrutura. Ou melhor, a estrutura &#233; um estado de equil&#237;brio din&#226;mico sustentado continuamente pela energia.</p><p style="text-align: right;"><em>A lente do cristalino n&#227;o fica transparente porque foi constru&#237;da como estrutura transparente h&#225; d&#233;cadas atr&#225;s. Ela continua transparente porque a cada instante, <strong>a cada milissegundo,</strong> o epit&#233;lio mant&#233;m as condi&#231;&#245;es metab&#243;lico-energ&#233;ticas para que as prote&#237;nas permane&#231;am organizadas</em>.</p><p>A energia, biologicamente falando, &#233; como aquela tens&#227;o que mant&#233;m uma tenda armada, ou um redemoinho em movimento. Enquanto a tens&#227;o, o movimento existir, a tenda permanece de p&#233;, o redemoinho existe. Se a tens&#227;o, a energia ou o fluxo desaparecer, n&#227;o &#233; apenas o movimento que cessa, <em>a pr&#243;pria estrutura colapsa</em>.</p><p>Da&#237;, em todos os temas e abordagens de Peat, aparece essa permanente ideia bioenerg&#233;tica. A energia mant&#233;m a organiza&#231;&#227;o das prote&#237;nas, a transpar&#234;ncia do cristalino, a diferencia&#231;&#227;o celular, a difus&#227;o seletiva para dentro e fora da c&#233;lula de materiais.</p><p>E a pr&#243;pria &#8220;sele&#231;&#227;o&#8221; que &#233; feita pelo epit&#233;lio do cristalino de que subst&#226;ncias quer concentrar ou n&#227;o [a exemplo da vitamina C que est&#225; muito mais concentrada ali, no l&#237;quido que banha o cristalino do que em outros tecidos do corpo].</p><p>Por<span> </span>outro lado, toda vez que a energia cai, o organismo, a c&#233;lula, entrar&#227;o em um modo de emerg&#234;ncia, sacrificando a organiza&#231;&#227;o para sobreviver. Por exemplo, gerando cortisol que vai consumir m&#250;sculos e materiais da c&#233;lula para gerar a&#231;&#250;car, para garantir alguma energia [ver nota recente sobre o cortisol neste blog].</p><p>De forma que estamos &#8211; na g&#234;nese da catarata &#8211; diante de um princ&#237;pio unificador da biologia do corpo humano, t&#237;pico de Peat, que continua Ling, e que &#233; de uma coer&#234;ncia not&#225;vel.</p><p>E &#233; tamb&#233;m por isso que as diferentes abordagens do corpo humano da medicina oficial, e a espec&#237;fica do cristalino em especial, s&#227;o varia&#231;&#245;es sobre o mesmo tema, no sentido de que tendem a perder o foco. E nem sempre se d&#227;o conta de que <em>a vida &#233; a manuten&#231;&#227;o ativa da ordem atrav&#233;s do fluxo de energia constante.</em></p><p>Uma ordem que n&#227;o &#233; est&#225;tica, tem que ser renovada, reciclada continuamente pelo metabolismo. Essa ideia torna-se o pressuposto que definir&#225; uma estrat&#233;gia terap&#234;utica, como j&#225; foi mencionado.</p><p>E tudo isso, permite enxergar o corpo como uma totalidade em movimento, que &#233; a pura express&#227;o de que a l&#243;gica de funcionamento do nosso organismo &#233; dial&#233;tica. N&#227;o &#233; linear, formal e nem reducionista.</p><p style="text-align: right;"><em>E &#233; a falta dessa l&#243;gica, ou a substitui&#231;&#227;o da vis&#227;o dial&#233;tica pelo reducionismo, pelo formalismo, que faz com que a medicina moderna e a biologia carreguem um grave problema l&#243;gico: entendem o corpo humano, basicamente, como uma soma de partes. Um elemento que, portanto, caracteriza a biologia moderna e, na sequ&#234;ncia, a medicina, &#233; o empobrecimento da percep&#231;&#227;o da biologia humana.</em></p><p>Vejamos a quest&#227;o da &#225;gua dentro do cristalino. Quando a c&#233;lula &#233; fisiologicamente normal no corpo humano, sua &#225;gua &#233; <em>estruturada</em>, n&#227;o &#233; igual a &#225;gua de torneira, n&#227;o se trata de mol&#233;culas livres de &#225;gua.</p><p>Gerald Pollack j&#225; analisou sobre isso, e Peat o leva muito em conta. A maior parte da &#225;gua intracelular, ele dizia, n&#227;o &#233; &#225;gua livre como a &#225;gua que vem no copo. Ela est&#225; organizada pelas prote&#237;nas, formando um estado f&#237;sico diferente da &#225;gua comum. E essa organiza&#231;&#227;o da &#225;gua, essa ordem, &#233; um aspecto fundamental da vida. E da transpar&#234;ncia do cristalino.</p><p>E Pollack mostrou, pesquisando experimentalmente, que superf&#237;cies &#8211; como a das prote&#237;nas - podem ser hidrof&#237;licas, ou seja, que a &#225;gua adere a elas, &#224;s superf&#237;cies, e ali se forma uma regi&#227;o altamente organizada que ele chama <em>zona de exclus&#227;o</em>. Dessa forma, a &#225;gua, quando pr&#243;xima a certas superf&#237;cies, apresenta propriedades distintas da &#225;gua a granel.</p><p>No cristalino, essa organiza&#231;&#227;o precisa alcan&#231;ar um grau extraordin&#225;rio. Por qu&#234;? Porque em outros tecidos a luz n&#227;o os atravessa necessariamente, mas no cristalino, que &#233; atravessado pela luz, qualquer pequena desorganiza&#231;&#227;o das prote&#237;nas ou da &#225;gua ao redor delas faz a luz se espalhar. Rouba a transpar&#234;ncia natural do cristalino.</p><p>Resultado da perda de transpar&#234;ncia: catarata. Ou seja, a &#225;gua estruturada existe em todas as c&#233;lulas, mas no cristalino ela precisa <em>permanecer uniformemente organizada em toda a lente,</em> porque sua fun&#231;&#227;o &#233; &#243;ptica. N&#227;o &#233; como as c&#233;lulas da pele, do f&#237;gado ou do p&#226;ncreas.</p><p>E aqui, novamente, a coer&#234;ncia te&#243;rica de Peat diz que a energia mant&#233;m a organiza&#231;&#227;o molecular; isto &#233;, se o metabolismo for inibido, as prote&#237;nas tendem a perder sua organiza&#231;&#227;o. A &#225;gua associada a elas tamb&#233;m perde parte de sua organiza&#231;&#227;o. Certamente em um processo de longo prazo. Que n&#227;o ser&#225; enxergado assim pela narrativa oficial que vai substituir essa explica&#231;&#227;o por &#8220;envelhecimento&#8221;.<span> </span>A ideia de tempo - como um r&#243;tulo - entra, miseravelmente, no lugar da explica&#231;&#227;o biol&#243;gica.</p><p>De forma, como j&#225; foi mencionado, que a &#225;gua, dentro dos tecidos <em>vivos</em>, n&#227;o &#233; um solvente passivo, ela <strong>participa da organiza&#231;&#227;o da mat&#233;ria viva</strong>.</p><p>Portanto, a c&#233;lula, diferentemente do que a gente aprende na escola ou na faculdade de medicina, n&#227;o &#233; uma bolsa de solutos ou organelas funcionando com uma &#225;gua qualquer e assim por diante. N&#227;o &#233;. Em outras palavras: a &#225;gua que bebemos normalmente, esta n&#227;o &#233; a &#225;gua da c&#233;lula.</p><p>Por outro lado, considerando que o cristalino &#233; um tecido altamente exigente de energia e muito fr&#225;gil, comparado com outros, &#233; de se esperar que uma pessoa longeva, portadora de doen&#231;a cr&#244;nico-degenerativa tender&#225;, simultaneamente, a ter o cristalino em algum grau de degenera&#231;&#227;o.</p><p>Mas n&#227;o porque o cristalino envelhece por programa&#231;&#227;o, por <em>default</em>, ou por idade cronol&#243;gica, mas porque &#233; um dos tecidos mais sens&#237;veis que existem no corpo &#224; perda cr&#244;nica da capacidade metab&#243;lica. Ele depende criticamente de um epit&#233;lio local metabolicamente ativo.</p><p>Suas fibras centrais, suas prote&#237;nas, precisam permanecer organizadas por d&#233;cadas e d&#233;cadas, sem capacidade de repara&#231;&#227;o. Ent&#227;o, qualquer perda persistente da produ&#231;&#227;o de energia vai se manifestar ali como um estresse, com perda da opacidade. &#201; muito raro, mas alguns bons h&#225;bitos de estilo de vida de certas pessoas por d&#233;cadas, permitem que seu cristalino se preserve por mais tempo [contrariando a l&#243;gica &#8220;da idade&#8221;].</p><p>No entanto, quando se instala a doen&#231;a cr&#244;nico-degenerativa, aqui sim, por si s&#243;, isso j&#225; sugere que o metabolismo est&#225; [e esteve] comprometido de forma sist&#234;mica e j&#225; faz tempo.</p><p>E novamente: claro que se o organismo inteiro est&#225; tendo dificuldade em manter sua organiza&#231;&#227;o, &#233; plaus&#237;vel esperar que um tecido t&#227;o exigente como o cristalino tamb&#233;m apresente algum grau de catarata [perda de transpar&#234;ncia].</p><p>Isso quer dizer que, portanto, os tecidos mais dependentes de um metabolismo eficiente s&#227;o os <em>primeiros</em> a revelar quando a produ&#231;&#227;o de energia deixa de ser suficiente.</p><p>Al&#233;m do cristalino, que &#233; especial, h&#225; tamb&#233;m o exemplo da retina, do c&#233;rebro, do cora&#231;&#227;o. Eles todos dependem de uma organiza&#231;&#227;o extremamente sofisticada, refinada, e a perda cr&#244;nica de energia tende a impactar mais evidentemente essas estruturas.</p><p style="text-align: right;"><em>Ent&#227;o, em tudo isso, &#233; claro, ou fica claro, que o cristalino funciona como um marcador, um indicador metab&#243;lico, por conta de que sua transpar&#234;ncia depende da manuten&#231;&#227;o cont&#237;nua de uma organiza&#231;&#227;o molecular extremamente delicada das suas prote&#237;nas e da sua &#225;gua. Portanto &#8211; como foi dito mais de uma vez - depende de um fluxo de energia permanente, de vida inteira.</em></p><p>Em todas as c&#233;lulas existe &#225;gua organizada, sendo que no cristalino, a organiza&#231;&#227;o precisa ser extraordinariamente est&#225;vel, uniforme, porque disso &#8211; como foi mais de uma vez explicado - depende a transpar&#234;ncia da lente.</p><p>Perda de organiza&#231;&#227;o rima como opacifica&#231;&#227;o.</p><p>Em uma regi&#227;o do cristalino onde est&#225; o epit&#233;lio, que &#233; a regi&#227;o equatorial, sempre estar&#225; sendo poss&#237;vel produzir novas fibras. Essas novas fibras v&#227;o se somando na periferia do cristalino, formando o c&#243;rtex, e a&#237; as fibras centrais s&#227;o empurradas, s&#227;o pressionadas ali, e podem permanecer por toda a vida. Ent&#227;o, na pessoa de idade avan&#231;ada, algumas das suas fibras localizadas no centro do cristalino, podem ter sido produzidas ainda quando ele era feto, nos primeiros anos de vida, ficam ali preservadas.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!H_a_!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!H_a_!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg" width="265" height="265" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/a9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:265,&quot;width&quot;:265,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:14253,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/213002297?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!H_a_!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa9d79197-4e73-4fdd-84ec-f963efe7c36f_265x265.jpeg 1456w" sizes="100vw" loading="lazy"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Temos, no cristalino, milhares de c&#233;lulas altamente alongadas, que alguns chamam de <em>fibras do cristalino</em>, que se organizam em camadas conc&#234;ntricas, como se fosse uma cebola, compondo a estrutura final do cristalino. Cada nova camada de fibras &#233; produzida ao longo da vida. As mais novas ficam na periferia, as mais antigas empurradas para o centro, formando o n&#250;cleo do cristalino.</p><p>De forma que ele cresce continuamente, n&#227;o descarta c&#233;lulas. E isso torna o papel do epit&#233;lio do cristalino anterior mais importante ainda, j&#225; que as fibras, mais maduras, mesmo sendo normais, t&#234;m capacidade metab&#243;lica limitad&#237;ssima. O que mant&#233;m o ambiente energ&#233;tico adequado para garantir a transpar&#234;ncia &#233; o epit&#233;lio, do cristalino, que recebe o influxo l&#237;quido do humor aquoso.</p><p>Em outras palavras, as fibras s&#227;o a estrutura &#243;ptica, o epit&#233;lio &#233; o centro, a usina de manuten&#231;&#227;o metab&#243;lica que preserva essa estrutura ao longo da vida. Ent&#227;o ele &#233; feito quase inteiramente por c&#233;lulas vivas altamente especializadas, transformadas em uma lente biol&#243;gica de extraordin&#225;ria transpar&#234;ncia, mantida por energia que vem de fora.</p><p>De tal maneira que o cristalino &#233; um verdadeiro arquivo biol&#243;gico da hist&#243;ria metab&#243;lica do indiv&#237;duo, e um reflexo, a cada d&#233;cada, de qu&#227;o degradado estar&#225; o metabolismo, ou do ac&#250;mulo de estresse que vai caracterizando determinadas d&#233;cadas da vida.</p><p>De toda forma, eis a&#237; como as formula&#231;&#245;es anteriores ganham significado especial. Se as fibras precisam permanecer transparentes por tanto tempo, isso depende integralmente de um ambiente metab&#243;lico extraordinariamente est&#225;vel.</p><p>Finalmente, do ponto de vista conceitual, &#233; interessante entender que nessa an&#225;lise do cristalino, teve papel primordial <em>o ambiente</em>. Aqui n&#227;o se falou em gen&#233;tica. Ent&#227;o, para a Peat, duas pessoas da mesma idade podem ter cristalinos muito diferentes, n&#227;o porque herdaram genes diferentes, mas porque &#8211; como regra - <em>viveram hist&#243;rias metab&#243;licas diferentes, distintos estilos de vida</em>.</p><p>Uma delas, por exemplo, manteve a fun&#231;&#227;o tireoidiana boa ou razo&#225;vel, teve menor exposi&#231;&#227;o ao estresse cr&#244;nico, aos &#243;leos poli-insaturados, ao ferro, ao &#225;lcool, &#224; serotonina, manteve uma <em>melhor</em> produ&#231;&#227;o de CO2, teve menos n&#237;veis de peroxida&#231;&#227;o lip&#237;dica, ou consumiu muito menos &#243;leos poli-insaturados, e, portanto, preservou por mais tempo a organiza&#231;&#227;o das prote&#237;nas do cristalino.</p><p>Ent&#227;o, isso &#233; consistente com um princ&#237;pio que atravessa esse texto, que &#233;, o de que o organismo carrega a hist&#243;ria do seu metabolismo. E o cristalino talvez seja o melhor exemplo disso. Talvez, porque suas fibras permanecem ali por d&#233;cadas. Ent&#227;o, elas acabam registrando, tatuando, por assim dizer, a qualidade do ambiente metab&#243;lico em aquele indiv&#237;duo singular viveu.</p><p>Todos os nutrientes que favorecerem a fun&#231;&#227;o metab&#243;lica e a produ&#231;&#227;o de energia v&#227;o favorecer o cristalino. Porque, na vis&#227;o de Peat, o cristalino sofre catarata n&#227;o porque faltou um antioxidante. Seria uma explica&#231;&#227;o simplista. Mas por conta de que <em>o metabolismo n&#227;o est&#225; sendo capaz de sustentar a energia que o cristalino demanda,</em> incluindo o sistema antioxidante, que inclui, por exemplo, a glutationa.</p><p>Por outro lado, por exemplo, um nutriente como a riboflavina, a B2 opera a favor do cristalino; ao favorecer a regenera&#231;&#227;o da glutationa, melhorar a produ&#231;&#227;o de energia, essa vitamina permite que o epit&#233;lio continue preservando o estado organizado das fibras. Ent&#227;o n&#227;o se trata estritamente da prote&#231;&#227;o direta de um nutriente, poderia ser B2 ou B3, ou magn&#233;sio, mas sim o fato de que tais nutrientes protegem <em>o metabolismo do epit&#233;lio</em>.</p><p>Essa concep&#231;&#227;o entende que o metabolismo do epit&#233;lio &#233; que mant&#233;m o cristalino transparente, assim como a adequada produ&#231;&#227;o do humor aquoso. Ent&#227;o, raramente seria correto, e n&#227;o &#233; correto at&#233; o fim, analisar uma vitamina isoladamente. Em outras palavras: as subst&#226;ncias que favore&#231;am o cristalino o fazem porque aumentam a capacidade da c&#233;lula de produzir energia.</p><p>E essa &#233; a pergunta-chave de Peat, quando vai organizar qualquer estrat&#233;gia terap&#234;utica. Como tal medida aumentar&#225; a capacidade da c&#233;lula de produzir energia?</p><p>Dessa pergunta, dessa estrat&#233;gia, emergem elementos favor&#225;veis &#224; manuten&#231;&#227;o da transpar&#234;ncia do cristalino. Que seria, ao final, um desdobramento natural do metabolismo preservado.</p><p style="text-align: right;"><em>Enquanto a maioria das prote&#237;nas do corpo &#233; degradada, &#233; substitu&#237;da em horas, dias, semanas, as cristalinas precisam continuar no mesmo lugar por muitas dezenas de anos sem perder a organiza&#231;&#227;o.</em></p><p>Por isso que elas s&#227;o caracterizadas por alt&#237;ssima estabilidade, pretendem durar muito tempo, permanecem dissolvidas em concentra&#231;&#245;es enormes sem precipitar, com organiza&#231;&#227;o extremamente uniforme; e elas ficam distribu&#237;das de forma t&#227;o regular, t&#227;o exatamente regular, que praticamente n&#227;o espalham a luz.</p><p>As cristalinas n&#227;o s&#227;o extraordin&#225;rias porque nunca se alteram, e sim porque conseguem permanecer organizadas por longo tempo, mas sempre <em>desde que o metabolismo consiga sustent&#225;-las.</em></p><p>Ent&#227;o s&#227;o prote&#237;nas cuja fun&#231;&#227;o, diferentemente de outras, n&#227;o &#233; realizar uma rea&#231;&#227;o qu&#237;mica; ou ser anabolizada ou catabolizada, e sim permanecer perfeitamente organizada e transparente por toda a vida. Essa &#233; a diferen&#231;a central da prote&#237;na do cristalino em rela&#231;&#227;o &#224;s demais. Nesse caso, se poderia dizer, que o cristalino &#233; uma esp&#233;cie de &#8220;experimento&#8221; da natureza sobre a capacidade do metabolismo de preservar a ordem molecular ao longo do tempo, de muito tempo.</p><p>Elas vivem por d&#233;cadas e d&#233;cadas e &#8211; novamente - precisam permanecer organizadas, finamente organizadas por d&#233;cadas. Como foi explicado, quem fornece energia necess&#225;ria para essa manuten&#231;&#227;o &#233; o epit&#233;lio, que est&#225; Imerso no seio do metabolismo do corpo. E a transpar&#234;ncia &#233; a manifesta&#231;&#227;o mais vis&#237;vel dessa ordem.</p><p style="text-align: right;"><em>Por isso, o cristalino &#233; uma evid&#234;ncia da ideia central de Peat, que a energia mant&#233;m a ordem molecular, a energia &#233; que mant&#233;m a fun&#231;&#227;o. Quando h&#225; energia suficiente, a ordem &#233; preservada. Quando a energia deixa de sustentar essa ordem, as prote&#237;nas perdem a sua transpar&#234;ncia, a luz se dispersa e aparece a catarata.</em></p><p>De tal forma que, na perspectiva de Peat, o cristalino n&#227;o &#233; uma <em>pedra</em>, um cristal transparente, &#233;, sim, um tecido vivo que depende <em>continuamente</em> de um fluxo de energia para manter sua organiza&#231;&#227;o.</p><p>Ent&#227;o, &#233; diferente de pensar que a catarata acontece porque as prote&#237;nas <em>envelhecem</em>. N&#227;o &#233; a vis&#227;o dele. Peat est&#225; mais pr&#243;ximo da seguinte ideia. As prote&#237;nas <em>envelhecem</em> porque o metabolismo, cronicamente, por d&#233;cadas, deixou de fornecer a energia necess&#225;ria, ao longo do tempo, para mant&#234;-las organizadas.</p><p>Em outras palavras, a estrutura n&#227;o &#233; separada da energia, &#233; <em>mantida</em> pela energia.</p><p>Bem semelhante &#224;quela imagem do redemoinho, que &#233; mantido pelo fluxo da &#225;gua do rio, e se o movimento do rio cessa, o redemoinho se desfaz, perde a organiza&#231;&#227;o.</p><p>A palavra <em>fibra</em>: quando os livros dizem que o cristalino &#233; constru&#237;do de <em>fibras</em>, esta &#233; um tanto inapropriada porque induz ao erro. N&#227;o &#233; a mesma coisa que fibra muscular nervosa. Simplesmente, no caso do cristalino, se trata de uma c&#233;lula muito alongada e muito singular.</p><p>As fibras do cristalino s&#227;o c&#233;lulas que come&#231;am a se diferenciar a partir de uma zona do cristalino, se alongam cada vez mais, tornam-se extremamente compridas e finas. Perdem o n&#250;cleo, as mitoc&#244;ndrias, praticamente a maioria das organelas. E justamente <em>pela c&#233;lula do cristalino n&#227;o ter n&#250;cleo e outras organelas, &#233; que deixa passar luz de forma transparente, garante a transpar&#234;ncia.</em></p><p>Ent&#227;o elas s&#227;o, para dar uma imagem apenas, sacos transparentes preenchidos quase inteiramente por prote&#237;nas cristalinas, organizadas de forma rigorosamente regular e com a &#225;gua em torno delas, &#225;gua organizada de forma ativa.</p><p>E como a parte central do cristalino n&#227;o possui mais n&#250;cleo, nem organelas ele n&#227;o conseguiria reparar danos por conta pr&#243;pria. Sua integridade, sua n&#227;o-opacidade, depende do epit&#233;lio, do ambiente qu&#237;mico em redor do epit&#233;lio e do contexto biol&#243;gico do corpo e do metabolismo do organismo no qual est&#225; inserido o olho e aquele epit&#233;lio por tabela.</p><p>E como foi j&#225; explicado, n&#227;o se trata de fibras constantemente substitu&#237;das como ocorre em tecidos conjuntivos. Tamb&#233;m n&#227;o est&#227;o completamente mortas, n&#227;o s&#227;o cristais. Continuam sendo c&#233;lulas vivas no sentido estrutural. Mant&#234;m o estado &#243;ptico, a estrutura, e a membrana e o conte&#250;do proteico, e trocam mol&#233;culas e energia com as fibras vizinhas por meio de jun&#231;&#245;es, e de forma que glicose, glutationa, que &#233; o maior antioxidante do corpo, e outros metab&#243;litos podem se difundir do epit&#233;lio das fibras mais superficiais para as fibras mais profundas.</p><p>De forma que &#233; como se no cristalino existissem dois esferas, dois mundos. O &#243;ptico, formado pelas fibras, cuja fun&#231;&#227;o &#233; transmitir e focalizar luz, movida pela musculatura ciliar. E o mundo metab&#243;lico &#233; formado pelo epit&#233;lio, cuja fun&#231;&#227;o &#233; produzir energia, sintetizar novas prote&#237;nas, preservar a organiza&#231;&#227;o das fibras, oferecendo energia.</p><p>&#201; uma divis&#227;o do trabalho. Mas na qual a estrutura n&#227;o se mant&#233;m sozinha. Ela &#233; sustentada continuamente pela energia, pela bioenergia ofertada pelo metabolismo. Isso, esse processo, no caso do cristalino, fica simplesmente did&#225;tico.</p><p style="text-align: right;"><em>Ent&#227;o, para Peat, o cristalino &#233; uma bela ilustra&#231;&#227;o da transpar&#234;ncia da vida, por assim dizer, e de um princ&#237;pio que ele aplicava ao organismo inteiro. A forma depende da energia. Quando o metabolismo declina, a estrutura deixa de conseguir preservar a sua organiza&#231;&#227;o e come&#231;a a degradar. No cristalino, isso &#233; muito patente, e a tradu&#231;&#227;o disso &#233; a catarata.</em></p><p>Portanto, na vis&#227;o de Peat, quando a produ&#231;&#227;o de energia do epit&#233;lio diminui, as prote&#237;nas das fibras deixam de manter sua organiza&#231;&#227;o e come&#231;am a formar agregados, levando progressivamente &#224; catarata.</p><p>O cristalino &#233; uma das estruturas mais extraordin&#225;rias do corpo humano justamente porque &#233; transparente, praticamente avascular, mas tamb&#233;m extremamente rico em prote&#237;nas, como nenhum outro tecido. Possui aproximadamente 35% de prote&#237;nas &#233; uma propor&#231;&#227;o enorme. A maioria dos tecidos do corpo tem muito menos prote&#237;na por unidade de volume.</p><p>Essas prote&#237;nas recebem, como foi dito, um nome especial: cristalinas (<em>crystallins</em>). Elas representam cerca de 90% das prote&#237;nas do cristalino e s&#227;o divididas em tr&#234;s fam&#237;lias principais:<span> </span>&#945;-cristalinas<span> </span>&#946;-cristalinas<span> </span>&#947;-cristalinas</p><p>As &#945;-cristalinas t&#234;m uma fun&#231;&#227;o particularmente interessante: al&#233;m de fazerem parte da estrutura, elas funcionam como pequenas &#8220;prote&#237;nas protetoras&#8221; (<em>chaperonas</em>), impedindo que outras prote&#237;nas se agreguem e percam a transpar&#234;ncia.</p><p>Al&#233;m das prote&#237;nas e da &#225;gua, existe uma pequena quantidade de eletr&#243;litos (pot&#225;ssio, s&#243;dio, magn&#233;sio etc.); ATP e outras mol&#233;culas relacionadas ao metabolismo; antioxidantes, especialmente glutationa, que protege aquelas prote&#237;nas contra oxida&#231;&#227;o.</p><p>[continua na parte 3 de 3]</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p></p><p><strong>Refer&#234;ncias:_______________</strong></p><p>[A]<span> </span>PEAT, Ray, <span>Cataracts: water, energy, light, and aging <br></span><a href="https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml"><span>https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml</span></a></p><p>[B]<span> </span>  Sobre anatomia do olho, v&#237;deo de uma oftalmologista &#8211; </p><div id="youtube2-mztpNNWZoh4" class="youtube-wrap" data-attrs="{&quot;videoId&quot;:&quot;mztpNNWZoh4&quot;,&quot;startTime&quot;:null,&quot;endTime&quot;:null}" data-component-name="Youtube2ToDOM"><div class="youtube-inner"><iframe src="https://www.youtube-nocookie.com/embed/mztpNNWZoh4?rel=0&amp;autoplay=0&amp;showinfo=0&amp;enablejsapi=0" frameborder="0" loading="lazy" gesture="media" allow="autoplay; fullscreen" allowautoplay="true" allowfullscreen="true" width="728" height="409"></iframe></div></div><p>[D]<span> </span>Outro v&#237;deo, mais curto, sobre anatomia do olho: </p><div id="youtube2-SiGLUvppKuI" class="youtube-wrap" data-attrs="{&quot;videoId&quot;:&quot;SiGLUvppKuI&quot;,&quot;startTime&quot;:null,&quot;endTime&quot;:null}" data-component-name="Youtube2ToDOM"><div class="youtube-inner"><iframe src="https://www.youtube-nocookie.com/embed/SiGLUvppKuI?rel=0&amp;autoplay=0&amp;showinfo=0&amp;enablejsapi=0" frameborder="0" loading="lazy" gesture="media" allow="autoplay; fullscreen" allowautoplay="true" allowfullscreen="true" width="728" height="409"></iframe></div></div><p>[C]<span> </span>LINHARES, S.; GEWANDSZNAJDER, F. <em>Biologia hoje</em>. Editora &#193;tica, S&#227;o Paulo, 2014.</p><p>[D]<span> </span>TORTORA, G. J.; GRABOWSKI, S. R. <em>Corpo humano: fundamentos de Anatomia e Fisiologia</em>. 6. Ed. Porto alegre: Artmed, 2006.</p>]]></content:encoded></item><item><title><![CDATA[Como vive o cristalino do olho, se não tem vascularização? O cristalino e a “transparência da vida” [Parte 1 de 3]]]></title><description><![CDATA[S&#201;RIE DE NOTAS sobre catarata-glaucoma-fisiologia do olho [Nota 1 de 8 ].]]></description><link>https://outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-se</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/como-vive-o-cristalino-do-olho-se</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Wed, 26 Aug 2026 19:08:27 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!zM5n!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!zM5n!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!zM5n!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg" width="515" height="324" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/c132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:324,&quot;width&quot;:515,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:22382,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212894452?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!zM5n!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc132a082-e828-48d7-b961-8cf22f67e135_515x324.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><h5>[Nestas notas tentaremos adotar a perspectiva de explica&#231;&#227;o metab&#243;lica de R. Peat, n&#227;o estritamente a da fisiologia convencional; uma consequ&#234;ncia &#233; a de que isso tende a nos permitir uma abordagem estrat&#233;gia na preven&#231;&#227;o, por exemplo].</h5><p>A quest&#227;o abordada nesta nota: o que mant&#233;m a ordem molecular [transpar&#234;ncia] do cristalino por d&#233;cadas?</p><p>O cristalino [nossa lente natural] n&#227;o possui vasos sangu&#237;neos; nenhuma veia, nenhuma art&#233;ria entra nele. &#201; caracter&#237;stica bem sua. E isso &#233; essencial para sua transpar&#234;ncia, porque a vis&#227;o seria prejudicada se ele fosse atravessado por microvasos.</p><p>Por outro lado, cria uma quest&#227;o chave que: &#233; como ele vive? Como sobrevive em sua transpar&#234;ncia?</p><p>Mas justamente &#233; isso: o cristalino &#233; uma das estruturas mais extraordin&#225;rias do corpo humano, pelo fato de ser transparente, praticamente avascular e extremamente rico em prote&#237;nas.</p><p>Uma de suas caracter&#237;sticas &#233; a de que nenhum tecido do corpo tem a concentra&#231;&#227;o proteica do cristalino. S&#227;o prote&#237;nas chamadas de <em>cristalinas</em>. A maioria dos tecidos do corpo tem <em>menos</em> prote&#237;na por unidade de volume; de forma que o cristalino est&#225; na dianteira entre os tecidos com maior concentra&#231;&#227;o proteica do organismo: 35% de prote&#237;na e 65 % &#225;gua, aproximadamente. As prote&#237;nas est&#227;o &#8220;armazenadas&#8221; dentro de c&#233;lulas alongadas, que os livros costumam chamar de <em>fibras</em>, e fazem parte de uma estrutura respons&#225;vel por manter a transpar&#234;ncia. Adiantando: o cristalino s&#243; &#233; mantido transparente por conta do <em>fluxo de energia incessante</em> que o atravessa.</p><p>Peat chama a aten&#231;&#227;o para esse ponto, que ele chama de &#8220;transpar&#234;ncia da vida&#8221;.</p><p>O cristalino recebe tudo o que precisa por difus&#227;o, a partir principalmente do humor aquoso que banha a sua face anterior e daquele epit&#233;lio tamb&#233;m na sua face externa anterior. Pode-se ver algo disso, graficamente, no desenho ao final, bem simplificado [ali&#225;s, ao final consta uma descri&#231;&#227;o anat&#244;mica mais detalhada do olho]. </p><p>E &#233; dali, do humor aquoso e daquele epit&#233;lio, que vir&#225; o suprimento de oxig&#234;nio, glicose, amino&#225;cidos, vitaminas e que continuamente fluem para o interior do cristalino, entregando suprimento; tais materiais ter&#227;o circula&#231;&#227;o pr&#243;pria dentro do cristalino.</p><p>O humor aquoso &#233; composto por aproximadamente 98&#8211;99% de &#225;gua e 1&#8211;2% de solutos, principalmente: glicose; vitamina C (&#225;cido asc&#243;rbico), este em concentra&#231;&#227;o muito superior &#224; do plasma; amino&#225;cidos; bicarbonato; s&#243;dio, pot&#225;ssio, cloreto, c&#225;lcio e magn&#233;sio; pequenas quantidades de ureia e outros metab&#243;litos.</p><p>O que chama a aten&#231;&#227;o, como foi dito,  &#233; que ele praticamente cont&#233;m pouqu&#237;ssimas prote&#237;nas (cerca de 200 vezes menos que o plasma); quase nenhuma c&#233;lula; lip&#237;dios em quantidades muito baixas. E se renova constantemente, ao contr&#225;rio do humor v&#237;treo. [Visualizar ambos, nos desenhos ao final]</p><p>Portanto, embora ambos sejam constitu&#237;dos quase inteiramente por &#225;gua, eles t&#234;m fun&#231;&#245;es muito diferentes:<span> </span>o humor aquoso &#233; um l&#237;quido de nutri&#231;&#227;o e transporte, que leva nutrientes ao cristalino e &#224; c&#243;rnea e remove res&#237;duos metab&#243;licos; o humor v&#237;treo, por sua vez, &#233; principalmente um suporte mec&#226;nico e &#243;ptico, mantendo a forma do globo ocular e a retina, esta aplicada contra a parede do olho.</p><p>De forma que sendo o cristalino um tecido que n&#227;o possui sistema vascular, mas ao mesmo tempo ele &#233; <em>vivo</em>, metabolicamente ativo, captando glicose, produzindo ATP, sintetizando novas prote&#237;nas cristalinas - muito lentamente, mas sim -, controlando a composi&#231;&#227;o de &#225;gua e eletr&#243;litos.</p><p>O cristalino &#233; composto de <em>fibras</em> longitudinais, ou c&#233;lulas, no interior das quais as prote&#237;nas s&#227;o mantidas em ordem, e &#225;gua tamb&#233;m est&#225; bem presente, mas em uma ordem <em>determinada</em>, na condi&#231;&#227;o de <em>&#225;gua</em> <em>estruturada</em>, mantida nesta ordem especial e espacial a partir da usina metab&#243;lica, que &#233; o epit&#233;lio do cristalino. Manter essa estrutura&#231;&#227;o da &#225;gua requer energia constante, a ser oferecida pela vida afora.</p><p>Apesar de pequeno, aquele esse epit&#233;lio que mant&#233;m o cristalino. O metabolismo do cristalino &#233; m&#237;nimo, e depende diretamente daquele epit&#233;lio para conservar sua organiza&#231;&#227;o, isto &#233;, sua transpar&#234;ncia.</p><p>Quando a produ&#231;&#227;o de energia do epit&#233;lio <em>diminui</em>, as prote&#237;nas das fibras deixam de manter sua organiza&#231;&#227;o. O nome da coisa &#233; catarata, e significa <em>perda da transpar&#234;ncia</em>.</p><p>O cristalino 65% &#233; &#225;gua, 35% &#233; prote&#237;na, como j&#225; foi dito. E ele recebe tudo o que precisa por difus&#227;o. Sua nutri&#231;&#227;o vem, como foi mencionado, a partir do seu pequeno epit&#233;lio [somente uma camada de c&#233;lulas] que, por sua vez, &#233; banhado pelo humor aquoso, uma esp&#233;cie de &#8220;filtrado&#8221; <em>ativo</em> do plasma.</p><p>Uma pequena observa&#231;&#227;o sobre o humor aquoso e o nosso antioxidante-mor glutationa.</p><p>O humor aquoso n&#227;o transporta quantidades significativas de glutationa do plasma para o cristalino. O motivo &#233; que a glutationa (GSH) &#233; um pequeno tripept&#237;deo, mas sua concentra&#231;&#227;o no plasma costuma ser baixa, ela &#233; rapidamente metabolizada e n&#227;o atravessa livremente o epit&#233;lio ciliar para se acumular no humor aquoso.</p><p>De acordo com o conhecimento atual, o que acontece &#233; que o corpo ciliar seleciona do plasma amino&#225;cidos (como glutamato, ciste&#237;na e glicina) e outros nutrientes. O humor aquoso leva esses amino&#225;cidos ao epit&#233;lio e &#224;s fibras superficiais do cristalino e as pr&#243;prias c&#233;lulas vivas do cristalino <em>sintetizam</em> <em>sua</em> glutationa.</p><p>Ou seja, o cristalino &#233;, em grande parte, autossuficiente na produ&#231;&#227;o de glutationa [desde que disponha de glicose para produzir energia; tamb&#233;m ciste&#237;na; glutamato; glicina; ATP suficiente para realizar a s&#237;ntese.</p><p>Ou seja, a glutationa n&#227;o &#233; simplesmente &#8220;entregue&#8221; ao cristalino. Ela <em>precisa ser produzida</em> pelas c&#233;lulas metabolicamente ativas, principalmente pelo epit&#233;lio anterior e pelas fibras mais jovens.</p><p>Uma consequ&#234;ncia disso &#233; que se o metabolismo do epit&#233;lio cai, n&#227;o diminui apenas a produ&#231;&#227;o de ATP. Tamb&#233;m diminui a capacidade de sintetizar e regenerar glutationa. Por essa via, o cristalino perde uma de suas principais defesas contra a oxida&#231;&#227;o das cristalinas, portanto por conta do simples fato da inibi&#231;&#227;o do metabolismo [por exemplo, por &#243;leos poli-insaturados].</p><p>Eis outro por qu&#234; de o estado metab&#243;lico do epit&#233;lio anterior ser decisivo para a sa&#250;de do cristalino: glutationa &#233;, como foi dito, produzida <em>predominantemente</em> dentro do pr&#243;prio cristalino pelas c&#233;lulas vivas; o humor aquoso fornece os precursores, mas n&#227;o grandes quantidades de glutationa pronta.</p><p>De forma que o cristalino, na perspectiva de Peat, &#233; uma estrutura cuja ordem depende continuamente da produ&#231;&#227;o de energia vinda <em>de fora</em>. As prote&#237;nas n&#227;o permanecem transparentes por serem inerentemente est&#225;veis ou alguma coisa como cristal, algo inerte.</p><p>Elas <em>somente permanecem organizadas porque o epit&#233;lio mant&#233;m um ambiente metab&#243;lico adequado</em>. E recebendo um banho ininterrupto do humor aquoso. Um sistema de &#8220;vasos comunicantes&#8221;.</p><p>Quando a energia celular cai no epit&#233;lio e, portanto, ter&#225; ca&#237;do antes e <em>em geral</em> no sistema do corpo/plasma - por exemplo, por hipotireoidismo, excesso de estresse -, aquela manuten&#231;&#227;o do cristalino falha, as prote&#237;nas cristalinas come&#231;am a se agregar, a luz passa a ser espalhada ao inv&#233;s de atravessar o cristalino de maneira uniforme. Teremos a catarata em processo.</p><p>Ent&#227;o, mais uma vez, a transpar&#234;ncia do cristalino n&#227;o &#233; um estado <em>passivo</em>, mas sim consequ&#234;ncia - como diria uma pessoa -, de um sangue que &#8220;ficou ruim&#8221;.</p><p>Aqui, visivelmente, e de forma mais not&#225;vel, aparece o fen&#244;meno em que estrutura e energia s&#227;o insepar&#225;veis.</p><p style="text-align: right;"><em>O estado estrutural e sua transpar&#234;ncia precisam ser constantemente sustentados pela energia produzida pelo metabolismo, seja o metabolismo ali do epit&#233;lio, seja o geral do corpo, que impacta o epit&#233;lio do cristalino.</em></p><p>Portanto, temos aqui a rela&#231;&#227;o direta e inequ&#237;voca entre sa&#250;de metab&#243;lica e sa&#250;de/evolu&#231;&#227;o do cristalino.      [Continua na nota 2 de 3]</p><p>G Dantas,  SP, 26-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong>Refer&#234;ncias:</strong></p><p>[A]<span> </span>PEAT, Ray, <em><span>Cataracts: water, energy, light, and aging </span></em><span><br></span><a href="https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml"><span>https://raypeat.com/articles/articles/cataracts-water-energy-light-aging.shtml</span></a></p><p>[B]<span> </span>Sobre anatomia do olho, v&#237;deo de uma oftalmologista &#8211; </p><div id="youtube2-mztpNNWZoh4" class="youtube-wrap" data-attrs="{&quot;videoId&quot;:&quot;mztpNNWZoh4&quot;,&quot;startTime&quot;:null,&quot;endTime&quot;:null}" data-component-name="Youtube2ToDOM"><div class="youtube-inner"><iframe src="https://www.youtube-nocookie.com/embed/mztpNNWZoh4?rel=0&amp;autoplay=0&amp;showinfo=0&amp;enablejsapi=0" frameborder="0" loading="lazy" gesture="media" allow="autoplay; fullscreen" allowautoplay="true" allowfullscreen="true" width="728" height="409"></iframe></div></div><p>[C]<span> </span>Outro v&#237;deo, mais curto, sobre anatomia do olho: </p><div id="youtube2-SiGLUvppKuI" class="youtube-wrap" data-attrs="{&quot;videoId&quot;:&quot;SiGLUvppKuI&quot;,&quot;startTime&quot;:null,&quot;endTime&quot;:null}" data-component-name="Youtube2ToDOM"><div class="youtube-inner"><iframe src="https://www.youtube-nocookie.com/embed/SiGLUvppKuI?rel=0&amp;autoplay=0&amp;showinfo=0&amp;enablejsapi=0" frameborder="0" loading="lazy" gesture="media" allow="autoplay; fullscreen" allowautoplay="true" allowfullscreen="true" width="728" height="409"></iframe></div></div><p>[E]<span> </span>LINHARES, S.; GEWANDSZNAJDER, F. <em>Biologia hoje</em>. Editora &#193;tica, S&#227;o Paulo, 2014.</p><p>[F]<span> </span>TORTORA, G. J.; GRABOWSKI, S. R. <em>Corpo humano: fundamentos de Anatomia e Fisiologia</em>. 6. Ed. Porto alegre: Artmed, 2006.</p><p style="text-align: center;">**********</p><h4><strong>ADENDO AO ARTIGO ACIMA &#8211; ANATOMIA DA FUN&#199;&#195;O OCULAR</strong></h4><p>[Para melhor compreens&#227;o espacial e anat&#244;mica, consulte um livro especializado; as informa&#231;&#245;es abaixo, s&#227;o simplificadas; e as imagens idem, ser&#227;o ilustrativas, para melhor compreens&#227;o do texto acima]</p><p>ELEMENTOS DE ANATOMIA FUNCIONAL DO OLHO</p><p>Resumo da imagem do olho:</p><p>C&#243;rnea &#8211; a lente transparente mais externa.</p><p>&#205;ris &#8211; a parte colorida do olho.</p><p>Pupila &#8211; a abertura no centro da &#237;ris.</p><p>Cristalino &#8211; a lente transparente logo atr&#225;s da pupila.</p><p>Corpo ciliar &#8211; prende o cristalino, em redor de todo ele, por meio das  fibras zonulares e ajusta seu foco; aqui &#233; sintetizado o</p><p>Humor aquoso - circula na c&#226;mara anterior do olho.</p><p>Humor v&#237;treo &#8211; o gel que ocupa quase todo o interior do olho; c&#226;mara posterior.</p><p>Retina &#8211; a camada que recebe a imagem.</p><p>Na imagem abaixo, do cristalino, ficam evidentes:</p><p>C&#225;psula do cristalino &#8211; uma membrana transparente que envolve todo o cristalino.</p><p>Epit&#233;lio do cristalino &#8211; uma &#250;nica camada de c&#233;lulas localizada <em>apenas na face anterior</em>, logo abaixo da c&#225;psula. Essas c&#233;lulas s&#227;o metabolicamente muito ativas.</p><p>Zona equatorial &#8211; regi&#227;o onde as c&#233;lulas epiteliais come&#231;am a se transformar em novas fibras.</p><p>Fibras do cristalino &#8211; c&#233;lulas extremamente alongadas e transparentes que comp&#245;em praticamente toda a massa do cristalino.</p><p>N&#250;cleo do cristalino &#8211; fibras mais antigas, situadas no centro.</p><p>C&#243;rtex do cristalino &#8211; fibras mais jovens, na periferia.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!hs6P!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 424w, /__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 848w, /__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 1272w, /__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!hs6P!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png" width="298" height="302" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/b6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:302,&quot;width&quot;:298,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:90142,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212894452?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 424w, /__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 848w, /__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 1272w, /__u/substackcdn.com/image/fetch/$s_!hs6P!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb6d55358-77b3-4d1f-84e7-e66f01224968_298x302.png 1456w" sizes="100vw" loading="lazy"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Observe-se que o globo ocular &#233; envolvido por uma membrana branca chamada esclera, que na frente do olho, na parte anterior, se transforma na c&#243;rnea; c&#243;rnea &#233; a primeira lente natural do olho. A esclera, portanto, fica transparente na face anterior do olho e passa a ser chamada de c&#243;rnea. A c&#243;rnea &#233; como se fosse o vidro do rel&#243;gio. N&#227;o &#233;, portanto, quem regula o foco da vis&#227;o.</p><p>O globo ocular possui m&#250;sculos externos que fazem com que se mova em v&#225;rias dire&#231;&#245;es, simultaneamente e igualmente, na dire&#231;&#227;o necess&#225;ria. A esclera &#233; como se fosse a parede que recobre o globo ocular.</p><p>Por sua vez, vasos calibrosos passam dentro do nervo &#243;ptico para nutrir a retina.</p><p>A esclera &#233; endurecida, resistente, enquanto a conjuntiva, a membrana que envolve a esclera, &#233; mais suave. A esclera, portanto, fica abaixo da conjuntiva. A  p&#225;lpebra, por sua vez, cobre e protege o globo ocular, e os c&#237;lios funcionam como toldo para proteger automaticamente do excesso de luz.</p><p>As p&#225;lpebras s&#227;o dobras de pele e m&#250;sculo, e cobrem os olhos durante o sono e, ao piscar, tamb&#233;m espalha as secre&#231;&#245;es lubrificantes na superf&#237;cie do olho. Possuem fileiras de c&#237;lios que tem como fun&#231;&#227;o proteger o olho da luz, poeira e outras agress&#245;es do meio externo.</p><p>Os c&#237;lios auxiliam na prote&#231;&#227;o contra os corpos estranhos, a transpira&#231;&#227;o e dos raios luminosos; os m&#250;sculos extr&#237;nsecos oculares: inseridos na superf&#237;cie externa, garantem os movimentos coordenados dos dois globos oculares; o aparelho lacrimal assegura a produ&#231;&#227;o de l&#225;grimas atrav&#233;s da <a href="https://www.infoescola.com/glandulas/glandula-lacrimal/">gl&#226;ndula lacrimal</a>. Fazem parte tamb&#233;m os ductos e canais que transportam e drenam a l&#225;grima.</p><p>A l&#225;grima &#233; uma subst&#226;ncia aquosa que impede o ressecamento das camadas do globo ocular, atrav&#233;s da lubrifica&#231;&#227;o da superf&#237;cie do olho. Al&#233;m disso, apresenta uma enzima chamada lisozima que possui fun&#231;&#227;o bactericida. Em momentos de emo&#231;&#227;o, como a felicidade e tristeza, as <a href="https://www.infoescola.com/fisiologia/lagrimas/">l&#225;grimas</a> s&#227;o liberadas em forma de choro. L&#225;grimas e emo&#231;&#245;es de m&#227;os dadas.</p><p>A c&#243;rnea &#233; como se fosse uma lente, onde qualquer altera&#231;&#227;o prejudica a vis&#227;o, mas &#8211; como j&#225; foi mencionado - ela <em>n&#227;o &#233; a lente que vai focar o raio de luz</em>. A &#237;ris &#233; o tecido colorido. Atr&#225;s da &#237;ris fica o cristalino.</p><p>Em redor do cristalino [mas que aparece no desenho como se fosse em cima e embaixo], existe a musculatura ciliar, que movimenta o cristalino para adapt&#225;-lo a enxergar longe ou perto.</p><p>O humor v&#237;treo &#233; gelatinoso, ao contr&#225;rio do aquoso, e constitui uma esp&#233;cie de almofada, de amortecedor, que protege a retina e que d&#225; consist&#234;ncia ao globo.</p><p>A musculatura ciliar, &#224; qual o cristalino est&#225; preso [e que forma um &#8220;anel&#8221; em torno do cristalino, &#233; acionada pelo simp&#225;tico ou parassimp&#225;tico, conforme o olho vai se contrair, contraindo a &#237;ris, ou conforme vai se abrir, dilatar].</p><p>De forma que, de conjunto, temos no olho duas c&#226;maras, separadas pela &#237;ris.</p><p>Os ligamentos suspensores do cristalino, contraindo ou relaxando, garantem a vis&#227;o mais pr&#243;xima ou mais afastada. Portanto, a musculatura ciliar &#233; chamada <em>musculatura da acomoda&#231;&#227;o.</em> Quem garante o foco, portanto, &#233; a musculatura ciliar, puxando ou afrouxando o cristalino em sua dimens&#227;o.</p><div class="captioned-image-container"><figure><a class="image-link image2" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!yUBx!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!yUBx!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg" width="316" height="217" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:217,&quot;width&quot;:316,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:14488,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212894452?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!yUBx!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F10ce53a3-4caf-48f4-ac5e-e251b7a57fbd_316x217.jpeg 1456w" sizes="100vw" loading="lazy"></picture><div></div></div></a></figure></div><p>O pequeno epit&#233;lio fica na parte anterior da lente.</p><p>A esclera aparece na frente do globo ocular como aquilo que popularmente se chama de branco do olho. Na parte anterior, portanto, como foi dito, a esclera &#233; transparente e saliente, recebendo o nome de <a href="https://www.infoescola.com/visao/cornea/">c&#243;rnea</a>, uma camada que cobre a &#237;ris.</p><p>A &#237;ris &#233; a parte colorida e fecha e abre a pupila, que fica no seu centro. A &#237;ris &#233; uma membrana de forma circular, com cerca de 12 mm de di&#226;metro. Possui uma abertura central e circular chamada de pupila, que possui cerca de 4,4 mm de di&#226;metro. Apesar de aparentar ter uma cor preta, &#233; totalmente transparente. Funciona de forma semelhante ao diafragma de uma m&#225;quina fotogr&#225;fica: quando exposta a uma luminosidade intensa, a abertura central diminui; em situa&#231;&#245;es de fraca ilumina&#231;&#227;o, a abertura dilata-se para conseguir captar mais luz.</p><p>A regula&#231;&#227;o ocorre atrav&#233;s da contra&#231;&#227;o do seu m&#250;sculo esf&#237;ncter. Desta forma, &#233; poss&#237;vel controlar a entrada de luz no olho e aumentar a acuidade visual.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!ncko!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!ncko!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg" width="265" height="265" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:265,&quot;width&quot;:265,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:14253,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212894452?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!ncko!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F18f43c29-5d39-4275-b6fc-7e5e75cbf642_265x265.jpeg 1456w" sizes="100vw" loading="lazy"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p></p><p>Quem mant&#233;m a <em>forma</em> do olho &#233; o gel chamado humor v&#237;treo.</p><p>Enquanto a retina, por sua vez, <em>converte energia luminosa em energia el&#233;trica</em>, que segue pelo nervo &#243;ptico para formar a imagem <em>no c&#233;rebro</em>. A <a href="https://www.infoescola.com/visao/retina/">retina</a> &#233; a camada mais interna do olho, uma regi&#227;o sens&#237;vel onde chega a luz. A luz, depois que passa pela pupila, &#233; convergida pela lente &#224; <a href="https://www.infoescola.com/visao/retina/">retina</a>, onde &#233; recebida por c&#233;lulas que s&#227;o capazes de perceberem os est&#237;mulos luminosos. Que se tornam impulsos nervosos em el&#233;tricos, que v&#227;o para o <a href="https://www.infoescola.com/anatomia-humana/encefalo/">enc&#233;falo</a>.</p><p>No cristalino, o que chama aten&#231;&#227;o &#233; que aquele epit&#233;lio do cristalino &#233; muito fino, com apenas uma camada de c&#233;lulas, mas exerce praticamente todo o controle metab&#243;lico do cristalino.</p><p>A regi&#227;o equatorial do cristalino: &#224; medida que as c&#233;lulas epiteliais migram em dire&#231;&#227;o ao equador, elas come&#231;am a se alongar, sintetizam enormes quantidades de cristalinas, perdem o n&#250;cleo e as demais organelas e se transformam nas novas fibras do cristalino. &#201; esse processo que permite que o cristalino continue crescendo durante toda a vida.</p><div class="captioned-image-container"><figure><a class="image-link image2" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!jbpZ!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!jbpZ!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg" width="400" height="227" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/b7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:227,&quot;width&quot;:400,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:20468,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212894452?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!jbpZ!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb7bc9cd5-840e-4744-b3f7-e31d602df496_400x227.jpeg 1456w" sizes="100vw" loading="lazy"></picture><div></div></div></a></figure></div><p>Ou seja, de fora para dentro, a <em>sequ&#234;ncia</em> &#233;:<span> </span>humor aquoso; c&#225;psula anterior do cristalino (uma membrana basal espessa, acelular e transparente); epit&#233;lio anterior do cristalino (uma &#250;nica camada de c&#233;lulas c&#250;bicas); fibras do cristalino (que formam praticamente toda a massa da lente).</p><p>Portanto, o epit&#233;lio do cristalino n&#227;o fica sobre a c&#225;psula, mas logo abaixo dela, aderido &#224; sua face interna.</p><p>Tem mais: esse epit&#233;lio, como foi mencionado mais de uma vez, existe <em>apenas</em> na face anterior do cristalino. A face posterior n&#227;o possui epit&#233;lio. Por isso, na face posterior encontramos apenas a c&#225;psula posterior recobrindo as fibras. Enquanto isso, como foi reiterado acima, o epit&#233;lio anterior &#233; o grande &#8220;centro metab&#243;lico&#8221; do cristalino.</p><p>Ele &#233; respons&#225;vel por: produzir os componentes da c&#225;psula do cristalino; sintetizar prote&#237;nas (cristalinas); regular o transporte de &#237;ons, glicose e amino&#225;cidos; manter o equil&#237;brio osm&#243;tico e energ&#233;tico das fibras; originar continuamente novas fibras na regi&#227;o equatorial.</p><p>As fibras mais internas [as do n&#250;cleo do cristalino], praticamente n&#227;o t&#234;m organelas nem capacidade metab&#243;lica pr&#243;pria e dependem do epit&#233;lio e das fibras mais superficiais para manter sua integridade durante d&#233;cadas.</p><p>Isso torna o epit&#233;lio anterior uma <em>estrutura cr&#237;tica</em>: les&#245;es metab&#243;licas, estresse oxidativo, diabetes, endotoxinas, radia&#231;&#227;o ou n&#237;veis mais altos de horm&#244;nios do estresse [especialmente serotonina, melatonina], podem comprometer sua fun&#231;&#227;o e favorecer o desenvolvimento da catarata.</p><p>Existem alguns dist&#250;rbios de <a href="https://www.infoescola.com/fisica/refracao/">refra&#231;&#227;o</a> que s&#227;o causados por problemas no cristalino ou na c&#243;rnea. Estes podem ser corrigidos com o uso de <a href="https://www.infoescola.com/visao/lentes-de-contato/">lentes de contato</a> ou &#243;culos de grau, podendo vir acompanhados ou n&#227;o, de doen&#231;as oculares mais graves. Dentre esses problemas encontram-se:</p><p><a href="https://www.infoescola.com/visao/miopia/">Miopia</a>: indiv&#237;duos que portam a miopia possuem dificuldade de <em>enxergar longe</em>.</p><p><a href="https://www.infoescola.com/visao/hipermetropia/">Hipermetropia</a>: indiv&#237;duos portadores de hipermetropia possuem dificuldade de <em>enxergar perto</em>.</p><p><a href="https://www.infoescola.com/visao/presbiopia/">Presbiopia</a>: tamb&#233;m conhecido como vista cansada, esse dist&#250;rbio geralmente aparece ap&#243;s os 40 anos de idade e seus portadores possuem dificuldade para <em>enxergar de perto</em>.</p><p><a href="https://www.infoescola.com/visao/astigmatismo/">Astigmatismo</a>: geralmente ocorre quando h&#225; uma diferen&#231;a entre as curvaturas corneanas, levando &#224; dificuldade de enxergar uma reta em determinada posi&#231;&#227;o e n&#227;o em outra.</p><p style="text-align: center;">**********</p>]]></content:encoded></item><item><title><![CDATA[A ciência moderna demonstrou algum interesse em estudar AAS em câncer em humanos?]]></title><description><![CDATA[O AAS [aspirina] oderia perfeitamente ocupar um lugar na oncologia se a abordagem fosse de interesse puramente m&#233;dico-cient&#237;fico; n&#227;o tem sido]]></description><link>https://outramedicina2024.substack.com/p/a-ciencia-moderna-demonstrou-algum</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/a-ciencia-moderna-demonstrou-algum</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sun, 23 Aug 2026 16:49:27 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!V63a!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!V63a!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!V63a!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg" width="446" height="300" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:300,&quot;width&quot;:446,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:54043,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212430727?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!V63a!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F103334ab-fe09-452f-b316-1a6430764312_446x300.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>A pergunta: existem artigos cient&#237;ficos que testaram o AAS no tratamento do c&#226;ncer de mama?<span> </span>A resposta: SIM, existem. Mas raramente em humanos; neste caso, grande parte dos estudos que existem em humanos, n&#227;o s&#227;o experimentos mas estudos de natureza epidemiol&#243;gica, isto &#233;, apenas observacionais, os quais, por defini&#231;&#227;o, n&#227;o permitem conclus&#245;es cl&#237;nicas.</p><p>Por outro lado, h&#225; in&#250;meros experimentos em c&#233;lulas <em>in vivo</em>, em animais.</p><p>De forma que se a pergunta agora for dirigida &#224; biologia, ao estudo com animais e c&#233;lulas em laborat&#243;rio, a resposta ser&#225; bem diferente e completamente a favor do potencial antic&#226;ncer da aspirina. Se a pergunta for: o AAS, biologicamente,<span> </span>interfere nos mecanismos do tumor, contra o tumor? O AAS reduz prolifera&#231;&#227;o, angiog&#234;nese, inflama&#231;&#227;o, sobreviv&#234;ncia celular do c&#226;ncer? A resposta &#233; que sim, isso o AAS mostrou que faz.</p><p>E sim, mecanismos bioqu&#237;micos sobre essa a&#231;&#227;o do AAS foram demonstrados em v&#225;rios desses estudos.</p><p>Estudo experimental, laboratorial, com plaquetas identificou um dos prov&#225;veis mecanismos contra o processo inflamat&#243;rio tumoral [A] por AAS.</p><p>Outro estudo com AAS tamb&#233;m descobriu outro mecanismo antic&#226;ncer do AAS [B]. Sua conclus&#227;o foi de que nossos &#8220;resultados indicaram que o mecanismo molecular subjacente aos efeitos antitumorais da aspirina pode estar associado &#224; inibi&#231;&#227;o da invas&#227;o tumoral e &#224; indu&#231;&#227;o de apoptose&#8221;. Isto &#233;, elucidaram um diferente e positivo mecanismo de a&#231;&#227;o antitumoral da aspirina.</p><p>Em outro caso, novamente o AAS como antitumoral - estudo em Pequim, com c&#233;lulas em laborat&#243;rio -, foi positivo, descobriu mecanismos antic&#226;ncer da aspirina [C].</p><p>Alguns autores reconhecem explicitamente que h&#225; baixo interesse cl&#237;nico em desenvolver pesquisas a respeito e que isso decorre n&#227;o do AAS em si, como mol&#233;cula terap&#234;utica, mas sim de fatores n&#227;o cient&#237;ficos.</p><p>No entanto, a verdade - a <em>estranha</em> verdade - &#233; que h&#225; relativamente poucos trabalhos em humanos a respeito do AAS no tratamento de c&#226;nceres.</p><p>H&#225; que sempre considerar que esse fen&#244;meno n&#227;o &#233; sobre ci&#234;ncia, &#233; muito mais sobre economia e regula&#231;&#227;o estatal, se entendermos que a aspirina &#233; barata, sem patente, antiga. N&#227;o geraria financiamento robusto, retorno industrial, marketing terap&#234;utico. Tais estudos fariam todo sentido mas n&#227;o dariam o retorno financeiro que os mercados exigem.</p><p>De toda forma o fato de o AAS &#8220;n&#227;o ser visto como tratamento estabelecido&#8221;, portanto, n&#227;o traduz suas potencialidades terap&#234;uticas. E nem invalida a hip&#243;tese terap&#234;utica.</p><p>E o fato &#233; que, sim, existem estudos experimentais, celulares, animais e translacionais que utilizam AAS como agente antitumoral no c&#226;ncer de mama. A aus&#234;ncia de ado&#231;&#227;o cl&#237;nica n&#227;o &#233; prova de inefic&#225;cia biol&#243;gica, mas de falta de prioridades institucionais.</p><p>Dentro da l&#243;gica de Ray Peat, e a partir de estudos em n&#227;o-humanos, o interesse no AAS deveria ser &#243;bvio, j&#225; h&#225; evid&#234;ncias de sobra de que o AAS reduz inflama&#231;&#227;o, prostaglandinas, diminui o consumo patol&#243;gico de NAD, diminui o cortisol e, em consequ&#234;ncia, o ambiente tumoral hostil. Tudo isso traduz modifica&#231;&#227;o ativa do terreno tumoral e contra o<span> </span>c&#226;ncer.</p><p>Em estudos celulares (<em>in vitro</em>) em linhas de c&#226;ncer de mama, a aspirina mostrou inibir proliferac&#807;a&#771;o e migrac&#807;a&#771;o de c&#233;lulas de c&#226;ncer de mama (por exemplo em linhas como 4T1, MCF-7, MDA-MB-231) em culturas celulares, muitas vezes associada &#224; redu&#231;&#227;o de marcadores inflamat&#243;rios, migra&#231;&#227;o e invas&#227;o [D].</p><p>Tais estudos s&#227;o <em>in vitro</em>, mas demonstram mecanismos antitumorais celulares (bloqueio de COX-2, redu&#231;&#227;o de sinaliza&#231;&#227;o pr&#243;-tumoral, impacto em ades&#227;o/migra&#231;&#227;o).</p><p>J&#225; estudos em animais / pr&#233;-cl&#237;nicos &#8211; ratos, por exemplo &#8211; com modelos de c&#226;ncer de mama (por exemplo, linhas tumorais transplantadas em camundongos) mostraram que&#775;<span> </span>AAS altera a biologia tumoral, reduzindo crescimento ou comportamento invasivo em alguns modelos [E].<span data-color="rgb(70, 120, 134)" style="color: rgb(70, 120, 134);"> E </span>em modelos combinados de adip&#243;citos e c&#233;lulas 4T1, aspirina reduziu viabilidade e migra&#231;&#227;o celular <em>in vitro</em> e pode ter efeitos antitumorais <em>in vivo</em>.</p><p>Outros estudos animais em modelos de met&#225;stase (por exemplo, camundongos com tumores transplantados) sugerem que a aspirina pode reduzir a dissemina&#231;&#227;o metast&#225;tica, possivelmente por mecanismos relacionados &#224; atividade plaquet&#225;ria e resposta imune (mecanismos tamb&#233;m reportados em <em>Nature</em>) [F].</p><p>Estudos observacionais <em>valorizam</em> o AAS no c&#226;ncer, estudos i<em>n vivo</em> e i<em>n vitro</em> &#8211; laboratoriais tamb&#233;m apontam para o potencial antic&#226;ncer do AAS. Mas nada disso teve o poder de mudar a agenda da pesquisa m&#233;dica.</p><p>Em humanos, como foi dito, a pesquisa n&#227;o costuma ir muito al&#233;m de trabalhos observacionais/epidemiol&#243;gicos. H&#225;, eventualmente, trabalho em humanos &#8211; encontramos apenas um, em uma primeira investiga&#231;&#227;o ali&#225;s -, e um trabalho que n&#227;o foi a favor do AAS; utilizou dose insignificante de AAS [300 mg], de forma que seu resultado n&#227;o convence. E se trata de um &#250;nico estudo que cumpre <em>formalmente</em> o crit&#233;rio metodol&#243;gico (duplo-cego + randomizado) mas que usou 300 mg/dia &#8212; e apenas como terapia adjuvante tardia, n&#227;o como interven&#231;&#227;o metab&#243;lica antitumoral propriamente dita.</p><p>Ou seja: &#233; um estudo negativo com uma dose biologicamente irrelevante para o alvo proposto [doses entre 1 e 4 g/dia de AAS j&#225; foram rotina cl&#237;nica durante d&#233;cadas; com o adequado cuidado contra efeitos indesej&#225;veis].</p><p>De toda forma, o mais &#8220;estranho&#8221; &#233; que at&#233; onde vai a literatura cient&#237;fica mundial, n&#227;o existe ensaio cl&#237;nico duplo-cego, randomizado, controlado por placebo, <em>em humanos</em>, usando AAS em dose farmacologicamente relevante/antitumoral no c&#226;ncer de mama, por exemplo. Ou seja, n&#227;o planejado com doses tipo 1-3 g por dia e nem desenhado, especificamente para efeito metab&#243;lico antitumoral, como interven&#231;&#227;o ativa.</p><p>N&#227;o h&#225;, at&#233; o momento [janeiro 26], ensaio cl&#237;nico duplo-cego, randomizado, em humanos, que tenha testado seriamente o &#225;cido acetilsalic&#237;lico em dose antitumoral no c&#226;ncer de mama.</p><p>Mas a verdade &#233; que isso n&#227;o prova nada contra o<span> </span>AAS, &#233; uma pura e simples <em>aus&#234;ncia</em> de experimento adequado; provavelmente tem a ver n&#227;o com seu potencial terap&#234;utico mas sim com falta de patente, baixo interesse econ&#244;mico, risco regulat&#243;rio, conflito com o paradigma oncog&#234;nico dominante.</p><p>Ou seja: a dose &#8220;antitumoral plaus&#237;vel&#8221; - que n&#227;o seria a dose <em>cardiol&#243;gica </em>- est&#225; <em>dentro</em> da faixa hist&#243;rica de uso humano: n&#227;o &#233; uma extrapola&#231;&#227;o absurda, n&#227;o &#233; territ&#243;rio desconhecido [G], mas n&#227;o gera pesquisa financiada pelo Estado, por exemplo, mesmo quando, eventualmente, esse Estado se orgulha de ter um bom sistema de sa&#250;de p&#250;blica [caso da ditadura cubana ou a nicaraguense].</p><p>Neste ponto, comportaria o necess&#225;rio debate, mas que <em>j&#225; feito neste blog</em>, sobre seguran&#231;a cl&#237;nica hist&#243;rica real (n&#227;o te&#243;rica) no uso do AAS.</p><p>De toda forma, a aus&#234;ncia de <em>trials</em> com doses mais altas n&#227;o &#233; de ordem cient&#237;fica; como foi dito &#233; muito mais um fen&#244;meno derivado da esfera econ&#244;mica e da pol&#237;tica.</p><p>G Dantas, SP, 23-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p></p><p><strong>Refer&#234;ncias</strong> _______________</p><p>[A]<span> </span>JOHNSON K E CEGLOWSKI J R, 2019. <em>Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis</em><strong>. </strong>Blood Adv . 2019 Jan 22;3(2):198-211. doi: 10.1182/bloodadvances.2018026161. PMID: 30670536<span> </span>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6341186/">PMC6341186</a><span> </span>DOI: <a href="https://doi.org/10.1182/bloodadvances.2018026161">10.1182/bloodadvances.2018026161</a></p><p><strong>Abstract</strong></p><p>It is now recognized that compounds released from tumor cells can activate platelets, causing the release of platelet-derived factors into the tumor microenvironment. Several of these factors have been shown to directly promote neovascularization and metastasis, yet how the feedback between platelet releasate and the tumor cell affects metastatic phenotype remains largely unstudied. Here, we identify that breast tumor cells secrete high levels of interleukin 8 (IL-8, CXCL8) in response to platelet releasate, which promotes their invasive capacity. Furthermore, we found that platelets activate the Akt pathway in breast tumor cells, and inhibition of this pathway eliminated IL-8 production. We therefore hypothesized inhibiting platelets with aspirin could reverse the prometastatic effects of platelets on tumor cell signaling. Platelets treated with aspirin did not activate the Akt pathway, resulting in reduced IL-8 secretion and impaired tumor cell invasion. Of note, patients with breast cancer receiving aspirin had lower circulating IL-8, and their platelets did not increase tumor cell invasion compared with patients not receiving aspirin. Our data suggest platelets support breast tumor metastasis by inducing tumor cells to secrete IL-8. Our data further support that aspirin acts as an anticancer agent by disrupting the communication between platelets and breast tumor cells.</p><p>[B]<span> </span>JIN M LI CHUNYU<span> </span>2018. <em>Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-&#954;B/survivin signaling pathway</em>.<em><strong> </strong>Oncol Lett . 2018 Mar 29;15(6):8454&#8211;8460. doi: <a href="https://doi.org/10.3892/ol.2018.8377">10.3892/ol.2018.8377</a></em></p><p><em>PMCID: PMC5950550 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29805582/">29805582</a></em></p><p><em>Abstract</em></p><p><em>Aspirin may exhibit antitumor activities, as it is able to inhibit cell proliferation. However, the ability of aspirin to inhibit cellular proliferation in Hep-2 cells and its underlying molecular mechanisms have been poorly determined. The aim of the present study was to investigate whether aspirin may induce cell apoptosis in the neoplastic cell line Hep-2. The effects of aspirin on the migratory and invasive abilities of Hep-2 cells were also investigated using Transwell assays. In the present study, it was demonstrated that aspirin induced apoptosis and inhibited proliferation, migration and invasion in Hep-2 cells. Aspirin also significantly decreased the expression of B-cell lymphoma 2 (Bcl-2) and caspase-3, and increased the expression of Bcl-2-associated X protein, suggesting that aspirin induced apoptosis through the intrinsic apoptotic pathway. Hep-2 cells treated with aspirin exhibited a significant upregulation of phosphatase and tensin homolog (PTEN) and decreased levels of phosphorylated protein kinase B (AKT). However, the total amount of AKT protein was not altered in response to aspirin treatment. Furthermore, the expression of nuclear factor (NF)-&#954;B and survivin, which are the downstream targets of the PTEN/AKT signaling pathway, was inhibited. <strong>These results indicated that the molecular mechanism underlying the antitumor effects of aspirin may be associated with the inhibition of tumor invasion and induction of apoptosis</strong> by regulating the activity of the PTEN/AKT/NF-&#954;B/survivin signaling pathway.<span> </span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5950550/">https://pmc.ncbi.nlm.nih.gov/articles/PMC5950550/</a></em></p><p>[C]<span> </span>CHENG R LIU Y-J CUI J-W, 2018.<span> </span><em>Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells<span> </span>Oncotarget. 2017; 8:30252-30264. <a href="https://doi.org/10.18632/oncotarget.16325">https://doi.org/10.18632/oncotarget.16325</a></em></p><p>[D]<span> </span>HSIEH C-C, HUANG Y-S, 2016. <em>Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production.</em><strong> </strong>Research Article Published: January 21, 2016<span> </span><a href="https://doi.org/10.1371/journal.pone.0147161">https://doi.org/10.1371/journal.pone.0147161</a></p><p>Abstract</p><p>Breast cancer is one of the most common cancers in women worldwide. The obesity process is normally accompanied by chronic, low-grade inflammation. Infiltration by inflammatory cytokines and immune cells provides a favorable microenvironment for tumor growth, migration, and metastasis. Epidemiological evidence has shown that aspirin is an effective agent against several types of cancer. The aim of this study is to investigate the anti-inflammatory and anti-cancer effects of aspirin on 3T3-L1 adipocytes, 4T1 murine breast cancer cells, and their crosstalk. The results showed that aspirin treatment inhibited differentiation and lipid accumulation by 3T3-L1 preadipocytes, and <em>decreased the secretion of the inflammatory adipokine MCP-1</em> after stimulation with tumor necrosis factor (TNF)-&#945; or conditioned medium from RAW264.7 cells. In 4T1 cells, treatment with aspirin decreased cell viability and migration, possibly by suppressing MCP-1 and VEGF secretion. Subsequently, culture of 4T1 cells in 3T3-L1 adipocyte-conditioned medium (Ad-CM) and co-culture of 3T3-L1 and 4T1 cells using a transwell plate were performed to clarify the relationship between these two cell lines. Aspirin exerted its inhibitory effects in the transwell co-culture system, as well as the conditioned-medium model. Aspirin treatment significantly inhibited the proliferation of 4T1 cells, and decreased the production of MCP-1 and PAI-1 in both the Ad-CM model and co-culture system. Aspirin inhibited inflammatory MCP-1 adipokine production by 3T3-L1 adipocytes and the cell growth and migration of 4T1 cells. It also broke the crosstalk between these two cell lines, possibly contributing to its chemopreventive properties in breast cancer. This is the first report that aspirin&#8217;s chemopreventive activity supports the potential application in auxiliary therapy against obesity-related breast cancer development.</p><p>References</p><ol><li><p><strong>1.</strong>World Health Organization (WHO) Media Center, Geneva. 2015. Obesity and overweight. Facts about overweight and obesity. Available: <a href="http://www.who.int/mediacentre/factsheets/fs311/en/">http://www.who.int/mediacentre/factsheets/fs311/en/#</a>.</p></li><li><p><strong>2.</strong>Catal&#225;n V, G&#243;mez-Ambrosi J, Rodr&#237;guez A, Fr&#252;hbeck G. Adipose tissue immunity and cancer. Front Physiol. 2013;4:275. pmid:24106481</p><ul><li><p><a href="https://doi.org/10.3389/fphys.2013.00275">View Article</a></p></li></ul></li></ol><ol start="2"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24106481">PubMed/NCBI</a></p></li></ul><ol start="2"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Adipose+tissue+immunity+and+cancer+Catal%C3%A1n+2013">Google Scholar</a></p></li></ul><ol start="3"><li><p><strong>3.</strong>Sundaram S, Johnson AR, Makowski L. Obesity, metabolism and the microenvironment: Links to cancer. J Carcinog. 2013;12:19. pmid:24227994</p><ul><li><p><a href="https://doi.org/10.4103/1477-3163.119606">View Article</a></p></li></ul></li></ol><ol start="3"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24227994">PubMed/NCBI</a></p></li></ul><ol start="3"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Obesity%2C+metabolism+and+the+microenvironment%3A+Links+to+cancer+Sundaram+2013">Google Scholar</a></p></li></ul><ol start="4"><li><p><strong>4.</strong>Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113&#8211;27. pmid:25006217</p><ul><li><p><a href="https://doi.org/10.1530/JOE-14-0283">View Article</a></p></li></ul></li></ol><ol start="4"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/25006217">PubMed/NCBI</a></p></li></ul><ol start="4"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=The+role+of+adipose+tissue+immune+cells+in+obesity+and+low-grade+inflammation+Mraz+2014">Google Scholar</a></p></li></ul><ol start="5"><li><p><strong>5.</strong>De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546. pmid:24073332</p><ul><li><p><a href="https://doi.org/10.1155/2013/291546">View Article</a></p></li></ul></li></ol><ol start="5"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24073332">PubMed/NCBI</a></p></li></ul><ol start="5"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Obesity+as+a+major+risk+factor+for+cancer+De+Pergola+2013">Google Scholar</a></p></li></ul><ol start="6"><li><p><strong>6.</strong>Alegre MM, Knowles MH, Robison RA, O&#8217;Neill KL. Mechanics behind breast cancer prevention&#8212;focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev. 2013;14(4):2207&#8211;2212. pmid:23725113</p><ul><li><p><a href="https://doi.org/http:/dx.doi.org/10.7314/APJCP.2013.14.4.2207">View Article</a></p></li></ul></li></ol><ol start="6"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23725113">PubMed/NCBI</a></p></li></ul><ol start="6"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Mechanics+behind+breast+cancer+prevention%E2%80%94focus+on+obesity%2C+exercise+and+dietary+fat+Alegre+2013">Google Scholar</a></p></li></ul><ol start="7"><li><p><strong>7.</strong>World Cancer Research Fund International (WCRF). Breast cancer statistics. 2012. Available: <a href="http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/breast-cancer-statistics">http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/breast-cancer-statistics</a>.</p></li><li><p><strong>8.</strong>Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available: </p></li></ol><p>http://globocan.iarc.fr</p><ol start="7"><li><p>, accessed on 16/01/2015.</p></li><li><p><strong>9.</strong>Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423&#8211;1437. pmid:24202395</p><ul><li><p><a href="https://doi.org/10.1038/nm.3394">View Article</a></p></li></ul></li></ol><ol start="9"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24202395">PubMed/NCBI</a></p></li></ul><ol start="9"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Microenvironmental+regulation+of+tumor+progression+and+metastasis+Quail+2013">Google Scholar</a></p></li></ul><ol start="10"><li><p><strong>10.</strong>Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 2008;18(1):3&#8211;10. pmid:18325755</p><ul><li><p><a href="https://doi.org/10.1016/j.gde.2008.01.003">View Article</a></p></li></ul></li></ol><ol start="10"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18325755">PubMed/NCBI</a></p></li></ul><ol start="10"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Pathways+connecting+inflammation+and+cancer+Allavena+2008">Google Scholar</a></p></li></ul><ol start="11"><li><p><strong>11.</strong>Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal. 2008;10(3):475&#8211;510. pmid:18154485</p><ul><li><p><a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0147161&amp;utm_source=chatgpt.com">View Article</a></p></li></ul></li></ol><ol start="11"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18154485">PubMed/NCBI</a></p></li></ul><ol start="11"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Cancer+chemoprevention+through+dietary+antioxidants%3A+progress+and+promise+Khan+2008">Google Scholar</a></p></li></ul><ol start="12"><li><p><strong>12.</strong>Ford NA, Lashinger LM, Allott EH, Hursting SD. Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link. Front Oncol. 2013;3:209. pmid:23967401</p><ul><li><p><a href="https://doi.org/10.3389/fonc.2013.00209">View Article</a></p></li></ul></li></ol><ol start="12"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23967401">PubMed/NCBI</a></p></li></ul><ol start="12"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Mechanistic+targets+and+phytochemical+strategies+for+breaking+the+obesity-cancer+link+Ford+2013">Google Scholar</a></p></li></ul><ol start="13"><li><p><strong>13.</strong>Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10(5):501&#8211;507. pmid:19410194</p><ul><li><p><a href="https://doi.org/10.1016/S1470-2045(09)70035-X">View Article</a></p></li></ul></li></ol><ol start="13"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19410194">PubMed/NCBI</a></p></li></ul><ol start="13"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+and+non-steroidal+anti-inflammatory+drugs+for+cancer+prevention%3A+an+international+consensus+statement+Cuzick+2009">Google Scholar</a></p></li></ul><ol start="14"><li><p><strong>14.</strong>Ansara AJ, Nisly SA, Arif SA, Koehler JM, Nordmeyer ST. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature. Ann Pharmacother. 2010;44(5):851&#8211;862. pmid:20388864</p><ul><li><p><a href="https://doi.org/10.1345/aph.1M346">View Article</a></p></li></ul></li></ol><ol start="14"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20388864">PubMed/NCBI</a></p></li></ul><ol start="14"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+dosing+for+the+prevention+and+treatment+of+ischemic+stroke%3A+an+indication-specific+review+of+the+literature+Ansara+2010">Google Scholar</a></p></li></ul><ol start="15"><li><p><strong>15.</strong>Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23(6):1403&#8211;1415. pmid:22517822</p><ul><li><p><a href="https://doi.org/10.1093/annonc/mds113">View Article</a></p></li></ul></li></ol><ol start="15"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22517822">PubMed/NCBI</a></p></li></ul><ol start="15"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+and+cancer+risk%3A+a+quantitative+review+to+2011+Bosetti+2012">Google Scholar</a></p></li></ul><ol start="16"><li><p><strong>16.</strong>Singh-Ranger G, Salhab M, Mokbel K. The role of cyclooxygenase-2 in breast cancer: Review. Breast Cancer Res Treat. 2008;109(2):189&#8211;198. pmid:17624587</p><ul><li><p><a href="https://doi.org/10.1007/s10549-007-9641-5">View Article</a></p></li></ul></li></ol><ol start="16"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17624587">PubMed/NCBI</a></p></li></ul><ol start="16"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=The+role+of+cyclooxygenase-2+in+breast+cancer%3A+Review+Singh-Ranger+2008">Google Scholar</a></p></li></ul><ol start="17"><li><p><strong>17.</strong>Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28(9):1467&#8211;1472. pmid:20159825</p><ul><li><p><a href="https://doi.org/10.1200/JCO.2009.22.7918">View Article</a></p></li></ul></li></ol><ol start="17"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20159825">PubMed/NCBI</a></p></li></ul><ol start="17"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+intake+and+survival+after+breast+cancer+Holmes+2010">Google Scholar</a></p></li></ul><ol start="18"><li><p><strong>18.</strong>Thorat MA, Cuzick J. Role of Aspirin in Cancer Prevention. Curr Oncol Rep. 2013;15:533&#8211;540. pmid:24114189</p><ul><li><p><a href="https://doi.org/10.1007/s11912-013-0351-3">View Article</a></p></li></ul></li></ol><ol start="18"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24114189">PubMed/NCBI</a></p></li></ul><ol start="18"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Role+of+Aspirin+in+Cancer+Prevention+Thorat+2013">Google Scholar</a></p></li></ul><ol start="19"><li><p><strong>19.</strong>Chattopadhyay M, Kodela R, Nath N, Barsegian A, Boring D, Kashfi K. Hydrogen sulfide-releasing aspirin suppresses NF-&#954;B signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochem Pharmacol. 2012;83(6):723&#8211;732. pmid:22209867</p><ul><li><p><a href="https://doi.org/10.1016/j.bcp.2011.12.019">View Article</a></p></li></ul></li></ol><ol start="19"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22209867">PubMed/NCBI</a></p></li></ul><ol start="19"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Hydrogen+sulfide-releasing+aspirin+suppresses+NF-%CE%BAB+signaling+in+estrogen+receptor+negative+breast+cancer+cells+in+vitro+and+in+vivo+Chattopadhyay+2012">Google Scholar</a></p></li></ul><ol start="20"><li><p><strong>20.</strong>Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95(7):702&#8211;717. pmid:25867761</p><ul><li><p><a href="https://doi.org/10.1038/labinvest.2015.49">View Article</a></p></li></ul></li></ol><ol start="20"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/25867761">PubMed/NCBI</a></p></li></ul><ol start="20"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+blocks+growth+of+breast+tumor+cells+and+tumor-initiating+cells+and+induces+reprogramming+factors+of+mesenchymal+to+epithelial+transition+Maity+2015">Google Scholar</a></p></li></ul><ol start="21"><li><p><strong>21.</strong>Patel PS, Buras ED, Balasubramanyam A. The role of the immune system in obesity and insulin resistance. J Obes. 2013;2013:616193. pmid:23577240</p><ul><li><p><a href="https://doi.org/10.1155/2013/616193">View Article</a></p></li></ul></li></ol><ol start="21"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23577240">PubMed/NCBI</a></p></li></ul><ol start="21"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=The+role+of+the+immune+system+in+obesity+and+insulin+resistance+Patel+2013">Google Scholar</a></p></li></ul><ol start="22"><li><p><strong>22.</strong>Mazid MA, Chowdhury AA, Nagao K, Nishimura K, Jisaka M, Nagaya T, et al. Endogenous 15-deoxy-D12,14-prostaglandin J2 synthesized by adipocytes during maturation phase contributes to upregulation of fat storage. FEBS Lett. 2006;580(30):6885&#8211;6890. pmid:17150216</p><ul><li><p><a href="https://doi.org/10.1016/j.febslet.2006.11.049">View Article</a></p></li></ul></li></ol><ol start="22"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17150216">PubMed/NCBI</a></p></li></ul><ol start="22"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Endogenous+15-deoxy-D12%2C14-prostaglandin+J2+synthesized+by+adipocytes+during+maturation+phase+contributes+to+upregulation+of+fat+storage+Mazid+2006">Google Scholar</a></p></li></ul><ol start="23"><li><p><strong>23.</strong>Su YF, Yang SH, Lee YH, Wu BC, Huang SC, Liu CM, et al. Aspirin-induced inhibition of adipogenesis was p53-dependentand associated with inactivation of pentose phosphate pathway. Eur J Pharmacol. 2014;738:101&#8211;110. pmid:24726874</p><ul><li><p><a href="https://doi.org/10.1016/j.ejphar.2014.03.009">View Article</a></p></li></ul></li></ol><ol start="23"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24726874">PubMed/NCBI</a></p></li></ul><ol start="23"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin-induced+inhibition+of+adipogenesis+was+p53-dependentand+associated+with+inactivation+of+pentose+phosphate+pathway+Su+2014">Google Scholar</a></p></li></ul><ol start="24"><li><p><strong>24.</strong>Newman G, Gonzalez-Perez RR. Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol. 2014;382(1):570&#8211;582. pmid:23562747</p><ul><li><p><a href="https://doi.org/10.1016/j.mce.2013.03.025">View Article</a></p></li></ul></li></ol><ol start="24"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23562747">PubMed/NCBI</a></p></li></ul><ol start="24"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Leptin-cytokine+crosstalk+in+breast+cancer+Newman+2014">Google Scholar</a></p></li></ul><ol start="25"><li><p><strong>25.</strong>Zhou Y, Liu BL, Liu K, Tang N, Huang J, An Y, et al. Establishment of the Insulin Resistance Induced by Inflammatory Response in 3T3-L1 Preadipocytes Cell Line. Inflammation. 2008;31(5):355&#8211;364. pmid:18807159</p><ul><li><p><a href="https://doi.org/10.1007/s10753-008-9086-y">View Article</a></p></li></ul></li></ol><ol start="25"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18807159">PubMed/NCBI</a></p></li></ul><ol start="25"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Establishment+of+the+Insulin+Resistance+Induced+by+Inflammatory+Response+in+3T3-L1+Preadipocytes+Cell+Line+Zhou+2008">Google Scholar</a></p></li></ul><ol start="26"><li><p><strong>26.</strong>An Y, Liu K, Zhou Y, Liu B. Salicylate Inhibits Macrophage-Secreted Factors Induced Adipocyte Inflammation and Changes of Adipokines in 3T3-L1 Adipocytes. Inflammation. 2009;32(5):296&#8211;303. pmid:19609658</p><ul><li><p><a href="https://doi.org/10.1007/s10753-009-9135-1">View Article</a></p></li></ul></li></ol><ol start="26"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19609658">PubMed/NCBI</a></p></li></ul><ol start="26"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Salicylate+Inhibits+Macrophage-Secreted+Factors+Induced+Adipocyte+Inflammation+and+Changes+of+Adipokines+in+3T3-L1+Adipocytes+An+2009">Google Scholar</a></p></li></ul><ol start="27"><li><p><strong>27.</strong>Ogston NC, Karastergiou K, Hosseinzadeh-Attar MJ, Bhome R, Madani R, Stables M, et al. Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue. Int J Obes. 2008;32(12):1807&#8211;15.</p><ul><li><p><a href="https://doi.org/10.1038/ijo.2008.190">View Article</a></p></li></ul></li></ol><ol start="27"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Low-dose+acetylsalicylic+acid+inhibits+the+secretion+of+interleukin-6+from+white+adipose+tissue+Ogston+2008">Google Scholar</a></p></li></ul><ol start="28"><li><p><strong>28.</strong>Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol. 2012;167(2):195&#8211;205. pmid:22235995</p><ul><li><p><a href="https://doi.org/10.1111/j.1365-2249.2011.04515.x">View Article</a></p></li></ul></li></ol><ol start="28"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22235995">PubMed/NCBI</a></p></li></ul><ol start="28"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Immunology+in+the+clinic+review+series%3B+focus+on+cancer%3A+tumour-associated+macrophages%3A+undisputed+stars+of+the+inflammatory+tumour+microenvironment+Allavena+2012">Google Scholar</a></p></li></ul><ol start="29"><li><p><strong>29.</strong>Song H, Jung JI, Cho HJ, Her S, Kwon SH, Yu R, Kang YH, Lee KW, Park JH. Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration. J Nutr Biochem. 2015 Nov;26(11):1368&#8211;78. pmid:26297476</p><ul><li><p><a href="https://doi.org/10.1016/j.jnutbio.2015.07.005">View Article</a></p></li></ul></li></ol><ol start="29"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26297476">PubMed/NCBI</a></p></li></ul><ol start="29"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Inhibition+of+tumor+progression+by+oral+piceatannol+in+mouse+4T1+mammary+cancer+is+associated+with+decreased+angiogenesis+and+macrophage+infiltration+Song+2015">Google Scholar</a></p></li></ul><ol start="30"><li><p><strong>30.</strong>Li M, Knight DA, Snyder LA, Smyth MJ, Stewart TJ. A role for CCL2 in both tumor progression and immunosurveillance. Oncoimmunology. 2013;2(7):e25474. pmid:24073384</p><ul><li><p><a href="https://doi.org/10.4161/onci.25474">View Article</a></p></li></ul></li></ol><ol start="30"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24073384">PubMed/NCBI</a></p></li></ul><ol start="30"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=A+role+for+CCL2+in+both+tumor+progression+and+immunosurveillance+Li+2013">Google Scholar</a></p></li></ul><ol start="31"><li><p><strong>31.</strong>Hitchcock JR, Watson CJ. Anti-CCL2: building a reservoir or opening the floodgates to metastasis? Breast Cancer Res. 2015,17:68. pmid:25990313</p><ul><li><p><a href="https://doi.org/10.1186/s13058-015-0573-4">View Article</a></p></li></ul></li></ol><ol start="31"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/25990313">PubMed/NCBI</a></p></li></ul><ol start="31"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Anti-CCL2%3A+building+a+reservoir+or+opening+the+floodgates+to+metastasis%3F+Hitchcock+2015">Google Scholar</a></p></li></ul><ol start="32"><li><p><strong>32.</strong>Zarogoulidis P, Tsakiridis K, Karapantzou C, Lampaki S, Kioumis I, Pitsiou G, et al. Use of proteins as biomarkers and their role in carcinogenesis. J Cancer. 2015;6(1):9&#8211;18. pmid:25553084</p><ul><li><p><a href="https://doi.org/10.7150/jca.10560">View Article</a></p></li></ul></li></ol><ol start="32"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/25553084">PubMed/NCBI</a></p></li></ul><ol start="32"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Use+of+proteins+as+biomarkers+and+their+role+in+carcinogenesis+Zarogoulidis+2015">Google Scholar</a></p></li></ul><ol start="33"><li><p><strong>33.</strong>Saxena NK, Sharma D. Multifaceted leptin network: the molecular connection between obesity and breast cancer. J Mammary Gland Biol Neoplasia. 2013;18(3&#8211;4):309&#8211;320. pmid:24214584</p><ul><li><p><a href="https://doi.org/10.1007/s10911-013-9308-2">View Article</a></p></li></ul></li></ol><ol start="33"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24214584">PubMed/NCBI</a></p></li></ul><ol start="33"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Multifaceted+leptin+network%3A+the+molecular+connection+between+obesity+and+breast+cancer+Saxena+2013">Google Scholar</a></p></li></ul><ol start="34"><li><p><strong>34.</strong>Viana CT, Castro PR, Marques SM, Lopes MT, Gon&#231;alves R, Campos PP, et al. Correction: Differential Contribution of Acute and Chronic Inflammation to the Development of Murine Mammary 4T1 Tumors. PLoS One. 2015;10(9):e0138408. pmid:26367444</p><ul><li><p><a href="https://doi.org/10.1371/journal.pone.0138408">View Article</a></p></li></ul></li></ol><ol start="34"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26367444">PubMed/NCBI</a></p></li></ul><ol start="34"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Correction%3A+Differential+Contribution+of+Acute+and+Chronic+Inflammation+to+the+Development+of+Murine+Mammary+4T1+Tumors+Viana+2015">Google Scholar</a></p></li></ul><ol start="35"><li><p><strong>35.</strong>Madera L, Greenshields A, Coombs MR, Hoskin DW. 4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses. PLoS One. 2015;10(7):e0133385. pmid:26177198</p><ul><li><p><a href="https://doi.org/10.1371/journal.pone.0133385">View Article</a></p></li></ul></li></ol><ol start="35"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26177198">PubMed/NCBI</a></p></li></ul><ol start="35"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=4T1+Murine+Mammary+Carcinoma+Cells+Enhance+Macrophage-Mediated+Innate+Inflammatory+Responses+Madera+2015">Google Scholar</a></p></li></ul><ol start="36"><li><p><strong>36.</strong>Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13(5):518&#8211;527. pmid:22440112</p><ul><li><p><a href="https://doi.org/10.1016/S1470-2045(12)70112-2">View Article</a></p></li></ul></li></ol><ol start="36"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22440112">PubMed/NCBI</a></p></li></ul><ol start="36"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Effects+of+regular+aspirin+on+long-term+cancer+incidence+and+metastasis%3A+a+systematic+comparison+of+evidence+from+observational+studies+versus+randomised+trials+Algra+2012">Google Scholar</a></p></li></ul><ol start="37"><li><p><strong>37.</strong>Holmes MD, Chen WY. Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res. 2012;14(6):216. pmid:23227958</p><ul><li><p><a href="https://doi.org/10.1186/bcr3336">View Article</a></p></li></ul></li></ol><ol start="37"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23227958">PubMed/NCBI</a></p></li></ul><ol start="37"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Hiding+in+plain+view%3A+the+potential+for+commonly+used+drugs+to+reduce+breast+cancer+mortality+Holmes+2012">Google Scholar</a></p></li></ul><ol start="38"><li><p><strong>38.</strong>Huang XZ, Gao P, Sun JX, Song YX, Tsai CC, Liu J, et al. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. Cancer Causes Control. 2015;26(4):589&#8211;600. pmid:25701248</p><ul><li><p><a href="https://doi.org/10.1007/s10552-015-0539-y">View Article</a></p></li></ul></li></ol><ol start="38"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/25701248">PubMed/NCBI</a></p></li></ul><ol start="38"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+and+nonsteroidal+anti-inflammatory+drugs+after+but+not+before+diagnosis+are+associated+with+improved+breast+cancer+survival%3A+a+meta-analysis+Huang+2015">Google Scholar</a></p></li></ul><ol start="39"><li><p><strong>39.</strong>Zhong S, Chen L, Zhang X, Yu D, Tang J, Zhao J. Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1&#8211;11.</p><ul><li><p><a href="https://doi.org/10.1158/1055-9965.EPI-15-0452">View Article</a></p></li></ul></li></ol><ol start="39"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Aspirin+Use+and+Risk+of+Breast+Cancer%3A+Systematic+Review+and+Meta-analysis+of+Observational+Studies+Zhong+2015">Google Scholar</a></p></li></ul><ol start="40"><li><p><strong>40.</strong>Usman MW, Luo F, Cheng H, Zhao JJ, Liu P. Chemopreventive effects of aspirin at a glance. Biochim Biophys Acta. 2015;1855(2):254&#8211;263. pmid:25842298</p><ul><li><p><a href="https://doi.org/10.1016/j.bbcan.2015.03.007">View Article</a></p></li></ul></li></ol><ol start="40"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/25842298">PubMed/NCBI</a></p></li></ul><ol start="40"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Chemopreventive+effects+of+aspirin+at+a+glance+Usman+2015">Google Scholar</a></p></li></ul><ol start="41"><li><p><strong>41.</strong><span>Chen CT, Du Y, Yamaguchi H, Hsu JM, Kuo HP, Hortobagyi GN, et al. Targeting the IKK&#946;/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer. Mol Cancer Ther. 2012;11(10):2212&#8211;2221. pmid:22826466</span></p><ul><li><p><a href="https://doi.org/10.1158/1535-7163.MCT-12-0180"><span>View Article</span></a></p></li></ul></li></ol><ol start="41"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22826466"><span>PubMed/NCBI</span></a></p></li></ul><ol start="41"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Targeting+the+IKK%CE%B2%2FmTOR%2FVEGF+signaling+pathway+as+a+potential+therapeutic+strategy+for+obesity-related+breast+cancer+Chen+2012"><span>Google Scholar</span></a></p></li></ul><ol start="42"><li><p><strong><span>42.</span></strong><span>Dubois V, Delort L, Billard H, Vasson MP, Caldefie-Chezet F. Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies? PLoS ONE 2013;8(3):e58541. pmid:23554900</span></p><ul><li><p><a href="https://doi.org/10.1371/journal.pone.0058541"><span>View Article</span></a></p></li></ul></li></ol><ol start="42"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23554900"><span>PubMed/NCBI</span></a></p></li></ul><ol start="42"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Breast+Cancer+and+Obesity%3A+In+Vitro+Interferences+between+Adipokines+and+Proangiogenic+Features+and%2For+Antitumor+Therapies%3F+Dubois+2013"><span>Google Scholar</span></a></p></li></ul><ol start="43"><li><p><strong><span>43.</span></strong><span>Carter JC, Church FC. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-&#947; and plasminogen activator inhibitor-1. PPAR Res. 2009;2009:345320. pmid:19672469</span></p></li></ol><ul><li><p><a href="https://doi.org/10.1155/2009/345320">View Article</a></p></li></ul><ol start="43"><li></li></ol><ul><li><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19672469">PubMed/NCBI</a></p></li></ul><ol start="43"><li></li></ol><ul><li><p><a href="http://scholar.google.com/scholar?q=Obesity+and+breast+cancer%3A+the+roles+of+peroxisome+proliferator-activated+receptor-%CE%B3+and+plasminogen+activator+inhibitor-1+Carter+2009">Google Scholar</a></p></li></ul><p>Fonte: <a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0147161&amp;utm_source=chatgpt.com">Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production | PLOS One</a></p><p>[E]<span> </span>MILLER I S KHAN S, 2022. <em>Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects</em><strong>. </strong>Cancer Med. 2022 Oct;11(20):3820-3836. doi: 10.1002/cam4.4756. Epub 2022 Apr 17. PMID: 35434898<span> </span>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9582689/">PMC9582689</a><span> </span>DOI: <a href="https://doi.org/10.1002/cam4.4756">10.1002/cam4.4756</a></p><p><strong>Abstract</strong></p><p><strong>Backgorund: </strong>Prior data suggest pre-diagnostic aspirin use impacts breast tumour biology and patient outcome. Here, we employed faithful surgical resection models of HER2+ and triple-negative breast cancer (TNBC), to study outcome and response mechanisms across breast cancer subtypes.</p><p><strong>Method: </strong>NOD/SCID mice were implanted with HER2+ MDA-MB-231/LN/2-4/H2N, trastuzumab-resistant HER2+ HCC1954 or a TNBC patient-derived xenograft (PDX). A daily low-dose aspirin regimen commenced until primary tumours reached ~250 mm<sup>3</sup> and subsequently resected. MDA-MB-231/LN/2-4/H2N mice were monitored for metastasis utilising imaging. To interrogate the survival benefit of pre-treatment aspirin, 3 weeks post-resection, HCC1954/TNBC animals received standard-of-care (SOC) chemotherapy for 6 weeks. Primary tumour response to aspirin was interrogated using immunohistochemistry.</p><p><strong>Results: </strong>Aspirin delayed time to metastasis in MDA-MB-231/LN/2-4/H2N xenografts and decreased growth of HER2<sup>+</sup> /TNBC primary tumours. Lymphangiogenic factors and lymph vessels number were decreased in HER2<sup>+</sup> tumours. However, no survival benefit was seen in aspirin pre-treated animals (HCC1954/TNBC) that further received adjuvant SOC, compared with animals treated with SOC alone. In an effort to study mechanisms responsible for the observed reduction in lymphangiogenesis in HER2<sup>+</sup> BC we utilised an in vitro co-culture system of HCC1954 tumour cells and mesenchymal stromal cells (MSC). <em>Aspirin abrogated the secretion of VEGF-C in MSCs and also decreased the lymph/angiogenic potential of the MSCs and HCC1954 by tubule formation assay. Furthermore, aspirin decreased the secretion of uPA in HCC1954 cells potentially diminishing its metastatic capability.</em></p><p><strong>Conclusion: </strong>Our data employing clinically relevant models demonstrate that aspirin alters breast tumour biology.</p><p>[F]<span> </span><a href="https://elpais.com/salud-y-bienestar/2025-03-05/descubierto-el-mecanismo-por-el-que-la-aspirina-puede-prevenir-metastasis.html?utm_source=chatgpt.com">Descubierto el mecanismo por el que la aspirina puede prevenir met&#225;stasis | Salud y bienestar | EL PA&#205;S</a></p><p>[G]<span> </span>As doses de AAS usadas em estudos celulares (<em>in vitro</em>) s&#227;o maiores do que as utilizadas daquela vez em humanos. Em cultura celular n&#227;o se fala em mg, e sim em concentra&#231;&#227;o molar. As doses usadas s&#227;o ordens de magnitude acima do que 300 mg produzem em humanos.</p><p>Faixas t&#237;picas usadas:</p><p><span>&#183; </span>0,5 mM</p><p><span>&#183; </span>1 mM</p><p><span>&#183; </span>2,5 mM</p><p><span>&#183; </span>5 mM</p><p><span>&#183; </span>10 mM</p><p>Essas concentra&#231;&#245;es s&#227;o usadas em linhas como: MCF-7 (ER+), MDA-MB-231 (triplo negativo), 4T1 (murina, altamente metast&#225;tica)</p><p>O que acontece nessas concentra&#231;&#245;es:<span> </span>inibi&#231;&#227;o clara de prolifera&#231;&#227;o; Indu&#231;&#227;o de apoptose; redu&#231;&#227;o de migra&#231;&#227;o e invas&#227;o; supress&#227;o de COX-2 / PGE&#8322;; altera&#231;&#245;es metab&#243;licas (mitoc&#244;ndria, glic&#243;lise)</p><p>Compara&#231;&#227;o direta:</p><p><span>&#183; </span>300 mg oral em humano &#8594; picos plasm&#225;ticos &#8776; 0,1&#8211;0,2 mM (quando muito)</p><p><span>&#183; </span>Estudos celulares eficazes &#8594; 0,5&#8211;10 mM</p><p>Ou seja: o RCT humano nunca chegou nem perto da faixa ativa usada in vitro.</p><p>Estudos em animais (pr&#233;-cl&#237;nicos)</p><p>Aqui falamos em mg/kg, e os n&#250;meros s&#227;o muito claros.</p><p>Doses t&#237;picas usadas:</p><p><span>&#183; </span>50 mg/kg/dia</p><p><span>&#183; </span>100 mg/kg/dia</p><p><span>&#183; </span>200 mg/kg/dia</p><p><span>&#183; </span>Alguns estudos chegam a 300 mg/kg/dia</p><p>Administradas por:</p><p><span>&#183; </span>gavagem oral</p><p><span>&#183; </span>&#225;gua de beber</p><p><span>&#183; </span>inje&#231;&#227;o intraperitoneal</p><p>Essas doses: reduzem crescimento tumoral; reduzem met&#225;stase; alteram microambiente inflamat&#243;rio; n&#227;o s&#227;o compar&#225;veis a &#8220;aspirina cardiol&#243;gica&#8221;, isto &#233;, AAS minidose.</p><p>Compara&#231;&#227;o simples (sem convers&#227;o ainda)</p><p>Modelo</p><p>Dose usada</p><p>Humano (RCT)</p><p>300 mg total/dia</p><p>Animal</p><p>50&#8211;200 mg/kg/dia</p><p>Celular</p><p>0,5&#8211;10 mM</p><p>S&#243; olhando isso j&#225; fica evidente: o ensaio humano foi sub-farmacol&#243;gico em rela&#231;&#227;o ao que funcionou nos modelos experimentais.</p><p>Exemplo real (t&#237;pico da literatura)</p><p>Animal: 100 mg/kg/dia em camundongo</p><p>Convers&#227;o:</p><p>100&#215;337&#8776;8,1 mg/kg (humano)100 \times \frac{3}{37} \approx 8,1 \text{ mg/kg (humano)}100&#215;373<span>&#8203;</span>&#8776;8,1 mg/kg (humano)</p><p>Para um adulto de 70 kg:</p><p>8,1&#215;70&#8776;567 mg/dia8,1 \times 70 \approx 567 \text{ mg/dia}8,1&#215;70&#8776;567 mg/dia</p><p>Isso j&#225; &#233; quase o dobro do ensaio cl&#237;nico (300 mg)<br>E isso &#233; uma dose intermedi&#225;ria, n&#227;o a mais alta usada.</p><p>Outro exemplo (dose comum em estudos mais &#8220;agressivos&#8221;)</p><p>Animal: 200 mg/kg/dia</p><p>Convers&#227;o:</p><p>200&#215;337&#8776;16,2 mg/kg200 \times \frac{3}{37} \approx 16,2 \text{ mg/kg}200&#215;373<span>&#8203;</span>&#8776;16,2 mg/kg</p><p>Humano (70 kg):</p><p>16,2&#215;70&#8776;1.130 mg/dia16,2 \times 70 \approx 1.130 \text{ mg/dia}16,2&#215;70&#8776;1.130 mg/dia</p><p>Ou seja: doses biologicamente equivalentes ficariam entre 600 mg e 1,2 g/dia, n&#227;o 300 mg.</p><p>E isso ainda &#233; conservador</p><p>Essas convers&#245;es n&#227;o consideram: metabolismo tumoral local;necessidade de atingir concentra&#231;&#227;o intratumoral;efeito de primeira passagem hep&#225;tica;assumem farmacocin&#233;tica &#8220;limpa&#8221;, o que n&#227;o ocorre em c&#226;ncer.</p><p>Na pr&#225;tica, para mimetizar 1&#8211;5 mM in vitro, seriam necess&#225;rias doses humanas ainda maiores, ou estrat&#233;gias de fracionamento / combina&#231;&#227;o metab&#243;lica.</p><p>Conclus&#227;o t&#233;cnica (sem opini&#227;o)</p><p><span>1. </span>Estudos celulares eficazes usam AAS em 0,5&#8211;10 mM</p><p><span>2. </span>Estudos animais eficazes usam 50&#8211;200+ mg/kg/dia</p><p><span>3. </span>A convers&#227;o alom&#233;trica indica 600&#8211;1.200 mg/dia humanos como faixa m&#237;nima compar&#225;vel</p><p><span>4. </span>O ensaio cl&#237;nico de 300 mg/dia ficou abaixo da faixa biologicamente ativa</p><p><span>5. </span>Portanto: o &#250;nico RCT humano existente n&#227;o testou a hip&#243;tese antitumoral de forma s&#233;ria do ponto de vista de dose</p><p>Fa&#231;amos a compara&#231;&#227;o direta entre as doses &#8220;antitumorais&#8221; discutidas e a seguran&#231;a cl&#237;nica hist&#243;rica real do AAS, com dados hist&#243;ricos e farmacol&#243;gicos.</p><p>Doses de AAS usadas historicamente na cl&#237;nica (humanos)</p><p>Antes da era &#8220;cardiol&#243;gica&#8221; (75&#8211;100 mg), o AAS sempre foi um f&#225;rmaco de dose grama.</p><p>Uso hist&#243;rico cl&#225;ssico (s&#233;culo XX)</p><p>Reumatologia / febre reum&#225;tica</p><p><span>&#183; </span>3 a 6 g/dia</p><p><span>&#183; </span>Uso cont&#237;nuo por meses ou anos</p><p><span>&#183; </span>Em adultos e crian&#231;as</p><p><span>&#183; </span>Era tratamento padr&#227;o, n&#227;o experimental</p><p>Isso est&#225; descrito em livros-texto cl&#225;ssicos de medicina interna e farmacologia.</p><p>Doen&#231;as inflamat&#243;rias cr&#244;nicas</p><p><span>&#183; </span>2 a 4 g/dia</p><p><span>&#183; </span>Doses fracionadas (ex.: 500 mg a cada 4&#8211;6 h)</p><p><span>&#183; </span>Usado antes do advento de corticoides e AINEs modernos</p><p>Analgesia / antipir&#233;tico (uso comum antigo)</p><p><span>&#183; </span>1 a 2 g/dia</p><p><span>&#183; </span>Em uso domiciliar, sem prescri&#231;&#227;o</p><p><span>&#183; </span>Por semanas</p><p>Conclus&#227;o hist&#243;rica simples</p><p>Doses entre 1 e 4 g/dia de AAS n&#227;o eram exce&#231;&#227;o &#8212; eram rotina cl&#237;nica durante d&#233;cadas.</p><p>Compara&#231;&#227;o direta com as doses &#8220;antitumorais equivalentes&#8221;</p><p>Vamos alinhar tudo na mesma tabela:</p><p>Contexto</p><p>Dose di&#225;ria</p><p>Aspirina cardiol&#243;gica moderna</p><p>75&#8211;100 mg</p><p>Ensaio cl&#237;nico c&#226;ncer de mama</p><p>300 mg</p><p>Convers&#227;o animal conservadora</p><p>600&#8211;1.200 mg</p><p>Dose antitumoral plaus&#237;vel (in vitro &#8594; humano)</p><p>1&#8211;3 g</p><p>Uso hist&#243;rico reumatol&#243;gico</p><p>3&#8211;6 g</p><p>Ou seja: a dose &#8220;antitumoral plaus&#237;vel&#8221; est&#225; <em>dentro</em> da faixa hist&#243;rica de uso humano: n&#227;o &#233; uma extrapola&#231;&#227;o absurda, n&#227;o &#233; territ&#243;rio desconhecido</p><p>Neste ponto, comportaria o necess&#225;rio debate, j&#225; feito neste blog, sobre seguran&#231;a cl&#237;nica hist&#243;rica real (n&#227;o te&#243;rica).</p><p>De toda forma a aus&#234;ncia de <em>trials</em> com doses mais altas n&#227;o &#233; de ordem cient&#237;fica; como foi dito &#233; muito mais econ&#244;mica e pol&#237;tica.</p><p>***</p>]]></content:encoded></item><item><title><![CDATA[Pregnenolona: algumas anotações de R. Peat ]]></title><description><![CDATA[Um horm&#244;nio que deveria ser parte do arsenal terap&#234;utico da medicina brasileira]]></description><link>https://outramedicina2024.substack.com/p/pregnenolona-algumas-anotacoes-de</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/pregnenolona-algumas-anotacoes-de</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sat, 22 Aug 2026 13:06:51 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!1g1m!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!1g1m!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!1g1m!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg" width="578" height="370" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:370,&quot;width&quot;:578,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:58022,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/212279394?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!1g1m!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39e8acc4-4d2e-4edc-9a48-564f7032d5a0_578x370.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p><span>A pregnenolona natural est&#225; presente em jovens de ambos os sexos em uma concentra&#231;&#227;o muito alta, e uma das raz&#245;es para a grande quantidade produzida &#8211; sobretudo na juventude - &#233; que ela &#233; uma de nossas defesas b&#225;sicas contra os efeitos colaterais nocivos que um desequil&#237;brio, mesmo de nossos horm&#244;nios naturais, pode produzir. Ela opera como um </span><em><span>horm&#244;nio</span></em><span> antiestresse por excel&#234;ncia.</span></p><p><span>Tamanha &#233; a import&#226;ncia sist&#234;mica da pregnenolona que ela &#233; produzida pelas adrenais, por praticamente todas as c&#233;lulas do organismo e, em especial, pelo c&#233;rebro, onde &#233; armazenada em grande quantidade, junto com a progesterona.</span></p><p><span>Portanto, fun&#231;&#245;es cr&#237;ticas e amplo potencial terap&#234;utico.</span></p><p><span>A realidade do nosso pa&#237;s, no entanto, nos coloca diante da seguinte e tr&#225;gica ironia: a import&#226;ncia da pregnenolona por aqui &#233; inversamente proporcional ao descaso das ag&#234;ncias reguladoras em rela&#231;&#227;o ao produto pregnenolona. Voc&#234; vai encontrar facilmente </span><em><span>tylenois, dipironas e omeprazois</span></em><span>, mas n&#227;o a pregnenolona</span></p><p><span>O texto de R. Peat, abaixo, destaca algumas de suas propriedades.</span></p><p><span>&#8220;Em excesso, a cortisona ou o estrog&#234;nio, naturais podem ser perigosos, mas quando h&#225; abund&#226;ncia de pregnenolona, &#8203;&#8203;seus efeitos colaterais s&#227;o prevenidos ou minimizados.</span></p><p><span>Em uma pessoa ou animal jovem e saud&#225;vel, a ingest&#227;o de uma dose alta de pregnenolona n&#227;o tem nenhuma a&#231;&#227;o semelhante &#224; de um horm&#244;nio ou medicamento. Ela &#233; </span><em><span>&#250;nica</span></em><span> nesse sentido. Mas se o animal ou a pessoa estiver </span><em><span>sob estresse</span></em><span> e produzindo mais cortisol do que o normal, a administra&#231;&#227;o de pregnenolona faz com que o cortisol retorne ao n&#237;vel normal.</span></p><p><span>Ap&#243;s os 40 ou 45 anos, aparentemente todos vivem em um estado de &#180;estresse&#180; cont&#237;nuo, como parte normal do envelhecimento. Isso coincide com a diminui&#231;&#227;o da </span><em><span>capacidade do corpo de produzir</span></em><span> pregnenolona em abund&#226;ncia.</span></p><p><span>Quando ratos idosos recebem um suplemento de pregnenolona, &#8203;&#8203;isso melhora imediatamente sua mem&#243;ria e desempenho geral. Estudos em humanos, j&#225; na d&#233;cada de 1940, tamb&#233;m demonstraram melhor desempenho em tarefas comuns. Sabe-se agora que a pregnenolona &#233; um dos </span><em><span>principais horm&#244;nios do c&#233;rebro</span></em><span>. Ela &#233; produzida por certas c&#233;lulas cerebrais, al&#233;m de ser absorvida pelo c&#233;rebro a partir do sangue.</span></p><p><span>Ela protege as c&#233;lulas cerebrais de les&#245;es causadas pela fadiga e, em quantidade adequada, tem um efeito calmante sobre as emo&#231;&#245;es, o que explica, em parte, por que nos protege da resposta ao estresse que leva &#224; produ&#231;&#227;o excessiva de cortisona. As pessoas sentem um estado de esp&#237;rito resiliente e uma capacidade de enfrentar desafios.</span></p><p><span>Muitos estudos demonstraram que a pregnenolona protege os &#180;tecidos fibrosos&#180; em geral e, nesse sentido, comprovou-se que ela previne tumores que podem ser causados &#8203;&#8203;pelo estrog&#234;nio.</span></p><p><span>A pregnenolona &#233; amplamente convertida em dois outros horm&#244;nios protetores &#180;associados &#224; juventude&#180;, a progesterona e o DHEA. Aos 30 anos, homens e mulheres produzem aproximadamente de 30 a 50 mg de pregnenolona por dia</span></p><p><span>Uma dose de aproximadamente 300 mg (o tamanho de um comprimido de aspirina) continua agindo por cerca de uma semana. Parte desse efeito duradouro se deve ao fato de que ela melhora a capacidade do corpo de produzir sua pr&#243;pria pregnenolona. Ela tende a melhorar a fun&#231;&#227;o da tireoide e de outras gl&#226;ndulas, e esse efeito &#180;normalizador&#180; sobre as outras gl&#226;ndulas ajuda a explicar sua ampla gama de efeitos ben&#233;ficos&#8221;.</span></p><p>A ironia vai mais longe: no nosso curso de medicina, UnB, a pregnenolona sequer foi citada e na endocrinologia ela continua sendo um grande ausente.</p><p>G Dantas, SP, 22-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong>Notas</strong> _____________</p><p>[A]<span> </span>MAYO W, GEORGE O, DARBRA S, 2003. <em>Individual differences in cognitive aging: implication of pregnenolone sulfate.</em><strong> </strong>Prog Neurobiol. 2003 Sep;71(1):43-8. doi: 10.1016/j.pneurobio.2003.09.006.   PMID: 14611866<span> </span>DOI: <a href="https://doi.org/10.1016/j.pneurobio.2003.09.006">10.1016/j.pneurobio.2003.09.006</a></p><p><strong>Abstract</strong></p><p>In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation between the cognitive performance and the cerebral concentration of a neurosteroid, the pregnenolone sulfate (PREG-S). Neurotransmitter systems modulated by this neurosteroid were unknown until our recent report of an enhancement of acetylcholine (ACh) release in basolateral amygdala, cortex and hippocampus induced by intracerebroventricular (i.c.v.) or intracerebral administrations of PREG-S. Central ACh neurotransmission is known to be involved in the regulation of memory processes and is affected in normal aging and severely altered in human neurodegenerative pathologies like Alzheimer&#8217;s disease. In the central nervous system, ACh neurotransmission is also involved in the modulation of sleep-wakefulness cycle, and particularly the paradoxical sleep (PS). Relationships between paradoxical sleep and memory are documented in the literature in old animals in which the spatial memory performance positively correlates with the basal amounts of paradoxical sleep. PREG-S infused at the level of ACh cell bodies (nucleus basalis magnocellularis, NBM, or pedunculopontine nucleus, PPT) increases paradoxical sleep in young animals.Finally, aging related cognitive dysfunctions, particularly those observed in Alzheimer&#8217;s disease, have also been related to alterations of mechanisms underlying cerebral plasticity. Amongst these mechanisms, neurogenesis has been extensively studied recently. Our data demonstrate that PREG-S central infusions dramatically increase neurogenesis, this effect could be related to the negative modulator properties of this steroid at the GABA(A) receptor level. Taken together these data suggest that neurosteroids can influence cognitive processes, particularly in senescent subjects, through a modulation of ACh neurotransmission associated with paradoxical sleep modifications; furthermore, our recent data suggest a critical role for neurosteroids in the modulation of cerebral plasticity, mainly on hippocampal neurogenesis.</p><p>[B]<span> </span>VALL&#201;E M MAYO W, 1997. <em>Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. </em>Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14865-70. doi: 10.1073/pnas.94.26.14865.<strong><span> </span></strong>PMID: 9405705<strong><span> </span></strong>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC25129/">PMC25129</a>DOI: <a href="https://doi.org/10.1073/pnas.94.26.14865">10.1073/pnas.94.26.14865</a></p><p><strong>Abstract</strong></p><p>Pregnenolone sulfate (PREG S) is synthesized in the nervous system and is a major neurosteroid in the rat brain. Its concentrations were measured in the hippocampus and other brain areas of single adult and aged (22-24 month-old) male Sprague-Dawley rats. Significantly lower levels were found in aged rats, although the values were widely scattered and reached, in about half the animals, the same range as those of young ones. The spatial memory performances of aged rats were investigated in two different spatial memory tasks, the Morris water maze and Y-maze. Performances in both tests were significantly correlated and, accompanied by appropriate controls, likely evaluated genuine memory function. Importantly, individual hippocampal PREG S and distance to reach the platform in the water maze were linked by a significant correlation, i.e., those rats with lower memory deficit had the highest PREG S levels, whereas no relationship was found with the PREG S content in other brain areas (amygdala, prefrontal cortex, parietal cortex, striatum). Moreover, the memory deficit of cognitively impaired aged rats was transiently corrected after either intraperitoneal or bilateral intrahippocampal injection of PREG S. PREG S is both a gamma-aminobutyric acid antagonist and a positive allosteric modulator at the N-methyl-D-aspartate receptor, and may reinforce neurotransmitter system(s) that decline with age. Indeed, intracerebroventricular injection of PREG S was shown to stimulate acetylcholine release in the adult rat hippocampus. In conclusion, it is proposed that the hippocampal content of PREG S plays a physiological role in preserving and/or enhancing cognitive abilities in old animals, possibly via an interaction with central cholinergic systems. Thus, neurosteroids should be further studied in the context of prevention and/or treatment of age-related memory disorders.</p><p>[C]<span> </span>AKWA Y BAULIEU E E 1999<em><strong>. [Neurosteroids: behavioral aspects and physiological implications]</strong></em><strong> </strong>J Soc Biol. 1999;193(3):293-8.<span> </span>[Article in French]   PMID: 10542960</p><p><strong>Abstract</strong></p><p>The term &#8220;neurosteroids&#8221; applies to those steroids that are both formed in the nervous system from sterol precursors, and accumulate in the nervous system, at least in part, independently of peripheral steroidogenic glands secretion. Neurosteroids that are active on the central nervous system include, mainly, pregnenolone (PREG), dehydroepiandrosterone (DHEA) and their sulfate esters (PREG-S and DHEA-S), as well as the reduced metabolite of progesterone, 3 alpha,5 alpha-TH PROG also called allopregnanolone. These neuroactive neurosteroids alter neuronal excitability by modulating the activity of several neurotransmitter receptors and thus can influence behavior. PREG-S decreases the sleeping time in rats anesthetized with a barbiturate, which is consistent with its antagonist action on the GABAA receptor (GABAA-R). Allopregnanolone is anxiolytic in rats tested in a conflict paradigm, through an interaction at a site specific for the benzodiazepine (BZ) receptor inverse agonist RO15-4513 and/or at the picrotoxinin site on GABAA-R. The contribution of the amygdala, a key region involved in the control of anxiety, is also demonstrated for the anxiolytic action of allopregnanolone. An anti-agressive effect of DHEA can be observed in castrated male mice who become agressive in the presence of lactating females. This inhibition of agressiveness by DHEA is associated to a selective decrease in the brain of PREG-S, which may, in turn, trigger an increase of endogenous GABAergic tone. Finally, cognitive performances of aged rats tested in the Morris water maze and the Y-maze can be correlated with individual concentrations of PREG-S in the hippocampus, i.e. poor performance in both tasks with low levels of PREG-S. Remarkably, the memory deficits are significantly improved, albeit transiently, by an intra-hippocampal injection of PREG-S in impaired aged rats. Promnesiant PREG-S may then reinforce some neurotransmitter systems that can decline with age. This brief review provides evidence of the pharmacology and physiological correlates of neurosteroids involved in behavioral phenomena. However, neurobiological mechanisms of behavioral effects of neurosteroids await further investigation.</p><p>[D]<span> </span>RAMIREZ S HADDAD-TOVOLLI R RADOSEVIC M, 2022. <em>Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders</em><strong><span> </span></strong>Cell Metab. 2022 Feb 1;34(2):269-284.e9. doi: 10.1016/j.cmet.2021.12.023.   PMID: 35108514<span> </span>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8815774/">PMC8815774</a><span> </span>DOI: <a href="https://doi.org/10.1016/j.cmet.2021.12.023">10.1016/j.cmet.2021.12.023</a></p><p><strong>Abstract</strong></p><p>Obesity and type 2 diabetes are associated with cognitive dysfunction. Because the hypothalamus is implicated in energy balance control and memory disorders, we hypothesized that specific neurons in this brain region are at the interface of metabolism and cognition. Acute obesogenic diet administration in mice impaired recognition memory due to defective production of the neurosteroid precursor pregnenolone in the hypothalamus. Genetic interference with pregnenolone synthesis by Star deletion in hypothalamic POMC, but not AgRP neurons, deteriorated recognition memory independently of metabolic disturbances. Our data suggest that pregnenolone&#8217;s effects on cognitive function were mediated via an autocrine mechanism on POMC neurons, influencing hippocampal long-term potentiation. The relevance of central pregnenolone on cognition was also confirmed in metabolically unhealthy patients with obesity. Our data reveal an unsuspected role for POMC neuron-derived neurosteroids in cognition. These results provide the basis for a framework to investigate new facets of POMC neuron biology with implications for cognitive disorders.</p><p>[E]<span> </span>Peat, R. <em>Three of youth</em> hormones. https://raypeat.com/articles/articles/three-hormones.shtml</p><p>[F]<span> ROBERTS, Eugene, 1995. </span><em><span>Pregnenolone&#8212;from selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABA</span><sub><span>A</span></sub><span> receptor</span></em><span>. </span><a href="https://www.sciencedirect.com/journal/biochemical-pharmacology"><span>Biochemical Pharmacology</span></a><span>.</span><a href="https://www.sciencedirect.com/journal/biochemical-pharmacology/vol/49/issue/1"><span>Volume 49,</span></a><strong><a href="https://www.sciencedirect.com/journal/biochemical-pharmacology/vol/49/issue/1"><span> </span></a></strong><a href="https://www.sciencedirect.com/journal/biochemical-pharmacology/vol/49/issue/1"><span>Issue 1</span></a><span>, 6 January 1995, Pages 1-16. Dispon&#237;vel em: </span><a href="https://www.sciencedirect.com/science/article/abs/pii/000629529400258N"><span>https://www.sciencedirect.com/science/article/abs/pii/000629529400258N</span></a></p><p>***</p>]]></content:encoded></item><item><title><![CDATA[Por que pode ser muito saudável respirar o ar próximo da cachoeira] [e das ondas do mar]?]]></title><description><![CDATA[A medicina da brisa marinha, da &#225;gua do mar e do ambiente litor&#226;neo. Parte 3 de 3.]]></description><link>https://outramedicina2024.substack.com/p/por-que-pode-ser-muito-saudavel-respirar</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/por-que-pode-ser-muito-saudavel-respirar</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sun, 16 Aug 2026 10:39:26 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!J2FM!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!J2FM!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!J2FM!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg" width="582" height="372" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:372,&quot;width&quot;:582,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:70701,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/211402952?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!J2FM!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e959f16-048a-4be8-b84d-7e5a112be4f1_582x372.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>[Continua&#231;&#227;o da <a href="/__u/outramedicina2024.substack.com/p/a-agua-do-mar-por-que-ela-e-a-brisa-fa0">Parte 2</a> de 3]</p><p>Pessoas que ficam um tempo contemplando e respirando o ar pr&#243;ximo a cachoeiras relatam bem-estar e conforto com essa experi&#234;ncia. H&#225; fundamentos cient&#237;ficos que explicam essa sensa&#231;&#227;o confort&#225;vel e tamb&#233;m aquela outra excelente experi&#234;ncia de respirar o ar pr&#243;ximo da arrebenta&#231;&#227;o, isto &#233;, daquela regi&#227;o da praia onde as ondas se quebram.</p><p>Nos dois casos, isso tem a ver com aquilo que os cientistas chamam de efeito Lenard (ou <em>Lenard effect</em>), tamb&#233;m chamado de <em>waterfall effect</em> quando ocorre em cachoeiras.</p><p>Esse ser&#225; nosso tema hoje, retomando as notas anteriores: tentar entender uma das raz&#245;es de a nossa sa&#250;de sair ganhando quando estamos ali na praia ou pr&#243;ximo a uma cachoeira, contemplando-a e respirando calmamente.</p><p>A explica&#231;&#227;o tem tudo a ver com &#237;ons negativos formados naqueles ambientes.</p><p>N&#227;o se trata apenas de ar mais puro, muito menos de eletricidade ambiental, ou do direto contato com a natureza, embora tudo isso estar&#225; inclu&#237;do.</p><p>Mas a particular explica&#231;&#227;o gira em torno do efeito anti-serotonin&#233;gico que tudo isso tem sobre nosso organismo, mais especificamente facilitando a fun&#231;&#227;o pulmonar na elimina&#231;&#227;o da inflamat&#243;ria e depressiva serotonina.</p><p>Como foi explicado em nota anterior, para Peat, os pulm&#245;es s&#227;o um dos principais locais de remo&#231;&#227;o/metaboliza&#231;&#227;o da serotonina circulante no nosso sangue. E justamente um ambiente natural com boa presen&#231;a de &#237;ons negativos poderia acelerar a detoxifica&#231;&#227;o da serotonina no pulm&#227;o. Este &#233; o ponto.</p><p>R. Peat associava essa condi&#231;&#227;o como estimuladora da forma&#231;&#227;o de super&#243;xido no pulm&#227;o quando se respira ar negativamente ionizado. E, para ele, isso &#233; interessante justamente porque o super&#243;xido n&#227;o deve ser automaticamente considerado algo destrutivo: naquele especial contexto ele poderia participar da destrui&#231;&#227;o da serotonina.</p><p>Os &#237;ons negativos acelerariam a etapa pulmonar de elimina&#231;&#227;o da serotonina circulante. E isso explica por que Peat relacionava o fen&#244;meno ao ar mar&#237;timo e &#224;s ondas quebrando: ambientes naturais pr&#243;ximos ao mar s&#227;o uma fonte importante de ioniza&#231;&#227;o negativa.</p><p>Dessa forma, no pensamento de Ray Peat, a liga&#231;&#227;o entre ioniza&#231;&#227;o negativa, asma, serotonina e CO&#8322; era estabelecida de forma bastante coerente.</p><p>A serotonina &#233; inflamat&#243;ria e broncoconstritora para a musculatura das vias a&#233;reas. Nesse sentido, serotonina elevada leva a contra&#231;&#227;o/estreitamento das vias a&#233;reas e, na sequ&#234;ncia, dificuldade respirat&#243;ria.</p><p>Por essa l&#243;gica, qualquer coisa que aumentasse a capacidade pulmonar de degradar serotonina poderia, teoricamente, diminuir uma das for&#231;as que favorecem a broncoconstri&#231;&#227;o.</p><p>Aqui entram os &#237;ons negativos; Peat considerava que respirar ar negativamente ionizado poderia favorecer rea&#231;&#245;es redox no pulm&#227;o, com super&#243;xido formado pelos &#237;ons negativos participando da degrada&#231;&#227;o da serotonina. Resultado: menor tend&#234;ncia &#224; broncoconstri&#231;&#227;o. Tamb&#233;m a determinado tipo de inflama&#231;&#227;o e &#224; depress&#227;o.</p><p>Nunca deixando de lembrar que, para Peat, um dos principais fatores que</p><p>favorecem a abertura das vias respirat&#243;rias &#233; o CO2.</p><p>De toda forma, portanto, mais CO&#8322; e menos serotonina tornaria o ambiente metab&#243;lico mais favor&#225;vel &#224; abertura das vias a&#233;reas.</p><p>Quem reside em baixa altitude pode compensar a baixa reten&#231;&#227;o de CO2 no corpo adotando medidas que aumentem o CO2 no organismo, tipo respira&#231;&#227;o correta [longa expira&#231;&#227;o], respirar periodicamente no saco de papel e outras que sejam eficientes.</p><p>Retomemos a quest&#227;o de por que o mar especialmente perto de onde as ondas est&#227;o quebrando &#8212; poderia produzir ioniza&#231;&#227;o negativa.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!1GPA!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!1GPA!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg" width="567" height="351" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/d4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:351,&quot;width&quot;:567,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:39716,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/211402952?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!1GPA!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4598f90-3da7-4e5a-8f5c-cfbce07d99fd_567x351.jpeg 1456w" sizes="100vw" loading="lazy"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>A proximidade do mar, especialmente onde h&#225; ondas quebrando, com espuma e got&#237;culas de &#225;gua, produz muitos &#237;ons negativos. Isso est&#225; relacionado ao acima citado efeito Lenard: a fragmenta&#231;&#227;o de &#225;gua gera separa&#231;&#227;o de cargas e favorece a forma&#231;&#227;o de &#237;ons negativos no ar. Estudos ambientais realmente encontram concentra&#231;&#245;es elevadas de &#237;ons negativos pr&#243;ximo ao mar e a quedas d&#8217;&#225;gua. A sequ&#234;ncia do processo seria: maior ioniza&#231;&#227;o negativa do ar &gt; contato desses &#237;ons com os pulm&#245;es &gt; maior capacidade pulmonar de eliminar serotonina.</p><p>Alguns dos &#237;ons negativos podem ser esp&#233;cies relacionadas ao oxig&#234;nio, como O&#8322;&#8315;, mas &#8220;&#237;on negativo do ar&#8221; n&#227;o significa necessariamente que o ar esteja simplesmente cheio de mol&#233;culas de oxig&#234;nio com um el&#233;tron a mais. &#205;ons negativos atmosf&#233;ricos podem envolver oxig&#234;nio, &#225;gua e outras mol&#233;culas.</p><p>O que acontece quando a onda quebra, isto &#233;, quando a &#225;gua do mar &#233; fragmentada violentamente em got&#237;culas muito pequenas: neste momento ocorre uma separa&#231;&#227;o de cargas na interface &#225;gua&#8211;ar. Formam-se microgot&#237;culas com separa&#231;&#227;o de cargas, lan&#231;ando &#237;ons negativos no ar</p><p>O ponto crucial &#233; que as got&#237;culas n&#227;o ficam eletricamente neutras de maneira perfeitamente aleat&#243;ria.</p><p>Na superf&#237;cie da &#225;gua existe uma distribui&#231;&#227;o desigual de &#237;ons. Quando uma bolha ou got&#237;cula se forma e depois se rompe, ocorre uma separa&#231;&#227;o preferencial de cargas. Parte das cargas negativas fica associada &#224;s microgot&#237;culas/aeross&#243;is e &#233; liberada para o ar.</p><p>Em determinadas condi&#231;&#245;es, isso produz um aumento significativo de &#237;ons negativos do ar, principalmente perto de ondas quebrando, do mar em ressaca; de cachoeiras; rios r&#225;pidos; fontes de &#225;gua e, em bem menor escala, chuveiros. No caso da onda quebrando na praia, a sequ&#234;ncia &#233; onda, espuma, bolhas, ruptura de bolhas, microgot&#237;culas</p><p>&#201; principalmente o rompimento das bolhas na superf&#237;cie que gera grande parte da ioniza&#231;&#227;o.</p><p>Quando uma bolha de ar est&#225; dentro da &#225;gua e chega &#224; superf&#237;cie, sua pel&#237;cula l&#237;quida se rompe. A ruptura produz uma enorme quantidade de pequenas got&#237;culas &#8212; especialmente aquelas provenientes do chamado <em>jet</em> de gotas que sobe do interior da cavidade da bolha. Surge a carga el&#233;trica, em um processo que pode ser chamado de eletrifica&#231;&#227;o por fragmenta&#231;&#227;o da &#225;gua. Surgir&#227;o &#237;ons negativos aglomerados em combos com &#225;gua.</p><p>Mas por que especificamente &#8220;negativos&#8221;?</p><p>A &#225;gua cont&#233;m v&#225;rios &#237;ons, principalmente Na<span>&#8314;</span>, Cl<span>&#8315;</span>, H<span>&#8314;</span>, OH<span>&#8315;</span></p><p>Mas a interface &#225;gua&#8211;ar n&#227;o distribui esses &#237;ons de maneira perfeitamente uniforme.</p><p>O rompimento da interface favorece uma separa&#231;&#227;o de cargas. Uma das hip&#243;teses f&#237;sico-qu&#237;micas envolve a prefer&#234;ncia dos OH<span>&#8315;</span> e esp<span>&#233;</span>cies relacionadas <span>&#224;</span> hidroxila pela interface &#225;gua&#8211;ar. Quando a interface &#233; violentamente fragmentada, essa qu&#237;mica superficial acaba participando da produ&#231;&#227;o de esp&#233;cies carregadas negativamente no ar.</p><p>&#201; por isso que uma cachoeira produz uma concentra&#231;&#227;o muito maior de &#237;ons negativos do que uma superf&#237;cie de &#225;gua parada.</p><p>E no mar &#233; particularmente interessante, j&#225; <em>mais</em> coisas acontecem ali: teremos simultaneamente: &#225;gua + sal + ondas + espuma + vento + enorme &#225;rea de interface &#225;gua/ar. De tal forma que a onda quebrando cria uma quantidade gigantesca de interfaces novas e milh&#245;es de microgot&#237;culas ser&#227;o produzidas continuamente pela quebra das ondas.</p><p>E mais, a concentra&#231;&#227;o de &#237;ons negativos tende a ser muito <em>maior imediatamente perto da zona de arrebenta&#231;&#227;o </em>do que simplesmente &#8220;em qualquer outro lugar da praia&#8221;.</p><p>Na vis&#227;o de Peat, isso poderia ser uma das raz&#245;es pelas quais respirar pr&#243;ximo a uma cachoeira ou ao mar agitado pode produzir uma sensa&#231;&#227;o respirat&#243;ria/metab&#243;lica diferente.</p><p>Em outro plano explicativo, h&#225; que entender que os &#237;ons negativos agem sobre os pulm&#245;es, mas n&#227;o simplesmente &#8220;entregando el&#233;trons ao tecido pulmonar. &#205;on negativo n&#227;o &#233; &#8220;el&#233;tron livre&#8221;.</p><p>O que realmente chega ao pulm&#227;o n&#227;o s&#227;o el&#233;trons livres, estes possuem vida muito curta no ambiente. Ele &#233; rapidamente &#233; capturado por mol&#233;culas, principalmente oxig&#234;nio, e tende a formar esp&#233;cies negativas. Al&#233;m disso, essas esp&#233;cies se hidratam, formando <em>aglomerados de &#237;ons + mol&#233;culas de &#225;gua</em>.</p><p>De tal forma que quando a pessoa respira &#8220;&#237;ons negativos&#8221;, n&#227;o est&#225; simplesmente aspirando uma nuvem de el&#233;trons livres, n&#227;o &#233; isso.</p><p>&#201; mais correto pensar em &#237;ons negativos &#8220;hidratados&#8221; entrando em contato com a superf&#237;cie respirat&#243;ria. Como acontece, de outra forma, com o aparelho ionizador colocado no quarto de dormir.</p><p>A despeito de explica&#231;&#245;es bioqu&#237;micas complicadas [P], o que importava para Peat e, creio, para os leitores, &#233; que a ioniza&#231;&#227;o negativa modifica a qu&#237;mica redox pulmonar, e que essa qu&#237;mica poderia <strong>favorecer a remo&#231;&#227;o/oxida&#231;&#227;o da serotonina</strong>.</p><p>Naquilo que nos interessa &#8211; e como resumo &#8211; a &#225;gua caindo na cachoeira, as ondas quebrando no mar, geram &#237;ons negativos que n&#227;o apenas agem sobre nossos pulm&#245;es degradando a t&#243;xica/inflamat&#243;ria serotonina, ajudando, dessa forma, a aumentar o CO2 no corpo, que significa melhora metab&#243;lica geral. Deste ponto de vista, caminhar ou brincar com as ondas ali onde elas se quebram, caminhar na beira do mar, perto das ondas se quebrando ou contemplar uma cachoeira fazem um enorme bem &#224; sa&#250;de. Especialmente se a pessoa respira calmamente.<span> </span>O saldo ser&#225; queda na serotonina e pequena melhora na oferta de CO2 no organismo [n&#227;o t&#227;o grande quanto em maiores altitudes].</p><p>G Dantas, SP, 16-8-26</p><h6><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></h6><p><strong>Notas</strong> ______________</p><p>[A]<span> </span>Comparando soro fisiol&#243;gico (NaCl 0,9%) com &#225;gua do mar. Vamos por partes:</p><p>Composi&#231;&#227;o do Soro Fisiol&#243;gico</p><p>O soro fisiol&#243;gico &#233; uma solu&#231;&#227;o est&#233;ril de cloreto de s&#243;dio em &#225;gua, com:</p><p>NaCl: 0,9% (9 g/L)</p><p>Equivalente a aproximadamente:</p><p>S&#243;dio (Na&#8314;): ~154 mmol/L</p><p>Cloreto (Cl&#8315;): ~154 mmol/L</p><p>Osmolaridade total: ~308 mOsm/L, pr&#243;xima &#224; do plasma humano (&#8776;285&#8211;295 mOsm/L).</p><p>N&#227;o cont&#233;m outros &#237;ons, nem prote&#237;nas, nem nutrientes.</p><p>&#201; considerado isot&#244;nico em rela&#231;&#227;o &#224;s c&#233;lulas humanas.</p><p>Composi&#231;&#227;o da &#193;gua do Mar</p><p>Salinidade m&#233;dia: 35 g/L (3,5%), ou seja, quase 4 vezes mais concentrada que o soro fisiol&#243;gico.</p><p>Principais &#237;ons:</p><p>Cloreto (Cl&#8315;): ~19.000 mg/L (~550 mmol/L)</p><p>S&#243;dio (Na&#8314;): ~10.500 mg/L (~460 mmol/L)</p><p>Magn&#233;sio (Mg&#178;&#8314;): ~1.300 mg/L (~55 mmol/L)</p><p>C&#225;lcio (Ca&#178;&#8314;): ~400 mg/L (~10 mmol/L)</p><p>Pot&#225;ssio (K&#8314;): ~380 mg/L (~10 mmol/L)</p><p>Sulfato (SO&#8324;&#178;&#8315;), bicarbonato e tra&#231;os de outros minerais.</p><p>Osmolaridade total: ~1.000 mOsm/L, ou seja, bem hipert&#244;nica comparada ao plasma e ao soro.</p><p>3. Diferen&#231;as Essenciais</p><p>Caracter&#237;stica<span> </span>Soro fisiol&#243;gico<span> </span>&#193;gua do mar</p><p>Concentra&#231;&#227;o de sais<span> </span>0,9% (9 g/L)<span> </span>3,5% (35 g/L)</p><p>Osmolaridade<span> </span>~308 mOsm/L (isot&#244;nico)<span> </span>~1.000 mOsm/L (hipert&#244;nico)</p><p>&#205;ons principais<span> </span>Apenas Na&#8314; e Cl&#8315;<span> </span>Na&#8314;, Cl&#8315;, Mg&#178;&#8314;, Ca&#178;&#8314;, K&#8314;, SO&#8324;&#178;&#8315;, HCO&#8323;&#8315;</p><p>Uso m&#233;dico/soro fisiol&#243;gico.<span> </span>Reposi&#231;&#227;o de volume, dilui&#231;&#227;o de medicamentos, irriga&#231;&#227;o est&#233;ril; n&#227;o &#233; usado diretamente em infus&#227;o; algumas prepara&#231;&#245;es filtradas/dilu&#237;das s&#227;o usadas em sprays nasais ou cosm&#233;ticos. Seguran&#231;a para c&#233;lulas:<span> </span>compat&#237;vel (isot&#244;nico). Soro fisiol&#243;gico: seguro para uso intravenoso, ocular, nasal, limpeza de feridas.</p><p>&#193;gua do mar: s&#243; pode ser usada topicamente (ex.: sprays nasais, solu&#231;&#245;es para pele), nunca intravenosa, pois sua hipertonicidade danifica c&#233;lulas; provoca sa&#237;da de &#225;gua da c&#233;lula (crena&#231;&#227;o)</p><p>Em resumo: o soro fisiol&#243;gico foi criado para imitar a tonicidade do plasma, mantendo equil&#237;brio celular.</p><p>A &#225;gua do mar tem a mesma variedade de &#237;ons que o corpo usa, mas em concentra&#231;&#245;es muito mais altas, tornando-a inadequada para contato direto com o meio interno.</p><p>A osmolaridade total do soro &#233; de cerca de 285&#8211;295 mOsm/L, o que &#233; bem menor que a da &#225;gua do mar.</p><p>[B]<span>   </span>&#201; de Peat a cita&#231;&#227;o: &#8220;Breathing pure oxygen lowers the oxygen content of tissues; breathing rarefied air, or air with carbon dioxide, oxygenates and energizes the tissues&#8221;. Ou seja, dentro do modelo de Peat, a altitude &#233; quase um experimento natural mostrando que &#8220;mais O&#8322; inspirado&#8221; n&#227;o equivale a &#8220;mais O&#8322; utilizado pelos tecidos&#8221;.<span> </span>Peat &#233; bastante expl&#237;cito a respeito disso; ele diz que a menor press&#227;o de O&#8322; em altitude permite que o organismo retenha mais CO&#8322; pelo efeito Haldane, e que essa reten&#231;&#227;o ocorre naturalmente em pessoas adaptadas &#224; altitude. E Peat escreveu que a altitude elevada est&#225; associada a menor mortalidade e menor incid&#234;ncia de doen&#231;as degenerativas<span> </span>Ver R. Peat, <em>Altitude and Mortality.</em></p><p>[C]<span> </span>H&#225; inclusive experimentos <em>in vitro</em> mostrando que o super&#243;xido pode oxidar serotonina formando tryptamine-4,5-dione.</p><p>N&#227;o devemos imaginar que o o &#237;on negativo entra no pulm&#227;o e captura uma mol&#233;cula de serotonina. &#201; mais plaus&#237;vel pensar em um ambiente redox. O &#237;on negativo, particularmente esp&#233;cies de oxig&#234;nio como o super&#243;xido, pode participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons. A serotonina &#233; uma mol&#233;cula facilmente oxid&#225;vel. Portanto, a carga negativa associada ao oxig&#234;nio poderia favorecer sua transforma&#231;&#227;o qu&#237;mica. Fim da mol&#233;cula ativa de serotonina.</p><p>[D]<span> </span>Existe um per&#237;odo de adapta&#231;&#227;o quando a pessoa migra para uma regi&#227;o de alta altitude. L&#225; em cima diminui a press&#227;o de oxig&#234;nio, inicialmente haver&#225; um est&#237;mulo respirat&#243;rio. Neste caso aumenta a ventila&#231;&#227;o, tende a haver perda de CO2. Mas na sequ&#234;ncia ocorrer&#225; a adapta&#231;&#227;o. O corpo come&#231;ar&#225; a reter mais CO2.</p><p>[E]<span> </span>Peat j&#225; comparou hiperventila&#231;&#227;o [respira&#231;&#227;o r&#225;pida que perde CO2] a uma exposi&#231;&#227;o exagerada a altitude baixa, CO2. J&#225; que mais reten&#231;&#227;o de CO2 significa melhor oxigena&#231;&#227;o tecidual.<span> </span>Peat chega a dizer explicitamente que, em altitude, a menor press&#227;o de oxig&#234;nio permite maior reten&#231;&#227;o de CO&#8322; atrav&#233;s do efeito Haldane-Bohr. E atribui ao CO&#8322; fun&#231;&#245;es como: liberar O&#8322; para os tecidos; relaxar os vasos; reduzir edema; favorecer o metabolismo oxidativo; reduzir a produ&#231;&#227;o de lactato.</p><p>Em <em>Altitude and Mortality</em>, Peat afirma que popula&#231;&#245;es que vivem em grandes altitudes apresentam menor incid&#234;ncia de c&#226;ncer, doen&#231;a card&#237;aca e outras doen&#231;as degenerativas, e considera que a menor press&#227;o de oxig&#234;nio &#233; provavelmente um dos fatores importantes. Para Peat, CO&#8322; ajuda a: preservar a respira&#231;&#227;o celular; estabilizar prote&#237;nas e membranas; reduzir a excitabilidade; favorecer a circula&#231;&#227;o; proteger contra os efeitos excessivos da serotonina; atuar como um importante regulador do metabolismo. Por isso ele considerava a perda cr&#244;nica de CO&#8322; um componente de muitos estados patol&#243;gicos.</p><p>[F]<span> </span>Peat chegou a dizer que estudos realizados na Pol&#244;nia mostravam que a ioniza&#231;&#227;o negativa da atmosfera acelerava a elimina&#231;&#227;o da serotonina. Isso n&#227;o significa &#8211; em absoluto - defender, por exemplo, ozoniza&#231;&#227;o do ar para o mesmo objetivo. O ozone &#233;, certamente, t&#243;xico para os pulm&#245;es.</p><p>[G]<span> </span>OSTERBALLE O WEEKE B, 1979. <em>Influence of small atmospheric ions on the airways in patients with bronchial asthma.</em><strong> </strong>Allergy. 1979 Jun;34(3):187-94. doi: 10.1111/j.1398-9995.1979.tb01566.x.  PMID: 495917<span> </span>DOI: <a href="https://doi.org/10.1111/j.1398-9995.1979.tb01566.x">10.1111/j.1398-9995.1979.tb01566.x</a></p><p><strong>Abstract</strong></p><p>The influence of artificially generated atmospheric ions is studied in 15 patients with bronchial asthma. A slight but significant (at 5% level) improvement in the lung function was demonstrated in nine patients during positive as well as negative ion exposure, but the patients&#8217; subjective votings of the air quality did not show any changes due to ion exposure. No change in the histamine threshold of the airways in six patients with bronchial asthma was demonstrated during exposure to ions. Further controlled studies with electro-aerosols are needed.</p><p>[H]<span> </span>BEM-DOV I<span> </span>AMIRAV I SHOCHINA M, 1983.<em>Effect of negative ionisation of inspired air on the response of asthmatic children to exercise and inhaled histamine</em><strong>. </strong>Thorax. 1983 Aug;38(8):584-8. doi: 10.1136/thx.38.8.584.<span> </span>PMID: 6351332  PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC459615/">PMC459615</a>  DOI: <a href="https://doi.org/10.1136/thx.38.8.584">10.1136/thx.38.8.584</a></p><p><strong>Abstract</strong></p><p>To evaluate the effect of negative ionisation of inspired air on bronchial reactivity, 11 asthmatic children were challenged twice by exercise and 10 were challenged twice by histamine inhalation. The children breathed negatively ionised air (4 X 10(5) - 10 X 10(5) ions/cm3) or control room air in random order in a double-blind fashion. All challenges were matched in terms of basal lung function and the exercise tests were matched in terms of ventilation and respiratory heat loss. Exercise-induced asthma was significantly attenuated by exposure to negatively ionised air, the mean postexercise fall in one-second forced expiratory volume (FEV1) being 29% (SE 5%) of the initial value after the control and 21% (3%) after the ionised air test (p less than 0.02). Ten of the 11 subjects developed less exercise-induced asthma while breathing ionised air. Although the median dose of histamine (cumulative breath units) which caused a constant fall in FEV1 for each individual was higher with the ionised air challenge than with the control challenge the difference was not significant. Five of the 10 subjects were less sensitive to histamine and the other five more sensitive when breathing ionised air. It is concluded that negative ionisation of inspired air can modulate the bronchial response to exercise but the effect on the response to histamine is much more variable.</p><p>[I]<span> </span>ANDERSON S D, 1996. <em>Exercise-induced asthma and the use of hypertonic saline aerosol as a bronchial challenge.</em><strong> </strong>Respirology. 1996 Sep;1(3):175-81. doi: 10.1111/j.1440-1843.1996.tb00029.x.<span> </span>PMID: 9424393<span> </span>DOI: <a href="https://doi.org/10.1111/j.1440-1843.1996.tb00029.x">10.1111/j.1440-1843.1996.tb00029.x</a></p><p><strong>Abstract</strong></p><p>Exercise induced asthma is a common complaint and the prevalence appears to be increasing worldwide. Once confined to the research domain of university teaching hospitals, the study of EIA has extended into the school playground, defence force establishments and sports institutions. Standardized protocols have been developed to study EIA in the laboratory and in the field. A surrogate challenge using eucapnic or isocapnic hyperventilation with dry air is becoming popular because it has advantages over exercise, at least for adults. The stimulus that leads the airways to narrow is caused by the inhalation of dry air during hyperventilation and exercise, during which water is evaporated from the airways in order to condition the inspired air. The mechanism whereby the airways narrow is thought to be due to the dehydrating effects of water loss, particularly in relation to its potential to cause the airways to become hyperosmolar. Mast cell mediators such as histamine and the leucotrienes are probably involved in EIA because specific antagonists reduce severity. As a result of the osmotic theory of EIA, studies were carried out to determine whether subjects with EIA were sensitive to the effects of increasing airway osmolarity by inhalation of hyperosmolar aerosols of sodium chloride. A challenge protocol using an aerosol of 4.5% sodium chloride, generated from an ultrasonic nebulizer, has been used to identify persons with asthma and to assess response to drug therapy. There are many similarities between responses to exercise, hyperventilation and hypertonic saline in the physiological and biochemical responses and the responses to drugs. Challenge with hypertonic saline is easier and cheaper to use because expensive equipment and a source of dry air is not required as with exercise or hyperventilation. The ability to obtain a dose-response curve rather than a single response and the ability to collect inflammatory cells at the same time make challenge with hypertonic saline an attractive technique to study patients suspected of having asthma.</p><p>[J]<span> </span>JIANG S-Y MA A<span> </span>RAMACHANDRAN S, 2018. <em>Negative Air Ions and Their Effects on Human Health and Air Quality Improvement</em><strong>. </strong>Int J Mol Sci. 2018 Sep 28;19(10):2966. doi: <a href="https://doi.org/10.3390/ijms19102966">10.3390/ijms19102966</a><span> </span>PMCID: PMC6213340 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30274196/">30274196</a></p><p>Abstract</p><p>Negative air ions (NAIs) have been discovered for more than 100 years and are widely used for air cleaning. Here, we have carried out a comprehensive reviewing on the effects of NAIs on humans/animals, and microorganisms, and plant development. The presence of NAIs is credited for increasing psychological health, productivity, and overall well-being but without consistent or reliable evidence in therapeutic effects and with controversy in anti-microorganisms. Reports also showed that NAIs could help people in relieving symptoms of allergies to dust, mold spores, and other allergens. Particulate matter (PM) is a major air pollutant that affects human health. Experimental data showed that NAIs could be used to high-efficiently remove PM. Finally, we have reviewed the plant-based NAI release system under the pulsed electric field (PEF) stimulation. This is a new NAI generation system which releases a huge amount of NAIs under the PEF treatment. The system may be used to freshen indoor air and reduce PM concentration in addition to enriching oxygen content and indoor decoration at home, school, hospital, airport, and other indoor areas.<span> </span>Dispon&#237;vel em: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com</a></p><p>[K]<span> </span>SCHEUCH G GEBHART J, 1990. <em>Uptake of electrical charges in the human respiratory tract during exposure to air loaded with negative &#237;ons</em><strong><span> </span></strong>Journal Article<span> </span>Journal of Aerosol Science<span> </span>21(suppl. 1): VOLUME 1<span> </span>PAGE S439-S442</p><p>The uptake of negative charges in the human respiratory tract has been determined experimentally by breathing free ions and particles carrying negative charges. Free ions are deposited very effectively in the upper airways whereas charged particles penetrate to the deeper lungs.</p><p>Dispon&#237;vel em: <a href="https://hero.epa.gov/reference/6948/?utm_source=chatgpt.com">https://hero.epa.gov/reference/6948/?utm_source=chatgpt.com</a></p><p>[L]<span> </span><strong>Negative Air Ions and Their Generation</strong> -<span> </span>Air ions are electrically charged molecules or atoms in the atmosphere [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B2-ijms-19-02966">2</a>]. An air ion is formed when a gaseous molecule or atom receives sufficiently high energy to eject an electron [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B3-ijms-19-02966">3</a>]. NAIs are those that gain an electron, while positive air ions lose an electron. The natural and artificial energy sources include (1) radiant or cosmic rays in the atmosphere; (2) sunlight including ultraviolet; (3) natural and artificial corona discharge including thunder and lightning; (4) the shearing forces of water (Lenard effect); (5) plant-based sources of energy. [...]<span> </span>The considerable numbers of NAIs are found under waterfalls or in the seashores. These NAIs are generated by Lenard effect. Lenard effect was also called spray electrification or waterfall effect and was first systematically studied by Philipp Lenard [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B23-ijms-19-02966">23</a>], who won the Nobel Prize for Physics in 1905 for his research on cathode rays and the discovery of many of their properties. The study showed that NAIs were generated from the surrounding air molecules by charging themselves negatively when water droplets collide with each other or with a wetted solid to form fine spray of drops. The study also showed that several factors may affect the degree of charge separation in spray processes and, therefore, may affect the generation and concentration of NAIs. These factors include water drop temperature, dissolved impurities, speed of the impinging air blast, and foreign impinging surfaces of droplets. Based on the &#8220;Lenard effect&#8221;, water shearing appliance has been designed to generate NAIs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>]. Water shearing produced only superoxide ions (O<sub>2</sub><sup>&#8722;</sup>) which was bound to clusters of water molecules to form the structure O<sub>2</sub><sup>&#8722;</sup>(H<sub>2</sub>O)<sub>n</sub> [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B25-ijms-19-02966">25</a>], and was essentially regarded as a natural source of NAIs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>]. NAIs generated by the &#8220;Lenard effect&#8221; might improve erythrocyte deformability, thereby aerobic metabolism [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>].</p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com</a></p><p>[M]<span> </span>GOLDSTEIN N MERZLYAK M N, 1992. <em>Negative air ions as a source of superoxide.  </em>June 1992. <a href="https://www.researchgate.net/journal/International-Journal-of-Biometeorology-1432-1254">International Journal of Biometeorology</a> 36(2):118-122  DOI:<a href="https://doi.org/10.1007/BF01208923">10.1007/BF01208923</a>  <a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide#citations"><span>Citations (64)</span></a><span>   </span><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide#references"><span>References (34)</span></a></p><p>Abstract</p><p>The physico-chemical characteristics and possible formation mechanisms of negative air ions are considered. It was found that the products of oxygen and nitrogen negative ionization reduce ferricytochromec and nitroblue tetrazolium, and that these reactions were inhibited by superoxide dismutase. The interaction of negatively ionized oxygen with water led to hydrogen peroxide accumulation, which was inhibited by tetranitromethane or catalase. Nitrogen ionization under these conditions caused the formation of the hydrated electron e aq &#8212; and the superoxide anion O 2 &#8212; . The data obtained indicate that the biological activity of negative air ions may be dependent on superoxide. The generation of reactive oxygen ions in the gas phase and also at a gas/water interface is described. A scheme for superoxide production under oxygen and nitrogen ionization is proposed.<span> </span>Dispon&#237;vel em:<span> </span><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide">https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide</a></p><p>[N]<span> </span>WRONA M Z DRYHURST G, 1998. <em>Oxidation of Serotonin by Superoxide Radical:&#8201; Implications to Neurodegenerative Brain Disorders.</em><strong> </strong>Article| May 05, 1998     <em>Chem. Res. Toxicol.</em> (1998) 11 (6): 639&#8211;650.<span> </span><a href="https://doi.org/10.1021/tx970185w">https://doi.org/10.1021/tx970185w</a></p><p><strong>Abstract</strong></p><p>Many new lines of evidence implicate both superoxide anion radical (O<sub>2</sub><sup>&#8226;-</sup>) and biogenic amine neurotransmitters in the pathological mechanisms that underlie neuronal damage caused by methamphetamine (MA), glutamate-mediated oxidative toxicity, ischemia-reperfusion, and other neurodegenerative brain disorders. In this investigation the oxidation of 5-hydroxytryptamine (5-HT, serotonin) by an O<sub>2</sub><sup>&#8226;-</sup>-generating system (xanthine/xanthine oxidase) in buffered aqueous solution at pH 7.4 has been studied. The major product of the O<sub>2</sub><sup>&#8226;-</sup>-mediated oxidation of 5-HT is tryptamine-4,5-dione (T-4,5-D). However, O<sub>2</sub><sup>&#8226;-</sup> and H<sub>2</sub>O<sub>2</sub>, cogenerated by the xanthine oxidase-mediated oxidation of xanthine to uric acid, together react with trace levels of iron that contaminate buffer constituents to give a chemically ill-defined oxo-iron species. This species mediates the oxidation of 5-HT to a C(4)-centered carbocation intermediate that reacts with 5-HT to give 5,5&#8216;-dihydroxy-4,4&#8216;-bitryptamine (4,4&#8216;-D) and with uric acid to give 9-[3-(2-aminoethyl)-5-hydroxy-1<em>H</em>-indol-4-yl]-2,6,8-triketo-1<em>H</em>,3<em>H</em>,7<em>H</em>-purine (<strong>7</strong>) as the major products. These products differ from those formed in the HO<sup>&#8226;</sup>-mediated oxidation of 5-HT under similar conditions. When the reaction is carried out in the presence of the intraneuronal nucleophile glutathione (GSH), T-4,5-D is scavenged to give 7-(<em>S</em>-glutathionyl)tryptamine-4,5-dione, whereas the putative carbocation intermediate is scavenged to give 4-(<em>S</em>-glutathionyl)-5-hydroxytryptamine. T-4,5-D also reacts with the sulfhydryl residues of a model protein, alcohol dehydrogenase, and inhibits its activity. Previous investigators have proposed that T-4,5-D is a serotonergic neurotoxin. This raises the possibility that T-4,5-D and perhaps other putative intraneuronal metabolites formed by the O<sub>2</sub><sup>&#8226;-</sup>/H<sub>2</sub>O<sub>2</sub>/oxo-iron-mediated oxidations of 5-HT might be endotoxins that contribute to neurodegeneration in brain regions innervated by serotonergic neurons caused by MA, ischemia-reperfusion, and other neurodegenerative brain disorders.<span> </span>DISPON&#205;VEL EM: <a href="https://pubs.acs.org/crtoec/article-abstract/11/6/639/136678/Oxidation-of-Serotonin-by-Superoxide-Radical?redirectedFrom=fulltext">https://pubs.acs.org/crtoec/article-abstract/11/6/639/136678/Oxidation-of-Serotonin-by-Superoxide-Radical?redirectedFrom=fulltext</a></p><p>[O]<span> </span>XIMENES V F MAGHZAL G J TURNER R, 2009. <em>Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione.</em><strong> </strong>Biochem J. 2009 Dec 14;425(1):285-93. doi: 10.1042/BJ20090776.<span> </span>PMID: 19828014<span> </span>DOI: <a href="https://doi.org/10.1042/bj20090776">10.1042/BJ20090776</a></p><p>Abstract</p><p>During inflammatory events, neutrophils and platelets interact to release a variety of mediators. Neutrophils generate superoxide and hydrogen peroxide, and also discharge the haem enzyme myeloperoxidase. Among numerous other mediators, platelets liberate serotonin (5-hydroxytryptamine), which is a classical neurotransmitter and vasoactive amine that has significant effects on inflammation and immunity. In the present study, we show that serotonin is a favoured substrate for myeloperoxidase because other physiological substrates for this enzyme, including chloride, did not affect its rate of oxidation. At low micromolar concentrations, serotonin enhanced hypochlorous acid production by both purified myeloperoxidase and neutrophils. At higher concentrations, it almost completely blocked the formation of hypochlorous acid. Serotonin was oxidized to a dimer by myeloperoxidase and hydrogen peroxide. It was also converted into tryptamine-4,5-dione, especially in the presence of superoxide. This toxic quinone was produced by stimulated neutrophils in a reaction that required myeloperoxidase. In plasma, stimulated human neutrophils oxidized serotonin to its dimer using the NADPH oxidase and myeloperoxidase. We propose that myeloperoxidase will oxidize serotonin at sites of inflammation. In doing so, it will impair its physiological functions and generate a toxic metabolite that will exacerbate inflammatory tissue damage. Consequently, oxidation of serotonin by myeloperoxidase may profoundly influence inflammatory processes.</p><p>[P]<span> </span>Lembrando que para R. Peat n&#227;o se tratava de nada parecido com &#8220;carregar eletricamente os pulm&#245;es&#8221;. E sim de que &#8220;os &#237;ons negativos alteram a qu&#237;mica redox na superf&#237;cie respirat&#243;ria&#8221;, isto &#233;, transferem el&#233;trons. Com consequente aumento da degrada&#231;&#227;o da serotonina.</p><p>O<span> </span>&#237;on negativo consegue participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons, sim &#8212; mas isso &#233; muito diferente de dizer que, por exemplo, um aparelho ionizador transfere uma carga el&#233;trica macrosc&#243;pica para o pulm&#227;o.</p><p>H&#225; experimentos f&#237;sico-qu&#237;micos mostrando que produtos de ioniza&#231;&#227;o negativa do oxig&#234;nio podem produzir rea&#231;&#245;es caracter&#237;sticas de super&#243;xido (O&#8322;&#8226;<span>&#8315;</span>). Um trabalho de Goldstein e colaboradores, por exemplo, encontrou evid&#234;ncias de super&#243;xido e de el&#233;trons hidratados em sistemas submetidos &#224; ioniza&#231;&#227;o negativa.</p><p>Isso &#233; importante porque: O&#8322; + e<span>&#8315;</span> <span>&#8594;</span> O<span>&#8322;&#8226;&#8315;</span></p><p>Ou seja, o el&#233;tron n&#227;o precisa necessariamente entrar diretamente na c&#233;lula.</p><p>Ele pode ser transferido para o oxig&#234;nio e transformar O&#8322; em super&#243;xido. Eis o papel dos &#237;ons negativos que chegam do mar ou da cachoeira.</p><p>&#205;ons negativos do ar podem participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons e gerar esp&#233;cies redox, incluindo super&#243;xido, na interface ar&#8211;&#225;gua. Essas rea&#231;&#245;es podem ocorrer nas superf&#237;cies &#250;midas do trato respirat&#243;rio o que aumenta degrada&#231;&#227;o da serotonina.</p><p>E se houver CO2 adequado, teremos vias a&#233;reas mais abertas, promo&#231;&#227;o do metabolismo oxidativo do a&#231;&#250;car. Sendo que a pr&#243;pria queda da serotonina melhora a respira&#231;&#227;o celular e a oferta de CO2.</p><p>Experimentos mediram a absor&#231;&#227;o de carga el&#233;trica no trato respirat&#243;rio durante a respira&#231;&#227;o de ar contendo &#237;ons negativos. &#205;ons livres tendem a se depositar principalmente nas vias a&#233;reas superiores, enquanto part&#237;culas carregadas conseguem alcan&#231;ar regi&#245;es mais profundas do pulm&#227;o. Portanto, n&#227;o &#233; correto imaginar que &#8220;os &#237;ons negativos n&#227;o entram no aparelho respirat&#243;rio&#8221;. Entram e efetivamente interagem com ele.</p><p>A realidade f&#237;sico-qu&#237;mica &#233; muito mais din&#226;mica: &#237;ons, &#225;gua, oxig&#234;nio e mol&#233;culas da superf&#237;cie respirat&#243;ria trocam carga e sofrem rea&#231;&#245;es qu&#237;micas.</p><p>E aqui, neste particular caso, o super&#243;xido n&#227;o precisa ser simplesmente &#8220;dano oxidativo&#8221;. Na verdade, o super&#243;xido pode participar de rea&#231;&#245;es qu&#237;micas espec&#237;ficas. E h&#225; literatura experimental propondo que o super&#243;xido seja uma das principais esp&#233;cies associadas aos efeitos dos &#237;ons negativos naturais. Degradando a serotonina</p><p>A serotonina &#233; uma mol&#233;cula particularmente oxid&#225;vel</p><p>A serotonina (5-HT) cont&#233;m um grupo indol, que &#233; relativamente f&#225;cil de oxidar. Quando recebe/cede el&#233;trons em determinadas condi&#231;&#245;es, pode formar intermedi&#225;rios radicalares. O estudo cl&#225;ssico de Wrona e Dryhurst investigou justamente a rea&#231;&#227;o de serotonina com super&#243;xido em pH fisiol&#243;gico. Eles encontraram como produto importante a tryptamine-4,5-dione (T-4,5-D). Simplificando: serotonina + O&#8322;&#8226;<span>&#8315;</span> <span>&#8594;</span> serotonina oxidada <span>&#8594;</span> quinona/diona</p><p>Portanto, &#8220;destruir serotonina&#8221; n&#227;o significa simplesmente fazer a mol&#233;cula desaparecer instantaneamente. Significa transform&#225;-la quimicamente em outros produtos. O peroxido do oxig&#234;nio pode iniciar uma cadeia de rea&#231;&#245;es que aniquilam a mol&#233;cula de serotonina; pode formar intermedi&#193;rios a partir da serotonina, pode decompor a serotonina, pode gerar a triptamina-4-5 diona, pode simplesmente transferir el&#233;trons com oxig&#234;nio. Outro poss&#237;vel mecanismo &#233; a o super&#211;xido contribua para a forma&#231;&#227;o de H2O2 e este degrada a serotonina.</p><p>Tamb&#233;m existe uma revis&#227;o sobre &#237;ons negativos que resume a hip&#243;tese hist&#243;rica dessa maneira: o super&#243;xido seria uma das esp&#233;cies importantes produzidas pela ioniza&#231;&#227;o negativa e, em experimentos <em>in vitro</em>, a serotonina pode ser oxidada por super&#243;xido formando tryptamine-4,5-dione. Acaba de ser degradada. Em laborat&#243;rio se consegue oxidar serotonina a partir de super&#243;xido.</p><p>[Q] BIBLIOGRAFIA ADICIONAL:</p><p>Iwama H. Negative air ions created by water shearing improve erythrocyte deformability and aerobic metabolism. Indoor Air. 2004;14:293&#8211;297. doi: 10.1111/j.1600-0668.2004.00254.x. [<a href="https://doi.org/10.1111/j.1600-0668.2004.00254.x">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15217482/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indoor%20Air&amp;title=Negative%20air%20ions%20created%20by%20water%20shearing%20improve%20erythrocyte%20deformability%20and%20aerobic%20metabolism&amp;author=H.%20Iwama&amp;volume=14&amp;publication_year=2004&amp;pages=293-297&amp;pmid=15217482&amp;doi=10.1111/j.1600-0668.2004.00254.x&amp;">Google Scholar</a>]</p><p>Kosenko E.A., Kaminsky Y.G., Stavrovskaya I.G., Sirota T.V., Kondrashova M.N. The stimulatory effect of negative air ions and hydrogen peroxide on the activity of superoxide dismutase. FEBS Lett. 1997;410:309&#8211;312. doi: 10.1016/S0014-5793(97)00651-0. [<a href="https://doi.org/10.1016/S0014-5793(97)00651-0">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9237652/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett.&amp;title=The%20stimulatory%20effect%20of%20negative%20air%20ions%20and%20hydrogen%20peroxide%20on%20the%20activity%20of%20superoxide%20dismutase&amp;author=E.A.%20Kosenko&amp;author=Y.G.%20Kaminsky&amp;author=I.G.%20Stavrovskaya&amp;author=T.V.%20Sirota&amp;author=M.N.%20Kondrashova&amp;volume=410&amp;publication_year=1997&amp;pages=309-312&amp;pmid=9237652&amp;doi=10.1016/S0014-5793(97)00651-0&amp;">Google Scholar</a>]</p><p><span>Iwama H., Ohmizo H., Furuta S., Ohmori S., Watanabe K., Kaneko T., Tsutsumi K. Inspired superoxide anions attenuate blood lactate concentrations in postoperative patients. Crit. Care Med. 2002;30:1246&#8211;1249. doi: 10.1097/00003246-200206000-00014. [</span><a href="https://doi.org/10.1097/00003246-200206000-00014"><span>DOI</span></a><span>] [</span><a href="https://pubmed.ncbi.nlm.nih.gov/12072676/"><span>PubMed</span></a><span>] [</span><a href="https://scholar.google.com/scholar_lookup?journal=Crit.%20Care%20Med.&amp;title=Inspired%20superoxide%20anions%20attenuate%20blood%20lactate%20concentrations%20in%20postoperative%20patients&amp;author=H.%20Iwama&amp;author=H.%20Ohmizo&amp;author=S.%20Furuta&amp;author=S.%20Ohmori&amp;author=K.%20Watanabe&amp;volume=30&amp;publication_year=2002&amp;pages=1246-1249&amp;pmid=12072676&amp;doi=10.1097/00003246-200206000-00014&amp;"><span>Google Scholar</span></a><span>]</span></p><p><span>Yamada R., Yanoma S., Akaike M., Tsuburaya A., Sugimasa Y., Takemiya S., Motohashi H., Rino Y., Takanashi Y., Imada T. Water-generated negative air ions activate NK cell and inhibit carcinogenesis in mice. Cancer Lett. 2006;239:190&#8211;197. doi: 10.1016/j.canlet.2005.08.002. [</span><a href="https://doi.org/10.1016/j.canlet.2005.08.002"><span>DOI</span></a><span>] [</span><a href="https://pubmed.ncbi.nlm.nih.gov/16171944/"><span>PubMed</span></a><span>] [</span><a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett.&amp;title=Water-generated%20negative%20air%20ions%20activate%20NK%20cell%20and%20inhibit%20carcinogenesis%20in%20mice&amp;author=R.%20Yamada&amp;author=S.%20Yanoma&amp;author=M.%20Akaike&amp;author=A.%20Tsuburaya&amp;author=Y.%20Sugimasa&amp;volume=239&amp;publication_year=2006&amp;pages=190-197&amp;pmid=16171944&amp;doi=10.1016/j.canlet.2005.08.002&amp;"><span>Google Scholar</span></a><span>]</span></p><p>Pino O., Ragione F.L. There&#8217;s something in the air: Empirical evidence for the effects of negative air ions (NAI) on psychophysiological state and performance. Res. Psychol. Behav Sci. 2013;1:48&#8211;53. [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Psychol.%20Behav%20Sci.&amp;title=There%E2%80%99s%20something%20in%20the%20air:%20Empirical%20evidence%20for%20the%20effects%20of%20negative%20air%20ions%20(NAI)%20on%20psychophysiological%20state%20and%20performance&amp;author=O.%20Pino&amp;author=F.L.%20Ragione&amp;volume=1&amp;publication_year=2013&amp;pages=48-53&amp;">Google Scholar</a>]</p><p>Parts T.E., Luts A., Laakso L., Hirsikko A., Gronholm T., Kulmala M. Chemical composition of waterfall-induced air ions: Spectrometry vs. simulations. Boreal Environ. Res. 2007;12:409&#8211;420. [<a href="https://scholar.google.com/scholar_lookup?journal=Boreal%20Environ.%20Res.&amp;title=Chemical%20composition%20of%20waterfall-induced%20air%20ions:%20Spectrometry%20vs.%20simulations&amp;author=T.E.%20Parts&amp;author=A.%20Luts&amp;author=L.%20Laakso&amp;author=A.%20Hirsikko&amp;author=T.%20Gronholm&amp;volume=12&amp;publication_year=2007&amp;pages=409-420&amp;">Google Scholar</a>]</p><p>Lin H.F., Lin J.M. Generation and determination of negative air ions. J. Anal. Test. 2017;1:6. doi: 10.1007/s41664-017-0007-7. [<a href="https://doi.org/10.1007/s41664-017-0007-7">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Anal.%20Test.&amp;title=Generation%20and%20determination%20of%20negative%20air%20ions&amp;author=H.F.%20Lin&amp;author=J.M.%20Lin&amp;volume=1&amp;publication_year=2017&amp;pages=6&amp;doi=10.1007/s41664-017-0007-7&amp;">Google Scholar</a>]</p><p>Laakso L., Hirsikko A., Gr&#246;nholm T., Kulmala M., Luts A., Parts T.E. Waterfalls as sources of small charged aerosol particles. Atmos. Chem. Phys. 2006;6:9297&#8211;9314. doi: 10.5194/acpd-6-9297-2006. [<a href="https://doi.org/10.5194/acpd-6-9297-2006">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atmos.%20Chem.%20Phys.&amp;title=Waterfalls%20as%20sources%20of%20small%20charged%20aerosol%20particles&amp;author=L.%20Laakso&amp;author=A.%20Hirsikko&amp;author=T.%20Gr%C3%B6nholm&amp;author=M.%20Kulmala&amp;author=A.%20Luts&amp;volume=6&amp;publication_year=2006&amp;pages=9297-9314&amp;doi=10.5194/acpd-6-9297-2006&amp;">Google Scholar</a>]</p><p>Kolarz P., Gaisberger M., Madl P., Hofmann W., Ritter M., Hartl A. Characterization of ions at alpine waterfalls. atmos. Chem. Phys. 2012;12:3687&#8211;3697. doi: 10.5194/acp-12-3687-2012. [<a href="https://doi.org/10.5194/acp-12-3687-2012">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Phys.&amp;title=Characterization%20of%20ions%20at%20alpine%20waterfalls.%20atmos&amp;author=P.%20Kolarz&amp;author=M.%20Gaisberger&amp;author=P.%20Madl&amp;author=W.%20Hofmann&amp;author=M.%20Ritter&amp;volume=12&amp;publication_year=2012&amp;pages=3687-3697&amp;doi=10.5194/acp-12-3687-2012&amp;">Google Scholar</a>]</p><p>Nagato K., Matsui Y., Miyata T., Yamauchi T. An analysis of the evolution of negative ions produced by a corona ionizer in air. Int. J. Mass Spectrom. 2006;248:142&#8211;147. doi: 10.1016/j.ijms.2005.12.001. [<a href="https://doi.org/10.1016/j.ijms.2005.12.001">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mass%20Spectrom.&amp;title=An%20analysis%20of%20the%20evolution%20of%20negative%20ions%20produced%20by%20a%20corona%20ionizer%20in%20air&amp;author=K.%20Nagato&amp;author=Y.%20Matsui&amp;author=T.%20Miyata&amp;author=T.%20Yamauchi&amp;volume=248&amp;publication_year=2006&amp;pages=142-147&amp;doi=10.1016/j.ijms.2005.12.001&amp;">Google Scholar</a>]</p><p>Ryushi T., Kita I., Sakurai T., Yasumatsu M., Isokawa M., Aihara Y., Hama K. The effect of exposure to negative air ions on the recovery of physiological responses after moderate endurance exercise. Int. J. Biometeorol. 1998;41:132&#8211;136. doi: 10.1007/s004840050066. [<a href="https://doi.org/10.1007/s004840050066">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9531858/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Biometeorol.&amp;title=The%20effect%20of%20exposure%20to%20negative%20air%20ions%20on%20the%20recovery%20of%20physiological%20responses%20after%20moderate%20endurance%20exercise&amp;author=T.%20Ryushi&amp;author=I.%20Kita&amp;author=T.%20Sakurai&amp;author=M.%20Yasumatsu&amp;author=M.%20Isokawa&amp;volume=41&amp;publication_year=1998&amp;pages=132-136&amp;pmid=9531858&amp;doi=10.1007/s004840050066&amp;">Google Scholar</a>]</p><p>Wrona M.Z., Dryhurst G. Oxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders. Chem. Res. Toxicol. 1998;11:639&#8211;650. doi: 10.1021/tx970185w. [<a href="https://doi.org/10.1021/tx970185w">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9625732/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Res.%20Toxicol.&amp;title=Oxidation%20of%20serotonin%20by%20superoxide%20radical:%20Implications%20to%20neurodegenerative%20brain%20disorders&amp;author=M.Z.%20Wrona&amp;author=G.%20Dryhurst&amp;volume=11&amp;publication_year=1998&amp;pages=639-650&amp;pmid=9625732&amp;doi=10.1021/tx970185w&amp;">Google Scholar</a>]</p><p>Wiszniewski A., Suchanowski A., Wielgomas B. Effects of Air-Ions on human circulatory indicators. Pol. J. Environ. Stud. 2014;23:521&#8211;531. [<a href="https://scholar.google.com/scholar_lookup?journal=Pol.%20J.%20Environ.%20Stud.&amp;title=Effects%20of%20Air-Ions%20on%20human%20circulatory%20indicators&amp;author=A.%20Wiszniewski&amp;author=A.%20Suchanowski&amp;author=B.%20Wielgomas&amp;volume=23&amp;publication_year=2014&amp;pages=521-531&amp;">Google Scholar</a>]</p><p>Hedge A., Collis M.D. Do negative air ions affect human mood and performance? Ann. Occup. Hyg. 1987;31:285&#8211;290. doi: 10.1093/annhyg/31.3.285. [<a href="https://doi.org/10.1093/annhyg/31.3.285">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3426028/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Occup.%20Hyg.&amp;title=Do%20negative%20air%20ions%20affect%20human%20mood%20and%20performance?&amp;author=A.%20Hedge&amp;author=M.D.%20Collis&amp;volume=31&amp;publication_year=1987&amp;pages=285-290&amp;pmid=3426028&amp;doi=10.1093/annhyg/31.3.285&amp;">Google Scholar</a>]</p><p>Perez V., Alexander D.D., Bailey W.H. Air ions and mood outcomes: A review and meta-analysis. BMC Psychiatry. 2013;13:29. doi: 10.1186/1471-244X-13-29. [<a href="https://doi.org/10.1186/1471-244X-13-29">DOI</a>] [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3598548/">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23320516/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Psychiatry&amp;title=Air%20ions%20and%20mood%20outcomes:%20A%20review%20and%20meta-analysis&amp;author=V.%20Perez&amp;author=D.D.%20Alexander&amp;author=W.H.%20Bailey&amp;volume=13&amp;publication_year=2013&amp;pages=29&amp;pmid=23320516&amp;doi=10.1186/1471-244X-13-29&amp;">Google Scholar</a>]</p><p>Timoshkin I.V., Maclean M., Wilson M.P., Given M.J., MacGregor S.J., Wang T., Anderson J.G. Bactericidal effect of corona discharges in atmospheric air. IEEE Trans. Plasma Sci. 2012;40:2322&#8211;2333. doi: 10.1109/TPS.2012.2193621. [<a href="https://doi.org/10.1109/TPS.2012.2193621">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Trans.%20Plasma%20Sci.&amp;title=Bactericidal%20effect%20of%20corona%20discharges%20in%20atmospheric%20air&amp;author=I.V.%20Timoshkin&amp;author=M.%20Maclean&amp;author=M.P.%20Wilson&amp;author=M.J.%20Given&amp;author=S.J.%20MacGregor&amp;volume=40&amp;publication_year=2012&amp;pages=2322-2333&amp;doi=10.1109/TPS.2012.2193621&amp;">Google Scholar</a>]</p><p>Pratt R., Barnard R.W. Some effects of ionized air on Penicillium notatum. J. Am. Pharm. Assoc. Sci. 1960;49:643&#8211;646. doi: 10.1002/jps.3030491004. [<a href="https://doi.org/10.1002/jps.3030491004">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Pharm.%20Assoc.%20Sci.&amp;title=Some%20effects%20of%20ionized%20air%20on%20Penicillium%20notatum&amp;author=R.%20Pratt&amp;author=R.W.%20Barnard&amp;volume=49&amp;publication_year=1960&amp;pages=643-646&amp;doi=10.1002/jps.3030491004&amp;">Google Scholar</a>]</p><p>Mitchell B.W., King D.J. Effect of negative air ionization on airborne transmission of newcastle disease virus. Avian. Dis. 1994;38:725&#8211;732. doi: 10.2307/1592107. [<a href="https://doi.org/10.2307/1592107">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7702504/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Avian.%20Dis.&amp;title=Effect%20of%20negative%20air%20ionization%20on%20airborne%20transmission%20of%20newcastle%20disease%20virus&amp;author=B.W.%20Mitchell&amp;author=D.J.%20King&amp;volume=38&amp;publication_year=1994&amp;pages=725-732&amp;pmid=7702504&amp;doi=10.2307/1592107&amp;">Google Scholar</a>]</p><p>Wallner P., Kundi M., Panny M., Tappler P., Hutter H.P. Exposure to air ions in indoor environments: Experimental study with healthy adults. Int. J. Environ. Res. Public Health. 2015;12:14301&#8211;14311. doi: 10.3390/ijerph121114301. [<a href="https://doi.org/10.3390/ijerph121114301">DOI</a>] [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4661648/">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26569277/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Environ.%20Res.%20Public%20Health.&amp;title=Exposure%20to%20air%20ions%20in%20indoor%20environments:%20Experimental%20study%20with%20healthy%20adults&amp;author=P.%20Wallner&amp;author=M.%20Kundi&amp;author=M.%20Panny&amp;author=P.%20Tappler&amp;author=H.P.%20Hutter&amp;volume=12&amp;publication_year=2015&amp;pages=14301-14311&amp;pmid=26569277&amp;doi=10.3390/ijerph121114301&amp;">Google Scholar</a>]</p><p>Kellogg E.W., Yost M.G., Barthakur N., Kreuger A.P. Superoxide involvement in the bactericidal effects of negative air ions on Staphylococcus albus. Nature. 1979;281:400&#8211;401. doi: 10.1038/281400a0. [<a href="https://doi.org/10.1038/281400a0">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/225679/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Superoxide%20involvement%20in%20the%20bactericidal%20effects%20of%20negative%20air%20ions%20on%20Staphylococcus%20albus&amp;author=E.W.%20Kellogg&amp;author=M.G.%20Yost&amp;author=N.%20Barthakur&amp;author=A.P.%20Kreuger&amp;volume=281&amp;publication_year=1979&amp;pages=400-401&amp;pmid=225679&amp;doi=10.1038/281400a0&amp;">Google Scholar</a>]</p><p>Luts A., Salm J. Chemical composition of small atmospheric ions near the ground. J. Geophys. Res. 1994;99:10781&#8211;10785. doi: 10.1029/93JD03225. [<a href="https://doi.org/10.1029/93JD03225">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Geophys.%20Res.&amp;title=Chemical%20composition%20of%20small%20atmospheric%20ions%20near%20the%20ground&amp;author=A.%20Luts&amp;author=J.%20Salm&amp;volume=99&amp;publication_year=1994&amp;pages=10781-10785&amp;doi=10.1029/93JD03225&amp;">Google Scholar</a>]</p><p>Goldstein N., Lewin T., Kamensky A., Dubinin V., Baumann S., Konstantinova O. Exogenous gaseous superoxide potentiates the antinociceptive effect of opioid analgesic agents. Inflamm. Res. 1996;45:473&#8211;478. doi: 10.1007/BF02252319. [<a href="https://doi.org/10.1007/BF02252319">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8891759/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Res.&amp;title=Exogenous%20gaseous%20superoxide%20potentiates%20the%20antinociceptive%20effect%20of%20opioid%20analgesic%20agents&amp;author=N.%20Goldstein&amp;author=T.%20Lewin&amp;author=A.%20Kamensky&amp;author=V.%20Dubinin&amp;author=S.%20Baumann&amp;volume=45&amp;publication_year=1996&amp;pages=473-478&amp;pmid=8891759&amp;doi=10.1007/BF02252319&amp;">Google Scholar</a>]</p><p>Mayya Y.S., Sapra B.K., Khan A., Sunny F. Aerosol removal by unipolar ionization in indoor environments. Aerosol Sci. 2004;35:923&#8211;941. doi: 10.1016/j.jaerosci.2004.03.001. [<a href="https://doi.org/10.1016/j.jaerosci.2004.03.001">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aerosol%20Sci.&amp;title=Aerosol%20removal%20by%20unipolar%20ionization%20in%20indoor%20environments&amp;author=Y.S.%20Mayya&amp;author=B.K.%20Sapra&amp;author=A.%20Khan&amp;author=F.%20Sunny&amp;volume=35&amp;publication_year=2004&amp;pages=923-941&amp;doi=10.1016/j.jaerosci.2004.03.001&amp;">Google Scholar</a>]</p><p>Grinshpun S.A., Mainelis G., Trunov M., Adhikari A., Reponen T., Willeke K. Evaluation of ionic air purifiers for reducing aerosol exposure in confined indoor spaces. Indoor Air. 2005;15:235&#8211;245. doi: 10.1111/j.1600-0668.2005.00364.x. [<a href="https://doi.org/10.1111/j.1600-0668.2005.00364.x">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15982270/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indoor%20Air&amp;title=Evaluation%20of%20ionic%20air%20purifiers%20for%20reducing%20aerosol%20exposure%20in%20confined%20indoor%20spaces&amp;author=S.A.%20Grinshpun&amp;author=G.%20Mainelis&amp;author=M.%20Trunov&amp;author=A.%20Adhikari&amp;author=T.%20Reponen&amp;volume=15&amp;publication_year=2005&amp;pages=235-245&amp;pmid=15982270&amp;doi=10.1111/j.1600-0668.2005.00364.x&amp;">Google Scholar</a>]</p><p>Berry D., Mainelis G., Fennell D. Effect of an ionic air cleaner on indoor/outdoor particle ratios in a residential environment. Aerosol Sci. Technol. 2007;41:315&#8211;328. doi: 10.1080/02786820701199702. [<a href="https://doi.org/10.1080/02786820701199702">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aerosol%20Sci.%20Technol.&amp;title=Effect%20of%20an%20ionic%20air%20cleaner%20on%20indoor/outdoor%20particle%20ratios%20in%20a%20residential%20environment&amp;author=D.%20Berry&amp;author=G.%20Mainelis&amp;author=D.%20Fennell&amp;volume=41&amp;publication_year=2007&amp;pages=315-328&amp;doi=10.1080/02786820701199702&amp;">Google Scholar</a>]</p><p>Grabarczyk Z. Electiveness of indoor air cleaning with corona ionizers. J. Electrostat. 2001;51:278&#8211;283. doi: 10.1016/S0304-3886(01)00058-4. [<a href="https://doi.org/10.1016/S0304-3886(01)00058-4">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Electrostat.&amp;title=Electiveness%20of%20indoor%20air%20cleaning%20with%20corona%20ionizers&amp;author=Z.%20Grabarczyk&amp;volume=51&amp;publication_year=2001&amp;pages=278-283&amp;doi=10.1016/S0304-3886(01)00058-4&amp;">Google Scholar</a>]</p><p>Sawant V.S. Control of respirable particles in indoor air with portable negative air ion generator. IOSR J. Environ. Sci. Toxicol. Food Technol. 2013;3:28&#8211;31. doi: 10.9790/2402-0332831. [<a href="https://doi.org/10.9790/2402-0332831">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IOSR%20J.%20Environ.%20Sci.%20Toxicol.%20Food%20Technol.&amp;title=Control%20of%20respirable%20particles%20in%20indoor%20air%20with%20portable%20negative%20air%20ion%20generator&amp;author=V.S.%20Sawant&amp;volume=3&amp;publication_year=2013&amp;pages=28-31&amp;doi=10.9790/2402-0332831&amp;">Google Scholar</a>]</p><p>Sawant V.S. Removal of particulate matter by using negative electric discharge. Int. J. Eng. Innov. Technol. 2013;2:48&#8211;51. [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Eng.%20Innov.%20Technol.&amp;title=Removal%20of%20particulate%20matter%20by%20using%20negative%20electric%20discharge&amp;author=V.S.%20Sawant&amp;volume=2&amp;publication_year=2013&amp;pages=48-51&amp;">Google Scholar</a>]</p><p>&#268;erneck&#253; J., Valentov&#225; K., Pivar&#269;iov&#225; E., Bo&#382;ek P. Ionization impact on the air cleaning efficiency in the interior. Meas. Sci. Rev. 2015;15:156&#8211;166. doi: 10.1515/msr-2015-0023. [<a href="https://doi.org/10.1515/msr-2015-0023">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Meas.%20Sci.%20Rev.&amp;title=Ionization%20impact%20on%20the%20air%20cleaning%20efficiency%20in%20the%20interior&amp;author=J.%20%C4%8Cerneck%C3%BD&amp;author=K.%20Valentov%C3%A1&amp;author=E.%20Pivar%C4%8Diov%C3%A1&amp;author=P.%20Bo%C5%BEek&amp;volume=15&amp;publication_year=2015&amp;pages=156-166&amp;doi=10.1515/msr-2015-0023&amp;">Google Scholar</a>]</p><p>Pushpawela B., Jayaratne R., Nguy A., Morawska L. Efficiency of ionizers in removing airborne particles in indoor environments. J. Electrostatics. 2017;90:79&#8211;84. doi: 10.1016/j.elstat.2017.10.002. [<a href="https://doi.org/10.1016/j.elstat.2017.10.002">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Electrostatics&amp;title=Efficiency%20of%20ionizers%20in%20removing%20airborne%20particles%20in%20indoor%20environments&amp;author=B.%20Pushpawela&amp;author=R.%20Jayaratne&amp;author=A.%20Nguy&amp;author=L.%20Morawska&amp;volume=90&amp;publication_year=2017&amp;pages=79-84&amp;doi=10.1016/j.elstat.2017.10.002&amp;">Google Scholar</a>]</p>]]></content:encoded></item><item><title><![CDATA[A água do mar: por que ela e a brisa marinha são saúde? [Parte 2 de 3]]]></title><description><![CDATA[A medicina da brisa marinha, da &#225;gua do mar, seus sais e do ambiente litor&#226;neo [ 2 de 3]]]></description><link>https://outramedicina2024.substack.com/p/a-agua-do-mar-por-que-ela-e-a-brisa-fa0</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/a-agua-do-mar-por-que-ela-e-a-brisa-fa0</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Fri, 14 Aug 2026 11:49:31 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!aRZS!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!aRZS!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!aRZS!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg" width="582" height="372" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/cecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:372,&quot;width&quot;:582,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:98121,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/211164798?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!aRZS!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcecf9d25-e2f3-4bdc-b002-2d9e296509bf_582x372.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p></p><p>[Continua&#231;&#227;o da <a href="/__u/outramedicina2024.substack.com/p/a-agua-do-mar-por-que-ela-e-a-brisa">nota 1</a> de 3]</p><p>Propriedades da &#225;gua do mar em rela&#231;&#227;o a n&#243;s</p><p>A &#225;gua do mar, como j&#225; foi mencionado, &#233; hipert&#244;nica em rela&#231;&#227;o ao nosso sangue. E ambas, a &#225;gua do mar e o nosso soro [nosso sangue], possuem os mesmos &#237;ons, s&#243;dio, cloreto, pot&#225;ssio, c&#225;lcio, magn&#233;sio, carbonato, s&#243; que em concentra&#231;&#245;es diferentes.</p><p>Alguns fisiologistas como Ren&#233; Quinton, s&#233;culo XIX, observaram essa semelhan&#231;a qualitativa entre a &#225;gua do mar e o plasma. A &#225;gua do mar &#233; tr&#234;s vezes mais concentrada em sais que o plasma. &#201; <em>hipert&#244;nica</em>. A &#225;gua do mar tem uma salinidade m&#233;dia de 3,5%, ou seja, 4 vezes mais concentrada que o soro fisiol&#243;gico e com v&#225;rios outros &#237;ons presentes. &#201; uma solu&#231;&#227;o hipert&#244;nica comparada com plasma e com soro fisiol&#243;gico.</p><p>C&#233;lulas humanas colocadas diretamente na &#225;gua do mar,  murchariam, perderiam a &#225;gua por osmose. J&#225; o plasma [soro] &#233; <em>isot&#244;nico</em> para nossas c&#233;lulas, permitindo trocas adequadas sem danificar as membranas. O soro fisiol&#243;gico &#233; igualmente isot&#244;nico.</p><p>A &#225;gua do mar n&#227;o cont&#233;m prote&#237;nas significativas, apenas sais minerais de mat&#233;ria org&#226;nica dispersa. J&#225; o plasma cont&#233;m 7 a 8% de prote&#237;nas plasm&#225;ticas, tipo albumina, globulina, fibrinog&#234;nia, al&#233;m de glicose, horm&#244;nios, lip&#237;dios e gases. Nosso soro comparado com a &#225;gua do mar, tem 0,9% de cloreto e s&#243;dio, 9 g por litro.</p><p>A &#225;gua do mar cont&#233;m, sobretudo, cloreto de s&#243;dio; outros, s&#227;o em bem menores quantidades, como sulfato, magn&#233;sio, c&#225;lcio, pot&#225;ssio e carbonato. A salinidade m&#233;dia do mar &#233; de 3,5%, 35 gramas por litro. Os principais &#237;ons s&#227;o: Cloreto (Cl&#8315;), com ~55% dos sais dissolvidos, S&#243;dio (Na&#8314;), com ~30% e em bem menor quantidade temos sulfato (SO&#8324;&#178;&#8315;), magn&#233;sio (Mg&#178;&#8314;), c&#225;lcio (Ca&#178;&#8314;), pot&#225;ssio (K&#8314;), bicarbonato (HCO&#8323;&#8315;) e outros em menores quantidades. </p><p>O plasma humano cont&#233;m eletr&#243;litos em concentra&#231;&#245;es muito menores, j&#225; <em>ajustadas para manter o equil&#237;brio osm&#243;tico e bioqu&#237;mico</em>. Os sais/&#237;ons do plasma est&#227;o postos para assegurar uma osmolaridade [em torno de 285-295 mOsm/L [A]. Suas propor&#231;&#245;es s&#227;o finamente e energicamente reguladas pelo nosso organismo.</p><p>A &#225;gua do mar n&#227;o cont&#233;m outros &#237;ons, nem prote&#237;nas, nem nutrientes como nosso plasma. O plasma &#233; considerado isot&#244;nico em rela&#231;&#227;o &#224;s c&#233;lulas humanas, assim como o soro fisiol&#243;gico. O uso do soro fisiol&#243;gico, o uso m&#233;dico &#233; reposi&#231;&#227;o de volume, ou dilui&#231;&#227;o de medicamentos, ou irriga&#231;&#227;o est&#233;ril.</p><p>Algumas prepara&#231;&#245;es dilu&#237;das &#8211; &#225;gua salgada - s&#227;o usadas em spray nasal. O soro fisiol&#243;gico &#233; seguro para uso intravenoso, ocular, nasal e feridas. A &#225;gua do mar pode ser usada topicamente, tamb&#233;m em spray nasal [contra rinorreia]. Mas intravenosa, n&#227;o &#233; uma boa ideia - dentre muitas outras raz&#245;es - porque sua hipertonicidade danificaria as c&#233;lulas.</p><p>Existe uma &#225;rea da medicina &#8211; sobretudo era bem presente antes da era da <em>Big Pharma</em> &#8211; conhecida como talassoterapia, cujos m&#233;todos terap&#234;uticos se baseavam no uso da &#225;gua do mar e/ou do ambiente marinho. Havia cl&#237;nicas assim, na beira mar.</p><p>A &#225;gua do mar, quando usada externamente (banho de mar, talassoterapia), pode trazer benef&#237;cios reais para a pele [como foi explicado na primeira nota]. Por exemplo, por sua a&#231;&#227;o levemente anti-inflamat&#243;ria [minerais como magn&#233;sio e zinco t&#234;m propriedades anti-inflamat&#243;rias]. Na talassoterapia havia a tradi&#231;&#227;o de recorrer a banhos de mar para aliviar condi&#231;&#245;es como dermatite at&#243;pica, psor&#237;ase, eczema</p><p>Um lembrete importante &#233; o de que o contato prolongado com a &#225;gua do mar pode ressecar a pele (sobretudo em pessoas com pele sens&#237;vel), o que significa que &#233; bom enxaguar com &#225;gua doce depois do banho; al&#233;m de se prudente evitar exposi&#231;&#227;o prolongada ao sol + sal. Sobre problemas e vantagens da exposi&#231;&#227;o &#224; luz solar, melhores hor&#225;rios para a sa&#250;de etc. ver s&#233;rie de notas a respeito do <strong>sol e a sa&#250;de</strong> neste blog.</p><p><em>Asma altitude e mar</em></p><p>Em maior altitude, o oxig&#234;nio &#233; rarefeito, ser&#225; menor a press&#227;o de oxig&#234;nio do ar sobre os pulm&#245;es e, em consequ&#234;ncia, maior reten&#231;&#227;o de CO&#8322;, maior disponibilidade de CO&#8322; nos tecidos, que gera melhor entrega de oxig&#234;nio &#224;s c&#233;lulas e um metabolismo oxidativo mais eficiente. Isso favorece um ambiente, no organismo, contr&#225;rio &#224; doen&#231;a cr&#244;nico-degenerativa.</p><p>A altitude mais alta, comparada com o n&#237;vel do mar &#8211; zero altitude &#8211; &#233;, portanto, mais favor&#225;vel para a sa&#250;de, &#233; um ambiente que promove <em>menor</em> incid&#234;ncia de doen&#231;as cr&#244;nico-degenerativas, segundo R. Peat. &#201; um dos chamados paradoxos mais bem argumentados por este autor.</p><p>Paradoxo explicado pelo fato de que ao n&#237;vel do mar existe mais oxig&#234;nio dispon&#237;vel ao passo que em grande altitude existe menos oxig&#234;nio, o ar &#233; rarefeito. Mas &#233; em grande altitude que o metabolismo e a produ&#231;&#227;o de CO2 estar&#227;o mais bem servidos.</p><p>O chamado paradoxo vem pelo fato de que a pessoa em altitude elevada, depois de um tempo de adapta&#231;&#227;o, passa a reter <strong>mais</strong> CO2 no corpo [D]. &#201; o efeito Haldane e j&#225; foi tema de outras notas neste blog [sobre o CO2], n&#227;o vamos nos estender aqui; apenas lembrar que existe um mecanismo autom&#225;tico no nosso organismo de acordo com o qual, quando inspiramos MENOS oxig&#234;nio [em grande altitude], nosso corpo tende a reter MAIS CO2.</p><p>De tal forma que em grande altitude, comparado com o n&#237;vel do mar, &#233; onde a pessoa consegue melhor reter CO2.</p><p>Na mesma linha de racioc&#237;nio &#8211; e demonstrada na pr&#225;tica cl&#237;nica &#8211; mais oxig&#234;nio inspirado n&#227;o corresponde a mais oxig&#234;nio <strong>utilizado </strong>pelos tecidos; de tal forma que oferecer oxig&#234;nio com um pouco de CO2 &#8211; no hospital &#8211; seria melhor do que oxig&#234;nio puro, novamente uma discuss&#227;o que n&#227;o poderemos fazer aqui mas um procedimento que alguns hospitais j&#225; adotam [e alguns corpos de bombeiros mundo afora].</p><p>De toda forma, para Peat, o CO&#8322; &#233; respons&#225;vel por grande parte da capacidade de o organismo utilizar eficientemente o oxig&#234;nio dispon&#237;vel [efeito Haldane]. E em grande altitude o processo fisiol&#243;gico que ocorre &#233;: adapta&#231;&#227;o saud&#225;vel &#224; altitude: diminui a press&#227;o de O&#8322;, aumenta reten&#231;&#227;o de CO&#8322; e o CO&#8322; facilita a libera&#231;&#227;o e entrega de O&#8322; aos tecidos; teremos em consequ&#234;ncia, melhor metabolismo oxidativo, da&#237; a queda no lactato [B].</p><p>O ambiente litor&#226;neo, por sua vez, &#233; saud&#225;vel. Mas esta frase n&#227;o resume tudo.</p><p>Por exemplo, a pessoa com asma ficar&#225; melhor ou pior? A resposta, em princ&#237;pio, &#233; contradit&#243;ria: a brisa, o ar marinho, o sol, o bem-estar do ambiente marinho ser&#227;o claramente ben&#233;ficos. Mas a baixa altitude, em si, <em>n&#227;o ser&#225;. </em>A pessoa vai entregar menos oxig&#234;nio &#224;s c&#233;lulas [por conta do paradoxo acima mencionado]. Entregar&#225; menos oxig&#234;nio do que quando se vive em alta altitude.</p><p>E o processo &#233; que ao n&#237;vel do mar, a maior press&#227;o/presen&#231;a de oxig&#234;nio favorece a perda de CO&#8322; no nosso organismo [em altitude, a menor press&#227;o de oxig&#234;nio favorece sua reten&#231;&#227;o pelas c&#233;lulas como j&#225; foi mais de uma vez mencionado].</p><p>E isso explica por que Peat podia considerar altitude elevada protetora apesar de haver menos oxig&#234;nio no ar.</p><p>De forma que no caso da asma, h&#225; que pesar os pr&#243; e contras. A alta altitude &#233; favor&#225;vel ao metabolismo, &#224; broncodilata&#231;&#227;o [melhoraria a asma], o corpo dispor&#225; de mais CO2. Ao n&#237;vel do mar &#233; o contr&#225;rio; tomado <strong>isoladamente </strong>de outros fatores positivos, tende a ser pior para a asma. No litoral, melhora o metabolismo pulmonar da serotonina, teremos os &#237;ons negativos, aeross&#243;is marinhos, iodo, a pessoa tem ganhos, mas o metabolismo <em>como um todo</em> sai perdendo. Especialmente se a pessoa n&#227;o adotar formas de aumentar o CO2 nos seus sistemas.</p><p>Tanto assim que os dados estat&#237;sticos mostram menor incid&#234;ncia da doen&#231;a cr&#244;nico-degenerativa nos povos que vivem em mais altitude. Estes dados provavelmente n&#227;o mentem [E]. </p><p>Mas ent&#227;o h&#225; que ponderar, por exemplo, que elementos compensat&#243;rios - e que, sim,  existem - a pessoa que vive a n&#237;vel do mar pode adotar caso ela tenha, por exemplo, asma. N&#227;o &#233; uma quest&#227;o simples, em nenhum caso. E nem se pode dizer peremptoriamente que morar na praia <em>causa</em> doen&#231;a cr&#244;nico-degenerativa. Mas n&#237;vel do mar n&#227;o &#233; a mesma coisa que alta altitude, isso j&#225; est&#225; dado, como foi dito, na fisiologia. No alto, a incid&#234;ncia dessas doen&#231;as ser&#225; menor.</p><p>Sendo que, sim, o ar litor&#226;neo tem seus benef&#237;cios para doen&#231;as respirat&#243;rias como asma. N&#227;o estritamente porque seja ar &#250;mido. A quest&#227;o &#233; que respirar nas proximidades da &#225;gua do mar tem uma caracter&#237;stica adicional: as ondas quebrando produzem um aerossol de &#225;gua do mar. Isso significa que, no litoral, voc&#234; n&#227;o est&#225; simplesmente respirando &#8220;ar &#250;mido&#8221; [que combate ressecamento de mucosas]: h&#225; tamb&#233;m pequenas part&#237;culas/got&#237;culas provenientes da &#225;gua. E &#233; nesse contexto que a ideia dos &#237;ons negativos fica especialmente interessante do ponto de vista de Peat.</p><p>Vejamos.</p><p>Litoral significa ar &#250;mido com aerossol de &#225;gua salgada, &#237;ons negativos e boa ventila&#231;&#227;o; o resultado: menor tend&#234;ncia &#224; constri&#231;&#227;o das vias a&#233;reas e melhor metabolismo pulmonar. Respira-se obviamente melhor que em climas des&#233;rticos. Para algumas pessoas com vias respirat&#243;rias irrit&#225;veis, o ar &#250;mido marinho pode ser confort&#225;vel porque reduz o ressecamento das mucosas, portanto. Respirar &#233; bem mais agrad&#225;vel do que em um clima tipo deserto como o DF de agosto a outubro.</p><p>Sobre pulm&#245;es, &#237;ons negativos e serotonina, a verdade &#233; que os &#237;ons negativos, abundantes na brisa marinha, cumprem seu papel positivo. Peat considerava que os &#237;ons negativos poderiam favorecer a destrui&#231;&#227;o oxidativa da serotonina nos pulm&#245;es. Isso seria relevante para a asma porque, para Peat, serotonina elevada favorece constri&#231;&#227;o dos br&#244;nquios. De forma que diminui&#231;&#227;o da serotonina pulmonar levaria a menor tend&#234;ncia &#224; broncoconstri&#231;&#227;o.</p><p>As plaquetas chegam aos pulm&#245;es carreando serotonina; ali a mudan&#231;a CO2/oxig&#234;nio favorece sua libera&#231;&#227;o e destrui&#231;&#227;o [oxida&#231;&#227;o]. Na presen&#231;a de &#237;ons negativos isso &#233; <em>potencializado</em>. Para Peat, se intestino, plaquetas e pulm&#245;es n&#227;o conseguem eliminar adequadamente o excesso, mais serotonina pode chegar ao c&#233;rebro e isso &#233; ruim, j&#225;  que tem rela&#231;&#227;o com ansiedade, depress&#227;o, agressividade e ativa&#231;&#227;o do sistema de estresse.</p><p>O grande problema &#233; ter serotonina circulando [proveniente do intestino, por exemplo] e ela conseguir <em>escapar </em>da elimina&#231;&#227;o pulmonar. O ar do litoral com a constante produ&#231;&#227;o de &#237;ons negativos [pela quebra da &#225;gua] traz uma vantagem para a pessoa: derruba a carga serotonin&#233;rgica sist&#234;mica e, neste item, torna o metabolismo mais favor&#225;vel, no m&#237;nimo.</p><p>Para Peat os pulm&#245;es est&#227;o no centro da elimina&#231;&#227;o da serotonina do corpo. Quando os &#237;ons do mar entram em cena, o mecanismo proposto por Peat &#233; o seguinte: considerando que a serotonina das plaquetas &#233; oxidada [destru&#237;da] quando chega nos pulm&#245;es o &#237;on negativo relacionado ao oxig&#234;nio forma super&#243;xido que oxida a serotonina e a libera, agora<span> </span>j&#225; n&#227;o mais como serotonina; teremos <em>menos</em> serotonina biologicamente ativa [C] no sistema. &#8220;Os &#237;ons negativos no ar parecem ajudar os pulm&#245;es a destruir a serotonina em um processo oxidativo&#8221; [R. Peat].</p><p>Portanto, poderia ser formulado assim:</p><p>No n&#237;vel do mar n&#227;o se trata de &#8220;respirar mais oxig&#234;nio&#8221;. Sim, h&#225; mais oxig&#234;nio ao n&#237;vel do mar. Mas se trata de respirar um ambiente com maior concentra&#231;&#227;o de esp&#233;cies eletricamente negativas.</p><p>E isso se encaixa muito bem numa observa&#231;&#227;o pr&#225;tica que Peat fazia: ambientes como litoral, cachoeiras e depois de tempestades podem produzir uma sensa&#231;&#227;o de bem-estar, e ele relacionava parte disso &#224; a&#231;&#227;o dos &#237;ons negativos sobre a elimina&#231;&#227;o pulmonar da serotonina.</p><p>Sem excluir que, no caso do asm&#225;tico ou do portador de doen&#231;a cr&#244;nico-degenerativa,<span> </span>a ida para um lugar de grande altitude ser&#225; muito ben&#233;fica, ao sustentar um metabolismo mais eficaz, com maior reten&#231;&#227;o de CO2, enquanto a ida para o n&#237;vel do mar n&#227;o trar&#225; esse beneficio;  portanto, precisa ser acompanhada de &#8211; tudo permanecendo igual - medidas compensat&#243;rias para aumentar o <em>pool</em> corporal de CO2 [foi tema de outra nota sobre o CO2; em breve voltaremos ao tema, com uma s&#233;rie de artigos sobre o poder medicinal do CO2]. </p><p>E, invariavelmente, h&#225; que sempre considerar que uma doen&#231;a cr&#244;nico-degenerativa possui v&#225;rias determina&#231;&#245;es que devem ser levadas em conta pelo doutor, na linha de cuidar o paciente como pessoa singular [incluindo seus singulares maus e bons h&#225;bitos metab&#243;licos]. Apenas para dar um exemplo, uma pessoa que se empanturra todo dia com massas [amidos], saladas/legumes e evita o consumo de leite, &#233; aficcionada em jejuns, estar&#225; enferma seja no litoral seja no ar da montanha mais alta.</p><p>G Dantas, SP, 14-8-26</p><h6><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></h6><p></p><p><strong>Notas</strong>________________</p><p>[A]<span> </span>Comparando soro fisiol&#243;gico (NaCl 0,9%) com &#225;gua do mar. Vamos por partes:</p><p>Composi&#231;&#227;o do Soro Fisiol&#243;gico</p><p>O soro fisiol&#243;gico &#233; uma solu&#231;&#227;o est&#233;ril de cloreto de s&#243;dio em &#225;gua, com:</p><p>NaCl: 0,9% (9 g/L)</p><p>Equivalente a aproximadamente:</p><p>S&#243;dio (Na&#8314;): ~154 mmol/L</p><p>Cloreto (Cl&#8315;): ~154 mmol/L</p><p>Osmolaridade total: ~308 mOsm/L, pr&#243;xima &#224; do plasma humano (&#8776;285&#8211;295 mOsm/L).</p><p>N&#227;o cont&#233;m outros &#237;ons, nem prote&#237;nas, nem nutrientes.</p><p>&#201; considerado isot&#244;nico em rela&#231;&#227;o &#224;s c&#233;lulas humanas.</p><p>Composi&#231;&#227;o da &#193;gua do Mar</p><p>Salinidade m&#233;dia: 35 g/L (3,5%), ou seja, quase 4 vezes mais concentrada que o soro fisiol&#243;gico.</p><p>Principais &#237;ons:</p><p>Cloreto (Cl&#8315;): ~19.000 mg/L (~550 mmol/L)</p><p>S&#243;dio (Na&#8314;): ~10.500 mg/L (~460 mmol/L)</p><p>Magn&#233;sio (Mg&#178;&#8314;): ~1.300 mg/L (~55 mmol/L)</p><p>C&#225;lcio (Ca&#178;&#8314;): ~400 mg/L (~10 mmol/L)</p><p>Pot&#225;ssio (K&#8314;): ~380 mg/L (~10 mmol/L)</p><p>Sulfato (SO&#8324;&#178;&#8315;), bicarbonato e tra&#231;os de outros minerais.</p><p>Osmolaridade total: ~1.000 mOsm/L, ou seja, bem hipert&#244;nica comparada ao plasma e ao soro.</p><p>3. Diferen&#231;as Essenciais</p><p>Caracter&#237;stica<span> </span>Soro fisiol&#243;gico<span> </span>&#193;gua do mar</p><p>Concentra&#231;&#227;o de sais<span> </span>0,9% (9 g/L)<span> </span>3,5% (35 g/L)</p><p>Osmolaridade<span> </span>~308 mOsm/L (isot&#244;nico)<span> </span>~1.000 mOsm/L (hipert&#244;nico)</p><p>&#205;ons principais<span> </span>Apenas Na&#8314; e Cl&#8315;<span> </span>Na&#8314;, Cl&#8315;, Mg&#178;&#8314;, Ca&#178;&#8314;, K&#8314;, SO&#8324;&#178;&#8315;, HCO&#8323;&#8315;</p><p>Uso m&#233;dico/soro fisiol&#243;gico.<span> </span>Reposi&#231;&#227;o de volume, dilui&#231;&#227;o de medicamentos, irriga&#231;&#227;o est&#233;ril; n&#227;o &#233; usado diretamente em infus&#227;o; algumas prepara&#231;&#245;es filtradas/dilu&#237;das s&#227;o usadas em sprays nasais ou cosm&#233;ticos. Seguran&#231;a para c&#233;lulas:<span> </span>compat&#237;vel (isot&#244;nico). Soro fisiol&#243;gico: seguro para uso intravenoso, ocular, nasal, limpeza de feridas.</p><p>&#193;gua do mar: s&#243; pode ser usada topicamente (ex.: sprays nasais, solu&#231;&#245;es para pele), nunca intravenosa, pois sua hipertonicidade danifica c&#233;lulas; provoca sa&#237;da de &#225;gua da c&#233;lula (crena&#231;&#227;o)</p><p>Em resumo: o soro fisiol&#243;gico foi criado para imitar a tonicidade do plasma, mantendo equil&#237;brio celular.</p><p>A &#225;gua do mar tem a mesma variedade de &#237;ons que o corpo usa, mas em concentra&#231;&#245;es muito mais altas, tornando-a inadequada para contato direto com o meio interno.</p><p>A osmolaridade total do soro &#233; de cerca de 285&#8211;295 mOsm/L, o que &#233; bem menor que a da &#225;gua do mar.</p><p>[B]<span> </span>&#201; de Peat a cita&#231;&#227;o: &#8220;Breathing pure oxygen lowers the oxygen content of tissues; breathing rarefied air, or air with carbon dioxide, oxygenates and energizes the tissues&#8221;. Ou seja, dentro do modelo de Peat, a altitude &#233; quase um experimento natural mostrando que &#8220;mais O&#8322; inspirado&#8221; n&#227;o equivale a &#8220;mais O&#8322; utilizado pelos tecidos&#8221;.<span> </span>Peat &#233; bastante expl&#237;cito a respeito disso; ele diz que a menor press&#227;o de O&#8322; em altitude permite que o organismo retenha mais CO&#8322; pelo efeito Haldane, e que essa reten&#231;&#227;o ocorre naturalmente em pessoas adaptadas &#224; altitude. E Peat escreveu que a altitude elevada est&#225; associada a menor mortalidade e menor incid&#234;ncia de doen&#231;as degenerativas<span> </span>Ver R. Peat, <em>Altitude and Mortality.</em></p><p>[C]<span> </span>H&#225; inclusive experimentos <em>in vitro</em> mostrando que o super&#243;xido pode oxidar serotonina formando tryptamine-4,5-dione.</p><p>N&#227;o devemos imaginar que o o &#237;on negativo entra no pulm&#227;o e captura uma mol&#233;cula de serotonina. &#201; mais plaus&#237;vel pensar em um ambiente redox. O &#237;on negativo, particularmente esp&#233;cies de oxig&#234;nio como o super&#243;xido, pode participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons. A serotonina &#233; uma mol&#233;cula facilmente oxid&#225;vel. Portanto, a carga negativa associada ao oxig&#234;nio poderia favorecer sua transforma&#231;&#227;o qu&#237;mica. Fim da mol&#233;cula ativa de serotonina.</p><p>[D]<span> </span>Existe um per&#237;odo de adapta&#231;&#227;o quando a pessoa migra para uma regi&#227;o de alta altitude. L&#225; em cima diminui a press&#227;o de oxig&#234;nio, inicialmente haver&#225; um est&#237;mulo respirat&#243;rio. Neste caso aumenta a ventila&#231;&#227;o, tende a haver perda de CO2. Mas na sequ&#234;ncia ocorrer&#225; a adapta&#231;&#227;o. O corpo come&#231;ar&#225; a reter mais CO2.</p><p>[E]<span> </span>Peat j&#225; comparou hiperventila&#231;&#227;o [respira&#231;&#227;o r&#225;pida que perde CO2] a uma exposi&#231;&#227;o exagerada a altitude baixa, CO2. J&#225; que mais reten&#231;&#227;o de CO2 significa melhor oxigena&#231;&#227;o tecidual.<span> </span>Peat chega a dizer explicitamente que, em altitude, a menor press&#227;o de oxig&#234;nio permite maior reten&#231;&#227;o de CO&#8322; atrav&#233;s do efeito Haldane-Bohr. E atribui ao CO&#8322; fun&#231;&#245;es como: liberar O&#8322; para os tecidos; relaxar os vasos; reduzir edema; favorecer o metabolismo oxidativo; reduzir a produ&#231;&#227;o de lactato.</p><p>Em <em>Altitude and Mortality</em>, Peat afirma que popula&#231;&#245;es que vivem em grandes altitudes apresentam menor incid&#234;ncia de c&#226;ncer, doen&#231;a card&#237;aca e outras doen&#231;as degenerativas, e considera que a menor press&#227;o de oxig&#234;nio &#233; provavelmente um dos fatores importantes. Para Peat, CO&#8322; ajuda a: preservar a respira&#231;&#227;o celular; estabilizar prote&#237;nas e membranas; reduzir a excitabilidade; favorecer a circula&#231;&#227;o; proteger contra os efeitos excessivos da serotonina; atuar como um importante regulador do metabolismo. Por isso ele considerava a perda cr&#244;nica de CO&#8322; um componente de muitos estados patol&#243;gicos.</p><p>[F]<span> </span>Peat chegou a dizer que estudos realizados na Pol&#244;nia mostravam que a ioniza&#231;&#227;o negativa da atmosfera acelerava a elimina&#231;&#227;o da serotonina. Isso n&#227;o significa &#8211; em absoluto - defender, por exemplo, <strong>ozoniza&#231;&#227;o </strong>do ar para o mesmo objetivo. O ozone &#233;, certamente, t&#243;xico para os pulm&#245;es.</p><p>[G]<span> </span>OSTERBALLE O WEEKE B, 1979. <em>Influence of small atmospheric ions on the airways in patients with bronchial asthma.</em><strong> </strong>Allergy. 1979 Jun;34(3):187-94. doi: 10.1111/j.1398-9995.1979.tb01566.x.  PMID: 495917<span> </span>DOI: <a href="https://doi.org/10.1111/j.1398-9995.1979.tb01566.x">10.1111/j.1398-9995.1979.tb01566.x</a></p><p><strong>Abstract</strong></p><p>The influence of artificially generated atmospheric ions is studied in 15 patients with bronchial asthma. A slight but significant (at 5% level) improvement in the lung function was demonstrated in nine patients during positive as well as negative ion exposure, but the patients&#8217; subjective votings of the air quality did not show any changes due to ion exposure. No change in the histamine threshold of the airways in six patients with bronchial asthma was demonstrated during exposure to ions. Further controlled studies with electro-aerosols are needed.</p><p>[H]<span> </span>BEM-DOV I<span> </span>AMIRAV I SHOCHINA M, 1983.<em>Effect of negative ionisation of inspired air on the response of asthmatic children to exercise and inhaled histamine</em><strong>. </strong>Thorax. 1983 Aug;38(8):584-8. doi: 10.1136/thx.38.8.584.<span> </span>PMID: 6351332  PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC459615/">PMC459615</a>       DOI: <a href="https://doi.org/10.1136/thx.38.8.584">10.1136/thx.38.8.584</a></p><p><strong>Abstract</strong></p><p>To evaluate the effect of negative ionisation of inspired air on bronchial reactivity, 11 asthmatic children were challenged twice by exercise and 10 were challenged twice by histamine inhalation. The children breathed negatively ionised air (4 X 10(5) - 10 X 10(5) ions/cm3) or control room air in random order in a double-blind fashion. All challenges were matched in terms of basal lung function and the exercise tests were matched in terms of ventilation and respiratory heat loss. Exercise-induced asthma was significantly attenuated by exposure to negatively ionised air, the mean postexercise fall in one-second forced expiratory volume (FEV1) being 29% (SE 5%) of the initial value after the control and 21% (3%) after the ionised air test (p less than 0.02). Ten of the 11 subjects developed less exercise-induced asthma while breathing ionised air. Although the median dose of histamine (cumulative breath units) which caused a constant fall in FEV1 for each individual was higher with the ionised air challenge than with the control challenge the difference was not significant. Five of the 10 subjects were less sensitive to histamine and the other five more sensitive when breathing ionised air. It is concluded that negative ionisation of inspired air can modulate the bronchial response to exercise but the effect on the response to histamine is much more variable.</p><p>[I]<span> </span>ANDERSON S D, 1996. <em>Exercise-induced asthma and the use of hypertonic saline aerosol as a bronchial challenge.</em><strong> </strong>Respirology. 1996 Sep;1(3):175-81. doi: 10.1111/j.1440-1843.1996.tb00029.x.<span> </span>PMID: 9424393<span> </span>DOI: <a href="https://doi.org/10.1111/j.1440-1843.1996.tb00029.x">10.1111/j.1440-1843.1996.tb00029.x</a></p><p><strong>Abstract</strong></p><p>Exercise induced asthma is a common complaint and the prevalence appears to be increasing worldwide. Once confined to the research domain of university teaching hospitals, the study of EIA has extended into the school playground, defence force establishments and sports institutions. Standardized protocols have been developed to study EIA in the laboratory and in the field. A surrogate challenge using eucapnic or isocapnic hyperventilation with dry air is becoming popular because it has advantages over exercise, at least for adults. The stimulus that leads the airways to narrow is caused by the inhalation of dry air during hyperventilation and exercise, during which water is evaporated from the airways in order to condition the inspired air. The mechanism whereby the airways narrow is thought to be due to the dehydrating effects of water loss, particularly in relation to its potential to cause the airways to become hyperosmolar. Mast cell mediators such as histamine and the leucotrienes are probably involved in EIA because specific antagonists reduce severity. As a result of the osmotic theory of EIA, studies were carried out to determine whether subjects with EIA were sensitive to the effects of increasing airway osmolarity by inhalation of hyperosmolar aerosols of sodium chloride. A challenge protocol using an aerosol of 4.5% sodium chloride, generated from an ultrasonic nebulizer, has been used to identify persons with asthma and to assess response to drug therapy. There are many similarities between responses to exercise, hyperventilation and hypertonic saline in the physiological and biochemical responses and the responses to drugs. Challenge with hypertonic saline is easier and cheaper to use because expensive equipment and a source of dry air is not required as with exercise or hyperventilation. The ability to obtain a dose-response curve rather than a single response and the ability to collect inflammatory cells at the same time make challenge with hypertonic saline an attractive technique to study patients suspected of having asthma.</p><p>[J]<span> </span>JIANG S-Y MA A<span> </span>RAMACHANDRAN S, 2018. <em>Negative Air Ions and Their Effects on Human Health and Air Quality Improvement</em><strong>. </strong>Int J Mol Sci. 2018 Sep 28;19(10):2966. doi: <a href="https://doi.org/10.3390/ijms19102966">10.3390/ijms19102966</a><span> </span>PMCID: PMC6213340 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30274196/">30274196</a></p><p>Abstract</p><p>Negative air ions (NAIs) have been discovered for more than 100 years and are widely used for air cleaning. Here, we have carried out a comprehensive reviewing on the effects of NAIs on humans/animals, and microorganisms, and plant development. The presence of NAIs is credited for increasing psychological health, productivity, and overall well-being but without consistent or reliable evidence in therapeutic effects and with controversy in anti-microorganisms. Reports also showed that NAIs could help people in relieving symptoms of allergies to dust, mold spores, and other allergens. Particulate matter (PM) is a major air pollutant that affects human health. Experimental data showed that NAIs could be used to high-efficiently remove PM. Finally, we have reviewed the plant-based NAI release system under the pulsed electric field (PEF) stimulation. This is a new NAI generation system which releases a huge amount of NAIs under the PEF treatment. The system may be used to freshen indoor air and reduce PM concentration in addition to enriching oxygen content and indoor decoration at home, school, hospital, airport, and other indoor areas.<span> </span>Dispon&#237;vel em: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com</a></p><p>[K]<span> </span>SCHEUCH G GEBHART J, 1990. <em>Uptake of electrical charges in the human respiratory tract during exposure to air loaded with negative &#237;ons</em><strong><span> </span></strong>Journal Article<span> </span>Journal of Aerosol Science<span> </span>21(suppl. 1): VOLUME 1<span> </span>PAGE S439-S442</p><p>The uptake of negative charges in the human respiratory tract has been determined experimentally by breathing free ions and particles carrying negative charges. Free ions are deposited very effectively in the upper airways whereas charged particles penetrate to the deeper lungs.</p><p>Dispon&#237;vel em: <a href="https://hero.epa.gov/reference/6948/?utm_source=chatgpt.com">https://hero.epa.gov/reference/6948/?utm_source=chatgpt.com</a></p><p>[L]<span> </span><strong>Negative Air Ions and Their Generation</strong> -<span> </span>Air ions are electrically charged molecules or atoms in the atmosphere [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B2-ijms-19-02966">2</a>]. An air ion is formed when a gaseous molecule or atom receives sufficiently high energy to eject an electron [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B3-ijms-19-02966">3</a>]. NAIs are those that gain an electron, while positive air ions lose an electron. The natural and artificial energy sources include (1) radiant or cosmic rays in the atmosphere; (2) sunlight including ultraviolet; (3) natural and artificial corona discharge including thunder and lightning; (4) the shearing forces of water (Lenard effect); (5) plant-based sources of energy. [...]<span> </span>The considerable numbers of NAIs are found under waterfalls or in the seashores. These NAIs are generated by Lenard effect. Lenard effect was also called spray electrification or waterfall effect and was first systematically studied by Philipp Lenard [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B23-ijms-19-02966">23</a>], who won the Nobel Prize for Physics in 1905 for his research on cathode rays and the discovery of many of their properties. The study showed that NAIs were generated from the surrounding air molecules by charging themselves negatively when water droplets collide with each other or with a wetted solid to form fine spray of drops. The study also showed that several factors may affect the degree of charge separation in spray processes and, therefore, may affect the generation and concentration of NAIs. These factors include water drop temperature, dissolved impurities, speed of the impinging air blast, and foreign impinging surfaces of droplets. Based on the &#8220;Lenard effect&#8221;, water shearing appliance has been designed to generate NAIs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>]. Water shearing produced only superoxide ions (O<sub>2</sub><sup>&#8722;</sup>) which was bound to clusters of water molecules to form the structure O<sub>2</sub><sup>&#8722;</sup>(H<sub>2</sub>O)<sub>n</sub> [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B25-ijms-19-02966">25</a>], and was essentially regarded as a natural source of NAIs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>]. NAIs generated by the &#8220;Lenard effect&#8221; might improve erythrocyte deformability, thereby aerobic metabolism [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>].</p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com</a></p><p>[M]<span> </span>GOLDSTEIN N MERZLYAK M N, 1992. <em>Negative air ions as a source of superoxide. </em>June 1992. <a href="https://www.researchgate.net/journal/International-Journal-of-Biometeorology-1432-1254">International Journal of Biometeorology</a> 36(2):118-122<span> </span>DOI:<a href="https://doi.org/10.1007/BF01208923">10.1007/BF01208923</a>     <a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide#citations"><span>Citations (64)</span></a><span>         </span><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide#references"><span>References (34)</span></a></p><p>Abstract</p><p>The physico-chemical characteristics and possible formation mechanisms of negative air ions are considered. It was found that the products of oxygen and nitrogen negative ionization reduce ferricytochromec and nitroblue tetrazolium, and that these reactions were inhibited by superoxide dismutase. The interaction of negatively ionized oxygen with water led to hydrogen peroxide accumulation, which was inhibited by tetranitromethane or catalase. Nitrogen ionization under these conditions caused the formation of the hydrated electron e aq &#8212; and the superoxide anion O 2 &#8212; . The data obtained indicate that the biological activity of negative air ions may be dependent on superoxide. The generation of reactive oxygen ions in the gas phase and also at a gas/water interface is described. A scheme for superoxide production under oxygen and nitrogen ionization is proposed.<span> </span>Dispon&#237;vel em:<span> </span><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide">https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide</a></p><p>[N]<span> </span>WRONA M Z DRYHURST G, 1998. <em>Oxidation of Serotonin by Superoxide Radical:&#8201; Implications to Neurodegenerative Brain Disorders.</em><strong> </strong>Article| May 05, 1998  <em>Chem. Res. Toxicol.</em> (1998) 11 (6): 639&#8211;650.<span> </span><a href="https://doi.org/10.1021/tx970185w">https://doi.org/10.1021/tx970185w</a></p><p><strong>Abstract</strong></p><p>Many new lines of evidence implicate both superoxide anion radical (O<sub>2</sub><sup>&#8226;-</sup>) and biogenic amine neurotransmitters in the pathological mechanisms that underlie neuronal damage caused by methamphetamine (MA), glutamate-mediated oxidative toxicity, ischemia-reperfusion, and other neurodegenerative brain disorders. In this investigation the oxidation of 5-hydroxytryptamine (5-HT, serotonin) by an O<sub>2</sub><sup>&#8226;-</sup>-generating system (xanthine/xanthine oxidase) in buffered aqueous solution at pH 7.4 has been studied. The major product of the O<sub>2</sub><sup>&#8226;-</sup>-mediated oxidation of 5-HT is tryptamine-4,5-dione (T-4,5-D). However, O<sub>2</sub><sup>&#8226;-</sup> and H<sub>2</sub>O<sub>2</sub>, cogenerated by the xanthine oxidase-mediated oxidation of xanthine to uric acid, together react with trace levels of iron that contaminate buffer constituents to give a chemically ill-defined oxo-iron species. This species mediates the oxidation of 5-HT to a C(4)-centered carbocation intermediate that reacts with 5-HT to give 5,5&#8216;-dihydroxy-4,4&#8216;-bitryptamine (4,4&#8216;-D) and with uric acid to give 9-[3-(2-aminoethyl)-5-hydroxy-1<em>H</em>-indol-4-yl]-2,6,8-triketo-1<em>H</em>,3<em>H</em>,7<em>H</em>-purine (<strong>7</strong>) as the major products. These products differ from those formed in the HO<sup>&#8226;</sup>-mediated oxidation of 5-HT under similar conditions. When the reaction is carried out in the presence of the intraneuronal nucleophile glutathione (GSH), T-4,5-D is scavenged to give 7-(<em>S</em>-glutathionyl)tryptamine-4,5-dione, whereas the putative carbocation intermediate is scavenged to give 4-(<em>S</em>-glutathionyl)-5-hydroxytryptamine. T-4,5-D also reacts with the sulfhydryl residues of a model protein, alcohol dehydrogenase, and inhibits its activity. Previous investigators have proposed that T-4,5-D is a serotonergic neurotoxin. This raises the possibility that T-4,5-D and perhaps other putative intraneuronal metabolites formed by the O<sub>2</sub><sup>&#8226;-</sup>/H<sub>2</sub>O<sub>2</sub>/oxo-iron-mediated oxidations of 5-HT might be endotoxins that contribute to neurodegeneration in brain regions innervated by serotonergic neurons caused by MA, ischemia-reperfusion, and other neurodegenerative brain disorders.<span> </span>DISPON&#205;VEL EM: <a href="https://pubs.acs.org/crtoec/article-abstract/11/6/639/136678/Oxidation-of-Serotonin-by-Superoxide-Radical?redirectedFrom=fulltext">https://pubs.acs.org/crtoec/article-abstract/11/6/639/136678/Oxidation-of-Serotonin-by-Superoxide-Radical?redirectedFrom=fulltext</a></p><p>[O]<span> </span>XIMENES V F MAGHZAL G J TURNER R, 2009. <em>Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione.</em><strong> </strong>Biochem J. 2009 Dec 14;425(1):285-93. doi: 10.1042/BJ20090776.<span> </span>PMID: 19828014<span> </span>DOI: <a href="https://doi.org/10.1042/bj20090776">10.1042/BJ20090776</a></p><p>Abstract</p><p>During inflammatory events, neutrophils and platelets interact to release a variety of mediators. Neutrophils generate superoxide and hydrogen peroxide, and also discharge the haem enzyme myeloperoxidase. Among numerous other mediators, platelets liberate serotonin (5-hydroxytryptamine), which is a classical neurotransmitter and vasoactive amine that has significant effects on inflammation and immunity. In the present study, we show that serotonin is a favoured substrate for myeloperoxidase because other physiological substrates for this enzyme, including chloride, did not affect its rate of oxidation. At low micromolar concentrations, serotonin enhanced hypochlorous acid production by both purified myeloperoxidase and neutrophils. At higher concentrations, it almost completely blocked the formation of hypochlorous acid. Serotonin was oxidized to a dimer by myeloperoxidase and hydrogen peroxide. It was also converted into tryptamine-4,5-dione, especially in the presence of superoxide. This toxic quinone was produced by stimulated neutrophils in a reaction that required myeloperoxidase. In plasma, stimulated human neutrophils oxidized serotonin to its dimer using the NADPH oxidase and myeloperoxidase. We propose that myeloperoxidase will oxidize serotonin at sites of inflammation. In doing so, it will impair its physiological functions and generate a toxic metabolite that will exacerbate inflammatory tissue damage. Consequently, oxidation of serotonin by myeloperoxidase may profoundly influence inflammatory processes.</p><p>[P]<span> </span>Lembrando que para R. Peat n&#227;o se tratava de nada parecido com &#8220;carregar eletricamente os pulm&#245;es&#8221;. E sim de que &#8220;os &#237;ons negativos alteram a qu&#237;mica redox na superf&#237;cie respirat&#243;ria&#8221;, isto &#233;, transferem el&#233;trons. Com consequente aumento da degrada&#231;&#227;o da serotonina.</p><p>O<span> </span>&#237;on negativo consegue participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons, sim &#8212; mas isso &#233; muito diferente de dizer que, por exemplo, um aparelho ionizador transfere uma carga el&#233;trica macrosc&#243;pica para o pulm&#227;o.</p><p>H&#225; experimentos f&#237;sico-qu&#237;micos mostrando que produtos de ioniza&#231;&#227;o negativa do oxig&#234;nio podem produzir rea&#231;&#245;es caracter&#237;sticas de super&#243;xido (O&#8322;&#8226;<span>&#8315;</span>). Um trabalho de Goldstein e colaboradores, por exemplo, encontrou evid&#234;ncias de super&#243;xido e de el&#233;trons hidratados em sistemas submetidos &#224; ioniza&#231;&#227;o negativa.</p><p>Isso &#233; importante porque: O&#8322; + e<span>&#8315;</span> <span>&#8594;</span> O<span>&#8322;&#8226;&#8315;</span></p><p>Ou seja, o el&#233;tron n&#227;o precisa necessariamente entrar diretamente na c&#233;lula.</p><p>Ele pode ser transferido para o oxig&#234;nio e transformar O&#8322; em super&#243;xido. Eis o papel dos &#237;ons negativos que chegam do mar ou da cachoeira.</p><p>&#205;ons negativos do ar podem participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons e gerar esp&#233;cies redox, incluindo super&#243;xido, na interface ar&#8211;&#225;gua. Essas rea&#231;&#245;es podem ocorrer nas superf&#237;cies &#250;midas do trato respirat&#243;rio o que aumenta degrada&#231;&#227;o da serotonina.</p><p>E se houver CO2 adequado, teremos vias a&#233;reas mais abertas, promo&#231;&#227;o do metabolismo oxidativo do a&#231;&#250;car. Sendo que a pr&#243;pria queda da serotonina melhora a respira&#231;&#227;o celular e a oferta de CO2.</p><p>Experimentos mediram a absor&#231;&#227;o de carga el&#233;trica no trato respirat&#243;rio durante a respira&#231;&#227;o de ar contendo &#237;ons negativos. &#205;ons livres tendem a se depositar principalmente nas vias a&#233;reas superiores, enquanto part&#237;culas carregadas conseguem alcan&#231;ar regi&#245;es mais profundas do pulm&#227;o. Portanto, n&#227;o &#233; correto imaginar que &#8220;os &#237;ons negativos n&#227;o entram no aparelho respirat&#243;rio&#8221;. Entram e efetivamente interagem com ele.</p><p>A realidade f&#237;sico-qu&#237;mica &#233; muito mais din&#226;mica: &#237;ons, &#225;gua, oxig&#234;nio e mol&#233;culas da superf&#237;cie respirat&#243;ria trocam carga e sofrem rea&#231;&#245;es qu&#237;micas.</p><p>E aqui, neste particular caso, o super&#243;xido n&#227;o precisa ser simplesmente &#8220;dano oxidativo&#8221;. Na verdade, o super&#243;xido pode participar de rea&#231;&#245;es qu&#237;micas espec&#237;ficas. E h&#225; literatura experimental propondo que o super&#243;xido seja uma das principais esp&#233;cies associadas aos efeitos dos &#237;ons negativos naturais. Degradando a serotonina</p><p>A serotonina &#233; uma mol&#233;cula particularmente oxid&#225;vel</p><p>A serotonina (5-HT) cont&#233;m um <strong>grupo indol</strong>, que &#233; relativamente f&#225;cil de oxidar. Quando recebe/cede el&#233;trons em determinadas condi&#231;&#245;es, pode formar intermedi&#225;rios radicalares. O estudo cl&#225;ssico de Wrona e Dryhurst investigou justamente a rea&#231;&#227;o de serotonina com super&#243;xido em pH fisiol&#243;gico. Eles encontraram como produto importante a tryptamine-4,5-dione (T-4,5-D). Simplificando: serotonina + O&#8322;&#8226;<span>&#8315;</span> <span>&#8594;</span> serotonina oxidada <span>&#8594;</span> quinona/diona</p><p>Portanto, &#8220;destruir serotonina&#8221; n&#227;o significa simplesmente fazer a mol&#233;cula desaparecer instantaneamente. Significa transform&#225;-la quimicamente em outros produtos. O peroxido do oxig&#234;nio pode iniciar uma cadeia de rea&#231;&#245;es que aniquilam a mol&#233;cula de serotonina; pode formar intermedi&#193;rios a partir da serotonina, pode decompor a serotonina, pode gerar a triptamina-4-5 diona, pode simplesmente transferir el&#233;trons com oxig&#234;nio. Outro poss&#237;vel mecanismo &#233; a o super&#211;xido contribua para a forma&#231;&#227;o de H2O2 e este degrada a serotonina.</p><p>Tamb&#233;m existe uma revis&#227;o sobre &#237;ons negativos que resume a hip&#243;tese hist&#243;rica dessa maneira: o super&#243;xido seria uma das esp&#233;cies importantes produzidas pela ioniza&#231;&#227;o negativa e, em experimentos <em>in vitro</em>, a serotonina pode ser oxidada por super&#243;xido formando tryptamine-4,5-dione. Acaba de ser degradada. Em laborat&#243;rio se consegue oxidar serotonina a partir de super&#243;xido.</p><p>[Q] BIBLIOGRAFIA ADICIONAL:</p><p>Iwama H. Negative air ions created by water shearing improve erythrocyte deformability and aerobic metabolism. Indoor Air. 2004;14:293&#8211;297. doi: 10.1111/j.1600-0668.2004.00254.x. [<a href="https://doi.org/10.1111/j.1600-0668.2004.00254.x">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15217482/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indoor%20Air&amp;title=Negative%20air%20ions%20created%20by%20water%20shearing%20improve%20erythrocyte%20deformability%20and%20aerobic%20metabolism&amp;author=H.%20Iwama&amp;volume=14&amp;publication_year=2004&amp;pages=293-297&amp;pmid=15217482&amp;doi=10.1111/j.1600-0668.2004.00254.x&amp;">Google Scholar</a>]</p><p>Kosenko E.A., Kaminsky Y.G., Stavrovskaya I.G., Sirota T.V., Kondrashova M.N. The stimulatory effect of negative air ions and hydrogen peroxide on the activity of superoxide dismutase. FEBS Lett. 1997;410:309&#8211;312. doi: 10.1016/S0014-5793(97)00651-0. [<a href="https://doi.org/10.1016/S0014-5793(97)00651-0">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9237652/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett.&amp;title=The%20stimulatory%20effect%20of%20negative%20air%20ions%20and%20hydrogen%20peroxide%20on%20the%20activity%20of%20superoxide%20dismutase&amp;author=E.A.%20Kosenko&amp;author=Y.G.%20Kaminsky&amp;author=I.G.%20Stavrovskaya&amp;author=T.V.%20Sirota&amp;author=M.N.%20Kondrashova&amp;volume=410&amp;publication_year=1997&amp;pages=309-312&amp;pmid=9237652&amp;doi=10.1016/S0014-5793(97)00651-0&amp;">Google Scholar</a>]</p><p><span>Iwama H., Ohmizo H., Furuta S., Ohmori S., Watanabe K., Kaneko T., Tsutsumi K. Inspired superoxide anions attenuate blood lactate concentrations in postoperative patients. Crit. Care Med. 2002;30:1246&#8211;1249. doi: 10.1097/00003246-200206000-00014. [</span><a href="https://doi.org/10.1097/00003246-200206000-00014"><span>DOI</span></a><span>] [</span><a href="https://pubmed.ncbi.nlm.nih.gov/12072676/"><span>PubMed</span></a><span>] [</span><a href="https://scholar.google.com/scholar_lookup?journal=Crit.%20Care%20Med.&amp;title=Inspired%20superoxide%20anions%20attenuate%20blood%20lactate%20concentrations%20in%20postoperative%20patients&amp;author=H.%20Iwama&amp;author=H.%20Ohmizo&amp;author=S.%20Furuta&amp;author=S.%20Ohmori&amp;author=K.%20Watanabe&amp;volume=30&amp;publication_year=2002&amp;pages=1246-1249&amp;pmid=12072676&amp;doi=10.1097/00003246-200206000-00014&amp;"><span>Google Scholar</span></a><span>]</span></p><p><span>Yamada R., Yanoma S., Akaike M., Tsuburaya A., Sugimasa Y., Takemiya S., Motohashi H., Rino Y., Takanashi Y., Imada T. Water-generated negative air ions activate NK cell and inhibit carcinogenesis in mice. Cancer Lett. 2006;239:190&#8211;197. doi: 10.1016/j.canlet.2005.08.002. [</span><a href="https://doi.org/10.1016/j.canlet.2005.08.002"><span>DOI</span></a><span>] [</span><a href="https://pubmed.ncbi.nlm.nih.gov/16171944/"><span>PubMed</span></a><span>] [</span><a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett.&amp;title=Water-generated%20negative%20air%20ions%20activate%20NK%20cell%20and%20inhibit%20carcinogenesis%20in%20mice&amp;author=R.%20Yamada&amp;author=S.%20Yanoma&amp;author=M.%20Akaike&amp;author=A.%20Tsuburaya&amp;author=Y.%20Sugimasa&amp;volume=239&amp;publication_year=2006&amp;pages=190-197&amp;pmid=16171944&amp;doi=10.1016/j.canlet.2005.08.002&amp;"><span>Google Scholar</span></a><span>]</span></p><p>Pino O., Ragione F.L. There&#8217;s something in the air: Empirical evidence for the effects of negative air ions (NAI) on psychophysiological state and performance. Res. Psychol. Behav Sci. 2013;1:48&#8211;53. [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Psychol.%20Behav%20Sci.&amp;title=There%E2%80%99s%20something%20in%20the%20air:%20Empirical%20evidence%20for%20the%20effects%20of%20negative%20air%20ions%20(NAI)%20on%20psychophysiological%20state%20and%20performance&amp;author=O.%20Pino&amp;author=F.L.%20Ragione&amp;volume=1&amp;publication_year=2013&amp;pages=48-53&amp;">Google Scholar</a>]</p><p>Parts T.E., Luts A., Laakso L., Hirsikko A., Gronholm T., Kulmala M. Chemical composition of waterfall-induced air ions: Spectrometry vs. simulations. Boreal Environ. Res. 2007;12:409&#8211;420. [<a href="https://scholar.google.com/scholar_lookup?journal=Boreal%20Environ.%20Res.&amp;title=Chemical%20composition%20of%20waterfall-induced%20air%20ions:%20Spectrometry%20vs.%20simulations&amp;author=T.E.%20Parts&amp;author=A.%20Luts&amp;author=L.%20Laakso&amp;author=A.%20Hirsikko&amp;author=T.%20Gronholm&amp;volume=12&amp;publication_year=2007&amp;pages=409-420&amp;">Google Scholar</a>]</p><p>Lin H.F., Lin J.M. Generation and determination of negative air ions. J. Anal. Test. 2017;1:6. doi: 10.1007/s41664-017-0007-7. [<a href="https://doi.org/10.1007/s41664-017-0007-7">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Anal.%20Test.&amp;title=Generation%20and%20determination%20of%20negative%20air%20ions&amp;author=H.F.%20Lin&amp;author=J.M.%20Lin&amp;volume=1&amp;publication_year=2017&amp;pages=6&amp;doi=10.1007/s41664-017-0007-7&amp;">Google Scholar</a>]</p><p>Laakso L., Hirsikko A., Gr&#246;nholm T., Kulmala M., Luts A., Parts T.E. Waterfalls as sources of small charged aerosol particles. Atmos. Chem. Phys. 2006;6:9297&#8211;9314. doi: 10.5194/acpd-6-9297-2006. [<a href="https://doi.org/10.5194/acpd-6-9297-2006">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atmos.%20Chem.%20Phys.&amp;title=Waterfalls%20as%20sources%20of%20small%20charged%20aerosol%20particles&amp;author=L.%20Laakso&amp;author=A.%20Hirsikko&amp;author=T.%20Gr%C3%B6nholm&amp;author=M.%20Kulmala&amp;author=A.%20Luts&amp;volume=6&amp;publication_year=2006&amp;pages=9297-9314&amp;doi=10.5194/acpd-6-9297-2006&amp;">Google Scholar</a>]</p><p>Kolarz P., Gaisberger M., Madl P., Hofmann W., Ritter M., Hartl A. Characterization of ions at alpine waterfalls. atmos. Chem. Phys. 2012;12:3687&#8211;3697. doi: 10.5194/acp-12-3687-2012. [<a href="https://doi.org/10.5194/acp-12-3687-2012">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Phys.&amp;title=Characterization%20of%20ions%20at%20alpine%20waterfalls.%20atmos&amp;author=P.%20Kolarz&amp;author=M.%20Gaisberger&amp;author=P.%20Madl&amp;author=W.%20Hofmann&amp;author=M.%20Ritter&amp;volume=12&amp;publication_year=2012&amp;pages=3687-3697&amp;doi=10.5194/acp-12-3687-2012&amp;">Google Scholar</a>]</p><p>Nagato K., Matsui Y., Miyata T., Yamauchi T. An analysis of the evolution of negative ions produced by a corona ionizer in air. Int. J. Mass Spectrom. 2006;248:142&#8211;147. doi: 10.1016/j.ijms.2005.12.001. [<a href="https://doi.org/10.1016/j.ijms.2005.12.001">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mass%20Spectrom.&amp;title=An%20analysis%20of%20the%20evolution%20of%20negative%20ions%20produced%20by%20a%20corona%20ionizer%20in%20air&amp;author=K.%20Nagato&amp;author=Y.%20Matsui&amp;author=T.%20Miyata&amp;author=T.%20Yamauchi&amp;volume=248&amp;publication_year=2006&amp;pages=142-147&amp;doi=10.1016/j.ijms.2005.12.001&amp;">Google Scholar</a>]</p><p>Ryushi T., Kita I., Sakurai T., Yasumatsu M., Isokawa M., Aihara Y., Hama K. The effect of exposure to negative air ions on the recovery of physiological responses after moderate endurance exercise. Int. J. Biometeorol. 1998;41:132&#8211;136. doi: 10.1007/s004840050066. [<a href="https://doi.org/10.1007/s004840050066">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9531858/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Biometeorol.&amp;title=The%20effect%20of%20exposure%20to%20negative%20air%20ions%20on%20the%20recovery%20of%20physiological%20responses%20after%20moderate%20endurance%20exercise&amp;author=T.%20Ryushi&amp;author=I.%20Kita&amp;author=T.%20Sakurai&amp;author=M.%20Yasumatsu&amp;author=M.%20Isokawa&amp;volume=41&amp;publication_year=1998&amp;pages=132-136&amp;pmid=9531858&amp;doi=10.1007/s004840050066&amp;">Google Scholar</a>]</p><p>Wrona M.Z., Dryhurst G. Oxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders. Chem. Res. Toxicol. 1998;11:639&#8211;650. doi: 10.1021/tx970185w. [<a href="https://doi.org/10.1021/tx970185w">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9625732/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Res.%20Toxicol.&amp;title=Oxidation%20of%20serotonin%20by%20superoxide%20radical:%20Implications%20to%20neurodegenerative%20brain%20disorders&amp;author=M.Z.%20Wrona&amp;author=G.%20Dryhurst&amp;volume=11&amp;publication_year=1998&amp;pages=639-650&amp;pmid=9625732&amp;doi=10.1021/tx970185w&amp;">Google Scholar</a>]</p><p>Wiszniewski A., Suchanowski A., Wielgomas B. Effects of Air-Ions on human circulatory indicators. Pol. J. Environ. Stud. 2014;23:521&#8211;531. [<a href="https://scholar.google.com/scholar_lookup?journal=Pol.%20J.%20Environ.%20Stud.&amp;title=Effects%20of%20Air-Ions%20on%20human%20circulatory%20indicators&amp;author=A.%20Wiszniewski&amp;author=A.%20Suchanowski&amp;author=B.%20Wielgomas&amp;volume=23&amp;publication_year=2014&amp;pages=521-531&amp;">Google Scholar</a>]</p><p>Hedge A., Collis M.D. Do negative air ions affect human mood and performance? Ann. Occup. Hyg. 1987;31:285&#8211;290. doi: 10.1093/annhyg/31.3.285. [<a href="https://doi.org/10.1093/annhyg/31.3.285">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3426028/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Occup.%20Hyg.&amp;title=Do%20negative%20air%20ions%20affect%20human%20mood%20and%20performance?&amp;author=A.%20Hedge&amp;author=M.D.%20Collis&amp;volume=31&amp;publication_year=1987&amp;pages=285-290&amp;pmid=3426028&amp;doi=10.1093/annhyg/31.3.285&amp;">Google Scholar</a>]</p><p>Perez V., Alexander D.D., Bailey W.H. Air ions and mood outcomes: A review and meta-analysis. BMC Psychiatry. 2013;13:29. doi: 10.1186/1471-244X-13-29. [<a href="https://doi.org/10.1186/1471-244X-13-29">DOI</a>] [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3598548/">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23320516/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Psychiatry&amp;title=Air%20ions%20and%20mood%20outcomes:%20A%20review%20and%20meta-analysis&amp;author=V.%20Perez&amp;author=D.D.%20Alexander&amp;author=W.H.%20Bailey&amp;volume=13&amp;publication_year=2013&amp;pages=29&amp;pmid=23320516&amp;doi=10.1186/1471-244X-13-29&amp;">Google Scholar</a>]</p><p>Timoshkin I.V., Maclean M., Wilson M.P., Given M.J., MacGregor S.J., Wang T., Anderson J.G. Bactericidal effect of corona discharges in atmospheric air. IEEE Trans. Plasma Sci. 2012;40:2322&#8211;2333. doi: 10.1109/TPS.2012.2193621. [<a href="https://doi.org/10.1109/TPS.2012.2193621">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Trans.%20Plasma%20Sci.&amp;title=Bactericidal%20effect%20of%20corona%20discharges%20in%20atmospheric%20air&amp;author=I.V.%20Timoshkin&amp;author=M.%20Maclean&amp;author=M.P.%20Wilson&amp;author=M.J.%20Given&amp;author=S.J.%20MacGregor&amp;volume=40&amp;publication_year=2012&amp;pages=2322-2333&amp;doi=10.1109/TPS.2012.2193621&amp;">Google Scholar</a>]</p><p>Pratt R., Barnard R.W. Some effects of ionized air on Penicillium notatum. J. Am. Pharm. Assoc. Sci. 1960;49:643&#8211;646. doi: 10.1002/jps.3030491004. [<a href="https://doi.org/10.1002/jps.3030491004">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Pharm.%20Assoc.%20Sci.&amp;title=Some%20effects%20of%20ionized%20air%20on%20Penicillium%20notatum&amp;author=R.%20Pratt&amp;author=R.W.%20Barnard&amp;volume=49&amp;publication_year=1960&amp;pages=643-646&amp;doi=10.1002/jps.3030491004&amp;">Google Scholar</a>]</p><p>Mitchell B.W., King D.J. Effect of negative air ionization on airborne transmission of newcastle disease virus. Avian. Dis. 1994;38:725&#8211;732. doi: 10.2307/1592107. [<a href="https://doi.org/10.2307/1592107">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7702504/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Avian.%20Dis.&amp;title=Effect%20of%20negative%20air%20ionization%20on%20airborne%20transmission%20of%20newcastle%20disease%20virus&amp;author=B.W.%20Mitchell&amp;author=D.J.%20King&amp;volume=38&amp;publication_year=1994&amp;pages=725-732&amp;pmid=7702504&amp;doi=10.2307/1592107&amp;">Google Scholar</a>]</p><p>Wallner P., Kundi M., Panny M., Tappler P., Hutter H.P. Exposure to air ions in indoor environments: Experimental study with healthy adults. Int. J. Environ. Res. Public Health. 2015;12:14301&#8211;14311. doi: 10.3390/ijerph121114301. [<a href="https://doi.org/10.3390/ijerph121114301">DOI</a>] [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4661648/">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26569277/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Environ.%20Res.%20Public%20Health.&amp;title=Exposure%20to%20air%20ions%20in%20indoor%20environments:%20Experimental%20study%20with%20healthy%20adults&amp;author=P.%20Wallner&amp;author=M.%20Kundi&amp;author=M.%20Panny&amp;author=P.%20Tappler&amp;author=H.P.%20Hutter&amp;volume=12&amp;publication_year=2015&amp;pages=14301-14311&amp;pmid=26569277&amp;doi=10.3390/ijerph121114301&amp;">Google Scholar</a>]</p><p>Kellogg E.W., Yost M.G., Barthakur N., Kreuger A.P. Superoxide involvement in the bactericidal effects of negative air ions on Staphylococcus albus. Nature. 1979;281:400&#8211;401. doi: 10.1038/281400a0. [<a href="https://doi.org/10.1038/281400a0">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/225679/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Superoxide%20involvement%20in%20the%20bactericidal%20effects%20of%20negative%20air%20ions%20on%20Staphylococcus%20albus&amp;author=E.W.%20Kellogg&amp;author=M.G.%20Yost&amp;author=N.%20Barthakur&amp;author=A.P.%20Kreuger&amp;volume=281&amp;publication_year=1979&amp;pages=400-401&amp;pmid=225679&amp;doi=10.1038/281400a0&amp;">Google Scholar</a>]</p><p>Luts A., Salm J. Chemical composition of small atmospheric ions near the ground. J. Geophys. Res. 1994;99:10781&#8211;10785. doi: 10.1029/93JD03225. [<a href="https://doi.org/10.1029/93JD03225">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Geophys.%20Res.&amp;title=Chemical%20composition%20of%20small%20atmospheric%20ions%20near%20the%20ground&amp;author=A.%20Luts&amp;author=J.%20Salm&amp;volume=99&amp;publication_year=1994&amp;pages=10781-10785&amp;doi=10.1029/93JD03225&amp;">Google Scholar</a>]</p><p>Goldstein N., Lewin T., Kamensky A., Dubinin V., Baumann S., Konstantinova O. Exogenous gaseous superoxide potentiates the antinociceptive effect of opioid analgesic agents. Inflamm. Res. 1996;45:473&#8211;478. doi: 10.1007/BF02252319. [<a href="https://doi.org/10.1007/BF02252319">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8891759/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Res.&amp;title=Exogenous%20gaseous%20superoxide%20potentiates%20the%20antinociceptive%20effect%20of%20opioid%20analgesic%20agents&amp;author=N.%20Goldstein&amp;author=T.%20Lewin&amp;author=A.%20Kamensky&amp;author=V.%20Dubinin&amp;author=S.%20Baumann&amp;volume=45&amp;publication_year=1996&amp;pages=473-478&amp;pmid=8891759&amp;doi=10.1007/BF02252319&amp;">Google Scholar</a>]</p><p>Mayya Y.S., Sapra B.K., Khan A., Sunny F. Aerosol removal by unipolar ionization in indoor environments. Aerosol Sci. 2004;35:923&#8211;941. doi: 10.1016/j.jaerosci.2004.03.001. [<a href="https://doi.org/10.1016/j.jaerosci.2004.03.001">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aerosol%20Sci.&amp;title=Aerosol%20removal%20by%20unipolar%20ionization%20in%20indoor%20environments&amp;author=Y.S.%20Mayya&amp;author=B.K.%20Sapra&amp;author=A.%20Khan&amp;author=F.%20Sunny&amp;volume=35&amp;publication_year=2004&amp;pages=923-941&amp;doi=10.1016/j.jaerosci.2004.03.001&amp;">Google Scholar</a>]</p><p>Grinshpun S.A., Mainelis G., Trunov M., Adhikari A., Reponen T., Willeke K. Evaluation of ionic air purifiers for reducing aerosol exposure in confined indoor spaces. Indoor Air. 2005;15:235&#8211;245. doi: 10.1111/j.1600-0668.2005.00364.x. [<a href="https://doi.org/10.1111/j.1600-0668.2005.00364.x">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15982270/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indoor%20Air&amp;title=Evaluation%20of%20ionic%20air%20purifiers%20for%20reducing%20aerosol%20exposure%20in%20confined%20indoor%20spaces&amp;author=S.A.%20Grinshpun&amp;author=G.%20Mainelis&amp;author=M.%20Trunov&amp;author=A.%20Adhikari&amp;author=T.%20Reponen&amp;volume=15&amp;publication_year=2005&amp;pages=235-245&amp;pmid=15982270&amp;doi=10.1111/j.1600-0668.2005.00364.x&amp;">Google Scholar</a>]</p><p>Berry D., Mainelis G., Fennell D. Effect of an ionic air cleaner on indoor/outdoor particle ratios in a residential environment. Aerosol Sci. Technol. 2007;41:315&#8211;328. doi: 10.1080/02786820701199702. [<a href="https://doi.org/10.1080/02786820701199702">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aerosol%20Sci.%20Technol.&amp;title=Effect%20of%20an%20ionic%20air%20cleaner%20on%20indoor/outdoor%20particle%20ratios%20in%20a%20residential%20environment&amp;author=D.%20Berry&amp;author=G.%20Mainelis&amp;author=D.%20Fennell&amp;volume=41&amp;publication_year=2007&amp;pages=315-328&amp;doi=10.1080/02786820701199702&amp;">Google Scholar</a>]</p><p>Grabarczyk Z. Electiveness of indoor air cleaning with corona ionizers. J. Electrostat. 2001;51:278&#8211;283. doi: 10.1016/S0304-3886(01)00058-4. [<a href="https://doi.org/10.1016/S0304-3886(01)00058-4">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Electrostat.&amp;title=Electiveness%20of%20indoor%20air%20cleaning%20with%20corona%20ionizers&amp;author=Z.%20Grabarczyk&amp;volume=51&amp;publication_year=2001&amp;pages=278-283&amp;doi=10.1016/S0304-3886(01)00058-4&amp;">Google Scholar</a>]</p><p>Sawant V.S. Control of respirable particles in indoor air with portable negative air ion generator. IOSR J. Environ. Sci. Toxicol. Food Technol. 2013;3:28&#8211;31. doi: 10.9790/2402-0332831. [<a href="https://doi.org/10.9790/2402-0332831">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IOSR%20J.%20Environ.%20Sci.%20Toxicol.%20Food%20Technol.&amp;title=Control%20of%20respirable%20particles%20in%20indoor%20air%20with%20portable%20negative%20air%20ion%20generator&amp;author=V.S.%20Sawant&amp;volume=3&amp;publication_year=2013&amp;pages=28-31&amp;doi=10.9790/2402-0332831&amp;">Google Scholar</a>]</p><p>Sawant V.S. Removal of particulate matter by using negative electric discharge. Int. J. Eng. Innov. Technol. 2013;2:48&#8211;51. [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Eng.%20Innov.%20Technol.&amp;title=Removal%20of%20particulate%20matter%20by%20using%20negative%20electric%20discharge&amp;author=V.S.%20Sawant&amp;volume=2&amp;publication_year=2013&amp;pages=48-51&amp;">Google Scholar</a>]</p><p>&#268;erneck&#253; J., Valentov&#225; K., Pivar&#269;iov&#225; E., Bo&#382;ek P. Ionization impact on the air cleaning efficiency in the interior. Meas. Sci. Rev. 2015;15:156&#8211;166. doi: 10.1515/msr-2015-0023. [<a href="https://doi.org/10.1515/msr-2015-0023">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Meas.%20Sci.%20Rev.&amp;title=Ionization%20impact%20on%20the%20air%20cleaning%20efficiency%20in%20the%20interior&amp;author=J.%20%C4%8Cerneck%C3%BD&amp;author=K.%20Valentov%C3%A1&amp;author=E.%20Pivar%C4%8Diov%C3%A1&amp;author=P.%20Bo%C5%BEek&amp;volume=15&amp;publication_year=2015&amp;pages=156-166&amp;doi=10.1515/msr-2015-0023&amp;">Google Scholar</a>]</p><p>Pushpawela B., Jayaratne R., Nguy A., Morawska L. Efficiency of ionizers in removing airborne particles in indoor environments. J. Electrostatics. 2017;90:79&#8211;84. doi: 10.1016/j.elstat.2017.10.002. [<a href="https://doi.org/10.1016/j.elstat.2017.10.002">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Electrostatics&amp;title=Efficiency%20of%20ionizers%20in%20removing%20airborne%20particles%20in%20indoor%20environments&amp;author=B.%20Pushpawela&amp;author=R.%20Jayaratne&amp;author=A.%20Nguy&amp;author=L.%20Morawska&amp;volume=90&amp;publication_year=2017&amp;pages=79-84&amp;doi=10.1016/j.elstat.2017.10.002&amp;">Google Scholar</a>]</p><p>***</p><p></p><p></p>]]></content:encoded></item><item><title><![CDATA[A água do mar: por que ela e a brisa marinha são saúde? [Parte 1 de 3]]]></title><description><![CDATA[A medicina da brisa marinha, da &#225;gua do mar, seus sais e do ambiente litor&#226;neo. [Parte 1 de 3]]]></description><link>https://outramedicina2024.substack.com/p/a-agua-do-mar-por-que-ela-e-a-brisa</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/a-agua-do-mar-por-que-ela-e-a-brisa</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Thu, 13 Aug 2026 11:58:48 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!jz0q!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!jz0q!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!jz0q!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg" width="582" height="372" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/cd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:372,&quot;width&quot;:582,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:71276,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/210966444?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!jz0q!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd6c1954-0aef-4a3e-b280-06f14a1d5273_582x372.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>O ar marinho &#8211; como regra - &#233; muito ben&#233;fico para n&#243;s, seja porque &#233; mais limpo, mais &#250;mido, rico em micropart&#237;culas salinas mas tamb&#233;m muito rico em &#237;ons negativos. Esse ar ajuda a melhorar a respira&#231;&#227;o, fortalece o sistema imunol&#243;gico, favorece o equil&#237;brio emocional e provoca uma sensa&#231;&#227;o geral de bem-estar. </p><p>Al&#233;m da qu&#237;mica do ar, h&#225; tamb&#233;m o efeito no humor, na boa sensa&#231;&#227;o da rela&#231;&#227;o com a natureza, al&#233;m de que o som das ondas, a paisagem e a luminosidade conformam um conjunto que possui a&#231;&#227;o calmante. Pode ajudar na melhora da qualidade do sono. E por isso mesmo, a rela&#231;&#227;o com a brisa marinha, o sol e o ambiente marinho pode ter efeito antidepressivo.</p><p>Portanto, esse efeito geral certamente tem tamb&#233;m a ver com a apari&#231;&#227;o de sentimentos que levam &#224; redu&#231;&#227;o da libera&#231;&#227;o de cortisol [via CRH], com a eventual melhora do sono noturno.</p><p>Tamb&#233;m, como foi dito, espera-se que seja um ar mais limpo, com <em>menor</em> ou nenhuma concentra&#231;&#227;o de poluentes urbanos, de poeira e de al&#233;rgenos e, nesse sentido, que favore&#231;a o sistema imune. &#201; um ar que quase n&#227;o carreia al&#233;rgenos [como o dos grandes centros], contribui para a menor irrita&#231;&#227;o das vias respirat&#243;rias, redu&#231;&#227;o de sintomas al&#233;rgicos, melhor funcionamento pulmonar.</p><p>Lembrando que a aus&#234;ncia de part&#237;culas do tipo poluentes urbanos ou poeira, melhora a fun&#231;&#227;o <em>detox</em> de serotonina do corpo, isto &#233;, dos pulm&#245;es [nota subsequente explica isso melhor]. </p><p>Por ora, vale destacar que quando existem part&#237;culas em suspens&#227;o no ambiente, alerg&#234;nicas ou n&#227;o, o impacto nos pulm&#245;es se traduz em redu&#231;&#227;o da elimina&#231;&#227;o da serotonina [que ocorre regularmente por essa via respirat&#243;ria]. Al&#233;m de um segundo efeito anti-serotonina que mencionaremos mais adiante. Por enquanto vale registrar que, por exemplo, pessoas que vivem pr&#243;ximas a ruas de tr&#226;nsito intenso ter&#227;o seus pulm&#245;es alcan&#231;ados por part&#237;culas em suspens&#227;o, e estas comprometem a fun&#231;&#227;o detox de serotonina dos pulm&#245;es.</p><p>O ar pr&#243;ximo ao mar, mais &#250;mido, como j&#225; foi mencionado, cont&#233;m micropart&#237;culas de cloreto de s&#243;dio e outros sais marinhos. Inaladas, elas podem fluidificar as secre&#231;&#245;es respirat&#243;rias, facilitar a respira&#231;&#227;o de pessoas com sinusite, bronquite ou asma, e ter leve efeito antiss&#233;ptico sobre as vias a&#233;reas. </p><p>Al&#233;m de que existe o conforto meio &#243;bvio de respirar um ar fisiologicamente mais &#250;mido, que poupa &#224;s vias a&#233;reas terem que <em>hidratar</em> o ar que seria um estresse se chegasse seco [sim, em cidades como Bras&#237;lia, as pessoas vivem esse estresse extra: maior dificuldade das vias a&#233;reas para umidificar o ar que entra muito seco].</p><p>A quest&#227;o dos &#237;ons negativos &#233; outro fato bem importante:<span> </span>o ar marinho consegue ter uma concentra&#231;&#227;o <em>maior</em> deles, ou seja, de mol&#233;culas de oxig&#234;nio carregadas eletricamente, de forma negativa. Elas s&#227;o formadas durante o processo de fric&#231;&#227;o das ondas e da evapora&#231;&#227;o, ali onde aparece a espuma das ondas quebrando.</p><p>A fric&#231;&#227;o que acontece nesse processo gera, por exemplo, mol&#233;culas de hidrog&#234;nio/oxig&#234;nio carregadas negativamente. Estes &#237;ons negativos - alcan&#231;ando os pulm&#245;es - est&#227;o associados a uma melhora do humor, redu&#231;&#227;o do estresse e sensa&#231;&#227;o de relaxamento e bem-estar [e especialmente pelo efeito anti-serotonina daqueles &#237;ons, a ser melhor examinado em outra nota desta s&#233;rie].</p><p>N&#243;s estamos falando do ar marinho, ou seja, da atmosfera das regi&#245;es costeiras, com polui&#231;&#227;o muito baixa ou praticamente nenhuma.</p><p>Com rela&#231;&#227;o ao iodo, a &#225;gua do mar e tamb&#233;m o ar costeiro, trazem iodo em formas de &#237;ons iodeto, principalmente. Varia conforme a regi&#227;o, profundidade e outros elementos. Esse iodo &#233; absorvido por organismos marinhos, por isso s&#227;o ricos em iodo [tamb&#233;m &#233; absorvido de peixes menores, capturados por maiores].</p><p>A concentra&#231;&#227;o m&#233;dia &#233; de cerca de 50 a 60 microgramas por litro (&#181;g/L), podendo variar conforme a regi&#227;o. Na verdade, o iodo do mar &#233; a principal fonte natural de reposi&#231;&#227;o de iodo na biosfera. Quanto ao iodo do <em>ar marinho</em>, ele est&#225; ali em concentra&#231;&#245;es certamente muito menores do que na &#225;gua do mar.</p><p>Em outras palavras, a &#225;gua do mar cont&#233;m iodo em quantidades mensur&#225;veis (dezenas de &#181;g/L) ao passo que o ar marinho: cont&#233;m apenas tra&#231;os de iodo (aeross&#243;is e compostos vol&#225;teis), insuficientes como fonte alimentar, mas relevantes para a qu&#237;mica atmosf&#233;rica e bem-vindos para n&#243;s.</p><p>A parte do iodo que chega pelo ar vem atrav&#233;s de aeross&#243;is marinhos, que s&#227;o min&#250;sculas got&#237;culas suspensas no ar. E eventualmente algum composto vol&#225;til de iodo produzido com a &#225;gua do mar, tipo iodo metano. De forma que o ar marinho cont&#233;m tra&#231;os, sim, de iodo;  sendo que, como foi dito, o impacto nutricional &#233; muito menor do que o da alimenta&#231;&#227;o [ostras, por exemplo] <em>incomparavelmente</em> menor.</p><p>Por sua vez, beber &#225;gua do mar n&#227;o &#233; uma boa ideia, porque se trata de um l&#237;quido <em>hipert&#244;nico</em> em rela&#231;&#227;o aos fluidos do nosso corpo. A salinidade da &#225;gua do mar fica em torno de 3,5%, muito maior do que a do plasma, que &#233; de 0,9%. A ingesta de &#225;gua do mar drenaria &#225;gua das nossas c&#233;lulas do intestino, por exemplo [crena&#231;&#227;o]. O resultado cl&#237;nico seria  desidrata&#231;&#227;o, com as c&#233;lulas perdendo &#225;gua, encolhendo em seu volume, aumento da diurese; os rins v&#227;o tentar eliminar o excesso de sal e v&#227;o usar <em>muito mais &#225;gua</em> do que a fornecida pela pr&#243;pria &#225;gua do mar eventualmente ingerida.</p><p>Ent&#227;o ao inv&#233;s de hidratar, o consumo de &#225;gua do mar levaria, a certa altura, &#224; desidrata&#231;&#227;o mais r&#225;pida do que se a pessoa - mantido tudo igual - n&#227;o tivesse bebido nada. Pode gerar na pessoa, dependendo da quantidade que usou, uma sede intensa. Teremos aqui um corpo clamando que <em>n&#227;o ganhou </em>&#225;gua. Est&#225; faltando &#225;gua &#250;til.</p><p>Isso pode levar a n&#225;useas, v&#244;mitos, eventualmente diarreia, c&#227;ibras, fraqueza muscular, confus&#227;o mental e, no limite, coma, se a desidrata&#231;&#227;o e o desequil&#237;brio eletrol&#237;tico forem graves e com risco de, l&#225; na ponta, de fal&#234;ncia renal.</p><p>O n&#225;ufrago, portanto, acelera a desidrata&#231;&#227;o e o risco de morte se ele ousar beber &#225;gua do mar; em suma, em casos de n&#225;ufragos, beber &#225;gua do mar acelera a desidrata&#231;&#227;o e o risco de morte.</p><p>Nesse caso, a melhor estrat&#233;gia &#233;: coletar &#225;gua da chuva, dessalinizar (com evapora&#231;&#227;o/condensa&#231;&#227;o), ou usar recursos improvisados como um &#8220;destilador solar&#8221;.</p><p>Sobre beber &#225;gua do mar, portanto, a recomenda&#231;&#227;o universal dos doutores &#233; nunca faz&#234;-lo. Melhor coletar &#225;gua da chuva, dessalinizar, por exemplo, recorrer &#224; evapora&#231;&#227;o e condensa&#231;&#227;o ou outro recurso qualquer. Embora a &#225;gua do mar n&#227;o mate instantaneamente, mas acelera a desidrata&#231;&#227;o. Em suma: os rins n&#227;o conseguem eliminar tanto sal sem gastar mais &#225;gua do que a que foi ganha. O resultado ser&#225; a j&#225; citada desidrata&#231;&#227;o.</p><p>Tomar banho na praia, mergulhar tem outro significado, saud&#225;vel. Banhar-se com a &#225;gua do mar tem efeitos ben&#233;ficos para a pele, por conta da a&#231;&#227;o de limpeza, anti-inflamat&#243;ria, antiss&#233;ptica e estimulante na circula&#231;&#227;o, mas sempre sem exagero. E procurando hidratar a pele depois, no p&#243;s-banho, enxaguando-se com &#225;gua doce.</p><p>A salinidade da &#225;gua ajuda a remover excesso de impureza, c&#233;lulas mortas, oleosidade. Da&#237; tende a acontecer de a pele ficar mais limpa e a pessoa com sensa&#231;&#227;o de frescor. O leve atrito da areia com sal tamb&#233;m funciona como um miniesfoliante natural.</p><p>E os sais marinhos, tipo cloreto de s&#243;dio, sobretudo, mas tamb&#233;m magn&#233;sio, c&#225;lcio, pot&#225;ssio, possuem efeito antimicrobiano suave, o que pode ajudar a secar pequenas espinhas, desinfetar algum pequeno ferimento superficial ou acelerar a cicatriza&#231;&#227;o de algum corte leve.</p><p>Que outros sais respiramos quando estamos no ar marinho?</p><p>Em primeiro lugar, claro, o cloreto de s&#243;dio &#233; o mais abundante, presente, como foi dito em microgot&#237;culas [microsc&#243;picas], e ser&#225; o grande respons&#225;vel pelo cheiro e sabor salgado do ar costeiro. O magn&#233;sio vem na forma de cloreto de magn&#233;sio e sulfato. &#201; muito pouca quantidade, mas tem propriedades anti-inflamat&#243;rias e calmantes.</p><p>O c&#225;lcio, bem menor quantidade. Pot&#225;ssio, menos ainda, mas aparecem tra&#231;os seus no aerossol marinho. Sulfatos, tamb&#233;m pouca quantidade, no caso, de c&#225;lcio, magn&#233;sio; bicarbonato, menos ainda, mas h&#225; libera&#231;&#227;o de muito pequena quantidade na atmosfera.</p><p>Parte do odor caracter&#237;stico do mar tamb&#233;m vem de compostos org&#226;nicos vol&#225;teis de algas marinhas, que participam da qu&#237;mica atmosf&#233;rica e at&#233; da forma&#231;&#227;o de nuvens. S&#227;o iodometano e dimetilssulfeto [o odor caracter&#237;stico do mar tem a ver, em parte, com esses elementos].</p><p>Resumindo: o efeito para a sa&#250;de do ar marinho &#233;, certamente, de melhora do humor; tamb&#233;m antiss&#233;ptico, j&#225; que aqueles sais que v&#234;m em aeross&#243;is na beira mar, t&#234;m a&#231;&#227;o levemente antimicrobiana; e teremos o bem-estar natural, j&#225; que &#237;ons negativos e minerais contribuem para uma melhora na respirat&#243;ria e sensa&#231;&#227;o de relaxamento. Tamb&#233;m o ar da beira-mar ser&#225; mais &#250;mido, adequadamente &#250;mido, tornando confort&#225;vel o ato de respirar, se comparando com ambientes des&#233;rticos como Bras&#237;lia, ou cidades do tipo.</p><p>[Continua na Parte 2 e 3]</p><p>G Dantas, SP, 13-8-26</p><h6><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></h6><p></p><p>Notas________________</p><p>[A]<span> </span>Comparando soro fisiol&#243;gico (NaCl 0,9%) com &#225;gua do mar. Vamos por partes:</p><p>Composi&#231;&#227;o do Soro Fisiol&#243;gico. O soro fisiol&#243;gico &#233; uma solu&#231;&#227;o est&#233;ril de cloreto de s&#243;dio em &#225;gua, com:</p><p>NaCl: 0,9% (9 g/L)</p><p>Equivalente a aproximadamente:</p><p>S&#243;dio (Na&#8314;): ~154 mmol/L</p><p>Cloreto (Cl&#8315;): ~154 mmol/L</p><p>Osmolaridade total: ~308 mOsm/L, pr&#243;xima &#224; do plasma humano (&#8776;285&#8211;295 mOsm/L).</p><p>N&#227;o cont&#233;m outros &#237;ons, nem prote&#237;nas, nem nutrientes.</p><p>&#201; considerado isot&#244;nico em rela&#231;&#227;o &#224;s c&#233;lulas humanas.</p><p>Composi&#231;&#227;o da &#193;gua do Mar. Salinidade m&#233;dia: 35 g/L (3,5%), ou seja, quase 4 vezes mais concentrada que o soro fisiol&#243;gico.</p><p>Principais &#237;ons:</p><p>Cloreto (Cl&#8315;): ~19.000 mg/L (~550 mmol/L)</p><p>S&#243;dio (Na&#8314;): ~10.500 mg/L (~460 mmol/L)</p><p>Magn&#233;sio (Mg&#178;&#8314;): ~1.300 mg/L (~55 mmol/L)</p><p>C&#225;lcio (Ca&#178;&#8314;): ~400 mg/L (~10 mmol/L)</p><p>Pot&#225;ssio (K&#8314;): ~380 mg/L (~10 mmol/L)</p><p>Sulfato (SO&#8324;&#178;&#8315;), bicarbonato e tra&#231;os de outros minerais.</p><p>Osmolaridade total: ~1.000 mOsm/L, ou seja, bem hipert&#244;nica comparada ao plasma e ao soro.</p><p><strong>Diferen&#231;as Essenciais</strong></p><p>Caracter&#237;stica<span> </span>Soro fisiol&#243;gico<span>                          </span>&#193;gua do mar</p><p>Concentra&#231;&#227;o de sais<span> </span>0,9% (9 g/L)                     <span> </span>3,5% (35 g/L)</p><p>Osmolaridade<span> </span>~308 mOsm/L (isot&#244;nico)<span>         </span>~1.000 mOsm/L (hipert&#244;nico)</p><p>&#205;ons principais<span> </span>Apenas Na&#8314; e Cl&#8315;<span>                      </span>Na&#8314;, Cl&#8315;, Mg&#178;&#8314;, Ca&#178;&#8314;, K&#8314;, SO&#8324;&#178;&#8315;, HCO&#8323;&#8315;</p><p>Uso m&#233;dico/soro fisiol&#243;gico.<span> </span>Reposi&#231;&#227;o de volume, dilui&#231;&#227;o de medicamentos, irriga&#231;&#227;o est&#233;ril; n&#227;o &#233; usado diretamente em infus&#227;o; algumas prepara&#231;&#245;es filtradas/dilu&#237;das s&#227;o usadas em sprays nasais ou cosm&#233;ticos. Seguran&#231;a para c&#233;lulas:<span> </span>compat&#237;vel (isot&#244;nico). Soro fisiol&#243;gico: seguro para uso intravenoso, ocular, nasal, limpeza de feridas.</p><p>&#193;gua do mar: s&#243; pode ser usada topicamente (ex.: sprays nasais, solu&#231;&#245;es para pele), nunca intravenosa, pois sua hipertonicidade danifica c&#233;lulas; provoca sa&#237;da de &#225;gua da c&#233;lula (crena&#231;&#227;o)</p><p>Em resumo: o soro fisiol&#243;gico foi criado para imitar a tonicidade do plasma, mantendo equil&#237;brio celular.</p><p>A &#225;gua do mar tem a mesma variedade de &#237;ons que o corpo usa, mas em concentra&#231;&#245;es muito mais altas, tornando-a inadequada para contato direto com o meio interno.</p><p>A osmolaridade total do soro &#233; de cerca de 285&#8211;295 mOsm/L, o que &#233; bem menor que a da &#225;gua do mar.</p><p>[B] &#201; de Peat a cita&#231;&#227;o: &#8220;Breathing pure oxygen lowers the oxygen content of tissues; breathing rarefied air, or air with carbon dioxide, oxygenates and energizes the tissues&#8221;. Ou seja, dentro do modelo de Peat, a altitude &#233; quase um experimento natural mostrando que &#8220;mais O&#8322; inspirado&#8221; n&#227;o equivale a &#8220;mais O&#8322; utilizado pelos tecidos&#8221;.<span> </span>Peat &#233; bastante expl&#237;cito a respeito disso; ele diz que a menor press&#227;o de O&#8322; em altitude permite que o organismo retenha mais CO&#8322; pelo efeito Haldane, e que essa reten&#231;&#227;o ocorre naturalmente em pessoas adaptadas &#224; altitude. E Peat escreveu que a altitude elevada est&#225; associada a menor mortalidade e menor incid&#234;ncia de doen&#231;as degenerativas<span> </span>Ver R. Peat, <em>Altitude and Mortality.</em></p><p>[C]<span>  </span>H&#225;  experimentos <em>in vitro</em> mostrando que o super&#243;xido pode oxidar serotonina formando tryptamine-4,5-dione.   N&#227;o devemos imaginar que o o &#237;on negativo entra no pulm&#227;o e captura uma mol&#233;cula de serotonina. &#201; mais plaus&#237;vel pensar em um ambiente redox. O &#237;on negativo, particularmente esp&#233;cies de oxig&#234;nio como o super&#243;xido, pode participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons. A serotonina &#233; uma mol&#233;cula facilmente oxid&#225;vel. Portanto, a carga negativa associada ao oxig&#234;nio poderia favorecer sua transforma&#231;&#227;o qu&#237;mica. Aniquilar a mol&#233;cula ativa de serotonina.</p><p>[D]<span> </span>Existe um per&#237;odo de adapta&#231;&#227;o quando a pessoa migra para uma regi&#227;o de alta altitude. L&#225; em cima diminui a press&#227;o de oxig&#234;nio, inicialmente haver&#225; um est&#237;mulo respirat&#243;rio. Neste caso, em um primeiro momento, aumenta a ventila&#231;&#227;o, tende a haver perda de CO2. Mas na sequ&#234;ncia ocorrer&#225; a adapta&#231;&#227;o. O corpo come&#231;ar&#225; a reter mais CO2.</p><p>[E]<span> </span>Peat j&#225; comparou hiperventila&#231;&#227;o [respira&#231;&#227;o r&#225;pida que perde CO2] a uma exposi&#231;&#227;o exagerada a altitude baixa, CO2. Alta altitude se traduz em mais reten&#231;&#227;o de CO2 e, em consequ&#234;ncia, melhor oxigena&#231;&#227;o tecidual.<span> &#201; justamente </span>Peat que chega a dizer explicitamente que, em altitude, a menor press&#227;o de oxig&#234;nio permite maior reten&#231;&#227;o de CO&#8322; atrav&#233;s do efeito Haldane-Bohr. E atribui ao CO&#8322; [e seu aumento no corpo] fun&#231;&#245;es como: liberar O&#8322; para os tecidos; relaxar os vasos; reduzir edema; favorecer o metabolismo oxidativo; reduzir a produ&#231;&#227;o de lactato.</p><p>Em <em>Altitude and Mortality</em>, Peat afirma que popula&#231;&#245;es que vivem em grandes altitudes apresentam menor incid&#234;ncia de c&#226;ncer, doen&#231;a card&#237;aca e outras doen&#231;as degenerativas, e considera que a menor press&#227;o de oxig&#234;nio &#233; provavelmente um dos fatores importantes. Para Peat, CO&#8322; ajuda a: preservar a respira&#231;&#227;o celular; estabilizar prote&#237;nas e membranas; reduzir a excitabilidade; favorecer a circula&#231;&#227;o; proteger contra os efeitos excessivos da serotonina; atuar como um importante regulador do metabolismo. Por isso ele considerava a perda cr&#244;nica de CO&#8322; um componente de muitos estados patol&#243;gicos.</p><p>[F]<span> </span>Peat chegou a dizer que estudos realizados na Pol&#244;nia mostravam que a ioniza&#231;&#227;o negativa da atmosfera acelerava a elimina&#231;&#227;o da serotonina.  Mas, por outro lado, isso n&#227;o significa &#8211; em absoluto - defender, por exemplo, ozoniza&#231;&#227;o do ar para o mesmo objetivo. O ozone &#233;, certamente, t&#243;xico para os pulm&#245;es ao contr&#225;rio do ar ionizado.</p><p>[G]<span> </span>OSTERBALLE O WEEKE B, 1979. <em>Influence of small atmospheric ions on the airways in patients with bronchial asthma.</em><strong> </strong>Allergy. 1979 Jun;34(3):187-94. doi: 10.1111/j.1398-9995.1979.tb01566.x. PMID: 495917<span> </span>DOI: <a href="https://doi.org/10.1111/j.1398-9995.1979.tb01566.x">10.1111/j.1398-9995.1979.tb01566.x</a></p><p><strong>Abstract</strong></p><p>The influence of artificially generated atmospheric ions is studied in 15 patients with bronchial asthma. A slight but significant (at 5% level) improvement in the lung function was demonstrated in nine patients during positive as well as negative ion exposure, but the patients&#8217; subjective votings of the air quality did not show any changes due to ion exposure. No change in the histamine threshold of the airways in six patients with bronchial asthma was demonstrated during exposure to ions. Further controlled studies with electro-aerosols are needed.</p><p>[H]<span> </span>BEM-DOV I<span> </span>AMIRAV I SHOCHINA M, 1983.<em>Effect of negative ionisation of inspired air on the response of asthmatic children to exercise and inhaled histamine</em><strong>. </strong>Thorax. 1983 Aug;38(8):584-8. doi: 10.1136/thx.38.8.584.<span> </span>PMID: 6351332        PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC459615/">PMC459615</a>         DOI: <a href="https://doi.org/10.1136/thx.38.8.584">10.1136/thx.38.8.584</a></p><p><strong>Abstract</strong></p><p>To evaluate the effect of negative ionisation of inspired air on bronchial reactivity, 11 asthmatic children were challenged twice by exercise and 10 were challenged twice by histamine inhalation. The children breathed negatively ionised air (4 X 10(5) - 10 X 10(5) ions/cm3) or control room air in random order in a double-blind fashion. All challenges were matched in terms of basal lung function and the exercise tests were matched in terms of ventilation and respiratory heat loss. Exercise-induced asthma was significantly attenuated by exposure to negatively ionised air, the mean postexercise fall in one-second forced expiratory volume (FEV1) being 29% (SE 5%) of the initial value after the control and 21% (3%) after the ionised air test (p less than 0.02). Ten of the 11 subjects developed less exercise-induced asthma while breathing ionised air. Although the median dose of histamine (cumulative breath units) which caused a constant fall in FEV1 for each individual was higher with the ionised air challenge than with the control challenge the difference was not significant. Five of the 10 subjects were less sensitive to histamine and the other five more sensitive when breathing ionised air. It is concluded that negative ionisation of inspired air can modulate the bronchial response to exercise but the effect on the response to histamine is much more variable.</p><p>[I]<span> </span>ANDERSON S D, 1996. <em>Exercise-induced asthma and the use of hypertonic saline aerosol as a bronchial challenge.</em><strong> </strong>Respirology. 1996 Sep;1(3):175-81. doi: 10.1111/j.1440-1843.1996.tb00029.x.<span> </span>PMID: 9424393<span> </span>DOI: <a href="https://doi.org/10.1111/j.1440-1843.1996.tb00029.x">10.1111/j.1440-1843.1996.tb00029.x</a></p><p><strong>Abstract</strong></p><p>Exercise induced asthma is a common complaint and the prevalence appears to be increasing worldwide. Once confined to the research domain of university teaching hospitals, the study of EIA has extended into the school playground, defence force establishments and sports institutions. Standardized protocols have been developed to study EIA in the laboratory and in the field. A surrogate challenge using eucapnic or isocapnic hyperventilation with dry air is becoming popular because it has advantages over exercise, at least for adults. The stimulus that leads the airways to narrow is caused by the inhalation of dry air during hyperventilation and exercise, during which water is evaporated from the airways in order to condition the inspired air. The mechanism whereby the airways narrow is thought to be due to the dehydrating effects of water loss, particularly in relation to its potential to cause the airways to become hyperosmolar. Mast cell mediators such as histamine and the leucotrienes are probably involved in EIA because specific antagonists reduce severity. As a result of the osmotic theory of EIA, studies were carried out to determine whether subjects with EIA were sensitive to the effects of increasing airway osmolarity by inhalation of hyperosmolar aerosols of sodium chloride. A challenge protocol using an aerosol of 4.5% sodium chloride, generated from an ultrasonic nebulizer, has been used to identify persons with asthma and to assess response to drug therapy. There are many similarities between responses to exercise, hyperventilation and hypertonic saline in the physiological and biochemical responses and the responses to drugs. Challenge with hypertonic saline is easier and cheaper to use because expensive equipment and a source of dry air is not required as with exercise or hyperventilation. The ability to obtain a dose-response curve rather than a single response and the ability to collect inflammatory cells at the same time make challenge with hypertonic saline an attractive technique to study patients suspected of having asthma.</p><p>[J]<span> </span>JIANG S-Y MA A<span> </span>RAMACHANDRAN S, 2018. <em>Negative Air Ions and Their Effects on Human Health and Air Quality Improvement</em><strong>. </strong>Int J Mol Sci. 2018 Sep 28;19(10):2966. doi: <a href="https://doi.org/10.3390/ijms19102966">10.3390/ijms19102966</a><span> </span>PMCID: PMC6213340 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30274196/">30274196</a></p><p>Abstract</p><p>Negative air ions (NAIs) have been discovered for more than 100 years and are widely used for air cleaning. Here, we have carried out a comprehensive reviewing on the effects of NAIs on humans/animals, and microorganisms, and plant development. The presence of NAIs is credited for increasing psychological health, productivity, and overall well-being but without consistent or reliable evidence in therapeutic effects and with controversy in anti-microorganisms. Reports also showed that NAIs could help people in relieving symptoms of allergies to dust, mold spores, and other allergens. Particulate matter (PM) is a major air pollutant that affects human health. Experimental data showed that NAIs could be used to high-efficiently remove PM. Finally, we have reviewed the plant-based NAI release system under the pulsed electric field (PEF) stimulation. This is a new NAI generation system which releases a huge amount of NAIs under the PEF treatment. The system may be used to freshen indoor air and reduce PM concentration in addition to enriching oxygen content and indoor decoration at home, school, hospital, airport, and other indoor areas.<span> </span>Dispon&#237;vel em: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com</a></p><p>[K]<span> </span>SCHEUCH G GEBHART J, 1990. <em>Uptake of electrical charges in the human respiratory tract during exposure to air loaded with negative &#237;ons</em><strong> </strong>Journal Article<span> </span>Journal of Aerosol Science<span> </span>21(suppl. 1): VOLUME 1<span> </span>PAGE S439-S442   The uptake of negative charges in the human respiratory tract has been determined experimentally by breathing free ions and particles carrying negative charges. Free ions are deposited very effectively in the upper airways whereas charged particles penetrate to the deeper lungs.</p><p>Dispon&#237;vel em: <a href="https://hero.epa.gov/reference/6948/?utm_source=chatgpt.com">https://hero.epa.gov/reference/6948/?utm_source=chatgpt.com</a></p><p>[L]<span> </span><strong>Negative Air Ions and Their Generation</strong> -<span> </span>Air ions are electrically charged molecules or atoms in the atmosphere [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B2-ijms-19-02966">2</a>]. An air ion is formed when a gaseous molecule or atom receives sufficiently high energy to eject an electron [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B3-ijms-19-02966">3</a>]. NAIs are those that gain an electron, while positive air ions lose an electron. The natural and artificial energy sources include (1) radiant or cosmic rays in the atmosphere; (2) sunlight including ultraviolet; (3) natural and artificial corona discharge including thunder and lightning; (4) the shearing forces of water (Lenard effect); (5) plant-based sources of energy. [...]<span> </span>The considerable numbers of NAIs are found under waterfalls or in the seashores. These NAIs are generated by Lenard effect. Lenard effect was also called spray electrification or waterfall effect and was first systematically studied by Philipp Lenard [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B23-ijms-19-02966">23</a>], who won the Nobel Prize for Physics in 1905 for his research on cathode rays and the discovery of many of their properties. The study showed that NAIs were generated from the surrounding air molecules by charging themselves negatively when water droplets collide with each other or with a wetted solid to form fine spray of drops. The study also showed that several factors may affect the degree of charge separation in spray processes and, therefore, may affect the generation and concentration of NAIs. These factors include water drop temperature, dissolved impurities, speed of the impinging air blast, and foreign impinging surfaces of droplets. Based on the &#8220;Lenard effect&#8221;, water shearing appliance has been designed to generate NAIs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>]. Water shearing produced only superoxide ions (O<sub>2</sub><sup>&#8722;</sup>) which was bound to clusters of water molecules to form the structure O<sub>2</sub><sup>&#8722;</sup>(H<sub>2</sub>O)<sub>n</sub> [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B25-ijms-19-02966">25</a>], and was essentially regarded as a natural source of NAIs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>]. NAIs generated by the &#8220;Lenard effect&#8221; might improve erythrocyte deformability, thereby aerobic metabolism [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com#B24-ijms-19-02966">24</a>].</p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6213340/?utm_source=chatgpt.com</a></p><p>[M]<span> </span>GOLDSTEIN N MERZLYAK M N, 1992. <em>Negative air ions as a source of superoxide</em></p><p>June 1992. <a href="https://www.researchgate.net/journal/International-Journal-of-Biometeorology-1432-1254">International Journal of Biometeorology</a> 36(2):118-122<span> </span>DOI:<a href="https://doi.org/10.1007/BF01208923">10.1007/BF01208923</a></p><p><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide#citations"><span>Citations (64)</span></a><span>      </span><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide#references"><span>References (34)</span></a></p><p>Abstract</p><p>The physico-chemical characteristics and possible formation mechanisms of negative air ions are considered. It was found that the products of oxygen and nitrogen negative ionization reduce ferricytochromec and nitroblue tetrazolium, and that these reactions were inhibited by superoxide dismutase. The interaction of negatively ionized oxygen with water led to hydrogen peroxide accumulation, which was inhibited by tetranitromethane or catalase. Nitrogen ionization under these conditions caused the formation of the hydrated electron e aq &#8212; and the superoxide anion O 2 &#8212; . The data obtained indicate that the biological activity of negative air ions may be dependent on superoxide. The generation of reactive oxygen ions in the gas phase and also at a gas/water interface is described. A scheme for superoxide production under oxygen and nitrogen ionization is proposed.<span> </span>Dispon&#237;vel em:<span> </span><a href="https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide">https://www.researchgate.net/publication/226426855_Negative_air_ions_as_a_source_of_superoxide</a></p><p>[N]<span> </span>WRONA M Z DRYHURST G, 1998. <em>Oxidation of Serotonin by Superoxide Radical:&#8201; Implications to Neurodegenerative Brain Disorders.</em><strong> </strong>Article| May 05, 1998</p><p><em>Chem. Res. Toxicol.</em> (1998) 11 (6): 639&#8211;650.<span> </span><a href="https://doi.org/10.1021/tx970185w">https://doi.org/10.1021/tx970185w</a></p><p><strong>Abstract</strong></p><p>Many new lines of evidence implicate both superoxide anion radical (O<sub>2</sub><sup>&#8226;-</sup>) and biogenic amine neurotransmitters in the pathological mechanisms that underlie neuronal damage caused by methamphetamine (MA), glutamate-mediated oxidative toxicity, ischemia-reperfusion, and other neurodegenerative brain disorders. In this investigation the oxidation of 5-hydroxytryptamine (5-HT, serotonin) by an O<sub>2</sub><sup>&#8226;-</sup>-generating system (xanthine/xanthine oxidase) in buffered aqueous solution at pH 7.4 has been studied. The major product of the O<sub>2</sub><sup>&#8226;-</sup>-mediated oxidation of 5-HT is tryptamine-4,5-dione (T-4,5-D). However, O<sub>2</sub><sup>&#8226;-</sup> and H<sub>2</sub>O<sub>2</sub>, cogenerated by the xanthine oxidase-mediated oxidation of xanthine to uric acid, together react with trace levels of iron that contaminate buffer constituents to give a chemically ill-defined oxo-iron species. This species mediates the oxidation of 5-HT to a C(4)-centered carbocation intermediate that reacts with 5-HT to give 5,5&#8216;-dihydroxy-4,4&#8216;-bitryptamine (4,4&#8216;-D) and with uric acid to give 9-[3-(2-aminoethyl)-5-hydroxy-1<em>H</em>-indol-4-yl]-2,6,8-triketo-1<em>H</em>,3<em>H</em>,7<em>H</em>-purine (<strong>7</strong>) as the major products. These products differ from those formed in the HO<sup>&#8226;</sup>-mediated oxidation of 5-HT under similar conditions. When the reaction is carried out in the presence of the intraneuronal nucleophile glutathione (GSH), T-4,5-D is scavenged to give 7-(<em>S</em>-glutathionyl)tryptamine-4,5-dione, whereas the putative carbocation intermediate is scavenged to give 4-(<em>S</em>-glutathionyl)-5-hydroxytryptamine. T-4,5-D also reacts with the sulfhydryl residues of a model protein, alcohol dehydrogenase, and inhibits its activity. Previous investigators have proposed that T-4,5-D is a serotonergic neurotoxin. This raises the possibility that T-4,5-D and perhaps other putative intraneuronal metabolites formed by the O<sub>2</sub><sup>&#8226;-</sup>/H<sub>2</sub>O<sub>2</sub>/oxo-iron-mediated oxidations of 5-HT might be endotoxins that contribute to neurodegeneration in brain regions innervated by serotonergic neurons caused by MA, ischemia-reperfusion, and other neurodegenerative brain disorders.<span> </span>DISPON&#205;VEL EM: <a href="https://pubs.acs.org/crtoec/article-abstract/11/6/639/136678/Oxidation-of-Serotonin-by-Superoxide-Radical?redirectedFrom=fulltext">https://pubs.acs.org/crtoec/article-abstract/11/6/639/136678/Oxidation-of-Serotonin-by-Superoxide-Radical?redirectedFrom=fulltext</a></p><p>[O]<span> </span>XIMENES V F MAGHZAL G J TURNER R, 2009. <em>Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione.</em><strong> </strong>Biochem J. 2009 Dec 14;425(1):285-93. doi: 10.1042/BJ20090776.<span> </span>PMID: 19828014<span> </span>DOI: <a href="https://doi.org/10.1042/bj20090776">10.1042/BJ20090776</a></p><p>Abstract</p><p>During inflammatory events, neutrophils and platelets interact to release a variety of mediators. Neutrophils generate superoxide and hydrogen peroxide, and also discharge the haem enzyme myeloperoxidase. Among numerous other mediators, platelets liberate serotonin (5-hydroxytryptamine), which is a classical neurotransmitter and vasoactive amine that has significant effects on inflammation and immunity. In the present study, we show that serotonin is a favoured substrate for myeloperoxidase because other physiological substrates for this enzyme, including chloride, did not affect its rate of oxidation. At low micromolar concentrations, serotonin enhanced hypochlorous acid production by both purified myeloperoxidase and neutrophils. At higher concentrations, it almost completely blocked the formation of hypochlorous acid. Serotonin was oxidized to a dimer by myeloperoxidase and hydrogen peroxide. It was also converted into tryptamine-4,5-dione, especially in the presence of superoxide. This toxic quinone was produced by stimulated neutrophils in a reaction that required myeloperoxidase. In plasma, stimulated human neutrophils oxidized serotonin to its dimer using the NADPH oxidase and myeloperoxidase. We propose that myeloperoxidase will oxidize serotonin at sites of inflammation. In doing so, it will impair its physiological functions and generate a toxic metabolite that will exacerbate inflammatory tissue damage. Consequently, oxidation of serotonin by myeloperoxidase may profoundly influence inflammatory processes.</p><p>[P]<span> </span>Lembrando que para R. Peat n&#227;o se tratava de nada parecido com &#8220;carregar eletricamente os pulm&#245;es&#8221;. E sim de que &#8220;os &#237;ons negativos alteram a qu&#237;mica redox na superf&#237;cie respirat&#243;ria&#8221;, isto &#233;, transferem el&#233;trons. Com consequente aumento da degrada&#231;&#227;o da serotonina.</p><p>O &#237;on negativo consegue participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons, sim &#8212; mas isso &#233; muito diferente de dizer que, por exemplo, um aparelho ionizador transfere uma carga el&#233;trica macrosc&#243;pica para o pulm&#227;o.</p><p>H&#225; experimentos f&#237;sico-qu&#237;micos mostrando que produtos de ioniza&#231;&#227;o negativa do oxig&#234;nio podem produzir rea&#231;&#245;es caracter&#237;sticas de super&#243;xido (O&#8322;&#8226;<span>&#8315;</span>). Um trabalho de Goldstein e colaboradores, por exemplo, encontrou evid&#234;ncias de super&#243;xido e de el&#233;trons hidratados em sistemas submetidos &#224; ioniza&#231;&#227;o negativa.</p><p>Isso &#233; importante porque: O&#8322; + e<span>&#8315;</span> <span>&#8594;</span> O<span>&#8322;&#8226;&#8315;</span></p><p>Ou seja, o el&#233;tron n&#227;o precisa necessariamente entrar diretamente na c&#233;lula.</p><p>Ele pode ser transferido para o oxig&#234;nio e transformar O&#8322; em super&#243;xido. Eis o papel dos &#237;ons negativos que chegam do mar ou da cachoeira.</p><p>&#205;ons negativos do ar podem participar de rea&#231;&#245;es de transfer&#234;ncia de el&#233;trons e gerar esp&#233;cies redox, incluindo super&#243;xido, na interface ar&#8211;&#225;gua. Essas rea&#231;&#245;es podem ocorrer nas superf&#237;cies &#250;midas do trato respirat&#243;rio o que aumenta degrada&#231;&#227;o da serotonina.</p><p>E se houver CO2 adequado, teremos vias a&#233;reas mais abertas, promo&#231;&#227;o do metabolismo oxidativo do a&#231;&#250;car. Sendo que a pr&#243;pria queda da serotonina melhora a respira&#231;&#227;o celular e a oferta de CO2.</p><p>Experimentos mediram a absor&#231;&#227;o de carga el&#233;trica no trato respirat&#243;rio durante a respira&#231;&#227;o de ar contendo &#237;ons negativos. &#205;ons livres tendem a se depositar principalmente nas vias a&#233;reas superiores, enquanto part&#237;culas carregadas conseguem alcan&#231;ar regi&#245;es mais profundas do pulm&#227;o. Portanto, n&#227;o &#233; correto imaginar que &#8220;os &#237;ons negativos n&#227;o entram no aparelho respirat&#243;rio&#8221;. Entram e efetivamente interagem com ele.</p><p>A realidade f&#237;sico-qu&#237;mica &#233; muito mais din&#226;mica: &#237;ons, &#225;gua, oxig&#234;nio e mol&#233;culas da superf&#237;cie respirat&#243;ria trocam carga e sofrem rea&#231;&#245;es qu&#237;micas.</p><p>E aqui, neste particular caso, o super&#243;xido n&#227;o precisa ser simplesmente &#8220;dano oxidativo&#8221;. Na verdade, o super&#243;xido pode participar de rea&#231;&#245;es qu&#237;micas espec&#237;ficas. E h&#225; literatura experimental propondo que o super&#243;xido seja uma das principais esp&#233;cies associadas aos efeitos dos &#237;ons negativos naturais. Degradando a serotonina</p><p>A serotonina &#233; uma mol&#233;cula particularmente oxid&#225;vel</p><p>A serotonina (5-HT) cont&#233;m um grupo indol, que &#233; relativamente f&#225;cil de oxidar. Quando recebe/cede el&#233;trons em determinadas condi&#231;&#245;es, pode formar intermedi&#225;rios radicalares. O estudo cl&#225;ssico de Wrona e Dryhurst investigou justamente a rea&#231;&#227;o de serotonina com super&#243;xido em pH fisiol&#243;gico. Eles encontraram como produto importante a tryptamine-4,5-dione (T-4,5-D). Simplificando: serotonina + O&#8322;&#8226;<span>&#8315;</span> <span>&#8594;</span> serotonina oxidada <span>&gt;</span> quinona/diona</p><p>Portanto, &#8220;destruir serotonina&#8221; n&#227;o significa simplesmente fazer a mol&#233;cula desaparecer instantaneamente. Significa transform&#225;-la quimicamente em outros produtos. O peroxido do oxig&#234;nio pode iniciar uma cadeia de rea&#231;&#245;es que aniquilam a mol&#233;cula de serotonina; pode formar intermedi&#225;rios a partir da serotonina, pode decompor a serotonina, pode gerar a triptamina-4-5 diona, pode simplesmente transferir el&#233;trons com oxig&#234;nio. Outro poss&#237;vel mecanismo &#233; a o super&#243;xido contribua para a forma&#231;&#227;o de H2O2 e este degrada a serotonina.</p><p>Tamb&#233;m existe uma revis&#227;o sobre &#237;ons negativos que resume a hip&#243;tese hist&#243;rica dessa maneira: o super&#243;xido seria uma das esp&#233;cies importantes produzidas pela ioniza&#231;&#227;o negativa e, em experimentos <em>in vitro</em>, a serotonina pode ser oxidada por super&#243;xido formando tryptamine-4,5-dione. Acaba de ser degradada. Em laborat&#243;rio se consegue oxidar serotonina a partir de super&#243;xido.</p><p>[Q] BIBLIOGRAFIA ADICIONAL:</p><p>Iwama H. Negative air ions created by water shearing improve erythrocyte deformability and aerobic metabolism. Indoor Air. 2004;14:293&#8211;297. doi: 10.1111/j.1600-0668.2004.00254.x. [<a href="https://doi.org/10.1111/j.1600-0668.2004.00254.x">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15217482/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indoor%20Air&amp;title=Negative%20air%20ions%20created%20by%20water%20shearing%20improve%20erythrocyte%20deformability%20and%20aerobic%20metabolism&amp;author=H.%20Iwama&amp;volume=14&amp;publication_year=2004&amp;pages=293-297&amp;pmid=15217482&amp;doi=10.1111/j.1600-0668.2004.00254.x&amp;">Google Scholar</a>]</p><p>Kosenko E.A., Kaminsky Y.G., Stavrovskaya I.G., Sirota T.V., Kondrashova M.N. The stimulatory effect of negative air ions and hydrogen peroxide on the activity of superoxide dismutase. FEBS Lett. 1997;410:309&#8211;312. doi: 10.1016/S0014-5793(97)00651-0. [<a href="https://doi.org/10.1016/S0014-5793(97)00651-0">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9237652/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett.&amp;title=The%20stimulatory%20effect%20of%20negative%20air%20ions%20and%20hydrogen%20peroxide%20on%20the%20activity%20of%20superoxide%20dismutase&amp;author=E.A.%20Kosenko&amp;author=Y.G.%20Kaminsky&amp;author=I.G.%20Stavrovskaya&amp;author=T.V.%20Sirota&amp;author=M.N.%20Kondrashova&amp;volume=410&amp;publication_year=1997&amp;pages=309-312&amp;pmid=9237652&amp;doi=10.1016/S0014-5793(97)00651-0&amp;">Google Scholar</a>]</p><p><span>Iwama H., Ohmizo H., Furuta S., Ohmori S., Watanabe K., Kaneko T., Tsutsumi K. Inspired superoxide anions attenuate blood lactate concentrations in postoperative patients. Crit. Care Med. 2002;30:1246&#8211;1249. doi: 10.1097/00003246-200206000-00014. [</span><a href="https://doi.org/10.1097/00003246-200206000-00014"><span>DOI</span></a><span>] [</span><a href="https://pubmed.ncbi.nlm.nih.gov/12072676/"><span>PubMed</span></a><span>] [</span><a href="https://scholar.google.com/scholar_lookup?journal=Crit.%20Care%20Med.&amp;title=Inspired%20superoxide%20anions%20attenuate%20blood%20lactate%20concentrations%20in%20postoperative%20patients&amp;author=H.%20Iwama&amp;author=H.%20Ohmizo&amp;author=S.%20Furuta&amp;author=S.%20Ohmori&amp;author=K.%20Watanabe&amp;volume=30&amp;publication_year=2002&amp;pages=1246-1249&amp;pmid=12072676&amp;doi=10.1097/00003246-200206000-00014&amp;"><span>Google Scholar</span></a><span>]</span></p><p><span>Yamada R., Yanoma S., Akaike M., Tsuburaya A., Sugimasa Y., Takemiya S., Motohashi H., Rino Y., Takanashi Y., Imada T. Water-generated negative air ions activate NK cell and inhibit carcinogenesis in mice. Cancer Lett. 2006;239:190&#8211;197. doi: 10.1016/j.canlet.2005.08.002. [</span><a href="https://doi.org/10.1016/j.canlet.2005.08.002"><span>DOI</span></a><span>] [</span><a href="https://pubmed.ncbi.nlm.nih.gov/16171944/"><span>PubMed</span></a><span>] [</span><a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett.&amp;title=Water-generated%20negative%20air%20ions%20activate%20NK%20cell%20and%20inhibit%20carcinogenesis%20in%20mice&amp;author=R.%20Yamada&amp;author=S.%20Yanoma&amp;author=M.%20Akaike&amp;author=A.%20Tsuburaya&amp;author=Y.%20Sugimasa&amp;volume=239&amp;publication_year=2006&amp;pages=190-197&amp;pmid=16171944&amp;doi=10.1016/j.canlet.2005.08.002&amp;"><span>Google Scholar</span></a><span>]</span></p><p>Pino O., Ragione F.L. There&#8217;s something in the air: Empirical evidence for the effects of negative air ions (NAI) on psychophysiological state and performance. Res. Psychol. Behav Sci. 2013;1:48&#8211;53. [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Psychol.%20Behav%20Sci.&amp;title=There%E2%80%99s%20something%20in%20the%20air:%20Empirical%20evidence%20for%20the%20effects%20of%20negative%20air%20ions%20(NAI)%20on%20psychophysiological%20state%20and%20performance&amp;author=O.%20Pino&amp;author=F.L.%20Ragione&amp;volume=1&amp;publication_year=2013&amp;pages=48-53&amp;">Google Scholar</a>]</p><p>Parts T.E., Luts A., Laakso L., Hirsikko A., Gronholm T., Kulmala M. Chemical composition of waterfall-induced air ions: Spectrometry vs. simulations. Boreal Environ. Res. 2007;12:409&#8211;420. [<a href="https://scholar.google.com/scholar_lookup?journal=Boreal%20Environ.%20Res.&amp;title=Chemical%20composition%20of%20waterfall-induced%20air%20ions:%20Spectrometry%20vs.%20simulations&amp;author=T.E.%20Parts&amp;author=A.%20Luts&amp;author=L.%20Laakso&amp;author=A.%20Hirsikko&amp;author=T.%20Gronholm&amp;volume=12&amp;publication_year=2007&amp;pages=409-420&amp;">Google Scholar</a>]</p><p>Lin H.F., Lin J.M. Generation and determination of negative air ions. J. Anal. Test. 2017;1:6. doi: 10.1007/s41664-017-0007-7. [<a href="https://doi.org/10.1007/s41664-017-0007-7">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Anal.%20Test.&amp;title=Generation%20and%20determination%20of%20negative%20air%20ions&amp;author=H.F.%20Lin&amp;author=J.M.%20Lin&amp;volume=1&amp;publication_year=2017&amp;pages=6&amp;doi=10.1007/s41664-017-0007-7&amp;">Google Scholar</a>]</p><p>Laakso L., Hirsikko A., Gr&#246;nholm T., Kulmala M., Luts A., Parts T.E. Waterfalls as sources of small charged aerosol particles. Atmos. Chem. Phys. 2006;6:9297&#8211;9314. doi: 10.5194/acpd-6-9297-2006. [<a href="https://doi.org/10.5194/acpd-6-9297-2006">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atmos.%20Chem.%20Phys.&amp;title=Waterfalls%20as%20sources%20of%20small%20charged%20aerosol%20particles&amp;author=L.%20Laakso&amp;author=A.%20Hirsikko&amp;author=T.%20Gr%C3%B6nholm&amp;author=M.%20Kulmala&amp;author=A.%20Luts&amp;volume=6&amp;publication_year=2006&amp;pages=9297-9314&amp;doi=10.5194/acpd-6-9297-2006&amp;">Google Scholar</a>]</p><p>Kolarz P., Gaisberger M., Madl P., Hofmann W., Ritter M., Hartl A. Characterization of ions at alpine waterfalls. atmos. Chem. Phys. 2012;12:3687&#8211;3697. doi: 10.5194/acp-12-3687-2012. [<a href="https://doi.org/10.5194/acp-12-3687-2012">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Phys.&amp;title=Characterization%20of%20ions%20at%20alpine%20waterfalls.%20atmos&amp;author=P.%20Kolarz&amp;author=M.%20Gaisberger&amp;author=P.%20Madl&amp;author=W.%20Hofmann&amp;author=M.%20Ritter&amp;volume=12&amp;publication_year=2012&amp;pages=3687-3697&amp;doi=10.5194/acp-12-3687-2012&amp;">Google Scholar</a>]</p><p>Nagato K., Matsui Y., Miyata T., Yamauchi T. An analysis of the evolution of negative ions produced by a corona ionizer in air. Int. J. Mass Spectrom. 2006;248:142&#8211;147. doi: 10.1016/j.ijms.2005.12.001. [<a href="https://doi.org/10.1016/j.ijms.2005.12.001">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mass%20Spectrom.&amp;title=An%20analysis%20of%20the%20evolution%20of%20negative%20ions%20produced%20by%20a%20corona%20ionizer%20in%20air&amp;author=K.%20Nagato&amp;author=Y.%20Matsui&amp;author=T.%20Miyata&amp;author=T.%20Yamauchi&amp;volume=248&amp;publication_year=2006&amp;pages=142-147&amp;doi=10.1016/j.ijms.2005.12.001&amp;">Google Scholar</a>]</p><p>Ryushi T., Kita I., Sakurai T., Yasumatsu M., Isokawa M., Aihara Y., Hama K. The effect of exposure to negative air ions on the recovery of physiological responses after moderate endurance exercise. Int. J. Biometeorol. 1998;41:132&#8211;136. doi: 10.1007/s004840050066. [<a href="https://doi.org/10.1007/s004840050066">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9531858/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Biometeorol.&amp;title=The%20effect%20of%20exposure%20to%20negative%20air%20ions%20on%20the%20recovery%20of%20physiological%20responses%20after%20moderate%20endurance%20exercise&amp;author=T.%20Ryushi&amp;author=I.%20Kita&amp;author=T.%20Sakurai&amp;author=M.%20Yasumatsu&amp;author=M.%20Isokawa&amp;volume=41&amp;publication_year=1998&amp;pages=132-136&amp;pmid=9531858&amp;doi=10.1007/s004840050066&amp;">Google Scholar</a>]</p><p>Wrona M.Z., Dryhurst G. Oxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders. Chem. Res. Toxicol. 1998;11:639&#8211;650. doi: 10.1021/tx970185w. [<a href="https://doi.org/10.1021/tx970185w">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9625732/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Res.%20Toxicol.&amp;title=Oxidation%20of%20serotonin%20by%20superoxide%20radical:%20Implications%20to%20neurodegenerative%20brain%20disorders&amp;author=M.Z.%20Wrona&amp;author=G.%20Dryhurst&amp;volume=11&amp;publication_year=1998&amp;pages=639-650&amp;pmid=9625732&amp;doi=10.1021/tx970185w&amp;">Google Scholar</a>]</p><p>Wiszniewski A., Suchanowski A., Wielgomas B. Effects of Air-Ions on human circulatory indicators. Pol. J. Environ. Stud. 2014;23:521&#8211;531. [<a href="https://scholar.google.com/scholar_lookup?journal=Pol.%20J.%20Environ.%20Stud.&amp;title=Effects%20of%20Air-Ions%20on%20human%20circulatory%20indicators&amp;author=A.%20Wiszniewski&amp;author=A.%20Suchanowski&amp;author=B.%20Wielgomas&amp;volume=23&amp;publication_year=2014&amp;pages=521-531&amp;">Google Scholar</a>]</p><p>Hedge A., Collis M.D. Do negative air ions affect human mood and performance? Ann. Occup. Hyg. 1987;31:285&#8211;290. doi: 10.1093/annhyg/31.3.285. [<a href="https://doi.org/10.1093/annhyg/31.3.285">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3426028/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Occup.%20Hyg.&amp;title=Do%20negative%20air%20ions%20affect%20human%20mood%20and%20performance?&amp;author=A.%20Hedge&amp;author=M.D.%20Collis&amp;volume=31&amp;publication_year=1987&amp;pages=285-290&amp;pmid=3426028&amp;doi=10.1093/annhyg/31.3.285&amp;">Google Scholar</a>]</p><p>Perez V., Alexander D.D., Bailey W.H. Air ions and mood outcomes: A review and meta-analysis. BMC Psychiatry. 2013;13:29. doi: 10.1186/1471-244X-13-29. [<a href="https://doi.org/10.1186/1471-244X-13-29">DOI</a>] [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3598548/">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23320516/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Psychiatry&amp;title=Air%20ions%20and%20mood%20outcomes:%20A%20review%20and%20meta-analysis&amp;author=V.%20Perez&amp;author=D.D.%20Alexander&amp;author=W.H.%20Bailey&amp;volume=13&amp;publication_year=2013&amp;pages=29&amp;pmid=23320516&amp;doi=10.1186/1471-244X-13-29&amp;">Google Scholar</a>]</p><p>Timoshkin I.V., Maclean M., Wilson M.P., Given M.J., MacGregor S.J., Wang T., Anderson J.G. Bactericidal effect of corona discharges in atmospheric air. IEEE Trans. Plasma Sci. 2012;40:2322&#8211;2333. doi: 10.1109/TPS.2012.2193621. [<a href="https://doi.org/10.1109/TPS.2012.2193621">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Trans.%20Plasma%20Sci.&amp;title=Bactericidal%20effect%20of%20corona%20discharges%20in%20atmospheric%20air&amp;author=I.V.%20Timoshkin&amp;author=M.%20Maclean&amp;author=M.P.%20Wilson&amp;author=M.J.%20Given&amp;author=S.J.%20MacGregor&amp;volume=40&amp;publication_year=2012&amp;pages=2322-2333&amp;doi=10.1109/TPS.2012.2193621&amp;">Google Scholar</a>]</p><p>Pratt R., Barnard R.W. Some effects of ionized air on Penicillium notatum. J. Am. Pharm. Assoc. Sci. 1960;49:643&#8211;646. doi: 10.1002/jps.3030491004. [<a href="https://doi.org/10.1002/jps.3030491004">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Pharm.%20Assoc.%20Sci.&amp;title=Some%20effects%20of%20ionized%20air%20on%20Penicillium%20notatum&amp;author=R.%20Pratt&amp;author=R.W.%20Barnard&amp;volume=49&amp;publication_year=1960&amp;pages=643-646&amp;doi=10.1002/jps.3030491004&amp;">Google Scholar</a>]</p><p>Mitchell B.W., King D.J. Effect of negative air ionization on airborne transmission of newcastle disease virus. Avian. Dis. 1994;38:725&#8211;732. doi: 10.2307/1592107. [<a href="https://doi.org/10.2307/1592107">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7702504/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Avian.%20Dis.&amp;title=Effect%20of%20negative%20air%20ionization%20on%20airborne%20transmission%20of%20newcastle%20disease%20virus&amp;author=B.W.%20Mitchell&amp;author=D.J.%20King&amp;volume=38&amp;publication_year=1994&amp;pages=725-732&amp;pmid=7702504&amp;doi=10.2307/1592107&amp;">Google Scholar</a>]</p><p>Wallner P., Kundi M., Panny M., Tappler P., Hutter H.P. Exposure to air ions in indoor environments: Experimental study with healthy adults. Int. J. Environ. Res. Public Health. 2015;12:14301&#8211;14311. doi: 10.3390/ijerph121114301. [<a href="https://doi.org/10.3390/ijerph121114301">DOI</a>] [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4661648/">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26569277/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Environ.%20Res.%20Public%20Health.&amp;title=Exposure%20to%20air%20ions%20in%20indoor%20environments:%20Experimental%20study%20with%20healthy%20adults&amp;author=P.%20Wallner&amp;author=M.%20Kundi&amp;author=M.%20Panny&amp;author=P.%20Tappler&amp;author=H.P.%20Hutter&amp;volume=12&amp;publication_year=2015&amp;pages=14301-14311&amp;pmid=26569277&amp;doi=10.3390/ijerph121114301&amp;">Google Scholar</a>]</p><p>Kellogg E.W., Yost M.G., Barthakur N., Kreuger A.P. Superoxide involvement in the bactericidal effects of negative air ions on Staphylococcus albus. Nature. 1979;281:400&#8211;401. doi: 10.1038/281400a0. [<a href="https://doi.org/10.1038/281400a0">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/225679/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Superoxide%20involvement%20in%20the%20bactericidal%20effects%20of%20negative%20air%20ions%20on%20Staphylococcus%20albus&amp;author=E.W.%20Kellogg&amp;author=M.G.%20Yost&amp;author=N.%20Barthakur&amp;author=A.P.%20Kreuger&amp;volume=281&amp;publication_year=1979&amp;pages=400-401&amp;pmid=225679&amp;doi=10.1038/281400a0&amp;">Google Scholar</a>]</p><p>Luts A., Salm J. Chemical composition of small atmospheric ions near the ground. J. Geophys. Res. 1994;99:10781&#8211;10785. doi: 10.1029/93JD03225. [<a href="https://doi.org/10.1029/93JD03225">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Geophys.%20Res.&amp;title=Chemical%20composition%20of%20small%20atmospheric%20ions%20near%20the%20ground&amp;author=A.%20Luts&amp;author=J.%20Salm&amp;volume=99&amp;publication_year=1994&amp;pages=10781-10785&amp;doi=10.1029/93JD03225&amp;">Google Scholar</a>]</p><p>Goldstein N., Lewin T., Kamensky A., Dubinin V., Baumann S., Konstantinova O. Exogenous gaseous superoxide potentiates the antinociceptive effect of opioid analgesic agents. Inflamm. Res. 1996;45:473&#8211;478. doi: 10.1007/BF02252319. [<a href="https://doi.org/10.1007/BF02252319">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8891759/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inflamm.%20Res.&amp;title=Exogenous%20gaseous%20superoxide%20potentiates%20the%20antinociceptive%20effect%20of%20opioid%20analgesic%20agents&amp;author=N.%20Goldstein&amp;author=T.%20Lewin&amp;author=A.%20Kamensky&amp;author=V.%20Dubinin&amp;author=S.%20Baumann&amp;volume=45&amp;publication_year=1996&amp;pages=473-478&amp;pmid=8891759&amp;doi=10.1007/BF02252319&amp;">Google Scholar</a>]</p><p>Mayya Y.S., Sapra B.K., Khan A., Sunny F. Aerosol removal by unipolar ionization in indoor environments. Aerosol Sci. 2004;35:923&#8211;941. doi: 10.1016/j.jaerosci.2004.03.001. [<a href="https://doi.org/10.1016/j.jaerosci.2004.03.001">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aerosol%20Sci.&amp;title=Aerosol%20removal%20by%20unipolar%20ionization%20in%20indoor%20environments&amp;author=Y.S.%20Mayya&amp;author=B.K.%20Sapra&amp;author=A.%20Khan&amp;author=F.%20Sunny&amp;volume=35&amp;publication_year=2004&amp;pages=923-941&amp;doi=10.1016/j.jaerosci.2004.03.001&amp;">Google Scholar</a>]</p><p>Grinshpun S.A., Mainelis G., Trunov M., Adhikari A., Reponen T., Willeke K. Evaluation of ionic air purifiers for reducing aerosol exposure in confined indoor spaces. Indoor Air. 2005;15:235&#8211;245. doi: 10.1111/j.1600-0668.2005.00364.x. [<a href="https://doi.org/10.1111/j.1600-0668.2005.00364.x">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15982270/">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indoor%20Air&amp;title=Evaluation%20of%20ionic%20air%20purifiers%20for%20reducing%20aerosol%20exposure%20in%20confined%20indoor%20spaces&amp;author=S.A.%20Grinshpun&amp;author=G.%20Mainelis&amp;author=M.%20Trunov&amp;author=A.%20Adhikari&amp;author=T.%20Reponen&amp;volume=15&amp;publication_year=2005&amp;pages=235-245&amp;pmid=15982270&amp;doi=10.1111/j.1600-0668.2005.00364.x&amp;">Google Scholar</a>]</p><p>Berry D., Mainelis G., Fennell D. Effect of an ionic air cleaner on indoor/outdoor particle ratios in a residential environment. Aerosol Sci. Technol. 2007;41:315&#8211;328. doi: 10.1080/02786820701199702. [<a href="https://doi.org/10.1080/02786820701199702">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aerosol%20Sci.%20Technol.&amp;title=Effect%20of%20an%20ionic%20air%20cleaner%20on%20indoor/outdoor%20particle%20ratios%20in%20a%20residential%20environment&amp;author=D.%20Berry&amp;author=G.%20Mainelis&amp;author=D.%20Fennell&amp;volume=41&amp;publication_year=2007&amp;pages=315-328&amp;doi=10.1080/02786820701199702&amp;">Google Scholar</a>]</p><p>Grabarczyk Z. Electiveness of indoor air cleaning with corona ionizers. J. Electrostat. 2001;51:278&#8211;283. doi: 10.1016/S0304-3886(01)00058-4. [<a href="https://doi.org/10.1016/S0304-3886(01)00058-4">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Electrostat.&amp;title=Electiveness%20of%20indoor%20air%20cleaning%20with%20corona%20ionizers&amp;author=Z.%20Grabarczyk&amp;volume=51&amp;publication_year=2001&amp;pages=278-283&amp;doi=10.1016/S0304-3886(01)00058-4&amp;">Google Scholar</a>]</p><p>Sawant V.S. Control of respirable particles in indoor air with portable negative air ion generator. IOSR J. Environ. Sci. Toxicol. Food Technol. 2013;3:28&#8211;31. doi: 10.9790/2402-0332831. [<a href="https://doi.org/10.9790/2402-0332831">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IOSR%20J.%20Environ.%20Sci.%20Toxicol.%20Food%20Technol.&amp;title=Control%20of%20respirable%20particles%20in%20indoor%20air%20with%20portable%20negative%20air%20ion%20generator&amp;author=V.S.%20Sawant&amp;volume=3&amp;publication_year=2013&amp;pages=28-31&amp;doi=10.9790/2402-0332831&amp;">Google Scholar</a>]</p><p>Sawant V.S. Removal of particulate matter by using negative electric discharge. Int. J. Eng. Innov. Technol. 2013;2:48&#8211;51. [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Eng.%20Innov.%20Technol.&amp;title=Removal%20of%20particulate%20matter%20by%20using%20negative%20electric%20discharge&amp;author=V.S.%20Sawant&amp;volume=2&amp;publication_year=2013&amp;pages=48-51&amp;">Google Scholar</a>]</p><p>&#268;erneck&#253; J., Valentov&#225; K., Pivar&#269;iov&#225; E., Bo&#382;ek P. Ionization impact on the air cleaning efficiency in the interior. Meas. Sci. Rev. 2015;15:156&#8211;166. doi: 10.1515/msr-2015-0023. [<a href="https://doi.org/10.1515/msr-2015-0023">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Meas.%20Sci.%20Rev.&amp;title=Ionization%20impact%20on%20the%20air%20cleaning%20efficiency%20in%20the%20interior&amp;author=J.%20%C4%8Cerneck%C3%BD&amp;author=K.%20Valentov%C3%A1&amp;author=E.%20Pivar%C4%8Diov%C3%A1&amp;author=P.%20Bo%C5%BEek&amp;volume=15&amp;publication_year=2015&amp;pages=156-166&amp;doi=10.1515/msr-2015-0023&amp;">Google Scholar</a>]</p><p>Pushpawela B., Jayaratne R., Nguy A., Morawska L. Efficiency of ionizers in removing airborne particles in indoor environments. J. Electrostatics. 2017;90:79&#8211;84. doi: 10.1016/j.elstat.2017.10.002. [<a href="https://doi.org/10.1016/j.elstat.2017.10.002">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Electrostatics&amp;title=Efficiency%20of%20ionizers%20in%20removing%20airborne%20particles%20in%20indoor%20environments&amp;author=B.%20Pushpawela&amp;author=R.%20Jayaratne&amp;author=A.%20Nguy&amp;author=L.%20Morawska&amp;volume=90&amp;publication_year=2017&amp;pages=79-84&amp;doi=10.1016/j.elstat.2017.10.002&amp;">Google Scholar</a>]</p><p>***</p>]]></content:encoded></item><item><title><![CDATA[Pregnenolona é um potente antagonista das endotoxinas ]]></title><description><![CDATA[Mais uma a&#231;&#227;o da pregnenolona [e seu metab&#243;lito alopregnanolona] de efeito estrat&#233;gico contra a doen&#231;a cr&#244;nico-degenerativa]]></description><link>https://outramedicina2024.substack.com/p/pregnenolona-e-um-potente-antagonista</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/pregnenolona-e-um-potente-antagonista</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sun, 09 Aug 2026 15:48:53 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!13q0!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!13q0!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!13q0!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg" width="427" height="399" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/d14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:399,&quot;width&quot;:427,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:53467,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/210480044?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!13q0!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd14efb2c-42fc-4e82-9456-09930b61ce1b_427x399.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Existe um receptor em tecidos humanos que, quando anormalmente ativado, desencadeia doen&#231;as como esclerose m&#250;ltipla, Alzheimer, doen&#231;as cardiovasculares, artrite e outras. Esse receptor, chamado de TLR4, &#233; acionado por toxinas vindas de um intestino rico em flora intestinal, endotoxinas.</p><p>Portanto, a nefasta rela&#231;&#227;o bact&#233;rias intestinais-doen&#231;a cr&#244;nico-degenerativa mais uma vez lembrada [h&#225; v&#225;rias notas neste blog a respeito].</p><p>O que o estudo abaixo mostrou [A] foi que a pregnenolona impediu a ativa&#231;&#227;o plena do TLR4 pelas endotoxinas, <em>impedindo</em> os efeitos da a&#231;&#227;o daquele receptor.</p><p>&#8220;<span>O artigo afirma que esse efeito de bloqueio do TLR4 pela pregnenolona pode torn&#225;-la um tratamento promissor para alcoolismo, esquizofrenia, epilepsia, esclerose m&#250;ltipla, sepse, transtorno de estresse p&#243;s-traum&#225;tico (TEPT), Alzheimer, doen&#231;as cardiovasculares (DCV), etc. - ou seja, </span><strong><span>todas as condi&#231;&#245;es associadas &#224; ativa&#231;&#227;o anormal do TLR4.</span></strong></p><p><span>O antagonismo do TLR4 tamb&#233;m pode explicar os benef&#237;cios da pregnenolona para artrite reumatoide (AR), conforme demonstrado por m&#250;ltiplos estudos em humanos na primeira metade do s&#233;culo XX.</span></p><p><span>O estudo mostrou que tanto a pregnenolona quanto seu metab&#243;lito subsequente, a alopregnanolona, &#8203;&#8203;</span><em><span>impediram</span></em><span> os efeitos inflamat&#243;rios associados &#224; ativa&#231;&#227;o do TLR4. A alopregnanolona mostrou-se ligeiramente mais potente que a pregnenolona, &#8203;&#8203;mas essa diferen&#231;a pode ser compensada simplesmente aumentando a dose de pregnenolona&#8221; [C].</span></p><p>No <em>paper</em> original os pr&#243;prios cientistas afirmam que &#8220;Pela primeira vez, cientistas descobriram como esteroides neuroativos, encontrados naturalmente no c&#233;rebro e na corrente sangu&#237;nea, inibem a atividade de um tipo espec&#237;fico de prote&#237;na chamada receptores do tipo Toll (TLR4), que desempenham um papel na inflama&#231;&#227;o de diversos &#243;rg&#227;os, inclusive o c&#233;rebro&#8221; [A].</p><p>E continuam argumentando que &#8220;o estudo demonstra como o neuroesteroide alopregnanolona impede a ativa&#231;&#227;o de prote&#237;nas pr&#243;-inflamat&#243;rias importantes para a regula&#231;&#227;o g&#234;nica, bem como a produ&#231;&#227;o de citocinas, subst&#226;ncias reconhecidamente envolvidas em diversas condi&#231;&#245;es inflamat&#243;rias.</p><p>A sinaliza&#231;&#227;o celular inflamat&#243;ria no c&#233;rebro encontra-se exacerbada em muitas condi&#231;&#245;es neuropsiqui&#225;tricas, incluindo o transtorno por uso de &#225;lcool, a depress&#227;o e o estresse p&#243;s-traum&#225;tico. Esse fen&#244;meno tamb&#233;m &#233; observado na sepse, na epilepsia, na esclerose m&#250;ltipla e na doen&#231;a de Alzheimer. &#180;Tem sido muito dif&#237;cil tratar doen&#231;as cerebrais que envolvem inflama&#231;&#227;o; no entanto, a inibi&#231;&#227;o da ativa&#231;&#227;o da sinaliza&#231;&#227;o TLR4 pela alopregnanolona &#8212; tanto em macr&#243;fagos quanto no c&#233;rebro &#8212; traz a esperan&#231;a de desenvolvermos terapias mais eficazes para ajudar milh&#245;es de pessoas que sofrem com essas condi&#231;&#245;es&#180;, afirmou a autora s&#234;nior A. Leslie Morrow, PhD, Professora Distinta &#8220;John Andrews&#8221; nos Departamentos de Psiquiatria e Farmacologia da Faculdade de Medicina da UNC&#8221; [A].</p><p>A alopregnanolona &#233; derivado direto da pregnenolona no nosso organismo.</p><p>Os estudiosos n&#227;o param por a&#237;: &#8220;Estudos recentes demonstraram que os compostos neuroesteroides pregnenolona e alopregnanolona apresentam efeitos terap&#234;uticos na depress&#227;o, na esquizofrenia e no transtorno de estresse p&#243;s-traum&#225;tico (TEPT).</p><p>No entanto, at&#233; o momento, os cientistas n&#227;o compreendiam o mecanismo de a&#231;&#227;o. O estudo realizado pela UNC e pela Universidade de Maryland sugere que a inibi&#231;&#227;o da sinaliza&#231;&#227;o inflamat&#243;ria pode contribuir para esses efeitos, indicando que a inibi&#231;&#227;o da sinaliza&#231;&#227;o via TLR4 pode representar um novo alvo terap&#234;utico para essas condi&#231;&#245;es. [...]</p><p>Em colabora&#231;&#227;o com a Dra. Laure Aurelian, da Universidade de Maryland, Morrow e sua equipe descobriram que a alopregnanolona inibe a ativa&#231;&#227;o do TLR4 em macr&#243;fagos &#8212; c&#233;lulas que integram o sistema imunol&#243;gico e est&#227;o presentes tanto na circula&#231;&#227;o sangu&#237;nea quanto no c&#233;rebro.</p><p>Mais especificamente, os pesquisadores constataram que a alopregnanolona impede a liga&#231;&#227;o do TLR4 a prote&#237;nas MD2; esses componentes atuam em conjunto para gerar [&#8230;] respostas inflamat&#243;rias em c&#233;lulas e tecidos. A alopregnanolona tamb&#233;m reduz os n&#237;veis de quimiocinas e citocinas &#8212; como NF-kB, HMGB1, MCP-1 e TNF-&#945; &#8212;, mol&#233;culas que fazem parte do sistema imunol&#243;gico e est&#227;o envolvidas em diversas doen&#231;as inflamat&#243;rias&#8221; [... ] &#8220;Morrow e colegas descobriram que a pregnenolona tamb&#233;m inibia a sinaliza&#231;&#227;o via TLR4 em macr&#243;fagos&#8221; [A].</p><p>Muito impressionante para um horm&#244;nio que j&#225; &#233; conhecido por atuar em tantas outras enfermidades, mas que, ironicamente, &#233; proibido no Brasil &#8211; sem qualquer argumento razo&#225;vel - apesar de ser vendido livremente nos Estados Unidos. Como dizia um m&#233;dico crist&#227;o preocupado com esse tipo de contradi&#231;&#227;o: oremos.</p><p>G Dantas, SP, 9-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong>Refer&#234;ncias</strong> ____________</p><p>[A]<span> </span>MURUGAN S JAKKA P NAMANI S, 2019. <em>The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation.</em><strong> </strong>J Biol Chem. 2019 Mar 22;294(12):4596-4607. doi: 10.1074/jbc.RA118.005543. Epub 2019 Jan 15.  PMID: 30647133<span> </span>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6433066/">PMC6433066</a> DOI: <a href="https://doi.org/10.1074/jbc.ra118.005543">10.1074/jbc.RA118.005543</a></p><p>Pregnenolone is a steroid hormone precursor that is synthesized in various steroidogenic tissues, in the brain, and in lymphocytes. In addition to serving as the precursor for other steroid hormones, pregnenolone exerts its own effect as an anti-inflammatory molecule to maintain immune homeostasis in various inflammatory conditions. Pregnenolone and its metabolic derivatives have been shown to have beneficial effects in the brain, including enhancing memory and learning, reversing depressive disorders, and modulating cognitive functions. A decreased level of pregnenolone has been observed in neuroinflammatory diseases, which emphasizes its role in neuroprotection and neuroregeneration. Although the anti-inflammatory property of pregnenolone was recognized several decades ago, its mechanism of action remains unknown. Here we report that pregnenolone promotes ubiquitination and degradation of the TLR2/4 adaptor protein TIRAP and TLR2 in macrophages and microglial cells. Pregnenolone and its metabolites suppressed the secretion of tumor necrosis factor &#945; and interleukin-6 mediated through TLR2 and TLR4 signaling. Pregnenolone has been reported to induce activation of cytoplasmic linker protein 170, and this protein has recently been shown to promote targeted degradation of TIRAP. We observed enhanced degradation of TIRAP and TLR4 suppression by cytoplasmic linker protein 170 in the presence of pregnenolone. Our experimental data reveal novel nongenomic targets of pregnenolone and provide important leads to understand its role in restoring immune homeostasis in various inflammatory conditions.</p><p>[B]<span> </span>BALAN I BEATTIE M C O&#180;BUCKLEY TD, 2019. <em>Endogenous Neurosteroid (3&#945;,5&#945;)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain.</em><strong> </strong>Sci Rep. 2019 Feb 4;9(1):1220. doi: 10.1038/s41598-018-37409-6. PMID: 30718548<span> </span>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6362084/">PMC6362084</a><span> </span>DOI: <a href="https://doi.org/10.1038/s41598-018-37409-6">10.1038/s41598-018-37409-6</a></p><p>The endogenous neurosteroid (3&#945;,5&#945;)3-hydroxypregnan-20-one (3&#945;,5&#945;-THP, allopregnanolone) has protective activity in animal models of alcoholism, depression, traumatic brain injury, schizophrenia, multiple sclerosis, and Alzheimer&#8217;s disease that is poorly understood. Because these conditions involve proinflammatory signaling through toll-like receptors (TLRs), we examined the effects of 3&#945;,5&#945;-THP, and pregnenolone on TLR4 activation in both the periphery and the central nervous system (CNS). We used monocytes/macrophages (RAW264.7) as a model of peripheral immune signaling and studied innately activated TLR4 in the ventral tegmental area (VTA) of selectively bred alcohol-preferring (P) rats. LPS activated the TLR4 pathway in RAW264.7 cells as evidenced by increased levels of p-TAK1, TRAF6, NF-&#954;B p50, phospho-NF-&#954;B- p65, pCREB, HMGB1, and inflammatory mediators, including MCP-1 and TNF&#945;. Both 3&#945;,5&#945;-THP and pregnenolone (0.5-1.0&#956;M) substantially (~80%) inhibited these effects, indicating pronounced inhibition of TLR4 signaling. The mechanism of inhibition appears to involve blockade of TLR4/MD-2 protein interactions in RAW246.7 cells. In VTA, 3&#945;,5&#945;-THP (15 mg/kg, IP) administration reduced TRAF6 (~20%), CRF (~30%), and MCP-1 (~20%) levels, as well as TLR4 binding to GABA<sub>A</sub> receptor &#945;2 subunits (~60%) and MyD88 (~40%). The data suggest that inhibition of proinflammatory neuroimmune signaling underlies protective effects of 3&#945;,5&#945;-THP in immune cells and brain, apparently involving blocking of protein-protein interactions that initiate TLR4-dependent signaling. Inhibition of pro-inflammatory TLR4 activation represents a new mechanism of 3&#945;,5&#945;-THP action in the periphery and the brain.</p><p>[C]<span> </span><a href="https://lowtoxinforum.com/threads/pregnenolone-is-a-potent-functional-endotoxin-tlr4-antagonist.27846/">https://lowtoxinforum.com/threads/pregnenolone-is-a-potent-functional-endotoxin-tlr4-antagonist.27846/</a> Para Dinkov, &#8220;<span>Como os potentes efeitos anti-inflamat&#243;rios foram observados em uma concentra&#231;&#227;o de 1 &#181;M/L, isso sugere que doses de 30 mg a 50 mg em humanos seriam suficientes para replicar o desenho do estudo. Al&#233;m disso, embora este estudo n&#227;o tenha analisado a progesterona, existem diversos outros que constataram que a progesterona tamb&#233;m &#233; um antagonista funcional do TLR4 em concentra&#231;&#245;es ainda menores que 1 &#181;M/L&#8221;.</span></p><p>[D]<span> </span>LU Y-C<span> </span>YEH W-C, 2008. <em>LPS/TLR4 signal transduction pathway.</em><strong> </strong>Cytokine. 2008 May;42(2):145-151. doi: 10.1016/j.cyto.2008.01.006. Epub 2008 Mar 4.  PMID: 18304834<span> </span>DOI: <a href="https://doi.org/10.1016/j.cyto.2008.01.006">10.1016/j.cyto.2008.01.006</a></p><p><strong>Abstract</strong></p><p>The stimulation of Toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) induces the release of critical proinflammatory cytokines that are necessary to activate potent immune responses. LPS/TLR4 signaling has been intensively studied in the past few years. Here we review molecules involved in TLR4-mediated signaling, including players that are involved in the negative regulation of this important pathway.</p><p>[E]<span> </span>AFROZ R TANVIR E M, 2022. <em>LPS/TLR4 Pathways in Breast Cancer: Insights into Cell Signalling</em><strong>. </strong>Curr Med Chem. 2022;29(13):2274-2289. doi: 10.2174/0929867328666210811145043.PMID: 34382520    DOI: <a href="https://doi.org/10.2174/0929867328666210811145043">10.2174/0929867328666210811145043</a></p><p><strong>Abstract</strong></p><p><strong>Background: </strong>Cancer cells are usually recognized as foreign particles by the immune cells. Mounting evidence suggest an important link between toll-like receptors (TLRs) and carcinogenesis. This review article focused on the role of TLRs, especially TLR4, in breast cancer.</p><p><strong>Methods: </strong>Research data on TLRs and cancer was explored in PubMed, Scopus, Google Scholar and reviewed. Although some pioneer works are referenced, papers published in the last ten years were mostly cited.</p><p><strong>Results: </strong>TLRs are widely investigated pattern recognition receptors (PRR), and TLR4 is the most studied TLRs, implicated with the occurrence of several types of cancers, including breast cancer. TLR4 activation occurs via the binding of its ligand lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria. Upon LPS binding, TLR4 dimerizes and recruits downstream signalling and/or adapter molecules, leading to gene expression related to cancer cell proliferation, survival, invasion, and metastasis. Although LPS/TLR4 signalling seems a single signal transduction pathway, the TLR4 activation results in the activation of multiple diverse intracellular networks with huge cellular responses in both immune and cancer cells. The role of TLR4 in the growth, invasion, and metastasis of breast cancer is attracting huge attention in oncology research. Several clinical and preclinical studies utilize both TLR4 agonists and antagonists as a treatment option for cancer therapy, either as monotherapy or adjuvants for vaccine development.</p><p><strong>Conclusion: </strong>This review narrates the role of LPS/TLR4 signalling in breast cancer development and future prospects for targeting LPS/TLR4 axis in the treatment of breast cancer.</p><p>[F]<span> SINGH-S SAHU K SING C, 2022. </span><em>Lipopolysaccharide induced altered signaling pathways in various neurological disorders</em><strong>. </strong>Naunyn Schmiedebergs Arch Pharmacol. 2022 Mar;395(3):285-294. doi: 10.1007/s00210-021-02198-9. Epub 2022 Jan 6.  PMID: 34989812<span> </span>DOI: <a href="https://doi.org/10.1007/s00210-021-02198-9">10.1007/s00210-021-02198-9</a></p><p><strong>Abstract</strong></p><p>Neuroinflammation is defined as an inflammatory response within the brain or spinal cord, whereas the brain&#8217;s innate immune system is triggered by various inflammatory challenges such as injury, infection, exposure to toxin (LPS) and ageing, which result in cognitive impairment and neurodegenerative diseases including Alzheimer&#8217;s disease (AD), Parkinson&#8217;s disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). Lipopolysaccharide (LPS) is a main structural component of the outer membrane of gram-negative bacteria, widely used systematically to stimulate the immune system and to generate profound physiological and behavioural changes. It consists of three parts: lipid A, a core oligosaccharide and an O side chain. It is reported by several scientists that, besides the systemic alteration, LPS also induces neurodegeneration by promoting neuroinflammation upon binding with the stimulation of Toll-like receptor-4 (TLR4) receptors present on glial cells. The mammalian Toll-like receptor (TLR) family consists of 13 membranes and TLR was discovered as a crucial pattern recognition receptor (PPR) involved in the recognition of pathogen-associated molecular patterns (PAMPs). Future studies will show that damage/danger-associated molecular patterns (DAMPs) are recognised by the involvement of PPRs, generated by the host itself. The stimulation of TLR4 by lipopolysaccharide phosphorylates two signalling pathways, namely the MyD88-dependent pathway and the MyD88-independent pathway. This activation subsequently triggers the release of various pro-inflammatory cytokines that are necessary to activate innate immune responses, and then promotes neuroinflammation. In this review, we critically demonstrated the epidemiology of neuroinflammation, types of TLRs, the molecular mechanism of TLR4 and management of neuroinflammation.</p><p>[G]<span> </span>LIU Y<span> </span>CHEN S, YU S, 2024. <em>LPS-TLR4 pathway exaggerates alcoholic hepatitis via provoking NETs formation<span> </span>[Article in English, Spanish</em>]. Gastroenterol Hepatol. 2024 Feb;47(2):158-169. doi: 10.1016/j.gastrohep.2023.05.002. Epub 2023 May 5.  PMID: 37150251 DOI: <a href="https://doi.org/10.1016/j.gastrohep.2023.05.002">10.1016/j.gastrohep.2023.05.002</a></p><p><strong>Abstract</strong></p><p><strong>Background: </strong>Intrahepatic infiltration of neutrophils is a character of alcoholic hepatitis (AH) and neutrophil extracellular traps (NETs) are an important strategy for neutrophils to fix and kill invading microorganisms. The gut-liver axis has been thought to play a critical role in many liver diseases also including AH. However, whether NETs appear in AH and play role in AH is still unsure.</p><p><strong>Methods: </strong>Serum samples from AH patients were collected and LPS and MPO-DNA were detected. WT, NE KO, and TLR4 KO mice were used to build the AH model, and the intestinal bacteria were eliminated at the same time and LPS was given. Then the formation of NETs and AH-related markers were detected.</p><p><strong>Results: </strong>The serum MPO-DNA and LPS concentration was increased in AH patients and a correlation was revealed between these two indexes. More intrahepatic NETs formed in AH mice. NETs formation decreased with antibiotic intervention and restored with antibiotic intervention plus LPS supplement. While NETs formation failed to change with gut microbiome or combine LPS supplement in TLR4 KO mice. As we tested AH-related characters, liver injury, intrahepatic fat deposition, inflammation, and fibrosis alleviated with depletion of NE. These related marks were also attenuated with gut sterilization by antibiotics and recovered with a combined treatment with antibiotics plus LPS. But the AH-related markers did show a difference in TLR4 KO mice when they received the same treatment.</p><p><strong>Conclusion: </strong>Intestinal-derived LPS promotes NETs formation in AH through the TLR4 pathway and further accelerates the AH process by NETs.</p><p>[H]<span> </span>WANG N MENG X, 2019. <em>LPS promote Osteosarcoma invasion and migration through TLR4/HOTAIR. </em>Gene. 2019 Jan 5:680:1-8. doi: 10.1016/j.gene.2018.09.031. Epub 2018 Sep 19.PMID: 30240881DOI: <a href="https://doi.org/10.1016/j.gene.2018.09.031">10.1016/j.gene.2018.09.031</a></p><p><strong>Abstract</strong></p><p><strong>Objectives: </strong>Osteosarcoma is one of common malignant tumors worldwide in the metaphysis of teenagers. The role of lncRNAs in Osteosarcoma has become an emerging area of research.</p><p><strong>Materials and methods: </strong>Cell migration and invasion were analyzed in Osteosarcoma cell following knockdown or overexpression by transfection with small interfering RNA (siRNA) or treated with LPS. Western blotting and Real-time RT-PCR methods were used to analyze the effects of LPS on EMT.</p><p><strong>Results: </strong>We discovered that LPS could regulate cell migration and invasion and promote EMT. At the same time, LPS could regulate the expression of TLR4 and HOTAIR. In addition, knockdown of the expression of TLR4 partially reverses the promotion of cell invasion induced by LPS.</p><p><strong>Conclusions: </strong>Our results indicated that LPS coordinate the Osteosarcoma through TLR4/HOTAIR.</p><p>[I]<span> </span>WIGER C W RANHEIM T ARNESEN H, 2025. <em>TLR4 Inhibition Attenuated LPS-Induced Proinflammatory Signaling and Cytokine Release in Mouse Hearts and Cardiomyocytes</em><strong>. </strong>Immun Inflamm Dis. 2025 Jan;13(1):e70133. doi: 10.1002/iid3.70133. PMID: 39853914<span> </span>PMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11760985/">PMC11760985</a><span> </span>DOI: <a href="https://doi.org/10.1002/iid3.70133">10.1002/iid3.70133</a></p><p><strong>Abstract</strong></p><p><strong>Background: </strong>Sepsis is associated with myocardial injury and early mortality. The innate immune receptor Toll-like receptor 4 (TLR4) can recognize pathogen-associated-molecular-patterns (PAMPs) and damage-associated molecular patterns (DAMPs); the latter are released during tissue injury. We hypothesized that TLR4 inhibition reduces proinflammatory signaling and cytokine release in: (1) LPS or Escherichia coli-treated isolated mouse heart; (2) LPS-treated mouse primary adult cardiomyocytes; and (3) the isolated heart during ischemia-reperfusion.</p><p><strong>Methods: </strong>Isolated C57BL/6N male mouse hearts were perfused for 120 min, with either LPS, E. coli, with and without CLI-095 (TLR4 inhibitor). Primary adult mouse cardiomyocytes were treated with LPS or LPS + CLI-095. Isolated hearts, exposed to 35 min of global ischemia, were treated with either vehicle or CLI-095 during reperfusion. Infarct size was quantified by triphenyltetrazolium staining. Cytokine expression was analyzed with ELISA, western blot analysis, and qPCR.</p><p><strong>Results: </strong>In isolated hearts, E. coli increased the expression of proinflammatory cytokines (IL-6 and CXCL2), which was not attenuated with TLR4 inhibition. TLR4 inhibition reduced expression (p = 0.004) and release of IL-6 (p &lt; 0.0001) in LPS-exposed isolated hearts. LPS activated the nuclear-factor &#954;-light-chain-enhancer of activated B cells signaling pathway (NF-&#954;B) in primary adult cardiomyocytes. Moreover, TLR4 inhibition reduced LPS-induced mRNA expression and release of IL-6 in primary adult cardiomyocytes. Isolated hearts treated with CLI-095 during reperfusion after ischemia (induced DAMPs release) showed reduced infarct size (39 &#177; 17% to 26 &#177; 8%, p = 0.034) and decreased IL-6 release (p = 0.006).</p><p><strong>Conclusion: </strong>Inhibition of TLR4 reduced proinflammatory signaling and cytokine release in LPS-treated and ischemia-reperfused isolated mouse hearts and in primary adult murine cardiomyocytes.</p><p>[J]<span> </span>LI X-P<span> </span>LIU P LI Y-F 2019. <em>LPS induces activation of the TLR4 pathway in fibroblasts and promotes skin scar formation through collagen I and TGF-&#946; in skin lesions.</em><strong> </strong>Int J Clin Exp Pathol. 2019 Jun 1;12(6):2121-2129. eCollection 2019.PMID: 31934034   pMCID: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6949634/">PMC6949634</a></p><p><strong>Abstract</strong></p><p>Hypertrophic scars are proliferative diseases of dermal fibroblasts that produce abundant amounts of collagen and extracellular matrix in the skin after severe burns, inflammation and trauma. Hypertrophic scars affect the daily life of patients and cause a series of problems. The biological mechanism of hypertrophic scar formation is still unclear and has received much attention in plastic surgery. Therefore, we hypothesized that LPS can activate TLR4 signaling, leading to the overexpression of collagen I and TGF-&#946; and the induction of hypertrophic scar formation. In the present study, we used LPS to validate the role of the TLR4 signaling pathway in 3T3-L1 cells <em>in vitro</em> and hypertrophic scar mouse models to determine the role of the TLR4 signaling pathway in proliferative scar formation <em>in vivo</em>. The results suggested that LPS leads to the activation of the TLR4 pathway in fibroblasts, and inhibitor experiments confirmed that TLR4 is involved in the expression of collagen I by regulating the NF-&#954;B pathway. The mouse skin wound model experiments demonstrated that TLR4 is involved in wound healing and scar formation. Our experiments demonstrated that the TLR4-IRAK4-NF-&#954;B pathway is involved in the production of hypertrophic scars and wound healing.</p><p>***</p>]]></content:encoded></item><item><title><![CDATA[Pregnenolona e proteção a dano cognitivo por estresse ]]></title><description><![CDATA[Estresse agudo e destrui&#231;&#227;o de zonas do c&#233;rebro: estresse cognitivo ou problemas depressivos: pregnenolona poderia ter seu papel aqui por inibir horm&#244;nios ligados ao problema.]]></description><link>https://outramedicina2024.substack.com/p/pregnenolona-e-protecao-a-dano-cognitivo</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/pregnenolona-e-protecao-a-dano-cognitivo</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Fri, 07 Aug 2026 11:35:24 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!382w!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!382w!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!382w!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg" width="429" height="390" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:390,&quot;width&quot;:429,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:35784,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/210207762?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!382w!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F50736aa9-0faa-4532-8107-d2e25868f76e_429x390.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p><span>Certos estudiosos t&#234;m grande preocupa&#231;&#227;o sobre qual seria o mecanismo que vai construindo o d&#233;ficit cognitivo, a destrui&#231;&#227;o de tecido cerebral durante o estresse.</span></p><p><span>Sendo que j&#225; &#233; sabido do papel do horm&#244;nio cerebral CRF [horm&#244;nio liberador do corticotrofina] nesse processo; este horm&#244;nio estimula a hip&#243;fise a produzir ACTH que comanda produ&#231;&#227;o de cortisol nas adrenais. Ou seja, CRF &#233; comando central, cerebral, para </span><em><span>boost</span></em><span> de cortisol no organismo.</span></p><p><span>E como foi explicado em outras notas neste blog, emo&#231;&#245;es negativas acionam o CRF l&#225; no c&#233;rebro. </span></p><p><span>Temos aqui um problema emocional acionando um particular horm&#244;nio do estresse que vai ativar a adrenal para produzir cortisol. Nada bom para a nossa sa&#250;de se esse processo se desenvolve no tempo, cronicamente.</span></p><p><span>Eis que um estudo de anos atr&#225;s vinculou libera&#231;&#227;o de CRH, de cortisol, a dano cognitivo.</span></p><p><span>&#8220;O estudo descobriu que a libera&#231;&#227;o de CRF/CRH como parte da resposta ao estresse &#233; a respons&#225;vel pelos danos na cogni&#231;&#227;o.</span></p><p><span>Sabe-se que, se o estresse for cr&#244;nico, ele pode levar &#224; depress&#227;o, esquizofrenia, dem&#234;ncia e at&#233; mesmo ao Alzheimer em est&#225;gio avan&#231;ado, &#224;s vezes em pessoas com apenas 30 anos de idade&#8221; [C].</span></p><p><span>&#8220;O c&#243;rtex pr&#233;-frontal &#233; uma regi&#227;o do c&#233;rebro respons&#225;vel pela atividade mental, percep&#231;&#227;o e reconhecimento, em suma, pela cogni&#231;&#227;o. N&#227;o importa se queremos responder de forma flex&#237;vel a determinadas situa&#231;&#245;es, se temos de fazer v&#225;rias coisas em simult&#226;neo ou de fazer planos para o futuro &#8211; nada disto seria poss&#237;vel sem o nosso c&#243;rtex pr&#233;-frontal. No entanto, esses processos s&#227;o muito suscet&#237;veis ao estresse.</span></p><p><span>Nossa raiva como resultado de ficarmos presos em um engarrafamento pela manh&#227; ou por conta de problemas com o chefe na hora do almo&#231;o, ou a perda de um amor, s&#227;o causas de estresse social. O chamado fator de libera&#231;&#227;o de corticotropina (CRF) controla nossa rea&#231;&#227;o no c&#243;rtex pr&#233;-frontal; no entanto, qual o papel exato que desempenha n&#227;o estava claro anteriormente&#8221; [C].</span></p><p><span>Mas agora, com esse estudo em animais novas revela&#231;&#245;es apareceram sobre esse processo.</span></p><p><span>Um grupo de animais foi colocado em regime de estresse agudo e o resultado foi decl&#237;nio cognitivo algumas </span><strong><span>horas</span></strong><span> depois. Foram submetidos a estresse social agudo. Na sequ&#234;ncia, &#8220;os camundongos n&#227;o foram capazes de demonstrar flexibilidade cognitiva em um labirinto de teste ou de se lembrar da sequ&#234;ncia cronol&#243;gica de eventos que haviam aprendido anteriormente&#8221; [C].</span></p><p><span>Comprometimento cognitivo declarado. Motivo: estresse agudo.</span></p><p><span>A pergunta dos cientistas do Instituto Max Planck de Psiquiatria era sobre o que exatamente acontece no c&#233;rebro de camundongos durante esses per&#237;odos estressantes.</span></p><p><span>&#8220;Para descobrir mais sobre o papel que o CRF desempenha nesse processo, os cientistas bloquearam a a&#231;&#227;o do pept&#237;deo usando um medicamento, um chamado antagonista do CRF. Desta vez, o desempenho dos camundongos </span><strong><span>n&#227;o diminuiu v&#225;rias horas ap&#243;s o evento</span></strong><span> estressante; eles foram capazes de realizar as tarefas necess&#225;rias com o mesmo sucesso que haviam feito sem estresse&#8221; [C].</span></p><p><span>Ora, a boa not&#237;cia &#233; que a pregnenolona tem tal efeito. N&#227;o seria necess&#225;rio utilizar a subst&#226;ncia t&#243;xica usada no experimento.</span></p><p><span>Para G. Dinkov, a pregnenolona na dose recomendada por Peat [100 mg VO/dia] seria capaz de deter aquele processo destrutivo e at&#233; reverter dano j&#225; existente, eventualmente [C]. Para este autor &#8211; e este tema j&#225; foi alvo de nota neste blog &#8211; a pregnenolona &#233; o mais potente inibidor do sinal de estresse, o CRH.</span></p><p><span>Estrog&#234;nio e cortisol elevados s&#227;o inclu&#237;dos como causas de depress&#227;o, explica Dinkov, tanto que &#8220;pessoas n&#227;o tratadas com problemas mentais/de humor t&#234;m CRF/CRH elevados no sangue. A depress&#227;o pode ser causada por estrog&#234;nio nas mulheres e cortisol nos homens&#8221; [C]. CRF e ACTH podem ser medidos eventualmente no processo de diagn&#243;stico.</span></p><p><span>Caso o estudioso Dinkov tenha raz&#227;o sobre a pregnenolona em humanos [cita&#231;&#227;o acima], o grande desafio seguinte seria o de encontrar pregnenolona pura e confi&#225;vel no mercado; no mercado norte-americano &#233; perfeitamente poss&#237;vel. No brasileiro sugiro que procurem saber que provid&#234;ncias a ag&#234;ncia reguladora estatal de medicamentos fez com a pregnenolona e entender&#227;o de onde vem a dificuldade em terras tupiniquins.</span></p><p><span>G Dantas, SP, 7-8-26</span></p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong><span>Refer&#234;ncias</span></strong><span> ______________</span></p><p><span>[A] SCHLEE A, 2016. </span><em><span>Hormone causes decline in cognition after social stress.</span></em></p><p><span>by Anke Schlee, </span><a href="http://www.mpg.de/english/portal/index.html"><span>Max Planck Society</span></a><span>   How does stress influence our cognitive performance? This is an issue scientists at the Max Planck Institute of Psychiatry in Munich have been dealing with. For the first time, they have identified a brain mechanism that explains why the cognitive performance of mice is reduced after being exposed to social stress. This finding will help to improve our understanding and treatment of disorders involving cognitive decline in humans.</span></p><p><span>The </span><a href="https://medicalxpress.com/tags/prefrontal+cortex/"><span>prefrontal cortex</span></a><span> is a brain region responsible for mental activity, perception and recognition, in short for cognition. No matter whether we want to respond flexibly to certain situations, have to do several things simultaneously or make plans for the future &#8211; none of this would be possible without our prefrontal cortex. However, these processes are very susceptible to stress. Our anger resulting from being stuck in a traffic jam in the morning or trouble with the boss at lunchtime causes social stress. The so-called Corticotropin-releasing factor (CRF) controls our reaction in the prefrontal cortex; however, which exact role it plays was not clear previously.</span></p><p><span>Therefore, scientists at the Max Planck Institute of Psychiatry tested what exactly happens in the brain during such stressful periods in mice. They exposed mice to acute </span><a href="https://medicalxpress.com/tags/social+stress/"><span>social stress</span></a><span> and observed a </span><a href="https://medicalxpress.com/tags/cognitive+decline/"><span>cognitive decline</span></a><span> in the rodents some hours later. The mice were not able to show </span><a href="https://medicalxpress.com/tags/cognitive+flexibility/"><span>cognitive flexibility</span></a><span> in a test maze or remember the chronological sequence of events they had learned before.</span></p><p><span>In order to find out more about the role CRF plays in this process, the scientists blocked the action of the peptide using a drug, a so-called CRF antagonist. This time, the performance of the mice did not decrease several hours after the stressful event; they were able to perform the required tasks as successfully as they had done without stress.</span></p><p><span>&#8220;The crucial point is that we were able to identify the mechanism responsible for the reduction in performance after stress,&#8221; Mathias Schmidt, research group leader and head of the study, summarizes. Understanding this mechanism is important in order to comprehend how stress affects our thinking, feeling and perceiving. Since the mechanisms underlying the flexibility in perception and memory performance are similar in </span><a href="https://medicalxpress.com/tags/mice/"><span>mice</span></a><span> and humans, it is very probable that the findings are transferable to humans. Many psychiatric diseases such as depression or schizophrenia are accompanied by impaired cognitive function. With their findings, the scientists hope to develop approaches for novel treatments and medications.</span></p><p><span>Publication details - Andr&#233;s Uribe-Mari&#241;o et al. Prefrontal cortex corticotropin-releasing hormone receptor 1 conveys acute stress-induced executive dysfunction, </span><em><span>Biological Psychiatry</span></em><span> (2016). </span><a href="http://dx.doi.org/10.1016/j.biopsych.2016.03.2106"><span>DOI: 10.1016/j.biopsych.2016.03.2106</span></a><span>    &#169; Medical Xpress 2011 - 2026 Dispon&#237;vel em </span><a href="https://medicalxpress.com/news/2016-06-hormone-decline-cognition-social-stress.html#google_vignette"><span>https://medicalxpress.com/news/2016-06-hormone-decline-cognition-social-stress.html#google_vignette</span></a></p><p><span>[B] URIBE-MARI&#209;O A Gassen NC, 2016. </span><em><span>Prefrontal Cortex Corticotropin-Releasing Factor Receptor 1 Conveys Acute Stress-Induced Executive Dysfunction. </span></em><strong><span>Archival Report</span></strong><a href="https://www.biologicalpsychiatryjournal.com/issue/S0006-3223(16)X0018-2"><span>Volume 80, Issue 10</span></a><span>p743-753November 15, 2016 DOI: </span><a href="https://doi.org/10.1016/j.biopsych.2016.03.2106"><span>10.1016/j.biopsych.2016.03.2106 External Link</span></a><span>Also available on </span><a href="https://www.sciencedirect.com/science/article/pii/S0006322316322703"><span>ScienceDirect External Link</span></a></p><p><span>Abstract</span></p><p><span>Background</span></p><p><span>The medial prefrontal cortex (mPFC) subserves complex cognition and is impaired by stress. Corticotropin-releasing factor (CRF), through CRF receptor 1 (CRFR1), constitutes a key element of the stress response. However, its contribution to the effects of stress in the mPFC remains unclear.</span></p><p><span>Methods Mice were exposed to acute social defeat stress and subsequently to either the temporal order memory (</span><em><span>n</span></em><span> = 11&#8211;12) or reversal learning (</span><em><span>n</span></em><span> = 9&#8211;11) behavioral test. Changes in mPFC </span><em><span>Crhr1</span></em><span> messenger RNA levels were measured in acutely stressed mice (</span><em><span>n</span></em><span> = 12). </span><em><span>Crhr1</span><sup><span>loxP/loxP</span></sup></em><span> mice received either intra-mPFC adeno-associated virus-Cre or empty microinjections (</span><em><span>n</span></em><span> = 17&#8211;20) and then were submitted to acute stress and later to the behavioral tests. Co-immunoprecipitation was used to detect activation of the protein kinase A (PKA) signaling pathway in the mPFC of acutely stressed mice (</span><em><span>n</span></em><span> = 8) or intra-mPFC CRF injected mice (</span><em><span>n</span></em><span> = 7). Finally, mice received intra-mPFC CRF (</span><em><span>n</span></em><span> = 11) and/or Rp-isomer cyclic adenosine 3&#8242;,5&#8242; monophosphorothioate (Rp-cAMPS) (</span><em><span>n</span></em><span> = 12) microinjections and underwent behavioral testing.</span></p><p><span>Results We report acute stress-induced effects on mPFC-mediated cognition, identify CRF&#8211;CRFR1-containing microcircuits within the mPFC, and demonstrate stress-induced changes in </span><em><span>Crhr1</span></em><span> messenger RNA expression. Importantly, intra-mPFC CRFR1 deletion abolishes acute stress-induced executive dysfunction, whereas intra-mPFC CRF mimics acute stress-induced mPFC dysfunction. Acute stress and intra-mPFC CRF activate the PKA signaling pathway in the mPFC, leading to cyclic AMP response element binding protein phosphorylation in intra-mPFC CRFR1-expressing neurons. Finally, PKA blockade reverses the intra-mPFC CRF-induced executive dysfunction.</span></p><p><span>Conclusions Taken together, these results unravel a molecular mechanism linking acute stress to executive dysfunction via CRFR1. This will aid in the development of novel therapeutic targets for stress-induced cognitive dysfunction.</span></p><p><span>References</span></p><p><span>1.</span></p><p><span>Kolb, B. &#8729; Mychasiuk, R. &#8729; Muhammad, A. ...</span></p><p><strong><span>Experience and the developing prefrontal cortex</span></strong></p><p><em><span>Proc Natl Acad Sci U S A.</span></em><span> 2012; </span><strong><span>109</span></strong><span>(suppl 2):17186-17193</span></p><p><a href="https://doi.org/10.1073/pnas.1121251109"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84872230029"><span>Scopus (397)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/23045653/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1121251109&amp;pmid=23045653"><span>Google Scholar</span></a></p><p><span>2.</span></p><p><span>Puig, M.V. &#8729; Antzoulatos, E.G. &#8729; Miller, E.K.</span></p><p><strong><span>Prefrontal dopamine in associative learning and memory</span></strong></p><p><em><span>Neuroscience.</span></em><span> 2014; </span><strong><span>282C</span></strong><span>:217-229</span></p><p><a href="https://doi.org/10.1016/j.neuroscience.2014.09.026"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84907779757"><span>Scopus (104)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuroscience.2014.09.026"><span>Google Scholar</span></a></p><p><span>3.</span></p><p><span>Volle, E. &#8729; Levy, R.</span></p><p><strong><span>[Role of the prefrontal cortex in human behavioral adaptation]</span></strong></p><p><em><span>Med Sci (Paris).</span></em><span> 2014; </span><strong><span>2</span></strong><span>:179-185</span></p><p><a href="https://doi.org/10.1051/medsci/20143002016"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84896796845"><span>Scopus (3)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1051%2Fmedsci%2F20143002016"><span>Google Scholar</span></a></p><p><span>4.</span></p><p><span>Butts, K.A. &#8729; Weinberg, J. &#8729; Young, A.H. ...</span></p><p><strong><span>Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function</span></strong></p><p><em><span>Proc Natl Acad Sci U S A.</span></em><span> 2011; </span><strong><span>45</span></strong><span>:18459-18464</span></p><p><a href="https://doi.org/10.1073/pnas.1111746108"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-81055130092"><span>Scopus (147)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1111746108"><span>Google Scholar</span></a></p><p><span>5.</span></p><p><span>Popoli, M. &#8729; Yan, Z. &#8729; McEwen, B.S. ...</span></p><p><strong><span>The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission</span></strong></p><p><em><span>Nat Rev Neurosci.</span></em><span> 2012; </span><strong><span>1</span></strong><span>:22-37</span></p><p><a href="https://scholar.google.com/scholar?q=M.PopoliZ.YanB.S.McEwenG.SanacoraThe+stressed+synapse%3A+the+impact+of+stress+and+glucocorticoids+on+glutamate+transmissionNat+Rev+Neurosci120122237"><span>Google Scholar</span></a></p><p><span>6.</span></p><p><span>Snyder, K.P. &#8729; Barry, M. &#8729; Valentino, R.J.</span></p><p><strong><span>Cognitive impact of social stress and coping strategy throughout development</span></strong></p><p><em><span>Psychopharmacology (Berl).</span></em><span> 2015; </span><strong><span>1</span></strong><span>:185-195</span></p><p><a href="https://doi.org/10.1007/s00213-014-3654-7"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84937993246"><span>Scopus (40)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00213-014-3654-7"><span>Google Scholar</span></a></p><p><span>7.</span></p><p><span>Maeng, L.Y. &#8729; Shors, T.J.</span></p><p><strong><span>The stressed female brain: neuronal activity in the prelimbic but not infralimbic region of the medial prefrontal cortex suppresses learning after acute stress</span></strong></p><p><em><span>Front Neural Circuits.</span></em><span> 2013; </span><strong><span>7</span></strong><span>:198</span></p><p><a href="https://doi.org/10.3389/fncir.2013.00198"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84891051315"><span>Scopus (36)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/24391548/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffncir.2013.00198&amp;pmid=24391548"><span>Google Scholar</span></a></p><p><span>8.</span></p><p><span>Bonfiglio, J.J. &#8729; Inda, C. &#8729; Refojo, D. ...</span></p><p><strong><span>The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved</span></strong></p><p><em><span>Neuroendocrinology.</span></em><span> 2011; </span><strong><span>1</span></strong><span>:12-20</span></p><p><a href="https://doi.org/10.1159/000328226"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-79960941611"><span>Scopus (106)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1159%2F000328226"><span>Google Scholar</span></a></p><p><span>9.</span></p><p><span>Steckler, T. &#8729; Holsboer, F.</span></p><p><strong><span>Corticotropin-releasing hormone receptor subtypes and emotion</span></strong></p><p><em><span>Biol Psychiatry.</span></em><span> 1999; </span><strong><span>11</span></strong><span>:1480-1508</span></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2FS0006-3223%2899%2900170-5&amp;cf=fulltext&amp;site=bps-site"><span>Full Text</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2FS0006-3223%2899%2900170-5&amp;cf=pdf&amp;site=bps-site"><span>Full Text (PDF)</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-0032751399"><span>Scopus (281)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0006-3223%2899%2900170-5"><span>Google Scholar</span></a></p><p><span>10.</span></p><p><span>Refojo, D. &#8729; Schweizer, M. &#8729; Kuehne, C. ...</span></p><p><strong><span>Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1</span></strong></p><p><em><span>Science.</span></em><span> 2011; </span><strong><span>6051</span></strong><span>:1903-1907</span></p><p><a href="https://doi.org/10.1126/science.1202107"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-80053365601"><span>Scopus (247)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1202107"><span>Google Scholar</span></a></p><p><span>11.</span></p><p><span>Wang, X.D. &#8729; Su, Y.A. &#8729; Wagner, K.V. ...</span></p><p><strong><span>Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss</span></strong></p><p><em><span>Nat Neurosci.</span></em><span> 2013; </span><strong><span>6</span></strong><span>:706-713</span></p><p><a href="https://doi.org/10.1038/nn.3395"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84878536363"><span>Scopus (115)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnn.3395"><span>Google Scholar</span></a></p><p><span>12.</span></p><p><span>Holsboer, F.</span></p><p><strong><span>Corticotropin-releasing hormone modulators and depression</span></strong></p><p><em><span>Curr Opin Investig Drugs.</span></em><span> 2003; </span><strong><span>1</span></strong><span>:46-50</span></p><p><a href="https://scholar.google.com/scholar?q=F.HolsboerCorticotropin-releasing+hormone+modulators+and+depressionCurr+Opin+Investig+Drugs120034650"><span>Google Scholar</span></a></p><p><span>13.</span></p><p><span>You, X. &#8729; Gao, L. &#8729; Liu, J. ...</span></p><p><strong><span>CRH activation of different signaling pathways results in differential calcium signaling in human pregnant myometrium before and during labor</span></strong></p><p><em><span>J Clin Endocrinol Metab.</span></em><span> 2012; </span><strong><span>10</span></strong><span>:E1851-E1861</span></p><p><a href="https://doi.org/10.1210/jc.2011-3383"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84867251549"><span>Scopus (24)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1210%2Fjc.2011-3383"><span>Google Scholar</span></a></p><p><span>14.</span></p><p><span>Sheng, H. &#8729; Xu, Y. &#8729; Chen, Y. ...</span></p><p><strong><span>Corticotropin-releasing hormone stimulates mitotic kinesin-like protein 1 expression via a PLC/PKC-dependent signaling pathway in hippocampal neurons</span></strong></p><p><em><span>Mol Cell Endocrinol.</span></em><span> 2012; </span><strong><span>1&#8211;2</span></strong><span>:157-164</span></p><p><a href="https://doi.org/10.1016/j.mce.2012.06.003"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84865284186"><span>Scopus (15)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.mce.2012.06.003"><span>Google Scholar</span></a></p><p><span>15.</span></p><p><span>Taniguchi, H. &#8729; He, M. &#8729; Wu, P. ...</span></p><p><strong><span>A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex</span></strong></p><p><em><span>Neuron.</span></em><span> 2011; </span><strong><span>6</span></strong><span>:995-1013</span></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.neuron.2011.07.026&amp;cf=fulltext&amp;site=cell-site"><span>Full Text</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.neuron.2011.07.026&amp;cf=pdf&amp;site=cell-site"><span>Full Text (PDF)</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-80053128156"><span>Scopus (1313)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuron.2011.07.026"><span>Google Scholar</span></a></p><p><span>16.</span></p><p><span>Justice, N.J. &#8729; Yuan, Z.F. &#8729; Sawchenko, P.E. ...</span></p><p><strong><span>Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system</span></strong></p><p><em><span>J Comp Neurol.</span></em><span> 2008; </span><strong><span>4</span></strong><span>:479-496</span></p><p><a href="https://doi.org/10.1002/cne.21848"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-58149280270"><span>Scopus (141)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fcne.21848"><span>Google Scholar</span></a></p><p><span>17.</span></p><p><span>Wagner, K.V. &#8729; Hartmann, J &#8729; Mangold, K ...</span></p><p><strong><span>Homer1 mediates acute stress-induced cognitive deficits in the dorsal hippocampus</span></strong></p><p><em><span>J Neurosci.</span></em><span> 2013; </span><strong><span>9</span></strong><span>:3857-3864</span></p><p><a href="https://doi.org/10.1523/JNEUROSCI.4333-12.2013"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84874626134"><span>Scopus (51)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.4333-12.2013"><span>Google Scholar</span></a></p><p><span>18.</span></p><p><span>Barker, G.R. &#8729; Bird, F. &#8729; Alexander, V. ...</span></p><p><strong><span>Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex</span></strong></p><p><em><span>J Neurosci.</span></em><span> 2007; </span><strong><span>11</span></strong><span>:2948-2957</span></p><p><a href="https://doi.org/10.1523/JNEUROSCI.5289-06.2007"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-33947302270"><span>Scopus (532)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.5289-06.2007"><span>Google Scholar</span></a></p><p><span>19.</span></p><p><span>Knapman, A. &#8729; Heinzmann, J.M. &#8729; Holsboer, F. ...</span></p><p><strong><span>Modeling psychotic and cognitive symptoms of affective disorders: disrupted latent inhibition and reversal learning deficits in highly stress reactive mice</span></strong></p><p><em><span>Neurobiol Learn Mem.</span></em><span> 2010; </span><strong><span>2</span></strong><span>:145-152</span></p><p><a href="https://doi.org/10.1016/j.nlm.2010.04.010"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-77955585421"><span>Scopus (34)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.nlm.2010.04.010"><span>Google Scholar</span></a></p><p><span>20.</span></p><p><span>Clark, L. &#8729; Cools, R. &#8729; Robbins, T.W.</span></p><p><strong><span>The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning</span></strong></p><p><em><span>Brain Cogn.</span></em><span> 2004; </span><strong><span>1</span></strong><span>:41-53</span></p><p><a href="https://doi.org/10.1016/S0278-2626(03)00284-7"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-2342650813"><span>Scopus (347)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0278-2626%2803%2900284-7"><span>Google Scholar</span></a></p><p><span>21.</span></p><p><span>Greetfeld, M. &#8729; Schmidt, M.V. &#8729; Ganea, K. ...</span></p><p><strong><span>A single episode of restraint stress regulates central corticotrophin- releasing hormone receptor expression and binding in specific areas of the mouse brain</span></strong></p><p><em><span>J Neuroendocrinol.</span></em><span> 2009; </span><strong><span>5</span></strong><span>:473-480</span></p><p><a href="https://doi.org/10.1111/j.1365-2826.2009.01865.x"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-64849095745"><span>Scopus (29)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1365-2826.2009.01865.x"><span>Google Scholar</span></a></p><p><span>22.</span></p><p><span>Gassen, N.C. &#8729; Hartmann, J. &#8729; Zschocke, J. ...</span></p><p><strong><span>Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans</span></strong></p><p><em><span>PLoS Med.</span></em><span> 2014; </span><strong><span>11</span></strong><span>:e1001755</span></p><p><a href="https://doi.org/10.1371/journal.pmed.1001755"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84922339636"><span>Scopus (133)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/25386878/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1001755&amp;pmid=25386878"><span>Google Scholar</span></a></p><p><span>23.</span></p><p><span>Chung, K. &#8729; Wallace, J. &#8729; Kim, S.Y. ...</span></p><p><strong><span>Structural and molecular interrogation of intact biological systems</span></strong></p><p><em><span>Nature.</span></em><span> 2013; </span><strong><span>7449</span></strong><span>:332-337</span></p><p><a href="https://doi.org/10.1038/nature12107"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84878115127"><span>Scopus (1537)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12107"><span>Google Scholar</span></a></p><p><span>24.</span></p><p><span>Yang, C.H. &#8729; Huang, C.C. &#8729; Hsu, K.S.</span></p><p><strong><span>Novelty exploration elicits a reversal of acute stress-induced modulation of hippocampal synaptic plasticity in the rat</span></strong></p><p><em><span>J Physiol.</span></em><span> 2006; </span><strong><span>577</span></strong><span>(pt 2):601-615</span></p><p><a href="https://doi.org/10.1113/jphysiol.2006.120386"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-33751331450"><span>Scopus (31)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/17008368/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1113%2Fjphysiol.2006.120386&amp;pmid=17008368"><span>Google Scholar</span></a></p><p><span>25.</span></p><p><span>Zimmer, C. &#8729; Boogert, N.J. &#8729; Spencer, K.A.</span></p><p><strong><span>Developmental programming: cumulative effects of increased pre-hatching corticosterone levels and post-hatching unpredictable food availability on physiology and behaviour in adulthood</span></strong></p><p><em><span>Horm Behav.</span></em><span> 2013; </span><strong><span>3</span></strong><span>:494-500</span></p><p><a href="https://doi.org/10.1016/j.yhbeh.2013.07.002"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84884138055"><span>Scopus (76)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.yhbeh.2013.07.002"><span>Google Scholar</span></a></p><p><span>26.</span></p><p><span>Glaser, Y.G. &#8729; Zubieta, J.K. &#8729; Hsu, D.T. ...</span></p><p><strong><span>Indirect effect of corticotropin-releasing hormone receptor 1 gene variation on negative emotionality and alcohol use via right ventrolateral prefrontal cortex</span></strong></p><p><em><span>J Neurosci.</span></em><span> 2014; </span><strong><span>11</span></strong><span>:4099-4107</span></p><p><a href="https://doi.org/10.1523/JNEUROSCI.3672-13.2014"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84896749919"><span>Scopus (43)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.3672-13.2014"><span>Google Scholar</span></a></p><p><span>27.</span></p><p><span>Veenit, V. &#8729; Riccio, O. &#8729; Sandi, C.</span></p><p><strong><span>CRHR1 links peripuberty stress with deficits in social and stress-coping behaviors</span></strong></p><p><em><span>J Psychiatr Res.</span></em><span> 2014; </span><strong><span>53</span></strong><span>:1-7</span></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.jpsychires.2014.02.015&amp;cf=fulltext&amp;site=piat-site"><span>Full Text</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.jpsychires.2014.02.015&amp;cf=pdf&amp;site=piat-site"><span>Full Text (PDF)</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84897386530"><span>Scopus (38)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/24630468/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jpsychires.2014.02.015&amp;pmid=24630468"><span>Google Scholar</span></a></p><p><span>28.</span></p><p><span>Kuhne, C. &#8729; Puk, O. &#8729; Graw, J. ...</span></p><p><strong><span>Visualizing corticotropin-releasing hormone receptor type 1 expression and neuronal connectivities in the mouse using a novel multifunctional allele</span></strong></p><p><em><span>J Comp Neurol.</span></em><span> 2012; </span><strong><span>14</span></strong><span>:3150-3180</span></p><p><a href="https://doi.org/10.1002/cne.23082"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84865089294"><span>Scopus (40)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fcne.23082"><span>Google Scholar</span></a></p><p><span>29.</span></p><p><span>Reul, J.M. &#8729; Holsboer, F.</span></p><p><strong><span>On the role of corticotropin-releasing hormone receptors in anxiety and depression</span></strong></p><p><em><span>Dialogues Clin Neurosci.</span></em><span> 2002; </span><strong><span>1</span></strong><span>:31-46</span></p><p><a href="https://scholar.google.com/scholar?q=J.M.ReulF.HolsboerOn+the+role+of+corticotropin-releasing+hormone+receptors+in+anxiety+and+depressionDialogues+Clin+Neurosci120023146"><span>Google Scholar</span></a></p><p><span>30.</span></p><p><span>Blank, T. &#8729; Nijholt, I. &#8729; Grammatopoulos, D.K. ...</span></p><p><strong><span>Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning</span></strong></p><p><em><span>J Neurosci.</span></em><span> 2003; </span><strong><span>2</span></strong><span>:700-707</span></p><p><a href="https://scholar.google.com/scholar?q=T.BlankI.NijholtD.K.GrammatopoulosH.S.RandevaE.W.HillhouseJ.SpiessCorticotropin-releasing+factor+receptors+couple+to+multiple+G-proteins+to+activate+diverse+intracellular+signaling+pathways+in+mouse+hippocampus%3A+role+in+neuronal+excitability+and+associative+learningJ+Neurosci22003700707"><span>Google Scholar</span></a></p><p><span>31.</span></p><p><span>Mayr, B. &#8729; Montminy, M.</span></p><p><strong><span>Transcriptional regulation by the phosphorylation-dependent factor CREB</span></strong></p><p><em><span>Nat Rev Mol Cell Biol.</span></em><span> 2001; </span><strong><span>8</span></strong><span>:599-609</span></p><p><a href="https://doi.org/10.1038/35085068"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-0035430282"><span>Scopus (2168)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F35085068"><span>Google Scholar</span></a></p><p><span>32.</span></p><p><span>Pawluski, J.L. &#8729; Lambert, K.G. &#8729; Kinsley, C.H.</span></p><p><strong><span>Neuroplasticity in the maternal hippocampus: relation to cognition and effects of repeated stress</span></strong></p><p><em><span>Horm Behav.</span></em><span> 2016; </span><strong><span>77</span></strong><span>:86-97</span></p><p><a href="https://doi.org/10.1016/j.yhbeh.2015.06.004"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84956575764"><span>Scopus (94)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/26122302/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.yhbeh.2015.06.004&amp;pmid=26122302"><span>Google Scholar</span></a></p><p><span>33.</span></p><p><span>Rau, A.R. &#8729; Chappell, A.M. &#8729; Butler, T.R. ...</span></p><p><strong><span>Increased basolateral amygdala pyramidal cell excitability may contribute to the anxiogenic phenotype induced by chronic early-life stress</span></strong></p><p><em><span>J Neurosci.</span></em><span> 2015; </span><strong><span>26</span></strong><span>:9730-9740</span></p><p><a href="https://doi.org/10.1523/JNEUROSCI.0384-15.2015"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84936156638"><span>Scopus (100)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.0384-15.2015"><span>Google Scholar</span></a></p><p><span>34.</span></p><p><span>Bondi, C.O. &#8729; Rodriguez, G. &#8729; Gould, G.G. ...</span></p><p><strong><span>Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment</span></strong></p><p><em><span>Neuropsychopharmacology.</span></em><span> 2008; </span><strong><span>2</span></strong><span>:320-331</span></p><p><a href="https://doi.org/10.1038/sj.npp.1301410"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-36949032115"><span>Scopus (324)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsj.npp.1301410"><span>Google Scholar</span></a></p><p><span>35.</span></p><p><span>Di Pietro, N.C. &#8729; Black, Y.D. &#8729; Green-Jordan, K. ...</span></p><p><strong><span>Complementary tasks to measure working memory in distinct prefrontal cortex subregions in rats</span></strong></p><p><em><span>Behav Neurosci.</span></em><span> 2004; </span><strong><span>5</span></strong><span>:1042-1051</span></p><p><a href="https://doi.org/10.1037/0735-7044.118.5.1042"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-5144224458"><span>Scopus (38)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1037%2F0735-7044.118.5.1042"><span>Google Scholar</span></a></p><p><span>36.</span></p><p><span>Graybeal, C. &#8729; Feyder, M. &#8729; Schulman, E. ...</span></p><p><strong><span>Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF</span></strong></p><p><em><span>Nat Neurosci.</span></em><span> 2011; </span><strong><span>12</span></strong><span>:1507-1509</span></p><p><a href="https://doi.org/10.1038/nn.2954"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-82255192187"><span>Scopus (135)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnn.2954"><span>Google Scholar</span></a></p><p><span>37.</span></p><p><span>Bryce, C.A. &#8729; Howland, J.G.</span></p><p><strong><span>Stress facilitates late reversal learning using a touchscreen-based visual discrimination procedure in male Long Evans rats</span></strong></p><p><em><span>Behav Brain Res.</span></em><span> 2015; </span><strong><span>278</span></strong><span>:21-28</span></p><p><a href="https://doi.org/10.1016/j.bbr.2014.09.027"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84908006170"><span>Scopus (28)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/25251839/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbr.2014.09.027&amp;pmid=25251839"><span>Google Scholar</span></a></p><p><span>38.</span></p><p><span>Dong, Z. &#8729; Bai, Y. &#8729; Wu, X. ...</span></p><p><strong><span>Hippocampal long-term depression mediates spatial reversal learning in the Morris water maze</span></strong></p><p><em><span>Neuropharmacology.</span></em><span> 2013; </span><strong><span>64</span></strong><span>:65-73</span></p><p><a href="https://doi.org/10.1016/j.neuropharm.2012.06.027"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84866426198"><span>Scopus (178)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/22732443/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2012.06.027&amp;pmid=22732443"><span>Google Scholar</span></a></p><p><span>39.</span></p><p><span>Kart-Teke, E. &#8729; De Souza Silva, M.A. &#8729; Huston, J.P. ...</span></p><p><strong><span>Wistar rats show episodic-like memory for unique experiences</span></strong></p><p><em><span>Neurobiol Learn Mem.</span></em><span> 2006; </span><strong><span>2</span></strong><span>:173-182</span></p><p><a href="https://doi.org/10.1016/j.nlm.2005.10.002"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-32644460665"><span>Scopus (184)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.nlm.2005.10.002"><span>Google Scholar</span></a></p><p><span>40.</span></p><p><span>Guez, J. &#8729; Cohen, J. &#8729; Naveh-Benjamin, M. ...</span></p><p><strong><span>Associative memory impairment in acute stress disorder: characteristics and time course</span></strong></p><p><em><span>Psychiatry Res.</span></em><span> 2013; </span><strong><span>3</span></strong><span>:479-484</span></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.psychres.2012.12.013&amp;cf=fulltext&amp;site=psy-site"><span>Full Text</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.psychres.2012.12.013&amp;cf=pdf&amp;site=psy-site"><span>Full Text (PDF)</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84885481441"><span>Scopus (18)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.psychres.2012.12.013"><span>Google Scholar</span></a></p><p><span>41.</span></p><p><span>Passecker, J. &#8729; Barlow, S. &#8729; O&#8217;Mara, S.M.</span></p><p><strong><span>Dissociating effects of acute photic stress on spatial, episodic-like and working memory in the rat</span></strong></p><p><em><span>Behav Brain Res.</span></em><span> 2014; </span><strong><span>272</span></strong><span>:218-225</span></p><p><a href="https://doi.org/10.1016/j.bbr.2014.07.007"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84904888385"><span>Scopus (5)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/25017570/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbr.2014.07.007&amp;pmid=25017570"><span>Google Scholar</span></a></p><p><span>42.</span></p><p><span>Jaferi, A. &#8729; Bhatnagar, S.</span></p><p><strong><span>Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxiety-related behavior regardless of prior stress experience</span></strong></p><p><em><span>Brain Res.</span></em><span> 2007; </span><strong><span>186</span></strong><span>:212-223</span></p><p><a href="https://doi.org/10.1016/j.brainres.2007.07.100"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-37649019314"><span>Scopus (74)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.brainres.2007.07.100"><span>Google Scholar</span></a></p><p><span>43.</span></p><p><span>Meng, Q.Y. &#8729; Chen, X.N. &#8729; Tong, D.L. ...</span></p><p><strong><span>Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex</span></strong></p><p><em><span>Mol Cell Endocrinol.</span></em><span> 2011; </span><strong><span>1&#8211;2</span></strong><span>:54-63</span></p><p><a href="https://doi.org/10.1016/j.mce.2011.05.035"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-79960835819"><span>Scopus (53)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.mce.2011.05.035"><span>Google Scholar</span></a></p><p><span>44.</span></p><p><span>Merali, Z. &#8729; Anisman, H. &#8729; James, J.S. ...</span></p><p><strong><span>Effects of corticosterone on corticotrophin-releasing hormone and gastrin-releasing peptide release in response to an aversive stimulus in two regions of the forebrain (central nucleus of the amygdala and prefrontal cortex)</span></strong></p><p><em><span>Eur J Neurosci.</span></em><span> 2008; </span><strong><span>1</span></strong><span>:165-172</span></p><p><a href="https://doi.org/10.1111/j.1460-9568.2008.06281.x"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-54049102097"><span>Scopus (37)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1460-9568.2008.06281.x"><span>Google Scholar</span></a></p><p><span>45.</span></p><p><span>Gray, J.M. &#8729; Wilson, C.D. &#8729; Lee, T.T. ...</span></p><p><strong><span>Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function</span></strong></p><p><em><span>Psychoneuroendocrinology.</span></em><span> 2016; </span><strong><span>66</span></strong><span>:151-158</span></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.psyneuen.2016.01.004&amp;cf=fulltext&amp;site=pnec-site"><span>Full Text</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2Fj.psyneuen.2016.01.004&amp;cf=pdf&amp;site=pnec-site"><span>Full Text (PDF)</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84960901292"><span>Scopus (45)</span></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/26821211/"><span>PubMed</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.psyneuen.2016.01.004&amp;pmid=26821211"><span>Google Scholar</span></a></p><p><span>46.</span></p><p><span>Magalhaes, A.C. &#8729; Holmes, K.D. &#8729; Dale, L.B. ...</span></p><p><strong><span>CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling</span></strong></p><p><em><span>Nat Neurosci.</span></em><span> 2010; </span><strong><span>5</span></strong><span>:622-629</span></p><p><a href="https://doi.org/10.1038/nn.2529"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-77951667861"><span>Scopus (170)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnn.2529"><span>Google Scholar</span></a></p><p><span>47.</span></p><p><span>George, O. &#8729; Sanders, C. &#8729; Freiling, J. ...</span></p><p><strong><span>Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking</span></strong></p><p><em><span>Proc Natl Acad Sci U S A.</span></em><span> 2012; </span><strong><span>44</span></strong><span>:18156-18161</span></p><p><a href="https://doi.org/10.1073/pnas.1116523109"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84868103665"><span>Scopus (189)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1116523109"><span>Google Scholar</span></a></p><p><span>48.</span></p><p><span>Kovalovsky, D. &#8729; Refojo, D. &#8729; Liberman, A.C. ...</span></p><p><strong><span>Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways</span></strong></p><p><em><span>Mol Endocrinol.</span></em><span> 2002; </span><strong><span>7</span></strong><span>:1638-1651</span></p><p><a href="https://doi.org/10.1210/mend.16.7.0863"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-85047684179"><span>Scopus (240)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1210%2Fmend.16.7.0863"><span>Google Scholar</span></a></p><p><span>49.</span></p><p><span>Refojo, D. &#8729; Echenique, C. &#8729; Muller, M.B. ...</span></p><p><strong><span>Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas</span></strong></p><p><em><span>Proc Natl Acad Sci U S A.</span></em><span> 2005; </span><strong><span>17</span></strong><span>:6183-6188</span></p><p><a href="https://doi.org/10.1073/pnas.0502070102"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-20944447408"><span>Scopus (84)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0502070102"><span>Google Scholar</span></a></p><p><span>50.</span></p><p><span>Tan, H. &#8729; Zhong, P. &#8729; Yan, Z.</span></p><p><strong><span>Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons</span></strong></p><p><em><span>J Neurosci.</span></em><span> 2004; </span><strong><span>21</span></strong><span>:5000-5008</span></p><p><a href="https://doi.org/10.1523/JNEUROSCI.0143-04.2004"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-2542527804"><span>Scopus (104)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.0143-04.2004"><span>Google Scholar</span></a></p><p><span>51.</span></p><p><span>Hains, A.B. &#8729; Vu, M.A. &#8729; Maciejewski, P.K. ...</span></p><p><strong><span>Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress</span></strong></p><p><em><span>Proc Natl Acad Sci U S A.</span></em><span> 2009; </span><strong><span>42</span></strong><span>:17957-17962</span></p><p><a href="https://doi.org/10.1073/pnas.0908563106"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-70449584553"><span>Scopus (180)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0908563106"><span>Google Scholar</span></a></p><p><span>52.</span></p><p><span>Birnbaum, S.G. &#8729; Yuan, P.X. &#8729; Wang, M. ...</span></p><p><strong><span>Protein kinase C overactivity impairs prefrontal cortical regulation of working memory</span></strong></p><p><em><span>Science.</span></em><span> 2004; </span><strong><span>5697</span></strong><span>:882-884</span></p><p><a href="https://doi.org/10.1126/science.1100021"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-7444256727"><span>Scopus (275)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1100021"><span>Google Scholar</span></a></p><p><span>53.</span></p><p><span>Ramos, B.P. &#8729; Birnbaum, S.G. &#8729; Lindenmayer, I. ...</span></p><p><strong><span>Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline</span></strong></p><p><em><span>Neuron.</span></em><span> 2003; </span><strong><span>4</span></strong><span>:835-845</span></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2FS0896-6273%2803%2900694-9&amp;cf=fulltext&amp;site=cell-site"><span>Full Text</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=4&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=10.1016%2FS0896-6273%2803%2900694-9&amp;cf=pdf&amp;site=cell-site"><span>Full Text (PDF)</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-0242460552"><span>Scopus (211)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0896-6273%2803%2900694-9"><span>Google Scholar</span></a></p><p><span>54.</span></p><p><span>Kobori, N. &#8729; Moore, A.N. &#8729; Dash, P.K.</span></p><p><strong><span>Altered regulation of protein kinase a activity in the medial prefrontal cortex of normal and brain-injured animals actively engaged in a working memory task</span></strong></p><p><em><span>J Neurotrauma.</span></em><span> 2015; </span><strong><span>2</span></strong><span>:139-148</span></p><p><a href="https://doi.org/10.1089/neu.2014.3487"><span>Crossref</span></a></p><p><a href="https://www.biologicalpsychiatryjournal.com/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.biopsych.2016.03.2106&amp;key=2-s2.0-84921038497"><span>Scopus (17)</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1089%2Fneu.2014.3487"><span>Google Scholar</span></a></p><p><span>55.</span></p><p><span>Gunby, P.</span></p><p><strong><span>Air controller strike spotlights job stress</span></strong></p><p><em><span>JAMA.</span></em><span> 1981; </span><strong><span>15</span></strong><span>:1632-1633</span></p><p><a href="https://doi.org/10.1001/jama.1981.03320150004002"><span>Crossref</span></a></p><p><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Fjama.1981.03320150004002"><span>Google Scholar</span></a></p><p><span>Dispon&#237;vel em: </span><a href="https://www.biologicalpsychiatryjournal.com/article/S0006-3223(16)32270-3/abstract"><span>https://www.biologicalpsychiatryjournal.com/article/S0006-3223(16)32270-3/abstract</span></a></p><p><span>[C] </span><a href="https://lowtoxinforum.com/threads/pregnenolone-may-protect-cognition-from-damage-by-stress.11313/"><span>https://lowtoxinforum.com/threads/pregnenolone-may-protect-cognition-from-damage-by-stress.11313/</span></a></p><p><span>[D] O CRF (tamb&#233;m chamado de CRH) &#233; o horm&#244;nio liberador de corticotropina. Produzido no hipot&#225;lamo, &#233; o principal elemento que comanda a resposta do corpo ao estresse. Ele estimula a hip&#243;fise a produzir ACTH, que por sua vez manda as gl&#226;ndulas suprarrenais liberarem cortisol.</span></p><p><span>***</span></p>]]></content:encoded></item><item><title><![CDATA[Cortisol – anti-inflamatório ou inflamatório?]]></title><description><![CDATA[NOTAS em fisiologia &#8211; o cortisol e suas contradi&#231;&#245;es [ou: por que voc&#234; precisa conhecer melhor o cortisol]]]></description><link>https://outramedicina2024.substack.com/p/cortisol-anti-inflamatorio-ou-inflamatorio</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/cortisol-anti-inflamatorio-ou-inflamatorio</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Wed, 05 Aug 2026 11:00:47 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!a392!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!a392!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!a392!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg" width="400" height="422" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:422,&quot;width&quot;:400,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:49750,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/209908931?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!a392!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ba70e10-9273-47f0-a00c-132c06e9f477_400x422.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>O usual &#233; falar que o <em>cortisol &#233; um anti-inflamat&#243;rio</em>; &#233; o que mais se ouve falar.</p><p>Mais uma vez, estamos diante de uma meia verdade. E, ao n&#227;o saber da verdade completa sobre o cortisol, o doutor - o mesmo o paciente que se automedica com corticoides - pode cometer um grave erro contra sua sa&#250;de.</p><p><span>A interpreta&#231;&#227;o de Ray Peat sobre o cortisol &#233; diferente da vis&#227;o biom&#233;dica convencional simplificada que p&#245;e um sinal de igualdade entre cortisol e anti-inflamat&#243;rio.</span></p><p><span>Peat via o cortisol sobretudo como horm&#244;nio de emerg&#234;ncia; marcador de fal&#234;ncia energ&#233;tica; mediador catab&#243;lico adaptativo.</span></p><p><span>De forma que cortisol alto no sangue n&#227;o &#233; bom sinal; invariavelmente significar&#225; estresse, ter&#225; consequ&#234;ncias contra a sa&#250;de da pessoa [mesmo quando usado, eventualmente, contra situa&#231;&#245;es extremas, na UTI].</span></p><p><span>O cortisol n&#227;o &#233; simplesmente &#8220;anti-inflamat&#243;rio&#8221;. Ele pode at&#233; reduzir alguns componentes </span><em><span>imediatos</span></em><span> da inflama&#231;&#227;o, mas ao custo de </span><em><span>aprofundar</span></em><span> o estado degenerativo e pr&#243;-inflamat&#243;rio no longo prazo, conforme explica mais de uma vez R. Peat.</span></p><p><span>Na l&#243;gica deste autor, quando tecidos n&#227;o conseguem oxidar glicose adequadamente &#8211; portanto decaem na produ&#231;&#227;o de energia - o organismo entra em estado de emerg&#234;ncia. Ent&#227;o tendem a subir, no plasma, n&#237;veis de horm&#244;nios do estresse: adrenalina; ACTH; cortisol.</span></p><p><span>O not&#243;rio papel do cortisol &#233; tentar mobilizar combust&#237;vel; liberar amino&#225;cidos dos m&#250;sculos para a sua convers&#227;o em a&#231;&#250;car [gliconeog&#234;nese] e restaura&#231;&#227;o da glicemia perdida. O organismo entende como emerg&#234;ncia a queda de a&#231;&#250;car, e reage para elevar o a&#231;&#250;car no sangue. O cortisol aparece, em sua fun&#231;&#227;o emergencial, para aumenta gliconeog&#234;nese [criar a&#231;&#250;car]; mantem o c&#233;rebro vivo garantindo o a&#231;&#250;car.</span></p><p><span>Ent&#227;o ele &#233; um horm&#244;nio compensat&#243;rio. De adapta&#231;&#227;o do organismo a um estado emergencial de perda de energia.</span></p><p><span>O problema &#233; que o cortisol faz isso </span><em><span>degradando tecidos, </span></em><span>cortisol sendo cortisol. Cortisol precisa &#8220;consumir&#8221; [destruir] tecidos saud&#225;veis para fabricar a&#231;&#250;car.</span></p><p><span>O cortisol degrada m&#250;sculo; reduz s&#237;ntese de col&#225;geno; reduz imunidade organizada; aumenta lip&#243;lise; aumenta &#225;cidos graxos livres; piora resist&#234;ncia &#224; glicose e uma longa lista de efeitos negativos. Como Peat explica, sua presen&#231;a e a&#231;&#227;o perpetua a fal&#234;ncia respirat&#243;ria celular. O cortisol, aqui, estende e aprofunda aquele estado inicial de baixa energia.</span></p><p><span>Para garantir o a&#231;&#250;car, superar a pior amea&#231;a [hipoglicemia] o cortisol aciona mecanismos destrutivos, catab&#243;licos. A pr&#243;pria degrada&#231;&#227;o de m&#250;sculos, do timo acaba favorecendo: inflama&#231;&#227;o; endotoxemia; ativa&#231;&#227;o de mediadores inflamat&#243;rios tipo NF-kB [ene-efe-capa-beta].</span></p><p><span>Ent&#227;o por que o cortisol parece &#8220;anti-inflamat&#243;rio&#8221;? E &#233; usado pela medicina como anti-inflamat&#243;rio?</span></p><p><span>Porque ele bloqueia certas partes da inflama&#231;&#227;o </span><em><span>aguda</span></em><span>: reduz prostaglandinas; reduz permeabilidade; reduz algumas &#8211; n&#227;o todas - citocinas; reduz infiltra&#231;&#227;o imune.</span></p><p><span>Mas isso </span><em><span>n&#227;o significa restaura&#231;&#227;o metab&#243;lica</span></em><span>. No plano mais de fundo, do metabolismo, o cortisol apenas significa, para diz&#234;-lo de alguma forma, supress&#227;o da rea&#231;&#227;o inflamat&#243;ria enquanto o </span><em><span>metabolismo continua piorando</span></em><span>.</span></p><p><span>Isso significa, por assim dizer, &#8220;desligar o alarme de inc&#234;ndio </span><strong><span>sem</span></strong><span> apagar o inc&#234;ndio&#8221;.</span></p><p><span>Ou seja, criando um ambiente de fundo, inflamat&#243;rio. De sa&#237;da, inibe e mascara elementos inflamat&#243;rios, mas o processo destrutivo e inflamat&#243;rio de fundo, segue em frente.</span></p><p><span>E v&#227;o ocorrer contradi&#231;&#245;es como a seguinte, para tomarmos o exemplo de um mediador inflamat&#243;rio, conhecido como ene-efe-kapa-beta [NF-kB]. Se abrirmos um livro da fisiologia oficial, ele dir&#225; que o cortisol pode inibir NF-kB diretamente via receptor glicocorticoide.</span></p><p><span>Isso &#233; real.</span></p><p><span>O pr&#243;prio estado metab&#243;lico que </span><em><span>produz cortisol cr&#244;nico</span></em><span> tamb&#233;m produz ativa&#231;&#227;o cr&#244;nica de NF-kB.</span></p><p><span>Por que? Porque o cortisol somente apareceu </span><strong><span>porque </span></strong><span>a queda do a&#231;&#250;car produziu hip&#243;xia funcional; lip&#243;lise; &#225;cidos graxos livres; endotoxina; serotonina; estresse oxidativo, todos eles ativam NF-kB. E cortisol. Enfim, ele s&#243; aparece porque foi criado - por conta da queda do a&#231;&#250;car no plasma - um ambiente de baixa energia [por exemplo, ansiedade cr&#244;nica cria esse estado, j&#225; que derruba cronicamente o a&#231;&#250;car sangu&#237;neo].</span></p><p><span>Ent&#227;o, mesmo que o cortisol tenha efeitos anti-inflamat&#243;rios imediatos, o estado fisiol&#243;gico associado ao cortisol elevado tende a ser pr&#243;-inflamat&#243;rio e degenerativo. O que equivale a dizer que cortisol &#233; parte das condi&#231;&#245;es de estresse que surgiram com a queda do a&#231;&#250;car e que, mesmo inibindo alguns elementos inflamat&#243;rios de in&#237;cio, a continuidade daquele estado de emerg&#234;ncia agrava todo o quadro. Libera mais agentes inflamat&#243;rios e o pr&#243;prio cortisol se tornar&#225; um deles.</span></p><p><span>O centro da quest&#227;o &#233; que cortisol est&#225; alto, porque h&#225; baixa disponibilidade energ&#233;tica eficiente. Se esse estado continua, o cortisol vai se somar ao crescente processo inflamat&#243;rio [o cortisol inibe a tireoide, por exemplo]. O estado &#233; de baixa energia mitocondrial, que ativa mecanismos inflamat&#243;rios; ativa NF-kB; aumenta &#243;xido n&#237;trico inflamat&#243;rio; aumenta serotonina; aumenta excitotoxicidade. Cortisol sobe.</span></p><p style="text-align: right;"><span>De tal forma que o cortisol seria mais um indicador de &#8220;organismo em modo sobreviv&#234;ncia&#8221;. E &#233; esse &#8220;modo sobreviv&#234;ncia&#8221;, esse estado de baixa energia que constr&#243;i um c&#237;rculo vicioso.</span></p><p><span>Eis o que acontece:  queda do a&#231;&#250;car no plasma &gt; baixa oxida&#231;&#227;o da glicose &gt; adrenalina &gt;cortisol &gt;lip&#243;lise &gt;&#225;cidos graxos livres &gt;supress&#227;o da oxida&#231;&#227;o da glicose [Randle] &gt;mais hip&#243;xia funcional &gt; mais NF-kB &gt;mais inflama&#231;&#227;o.</span></p><p><span>Ent&#227;o o cortisol n&#227;o seria o &#8220;grande anti-inflamat&#243;rio ben&#233;fico&#8221;, mas sim  </span><em><span>parte</span></em><span> de um ciclo adaptativo de estresse. Agente do agravamento do quadro inflamat&#243;rio, catab&#243;lico, de inibi&#231;&#227;o da produ&#231;&#227;o de energia.</span></p><p><span>Pior: o cortisol &#233; imunossupressor. Isso se chama agravar o quadro estressante e inflamat&#243;rio.</span></p><p><span>Redu&#231;&#227;o </span><em><span>saud&#225;vel</span></em><span> da inflama&#231;&#227;o &#233; uma coisa, &#233; o </span><em><span>processo desej&#225;vel </span></em><span>e passa por oferecer a&#231;&#250;car e nutri&#231;&#227;o adequada ao sistema. J&#225; a supress&#227;o metab&#243;lica/imunol&#243;gica, promovida pelo pr&#243;prio cortisol, n&#227;o &#233; o que queremos para a sa&#237;da daquele c&#237;rculo vicioso. E a presen&#231;a cont&#237;nua de cortisol refor&#231;a nessa dire&#231;&#227;o.</span></p><p><span>Essa ideia &#233; central na abordagem bioenerg&#233;tica dos processos do nosso corpo, na perspectiva de R. Peat.</span></p><p><span>Resumindo, n&#227;o &#233; sinal de sa&#250;de ter o cortisol alto. Para come&#231;o de conversa ele suprime a imunidade e inibe a fun&#231;&#227;o tireoidiana.</span></p><p><span>Mas a verdade &#233; que toda vez que o corpo entrar em estresse, toda vez que a produ&#231;&#227;o de energia cair &#8211; por exemplo, se a pessoa possui &#243;leos poli-insaturados no corpo &#8211; o cortisol ir&#225; subir; neste caso para cumprir a miss&#227;o de gerar algum n&#237;vel de energia, mas &#224;s custas de demolir m&#250;sculos. E aqui pouco importa se ele subiu porque a pessoa est&#225; em estresse emocional, em jejum de a&#231;&#250;car ou se usa corticoide cronicamente para &#8220;combater&#8221; inflama&#231;&#227;o. Em todos esses casos, </span><strong><span>cortisol continuar&#225; sendo cortisol</span></strong><span>, isto &#233;, o horm&#244;nio que destr&#243;i tecidos do corpo humano para produzir a&#231;&#250;car.</span></p><p><span>G Dantas, SP, 5-8-26</span></p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p></p><p><span>***</span></p>]]></content:encoded></item><item><title><![CDATA[AAS e câncer de cólon e de reto]]></title><description><![CDATA[Estudos apontam benef&#237;cios com o AAS; deveriam ser feitos estudos cl&#237;nicos em humanos: o potencial terap&#234;utico &#233; evidente.]]></description><link>https://outramedicina2024.substack.com/p/aas-e-cancer-de-colon-e-de-reto</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/aas-e-cancer-de-colon-e-de-reto</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Tue, 04 Aug 2026 10:29:47 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!KAZ9!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!KAZ9!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!KAZ9!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg" width="370" height="493" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/a167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:493,&quot;width&quot;:370,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:49326,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/209763237?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!KAZ9!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa167e58b-20de-4122-b993-fee95f6aafc0_370x493.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p><span>Mais um benef&#237;cio do AAS [aspirina], uma subst&#226;ncia de m&#250;ltiplas a&#231;&#245;es no nosso metabolismo, todas elas na dire&#231;&#227;o da promo&#231;&#227;o da produ&#231;&#227;o de energia, da desinflama&#231;&#227;o.</span></p><p><span>Desta vez no c&#226;ncer de c&#243;lon. &#8220;O c&#226;ncer colorretal (CCR) &#233; o terceiro c&#226;ncer mais comum no mundo. A inflama&#231;&#227;o cr&#244;nica parece aumentar o risco de CCR. Evid&#234;ncias recentes sugerem que mecanismos epigen&#233;ticos desempenham um papel importante no CCR. O &#225;cido acetilsalic&#237;lico (AAS) demonstrou prevenir o CCR&#8221; [A]; no caso, o c&#226;ncer de c&#243;lon associado a colite.</span></p><p><span>Estudo foi feito em animais e o AAS &#8220;suprimiu significativamente os sintomas da colite inflamat&#243;ria e a multiplicidade tumoral&#8221; [A]. Tamb&#233;m n&#237;veis de TNF-alfa e de IL-6 foram suprimidos, no caso dois mediadores inflamat&#243;rios importantes, implicados no desenvolvimento do c&#226;ncer.</span></p><p><span>Outro estudo, que tamb&#233;m utilizou aspirina concluiu no mesmo sentido que nossos &#8220;resultados sugerem que a aspirina/sulindac induz uma sele&#231;&#227;o gen&#233;tica para a estabilidade de microssat&#233;lites em um subconjunto de c&#233;lulas deficientes em MMR e pode fornecer uma terapia profil&#225;tica eficaz para fam&#237;lias com c&#226;ncer colorretal heredit&#225;rio n&#227;o poliposo&#8221;[B].</span></p><p><span>Aqui os estudiosos supuseram &#8211; sem evid&#234;ncias &#8211; que c&#226;ncer colorretal pode ser heredit&#225;rio e tamb&#233;m utilizaram, alternativamente, o sulindac, subst&#226;ncia t&#243;xica. De toda forma o AAS mostrou ser terap&#234;utico para aquele c&#226;ncer [B].</span></p><p><span>Na verdade, o AAS, por vias puramente n&#227;o-g&#234;nicas tem demonstrado mais de uma vez &#8211; ver notas neste blog &#8211; sua a&#231;&#227;o contra c&#233;lulas cancerigenas al&#233;m de est&#237;mulo &#224; produ&#231;&#227;o mitocondrial de energia.</span></p><p><span>G Dantas, SP, 4-8-26</span></p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong><span>Refer&#234;ncias</span></strong><span> ________________</span></p><p><span>[A] GUO Y LIU Y, 2016. </span><em><span>The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice </span></em><span>Carcinogenesis. 2016 Jun;37(6):616-624. doi: 10.1093/carcin/bgw042. Epub 2016 Apr 9.PMID: 27207670PMCID: </span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5006120/"><span>PMC5006120</span></a><span> DOI: </span><a href="https://doi.org/10.1093/carcin/bgw042"><span>10.1093/carcin/bgw042</span></a><span> &#8220;O c&#226;ncer colorretal (CCR) &#233; o terceiro c&#226;ncer mais comum no mundo. A inflama&#231;&#227;o cr&#244;nica parece aumentar o risco de CCR. Evid&#234;ncias recentes sugerem que mecanismos epigen&#233;ticos desempenham um papel importante no CCR. O &#225;cido acetilsalic&#237;lico (AAS) demonstrou prevenir o CCR; no entanto, os mecanismos epigen&#233;ticos de sua a&#231;&#227;o permanecem desconhecidos. Este estudo investigou o papel protetor do AAS no c&#226;ncer de c&#243;lon associado &#224; colite (CAC) iniciado por azoximetano (AOM) e promovido por sulfato de dextrano s&#243;dico (DSS), e examinou os efeitos epigen&#233;ticos, particularmente na acetila&#231;&#227;o da lisina 27 da histona 3 (H3K27ac), subjacentes ao efeito preventivo do AAS. Camundongos CF-1 foram alimentados com dieta AIN-93M com ou sem 0,02% de AAS, desde uma semana antes do in&#237;cio da administra&#231;&#227;o de AOM at&#233; o sacrif&#237;cio dos animais 20 semanas ap&#243;s a inje&#231;&#227;o de AOM. Nossos resultados mostraram que AOM/DSS + AAS suprimiu significativamente os sintomas da colite inflamat&#243;ria e a multiplicidade tumoral. AOM/DSS + ASA reduziu a express&#227;o proteica induzida por AOM/DSS e a atividade das histonas desacetilases (HDACs), al&#233;m de restaurar globalmente a H3K27ac. Ademais, AOM/DSS + ASA inibiu o enriquecimento de H3K27ac induzido por AOM/DSS nos promotores da &#243;xido n&#237;trico sintase induz&#237;vel (iNOS), do fator de necrose tumoral alfa (TNF-&#945;) e da interleucina 6 (IL-6), o que correspondeu &#224; supress&#227;o dr&#225;stica dos n&#237;veis de RNA mensageiro (mRNA) e prote&#237;na. Surprisingly, no significant changes in the H3K27ac abundance in the prostaglandin-endoperoxide synthase 2 (Cox-2) promoters or in the Cox-2 mRNA and protein expression were observed. Collectively, our results suggest that a potential novel epigenetic mechanism underlies the chemopreventive effects of ASA, and this mechanism attenuates CAC in AOM/DSS-induced CF-1 mice via the inhibition of HDACs and the modification of H3K27ac marks that suppress iNOS, TNF-&#945; and IL-6.</span></p><p><span>[B] RUSCHOFF J WALLINGER S, 1998. </span><em><span>Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection.   </span></em><span>Proc Natl Acad Sci U S A . 1998 Sep 15;95(19):11301&#8211;11306. doi: </span><a href="https://doi.org/10.1073/pnas.95.19.11301"><span>10.1073/pnas.95.19.11301</span></a><span> PMCID: PMC21637 PMID: </span><a href="https://pubmed.ncbi.nlm.nih.gov/9736731/"><span>9736731</span></a><span> &#8220;Nonsteroidal anti-inflammatory drugs (NSAIDs) are well-known cancer preventives, which have been largely attributed to their antiproliferative and apoptosis-inducing activities. In this study, we show that microsatellite instability (MSI) in colorectal cancer cells deficient for a subset of the human mismatch repair (MMR) genes (</span><em><span>hMLH1</span></em><span>, </span><em><span>hMSH2</span></em><span>, and </span><em><span>hMSH6</span></em><span>), is markedly reduced during exposure to aspirin or sulindac [or Clinoril, which is chemically related to indomethacin (Indocin)]. This effect was reversible, time and concentration dependent, and appeared independent of proliferation rate and cyclooxygenase function. In contrast, the MSI phenotype of a </span><em><span>hPMS2</span></em><span>-deficient endometrial cancer cell line was unaffected by aspirin/sulindac. We show that the MSI reduction in the susceptible MMR-deficient cells was confined to nonapoptotic cells, whereas apoptotic cells remained unstable and were eliminated from the growing population. These results suggest that aspirin/sulindac induces a genetic selection for microsatellite stability in a subset of MMR-deficient cells and may provide an effective prophylactic therapy for hereditary nonpolyposis colorectal cancer kindreds where alteration of the </span><em><span>hMSH2</span></em><span> and </span><em><span>hMLH1</span></em><span> genes are associated with the majority of cancer susceptibility cases&#8221;. Dispon&#237;vel em: </span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC21637/"><span>https://pmc.ncbi.nlm.nih.gov/articles/PMC21637/</span></a></p><p><span>***</span></p>]]></content:encoded></item><item><title><![CDATA[A lógica da doença e a doença da lógica [Parte3 de 3] ]]></title><description><![CDATA[NOTAS sobre bioqu&#237;mica da c&#233;lula na sa&#250;de e na doen&#231;a]]></description><link>https://outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da-952</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da-952</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Mon, 03 Aug 2026 08:06:15 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!JlbT!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!JlbT!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!JlbT!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg" width="427" height="370" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/d4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:370,&quot;width&quot;:427,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:62540,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/209595893?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!JlbT!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd4bad2f5-51ea-4520-85b2-8958c316ef70_427x370.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>[Parte 3 de 3][Parte final; continua&#231;&#227;o da <a href="/__u/outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da-633">Parte 2</a>]</p><p>Parece muito problem&#225;tica e deficiente uma l&#243;gica que pensa a c&#233;lula como estrutura est&#225;tica, ou que entende que <em>restaurar</em> o metabolismo &#233; apenas aumentar o ATP.</p><p>Quando, na verdade, se trata de <em>restaurar</em> a capacidade da c&#233;lula permanecer organizada e exercer sua fun&#231;&#227;o plena, via queima de a&#231;&#250;car eficiente na c&#233;lula. Ent&#227;o, a c&#233;lula n&#227;o &#233; um reservat&#243;rio de energia onde se bota ou tira energia. Ela &#233; um processo pelo qual a energia flui pelas estruturas.</p><p>Quando esse fluxo permanece intenso e ordenado, a estrutura existe. Os el&#233;trons arrancados do a&#231;&#250;car seguem seu caminho at&#233; o oxig&#234;nio e geram a energia consequente, e o CO2. Quando o fluxo de el&#233;trons enfraquece ou se dispersa, a estrutura come&#231;a a se desfazer. Este &#233; outro plano em que o processo se desenvolve.</p><p>Neste caso, a c&#233;lula entra em um estado de sobreviv&#234;ncia. E aqui s&#227;o acionadas enzimas e mediadores inflamat&#243;rios, cujo papel &#233; <em>preservar a vida em um estado minimalista,</em> j&#225; que <em>falta</em> energia. A pessoa adoeceu. A doen&#231;a come&#231;a quando a c&#233;lula deixa de conseguir sustentar o fluxo de energia necess&#225;rio para manter sua pr&#243;pria organiza&#231;&#227;o.</p><p>Essa &#233; a l&#243;gica bioenerg&#233;tica da doen&#231;a.</p><p>O envelhecimento tamb&#233;m passa a ser visto como uma dificuldade crescente de parte do organismo de sustentar aquele fluxo energ&#233;tico &#243;timo ao longo do tempo [o que daria outra nota aqui]. Ent&#227;o, o tema aqui n&#227;o &#233; sobre qual mol&#233;cula controla qual fun&#231;&#227;o. Mas sim se tal processo aumenta ou diminui a capacidade da c&#233;lula produzir energia.</p><p>A pergunta n&#227;o come&#231;a <em>pela mol&#233;cula</em>, mas pelo <em>ambiente</em> energ&#233;tico que permite que essa mol&#233;cula funcione a contento ou n&#227;o, ou que ela chegue a ficar ativa ou n&#227;o [como no caso do cortisol pelo 11-beta]. Quando o cortisol &#233; produzido na c&#233;lula, ele passa a ser um amplificador local de um estado de emerg&#234;ncia.</p><p>Cortisol &#233; a resposta de emerg&#234;ncia quando a energia se torna insuficiente.</p><p>Da mesma forma que a presen&#231;a suficiente de CO2 &#233; um sinal de que a respira&#231;&#227;o oxidativa est&#225; funcionando no seu &#243;timo; a glicose, por sua vez, &#233; o principal substrato para uma respira&#231;&#227;o eficiente, e o T3 &#233; um facilitador do fluxo energ&#233;tico [n&#227;o &#233; apenas um horm&#244;nio, <em>sensu stricto</em>, como seriam outros, de forma nenhuma].</p><p>Ent&#227;o, a estrutura n&#227;o &#233; algo que existe <em>primeiro</em> e <em>depois</em> recebe energia. A estrutura &#233; o <em>pr&#243;prio padr&#227;o</em> criado e mantido pelo fluxo de energia.</p><p>Esta afirma&#231;&#227;o &#233; muito dial&#233;tica e seminal e vai bem na contram&#227;o da <em>l&#243;gica da doen&#231;a</em> que aprendemos nas faculdades da &#225;rea de sa&#250;de.</p><p>A energia n&#227;o &#233; apenas uma consequ&#234;ncia da vida, ela &#233; a <em>condi&#231;&#227;o</em> para que a estrutura e a fun&#231;&#227;o da vida possam existir. O calor corporal n&#227;o &#233; express&#227;o da vida pura e simples, &#233; a <em>condi&#231;&#227;o</em>, o calor produzido pelas c&#233;lulas &#233; a <em>condi&#231;&#227;o para que a vida exista. </em>Foi demonstrado que, por exemplo, Alzheimer &#233; uma enfermidade da baixa produ&#231;&#227;o de energia por zonas do c&#233;rebro.</p><p>De forma que muitos elementos que a medicina toma de forma parcial ou pulverizada, poderiam ganhar seu sentido nesta l&#243;gica que est&#225; sendo aqui desenvolvida.</p><p>O CO2, a tireoide, a glicose, cortisol, acabam coincidindo no <em>mesmo princ&#237;pio</em>. N&#227;o s&#227;o assuntos separados, s&#227;o diferentes manifesta&#231;&#245;es de uma &#250;nica ideia: a <em>vida &#233; um processo de organiza&#231;&#227;o sustentado por um fluxo cont&#237;nuo de energia.</em></p><p>Pela mesma l&#243;gica, o pensamento de Peat n&#227;o se constr&#243;i a partir de listas de nutrientes ou mol&#233;culas ou mediadores moleculares ou coisa assim. Passa por a&#237;, mas o pressuposto s&#227;o princ&#237;pios organizadores.</p><p>Um princ&#237;pio organizador: tudo que favorece a respira&#231;&#227;o oxidativa fortalece a organiza&#231;&#227;o da vida. Tudo que dificulta essa respira&#231;&#227;o empurra o organismo para mecanismos de sobreviv&#234;ncia.</p><p>De forma que Ray Peat n&#227;o constr&#243;i seu pensamento fisiol&#243;gico a partir de ATP, de 11-beta, de cortisol. Ele insere essas mol&#233;culas no contexto de um princ&#237;pio organizador. Quando se enxerga esse princ&#237;pio, os detalhes, os elementos parciais deixam de parecer uma cole&#231;&#227;o de fatos isolados ou parciais. Passam a constituir um mapa ou uma gram&#225;tica dial&#233;tica e coerente da vida.</p><p>O estado energ&#233;tico &#233; o elemento inegoci&#225;vel da vida. &#201; o princ&#237;pio fundador e &#233; o pressuposto de Peat.</p><p>Por qu&#234;? Porque o organismo, como j&#225; sabemos atrav&#233;s do evento da doen&#231;a, ele consegue <em>negociar quase tudo </em>mas n&#227;o a energia em seu &#243;timo. Perda de massa muscular, redu&#231;&#227;o da fertilidade, hipotireoidismo [queda na fun&#231;&#227;o da tireoide], aumento do cortisol, autofagia, comprometimento de fun&#231;&#245;es especializadas do corpo [como a mic&#231;&#227;o, o intestino, a pr&#243;pria fun&#231;&#227;o da pele], <em>tudo isso &#233; negoci&#225;vel</em> e o corpo vai cedendo, o organismo vai cedendo.</p><p>Por qu&#234;? Qual &#233; o objetivo de ceder e minimizar fun&#231;&#245;es e dar passagem ao destrutivo cortisol?</p><p>Exatamente: tentar evitar at&#233; o &#250;ltimo momento a interrup&#231;&#227;o do fluxo energ&#233;tico.</p><p>Toda a fisiologia de emerg&#234;ncia existe [t&#227;o analisada de diferentes &#226;ngulos por Peat], para impedir esse colapso.</p><p>Quando a pessoa consome regularmente &#243;leos &#244;megas [&#243;leo de soja, milho, peixe e todos os &#244;megas 3 e 6], o impacto sobre as c&#233;lulas - e a tireoide - &#233; de inibi&#231;&#227;o da produ&#231;&#227;o de energia; ora, as c&#233;lulas n&#227;o podem tolerar essa queda e, simplesmente, continuarem suas fun&#231;&#245;es normais, consumindo a energia que n&#227;o mais existe; de forma que elas cedem, reduzem fun&#231;&#245;es, se adaptam &#224;quele estado de baixa energia; o corpo tamb&#233;m deixa de produzir todo o calor necess&#225;rio, ele esfria. Estado de emerg&#234;ncia, de estresse metab&#243;lico.</p><p>Por isso a pergunta fundamental nunca ser&#225; <em>qual doen&#231;a a pessoa tem</em>, e sim o <em>que est&#225; impedindo</em> essa pessoa de manter o metabolismo energ&#233;tico pleno, oxidativo pleno. &#201; a partir dessa pergunta que todo o restante da fisiologia, ao menos na perspectiva de Peat, passa a fazer sentido. </p><p>E tamb&#233;m a partir dela que elementos como o cortisol aparecem no seu papel de horm&#244;nio do envelhecimento, de horm&#244;nio que tenta garantir a oferta de a&#231;&#250;car no organismo debilitado e incapaz de fazer a queima plena do a&#231;&#250;car e que est&#225; deixando que ocorram processos como a fermenta&#231;&#227;o, a queima de gordura em vez do a&#231;&#250;car e assim por diante.</p><p>De toda forma, ao ceder ao regime do cortisol, ao minimalismo, o organismo entra numa escalada de doen&#231;as, que v&#227;o se expressar, a depender do indiv&#237;duo singular e seus pontos fracos, que expressam &#8211; todas as doen&#231;as cr&#244;nico-degenerativas - a partir dos princ&#237;pios organizadores aquilo que n&#243;s estamos discutindo aqui, uma perda do controle da produ&#231;&#227;o &#243;tima de energia.</p><p>Ent&#227;o a bioenergia n&#227;o &#233; apenas uma consequ&#234;ncia da vida, ela &#233; &#8211; novamente - a <em>condi&#231;&#227;o</em> para que a estrutura e a fun&#231;&#227;o da vida possam existir. Por isso que CO2, glicose, tireoide, o cristalino do olho, a pele, n&#227;o s&#227;o assuntos separados. S&#227;o agendas que obedecem a uma dial&#233;tica da produ&#231;&#227;o de energia, que &#233; a base da vida, no caso.</p><p>De forma que a ideia central do Peat, aparentemente, &#233; que a vida n&#227;o deve ser vista como um conjunto de mol&#233;culas, nem de rea&#231;&#245;es qu&#237;micas, mas como um <em>processo de fluxo de energia.</em> </p><p>Olhando o corpo a partir dessa perspectiva ou dessa camada mais profunda, parece muito clara uma <em>l&#243;gica da doen&#231;a</em> e tamb&#233;m do envelhecimento, n&#227;o j&#225; como desgaste mec&#226;nico, gen&#233;tico ou coisa no estilo, mas a perda progressiva da capacidade de manter um estado energ&#233;tico elevado &#224; altura das estruturas da vida.</p><p>E, portanto, &#224; medida que isso ocorra, aumenta a depend&#234;ncia de mecanismos de sobreviv&#234;ncia, cortisol, inflama&#231;&#227;o e todo o resto.</p><p>Eis o mau envelhecimento.</p><p>E essa ideia de Ray Peat mostra, de alguma maneira, o que j&#225; foi falado, a diferen&#231;a entre uma c&#233;lula e uma pedra. Um ser vivo e uma pedra. Um ser vivo existe porque h&#225; um fluxo de energia que o atravessa e organiza estruturas. Eis a mat&#233;ria viva. A pedra continua sendo uma pedra, n&#227;o produz energia que flua por si e por isso &#233; pedra, inerte.</p><p>A vida tem as caracter&#237;sticas pr&#243;prias. Enquanto existir um fluxo intenso de respira&#231;&#227;o mitocondrial &#243;timo, as prote&#237;nas do intracelular, do cristalino, continuam dobradas, tridimensionais, coerentes e a &#225;gua celular permanece organizada.</p><p>Os gradientes qu&#237;micos s&#227;o mantidos, as enzimas trabalham na velocidade adequada, o m&#250;sculo mant&#233;m sua elasticidade, o c&#233;rebro se mant&#233;m ativo, o cristalino do olho permanece transparente. Se aquele fluxo de energia diminuir, toda a organiza&#231;&#227;o org&#226;nica come&#231;a lentamente a se desfazer. Essa &#233; a dial&#233;tica mais profunda da vida, distinta daquela da mat&#233;ria inerte.</p><p><em>O CO2 abundante &#233; uma evid&#234;ncia de que a energia est&#225; realmente fluindo pela c&#233;lula. </em>Ele &#233; um <em>comprovante</em> disso. E &#233; por isso mesmo que, na rec&#237;proca, o CO2 &#233; um estrat&#233;gico agente terap&#234;utico, ou seja, n&#227;o por acaso, na doen&#231;a ele tem o seu papel <em>terap&#234;utico</em>. Precisamente porque a l&#243;gica da doen&#231;a, da constru&#231;&#227;o da doen&#231;a, deriva de uma <em>queda</em> na produ&#231;&#227;o de CO2.</p><p>Ent&#227;o o sistema vivo n&#227;o vive em equil&#237;brio <em>est&#225;tico</em>, ele est&#225; longe da ideia formal e vulgar de equil&#237;brio. Precisa de um fluxo constante de energia para manter sua organiza&#231;&#227;o. E sua infinita sinfonia de <em>feedbacks </em>bioqu&#237;micos.</p><p>Um exemplo extraordin&#225;rio disso &#233; a c&#233;lula.</p><p>Ent&#227;o, novamente, a pergunta sempre ser&#225;, diante da les&#227;o, diante da doen&#231;a, da disfun&#231;&#227;o:  <em>o que &#233; que fez essa estrutura perder a capacidade de manter seu <strong>fluxo</strong> de energia?</em> A perda da estrutura, em geral, vai ser consequ&#234;ncia daquela perda de capacidade e ser&#225; consequ&#234;ncia, ser&#225; vari&#225;vel dependente [em linguagem das matem&#225;ticas superiores].</p><p>A vida &#233; um fluxo de energia que consegue manter estruturas, e n&#227;o a cole&#231;&#227;o de estruturas que produz energia.</p><p>G Dantas, Bras&#237;lia, 3-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p>***</p>]]></content:encoded></item><item><title><![CDATA[A lógica da doença e a doença da lógica [Parte 2 de 3] ]]></title><description><![CDATA[NOTAS sobre bioqu&#237;mica da c&#233;lula na sa&#250;de e na doen&#231;a]]></description><link>https://outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da-633</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da-633</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sun, 02 Aug 2026 14:15:36 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!EMBQ!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<p><strong>[Parte 2 de 3]</strong></p><p>[Continua&#231;&#227;o da <a href="/__u/outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da">parte 1</a>]</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!EMBQ!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!EMBQ!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg" width="427" height="370" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/a3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:370,&quot;width&quot;:427,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:42732,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/209500069?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!EMBQ!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa3b0c1fd-56aa-4b98-99a3-ee97c1a0173e_427x370.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Voltemos ao exemplo daquela enzima 11-beta, que ativa cortisol na c&#233;lula, e algumas coisas ficar&#227;o mais claras.</p><p>Por exemplo, aquela enzima n&#227;o decide <em>sozinha</em> se vai ou n&#227;o produzir cortisol. Ela funciona como um amplificador, um bot&#227;o de volume. <em>&#201; o ambiente</em> &#8211; mais ou menos energizado &#8211; que a ativa. Estando em seu &#243;timo de energia, a c&#233;lula manter&#225; a enzima sintetizadora de cortisol inativada.</p><p>A c&#233;lula sempre vai se <em>perguntar</em>, por assim dizer, se existe energia suficiente para manter minha estrutura. Existe? Ent&#227;o <em>n&#227;o</em> vai ser acionada a 11-beta. Ou seja, se a resposta for de que a boa produ&#231;&#227;o de CO2 est&#225; continuando, e que existe ATP e oxida&#231;&#227;o da glicose suficiente, nesse caso, a 11-beta permanece inativa, ou pouco ativa. Quase nenhum cortisol ser&#225; produzido dentro da pr&#243;pria c&#233;lula.</p><p>Mas se a resposta for <em>n&#227;o</em>, se cai a produ&#231;&#227;o de CO2, ent&#227;o, na sequ&#234;ncia, come&#231;a a entrar c&#225;lcio na c&#233;lula, surgem sinais inflamat&#243;rios, como esse do c&#225;lcio, nesse caso, a c&#233;lula aumenta a express&#227;o daquela enzima, 11-beta.</p><p>&#201; aqui que a cortisona inativa passa a ser convertida em cortisol ativo naquele tecido em sofrimento. &#201; sofrimento, &#233; ind&#237;cio de doen&#231;a, queda na produ&#231;&#227;o de energia.</p><p>S&#243; que esse cortisol n&#227;o vem como agente do caos, especificamente. Sim, ele vai produzir destrui&#231;&#227;o, mas ele vem para tentar <em>salvar</em> a c&#233;lula, promovendo mobiliza&#231;&#227;o de glicose. &#8220;Seu&#8221; <em>entendimento</em> &#233;, se caiu a produ&#231;&#227;o de CO2, &#233; preciso garantir a&#231;&#250;car para transformar em CO2, energia e todo o resto. [Supondo a pessoa em jejum de a&#231;&#250;car].</p><p>O cortisol entrando em cena, vai degradar prote&#237;nas celulares para fornecer amino&#225;cidos. Tamb&#233;m vai mobilizar gordura para queimar, enquanto isso. E por essa via, vai economizar energia que seria usada em fun&#231;&#245;es menos urgentes. Vai acionar horm&#244;nios que diminuem fun&#231;&#245;es, como a adrenalina que retira perfus&#227;o sangu&#237;nea do aparelho reprodutor e digestivo.</p><p>&#201; <em>modo economia</em>, j&#225; que n&#227;o h&#225; energia abundante.</p><p>A fun&#231;&#227;o digestiva ser&#225; comprometida para garantir outras partes, mais determinantes ou urgentes da biologia corporal. Ent&#227;o, para Peat, essa a&#231;&#227;o da enzima &#233; uma <em>solu&#231;&#227;o de emerg&#234;ncia</em>, mas a essa altura, tamb&#233;m &#233; verdade que j&#225; n&#227;o estaremos mais em um estado plenamente saud&#225;vel e sim de estresse.</p><p>O interessante &#233; que isso muda completamente a forma de se enxergar o cortisol. Ele n&#227;o &#233; apenas um horm&#244;nio produzido pela adrenal que viaja pelo corpo. E sim que cada tecido tem uma certa autonomia local, portanto, para decidir <em>quanto cortisol ativo quer ter,</em> gra&#231;as &#224; enzima 11-beta.</p><p>De forma que o metabolismo &#233; autorregulado muito mais localmente pelas c&#233;lulas do que apenas pelo simples comando central da suprarrenal.</p><p>O que &#233; uma exce&#231;&#227;o a isso &#233; o T3. O T3 &#233; o grande organizador e garantidor central da produ&#231;&#227;o &#243;tima de energia. E toda vez que a tireoide foi inibida, tende a decair a produ&#231;&#227;o &#243;tima de energia e a c&#233;lula vai ter que sobreviver acionando horm&#244;nios como o cortisol.</p><p>Por isso que o hipotiroidismo significa que a pessoa estar&#225; produzindo cronicamente cortisol nos tecidos, porque a tireoide decaiu, n&#227;o est&#225; oferecendo o horm&#244;nio T3 suficiente para cada c&#233;lula. Cai o CO2. Ent&#227;o, neste caso, enzimas como a 11-beta, que foi tomada como exemplo [mas existem outras], v&#227;o ser agentes da passagem de um estado de abund&#226;ncia energ&#233;tica para um estado de estresse.</p><p>E somente a volta da produ&#231;&#227;o &#243;tima de energia far&#225; com que aquela enzima deixe de ser induzida e o cortisol tenda a cair.</p><p>De maneira que o cortisol, na vis&#227;o de Peat, &#233; em grande parte um horm&#244;nio de compensa&#231;&#227;o para defici&#234;ncia energ&#233;tica.</p><p>Ele n&#227;o &#233; apenas isso, claro. Mas quando a c&#233;lula consegue produzir energia de forma eficiente, este ambiente reduz naturalmente os mecanismos que aumentam a produ&#231;&#227;o local de cortisol.</p><p>E entendamos, sempre, que o emocional, quando entra em modo negativo, ele derruba a produ&#231;&#227;o de energia. E que tamb&#233;m por esse vi&#233;s, o cortisol aparece, a partir do CRH, que &#233; um horm&#244;nio cerebral, situado na esfera das emo&#231;&#245;es. E que leva a hipoglicemia, que provoca aumento do cortisol.</p><p>Para refor&#231;ar a l&#243;gica da doen&#231;a, o fato &#233;, que h&#225; evid&#234;ncias de que o horm&#244;nio tireoidiano reduz a express&#227;o da enzima 11-beta em diversos tecidos. Ou seja, o T3 aumenta a produ&#231;&#227;o de CO2 e inibe aquela enzima.</p><p>Ao mesmo tempo, existem v&#225;rios inibidores daquela enzima que produz cortisol.</p><p>O magn&#233;sio &#233; um deles, a progesterona &#233; outro, B6 tamb&#233;m, a B1, a glicina, v&#225;rios. Mas o T3 &#233; provavelmente <em>o mais importante</em>, porque ao inibir a produ&#231;&#227;o de cortisol, ele garante, em paralelo, um funcionamento &#243;timo de energia.</p><p>E o contr&#225;rio &#233; verdade. Se houver uma queda na produ&#231;&#227;o de CO2, haver&#225; um est&#237;mulo para o organismo ficar &#8220;congelado&#8221;, engessado, preso a uma emerg&#234;ncia de baixa produ&#231;&#227;o de energia, um estado de estresse, consequ&#234;ncia da baixa fun&#231;&#227;o tireoideana, por exemplo.</p><p>Ent&#227;o, o organismo, quando ele vive num estado de abund&#226;ncia energ&#233;tica, esse estado dispensa os horm&#244;nios de estresse.</p><p>Esse estado se confunde com sa&#250;de.</p><p>De tal forma que a <em>l&#243;gica da doen&#231;a</em> &#8211; especialmente da doen&#231;a cr&#244;nico-degenerativa - &#233; que ela expressa uma resposta de emerg&#234;ncia de um organismo que procura sobreviver quando se v&#234; ref&#233;m de um n&#237;vel de baixa produ&#231;&#227;o de energia.</p><p>O organismo <em>n&#227;o quer</em> morrer. Seu <em>objetivo</em> &#233; se manter vivo. Ent&#227;o, a resposta que vem atrav&#233;s daquela enzima, 11-beta, que est&#225; em todas as c&#233;lulas praticamente, &#233; a necess&#225;ria para que as estruturas continuem existindo, as estruturas da mat&#233;ria viva. A produ&#231;&#227;o de energia precisa ser suficiente, para se poder voltar ao estado de sa&#250;de.</p><p>Em outras palavras, quando a energia cai, a pr&#243;pria c&#233;lula aciona mecanismos de sobreviv&#234;ncia. Um deles &#8211; nosso exemplo - &#233; aumentar a atividade da 11-beta, produzir mais cortisol local, j&#225; que o cortisol ajuda a manter a c&#233;lula viva por algum tempo; s&#243; que &#224;s custas da pr&#243;pria estrutura, degradando prote&#237;nas, reduzindo fun&#231;&#245;es especializadas, colocando o tecido em um estado mais minimalista, mais econ&#244;mico, mais catab&#243;lico.</p><p>Se continua nesse estado ao longo do tempo, teremos um processo de desenvolvimento de enfermidades e de envelhecimento precoce.</p><p>A ideia &#233; mais ou menos a seguinte: se o fluxo de energia diminuir a c&#233;lula tende a mudar seu programa metab&#243;lico.</p><p>E a ativa&#231;&#227;o local do cortisol &#233; um sinal dessa transi&#231;&#227;o entre um estado de abund&#226;ncia de energia, de crescimento, manuten&#231;&#227;o, para um estado de sobreviv&#234;ncia. Ou seja, se a energia cai, a <em>estrutura vai ser consumida</em> para trazer mais energia, de forma emergencial, portanto, atrav&#233;s de horm&#244;nios do estresse.</p><p>A ideia tamb&#233;m &#233; a seguinte: n&#243;s estamos vivendo ou estamos morrendo? Estamos mais vivendo do que morrendo ou o contr&#225;rio?</p><p>Se a c&#233;lula perde energia, ela sai do estado de vida plena para um estado de emerg&#234;ncia. Em determinadas circunst&#226;ncias, vai haver muito mais autofagia, c&#233;lulas que adoecem e se destroem. Mas o organismo permanece vivo, agora em um estado tipo <em>modo sobreviv&#234;ncia</em>, consumindo lentamente sua pr&#243;pria organiza&#231;&#227;o/estrutura.</p><p>Por isso tem tanta import&#226;ncia a fun&#231;&#227;o da tireoide.</p><p>O T3 n&#227;o &#233; s&#243; um horm&#244;nio que &#8220;acelera a queima do a&#231;&#250;car&#8221;. Ele ajuda a manter a c&#233;lula num estado no qual ela <em>n&#227;o precise</em> recorrer &#224;quelas medidas de emerg&#234;ncia. A estrutura produz energia, mas &#233; essa energia em fluxo que mant&#233;m a estrutura.</p><p>A estrutura celular n&#227;o &#233; um objeto est&#225;tico, que ocasionalmente recebe ATP. Ela &#233; um processo continuamente sustentado por um fluxo de energia.</p><p>Se o fluxo cai por tempo suficiente, a estrutura deixa de conseguir se manter de p&#233; e, literalmente, passa a ser usada como combust&#237;vel. Isso explica porque, para Peat, o envelhecimento n&#227;o &#233; um desgaste mec&#226;nico do tempo, nem nada parecido. E nem pode ser biologicamente explicado pela categoria &#8220;tempo&#8221;.</p><p>&#201;, antes, uma perda progressiva da capacidade de manter um estado energ&#233;tico elevado. E &#224; medida que isso ocorra, aumentar&#225; a depend&#234;ncia de mecanismos de sobreviv&#234;ncia. Cortisol, inflama&#231;&#227;o, degrada&#231;&#227;o tecidual, em alguns contextos autofagia, disfun&#231;&#227;o, assim por diante.</p><p>E por que mencionamos de sa&#237;da o problema da <em>doen&#231;a da l&#243;gica</em>?</p><p>Para lembrar que essa l&#243;gica da doen&#231;a que aqui est&#225; sendo examinada &#233; praticamente passada desapercebida pela medicina oficial. Aqui prevalece uma l&#243;gica degradada, doente, que s&#243; consegue &#8220;ver&#8221; as partes. A medicina adota uma l&#243;gica doente, formal, reducionista.</p><p>A medicina moderna padece de uma grave defici&#234;ncia, a de olhar para o corpo de uma forma muito est&#225;tica e de fazer, em regra, a pergunta errada diante da doen&#231;a. Diante da doen&#231;a, sua pergunta &#233; reducionista, e por isso mesmo, sua regra &#233; medicalizar os sintomas.</p><p>Peat frequentemente inverte a pergunta. Ele diz, o que &#233; que fez essa estrutura perder a capacidade de manter o seu fluxo de energia? Essa pergunta remete diretamente para o plano da produ&#231;&#227;o de energia no corpo e no tecido, o que permite uma estrat&#233;gia de resposta bastante mais definida em seus objetivos e nos trar&#225; a resposta l&#243;gica, de fundo.</p><p>A vida &#233; um fluxo de energia biol&#243;gica que consegue manter estruturas.</p><p>Por exemplo, n&#227;o existe biosfera, sem o Sol. Se o Sol se ausentar do sistema, a biosfera desaparece. N&#227;o existe biosfera como estrutura que possa ser compreendida sem a presen&#231;a dos f&#243;tons do Sol.</p><p>No caso da c&#233;lula, a vida &#233; um fluxo de energia a partir da queima do a&#231;&#250;car, que tem que ser mantido num n&#237;vel &#243;timo de produ&#231;&#227;o de ATP, de CO2, ou a estrutura come&#231;a a se decompor, come&#231;a a ser consumida para garantir algum fluxo de energia.</p><p>Quando a energia diminui, o organismo n&#227;o morre imediatamente; ele entra em um modo de sobreviv&#234;ncia, no qual cada mecanismo, cortisol, 11-beta, adrenalina, PDK, autofagia, passa a ter como objetivo preservar algum fluxo energ&#233;tico poss&#237;vel, minimalista, mesmo que isso implique consumir gradualmente a pr&#243;pria estrutura que aquele fluxo sustentava.</p><p>E a queima do a&#231;&#250;car &#233; o elemento central que n&#227;o pode se deter, porque &#233; a maneira mais eficiente de manter um fluxo cont&#237;nuo de energia, isto &#233;, a queima do a&#231;&#250;car em seu &#243;timo.</p><p>A&#231;&#250;car, produ&#231;&#227;o de CO2, ATP abundante, preserva&#231;&#227;o da estrutura, diferencia&#231;&#227;o celular, sa&#250;de.</p><p>Essa &#233; a l&#243;gica. E o organismo se v&#234; obrigado a optar pela op&#231;&#227;o estressante de recorrer ao cortisol, degradar m&#250;sculo, mobilizar gordura, antes de simplesmente deixar faltar glicose para os tecidos que dela dependem.</p><p>S&#227;o mecanismos de emerg&#234;ncia, por isso que a <em>doen&#231;a da l&#243;gica</em>, &#233; fazer a pergunta errada, porque, neste caso, a resposta nunca vai ser compat&#237;vel com a din&#226;mica dial&#233;tica e real do organismo.</p><p>A vida &#233; uma for&#231;a organizadora da mat&#233;ria, mantida por um fluxo cont&#237;nuo de energia, capturada &#8211; em primeir&#237;ssimo lugar - pela biosfera a partir do Sol, como j&#225; foi falado.</p><p>E n&#227;o existe a parte sem o todo. A pergunta deve ser feita ao todo. A l&#243;gica &#233; a da totalidade e &#233; dial&#233;tica por defini&#231;&#227;o.</p><p>Os organismos vivos n&#227;o s&#227;o objetos passivos, obedecendo &#224;s leis da qu&#237;mica ou da bioqu&#237;mica. S&#227;o sistemas que reorganizam continuamente a mat&#233;ria <em>gra&#231;as ao fluxo de energia</em>, que &#233; um dado da f&#237;sica ou da biof&#237;sica, se se quiser. O redemoinho do nosso exemplo n&#227;o existe por causa da &#225;gua parada, ele existe <em>porque h&#225; fluxo cont&#237;nuo de &#225;gua</em>. Ent&#227;o, a <em>&#225;gua &#8211; somente a &#225;gua - n&#227;o explica o redemoinho, o movimento da &#225;gua sim</em>.</p><p>Vernadsky [1863-1945] analisava o planeta e a biosfera dessa forma, com a analogia de que aqui na biosfera h&#225; um enorme processo din&#226;mico mantido por fluxos de energia. Peat levou essa l&#243;gica para dentro da c&#233;lula, para o organismo e, antes dele, Ling.</p><p>E mais uma vez&#8221;: em vez de olhar apenas para a estrutura, a pergunta seria: <em>o que &#233; que mant&#233;m organizada</em> essa c&#233;lula? Resposta: fluxo cont&#237;nuo de energia. Gilbert Ling enfatizava a organiza&#231;&#227;o da &#225;gua e das prote&#237;nas dentro da c&#233;lula. Organiza&#231;&#227;o produzida pela energia, pelo fluxo de energia constante. E Peat: essa organiza&#231;&#227;o s&#243; pode ser mantida porque existe um metabolismo energ&#233;tico eficiente, ininterrupto, especificamente fundado na oxida&#231;&#227;o da glicose.</p><p>G Dantas, SP, 2-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong><span>***</span></strong></p>]]></content:encoded></item><item><title><![CDATA[Atrofia testicular, hipertrofia do clítoris e a que ponto chega certo pragmatismo ]]></title><description><![CDATA[Comportamento de risco: em certos ambientes de fisiculturismo e academias, suplementa&#231;&#227;o de testosterona e abuso iatrog&#234;nico andam de m&#227;os dadas:]]></description><link>https://outramedicina2024.substack.com/p/atrofia-testicular-hipertrofia-do</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/atrofia-testicular-hipertrofia-do</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Sat, 01 Aug 2026 10:22:02 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!k9JT!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!k9JT!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!k9JT!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg" width="576" height="370" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:370,&quot;width&quot;:576,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:24311,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/209361680?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!k9JT!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0562e945-f37a-4dc6-a8f5-afd3433b1eba_576x370.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Certos <em>bombados</em> de academia est&#227;o regularmente criando condi&#231;&#245;es penosas para seu envelhecimento e para sua vida sexual. N&#227;o todos e nem todo o tempo. Mas o problema envolvendo suplementos em dose suprafisiol&#243;gica e outras &#8220;bombas&#8221; &#233; bem real e ocorre com ou sem consentimento m&#233;dico.</p><p>Explicando.</p><p>Perseguindo seu ideal de construir m&#250;sculos, homens e mulheres est&#227;o fazendo uso de testosterona e &#8211; querendo ou n&#227;o &#8211; ganhando, com o tempo, doen&#231;as como o hipogonadismo.</p><p>No hipogonadismo seus test&#237;culos e ov&#225;rios deixam de funcionar normalmente.<span> </span>O nome da doen&#231;a: hipogonadismo hipogonadotr&#243;fico.</p><p>No homem, ocorrendo o desligamento do test&#237;culo levando a queda da libido, alguma disfun&#231;&#227;o er&#233;til, fadiga, eventualmente altera&#231;&#227;o do tamanho do p&#234;nis [atrofia] e at&#233; depress&#227;o.</p><p>Na mulher, seus ov&#225;rios s&#227;o praticamente suprimidos e, por haver muito andr&#243;geno circulante, surgem sinais de viriliza&#231;&#227;o, como: aumento do clit&#243;ris (clitoromegalia); engrossamento da voz; aumento de pelos corporais; acne; queda de cabelo em padr&#227;o masculino.</p><p>Como isso acontece.</p><p>Nos homens, que v&#227;o aplicando doses suprafisiol&#243;gicas [A] de testosterona [&#8220;para ter mais m&#250;sculos&#8221;], o mecanismo &#233;: o c&#233;rebro percebe que j&#225; h&#225; testosterona <em>demais</em> no sangue. Da&#237; ele reduz quase a zero a libera&#231;&#227;o de LH e FSH pela hip&#243;fise. Ora, sem LH e FSH, os test&#237;culos praticamente param de produzir testosterona e espermatozoides. E tamb&#233;m os mesmos test&#237;culos costumam diminuir de tamanho (atrofia testicular).</p><p>Enquanto o homem continua aplicando testosterona, o n&#237;vel de testosterona no sangue pode estar muito alto. Portanto, ele n&#227;o est&#225; &#8220;sem testosterona&#8221;, mas est&#225; com hipogonadismo hipogonadotr&#243;fico induzido por esteroides, porque seus pr&#243;prios test&#237;culos foram <em>desligados</em>.</p><p>O problema aparece quando ele interrompe as aplica&#231;&#245;es. Como o eixo hipot&#225;lamo-hip&#243;fise-g&#244;nadas ficou inibido, pode levar meses para voltar a funcionar &#8212; e, em alguns casos, a recupera&#231;&#227;o &#233; incompleta.</p><p>Nessa fase, a testosterona fica realmente baixa, surgindo sintomas como perda de libido, disfun&#231;&#227;o er&#233;til, fadiga, depress&#227;o e perda de massa muscular.</p><p>Na mulher usu&#225;ria de testosterona ocorre algo parecido.</p><p>Ao usar grandes doses de testosterona, o c&#233;rebro acusa o impacto:<span> </span>o LH e o FSH tamb&#233;m s&#227;o suprimidos; os ov&#225;rios diminuem sua produ&#231;&#227;o normal de estr&#243;genos e progesterona; a ovula&#231;&#227;o pode parar e a menstrua&#231;&#227;o desaparecer (amenorreia). E pode vir a hipertrofia do cl&#237;toris. Tudo isso em plena vig&#234;ncia de hipogonadismo [ov&#225;rios inibidos].</p><p>Portanto, mais n&#227;o &#233; melhor.</p><p>Promove hipogonadismo. O hipogonadismo se refere &#224; fal&#234;ncia ou supress&#227;o da fun&#231;&#227;o gonadal, n&#227;o necessariamente &#224; quantidade de testosterona que est&#225; circulando naquele momento. Ela pode ser alta e o cidad&#227;o, ainda assim, estar construindo atrofia testicular.</p><p>Enquanto o homem continuar aplicando testosterona, o n&#237;vel de testosterona no sangue pode estar muito alto. Portanto, ele n&#227;o est&#225; &#8220;sem testosterona&#8221;, mas est&#225; com hipogonadismo hipogonadotr&#243;fico induzido por esteroides, porque seus pr&#243;prios test&#237;culos foram desligados pela hip&#243;fise.</p><p>Nas especialidades de endocrinologia e urologia, &#233; amplamente reconhecido que o uso prolongado de esteroides anabolizantes em doses suprafisiol&#243;gicas pode causar supress&#227;o do eixo hormonal, infertilidade, atrofia testicular, altera&#231;&#245;es cardiovasculares, altera&#231;&#245;es hep&#225;ticas (dependendo da subst&#226;ncia), aumento do hemat&#243;crito, al&#233;m de efeitos psiqui&#225;tricos em algumas pessoas. Isso &#233; bem documentado na literatura cient&#237;fica.</p><p>O problema nem sempre &#233; que o m&#233;dico n&#227;o informa. Consentimento informado n&#227;o &#233; muito comum na medicina [o doutor raramente informa efeitos colaterais poss&#237;veis e prov&#225;veis das drogas que prescreve]. Mas no caso dessa &#8220;suplementa&#231;&#227;o&#8221; de testosterona, &#233; muito prov&#225;vel que o doutor informe, sim, mas em certos ambientes de fisiculturismo e academias, o atleta escolha a conduta de risco. Mesmo sabendo do prov&#225;vel risco.</p><p>O motivo &#233; objetivo do atleta de ganho de massa muscular, desempenho e todas essas coisas que viraram uma certa moda. Esses atletas acham que &#8220;vale o risco&#8221;, ou que &#8220;depois tudo se arranja&#8221; com terapias ou ent&#227;o &#8220;gra&#231;as a deus tudo terminar&#225; bem&#8221;. H&#225; profissionais pouco criteriosos, sim, mas h&#225; atletas cuja obsess&#227;o &#233;, de fato, correr todo risco que seja para ficar &#8220;bombado&#8221;.</p><p>E isso &#233; assim por conta de que existe o elemento psicol&#243;gico chamado vi&#233;s do presente: benef&#237;cios imediatos (mais m&#250;sculos, melhor desempenho, sucesso competitivo) costumam pesar mais na decis&#227;o do que poss&#237;veis consequ&#234;ncias que podem aparecer <em>anos depois.</em> Isso n&#227;o &#233; exclusivo do uso de testosterona; ocorre tamb&#233;m com tabagismo, exerc&#237;cio extenuante, &#225;lcool [o famigerado &#8220;uso social&#8221;], antidepressivos e ansiol&#237;ticos, alimenta&#231;&#227;o inadequada e outros comportamentos de risco.</p><p>Para que o usu&#225;rio/a de doses regulares de testosterona, alcance o hipogonadismo permanente, atrofia de p&#234;nis e test&#237;culos, cl&#237;toris grande, baixa libido etc. isso vai depender da idade, tempo de uso, doses, tipos de drogas utilizadas [h&#225; esteroides patenteados que, segundo Peat, promovem c&#226;ncer] e tamb&#233;m do metabolismo individual. Mas &#233; certo<span> </span>nem todos recuperar&#227;o a sa&#250;de hormonal depois do uso mais ou menos prolongado de doses de testosterona.</p><p>Lembrando que a testosterona &#233; um horm&#244;nio que facilmente se converte em estrog&#234;nio &#8211; por isso, como regra, <em>n&#227;o deveria ser suplementado</em> &#8211; j&#225; que sua mera suplementa&#231;&#227;o poderia levar a um estado de domin&#226;ncia estrog&#234;nica e, na sequ&#234;ncia, tumor de pr&#243;stata [ver notas no blog a respeito].</p><p>G Dantas, Bras&#237;lia, 1-8-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong><span>Notas ____________</span></strong></p><p><strong><span>[</span></strong><span>A] Um homem adulto saud&#225;vel produz aproximadamente </span><strong><span>3 a 10 mg de testosterona por dia</span></strong><span>, o que corresponde a algo em torno de </span><strong><span>20 a 70 mg por semana</span></strong><span> de testosterona efetivamente liberada pelo organismo. A produ&#231;&#227;o di&#225;ria de testosterona em uma mulher &#233; cerca de </span><strong><span>10 a 20 vezes menor</span></strong><span> do que em um homem. Quando a testosterona &#233; utilizada para indica&#231;&#245;es m&#233;dicas em mulheres (por exemplo, em situa&#231;&#245;es espec&#237;ficas e cuidadosamente avaliadas), as doses costumam ser </span><strong><span>muito pequenas</span></strong><span>, frequentemente na faixa de </span><strong><span>300 microgramas por dia</span></strong><span> em prepara&#231;&#245;es transd&#233;rmicas (quando dispon&#237;veis). De forma que a reposi&#231;&#227;o fisiol&#243;gica feminina: geralmente envolve microgramas por dia ou poucos miligramas por semana, dependendo da formula&#231;&#227;o. Mas a mesma dose pode ter efeito diferente em diferentes pessoas. Dois homens usando a mesma dose podem atingir concentra&#231;&#245;es sangu&#237;neas diferentes devido &#224; absor&#231;&#227;o, metabolismo, composi&#231;&#227;o corporal e intervalo entre aplica&#231;&#245;es; portanto, o mesmo n&#250;mero de miligramas pode ser fisiol&#243;gico para um indiv&#237;duo e suprafisiol&#243;gico para outro.</span></p><p><strong><span>***</span></strong></p>]]></content:encoded></item><item><title><![CDATA[A lógica da doença e a doença da lógica [Parte 1 de 3] ]]></title><description><![CDATA[NOTAS sobre bioqu&#237;mica da c&#233;lula na sa&#250;de e na doen&#231;a]]></description><link>https://outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/a-logica-da-doenca-e-a-doenca-da</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Fri, 31 Jul 2026 21:29:16 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!iQGU!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!iQGU!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!iQGU!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg" width="427" height="370" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/c79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:370,&quot;width&quot;:427,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:48279,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/209310370?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!iQGU!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc79285d8-a0e8-400d-8689-07b41c150996_427x370.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Vamos tomar dois exemplos da biologia celular na tentativa de desenvolver uma argumenta&#231;&#227;o em torno da l<em>&#243;gica da doen&#231;a.</em></p><p>O primeiro &#233; a enzima que d&#225; o <em>ponto de partida</em> para a respira&#231;&#227;o celular mitocondrial, que &#233; uma enzima chamada piruvato-desidrogenase [PDH]. Essa enzima depende da vitamina B1 para funcionar e &#233; ela quem come&#231;a &#8211; como uma esp&#233;cie de <em>porteiro mitocondrial</em> - o processo que termina na queima do a&#231;&#250;car at&#233; o final, quando ent&#227;o ter&#225; sido produzido calor, ATP e CO2. &#201; uma enzima, portanto, chave da respira&#231;&#227;o celular.</p><p>Vamos supor que haja um problema, que essa enzima n&#227;o consiga funcionar a contento.</p><p>Vamos supor que a respira&#231;&#227;o celular se tornou mais lenta, est&#225; sendo produzido menos CO2 que o &#243;timo, menos ATP; neste ambiente, aquela enzima ser&#225; inibida. Em outras palavras, a capacidade de produ&#231;&#227;o de energia sofreu uma queda a partir do momento que aquela enzima n&#227;o conseguiu, a partir de certo impulso <em>externo</em>, continuar operante. Isso pode ter sido efeito de uma car&#234;ncia vitam&#237;nica, proteica, ou um exerc&#237;cio extenuante, hiperventila&#231;&#227;o, algum elemento externo ou dentro da alimenta&#231;&#227;o, e que produziu um defeito na respira&#231;&#227;o celular, tendo como resultado inibi&#231;&#227;o da PDH.</p><p>Na sequ&#234;ncia, o g&#225;s carb&#244;nico cai, isto &#233;, o n&#237;vel de satura&#231;&#227;o de CO2 cai dentro da c&#233;lula. Neste ambiente aquela enzima, o PDH, ela vai deixar de funcionar.</p><p>Pode-se concluir que o CO2 , em um n&#237;vel bom, que mant&#233;m a enzima funcionando. Em outras palavras, &#233; <em>o ambiente</em> que faz a enzima continuar agindo. &#192; medida que o ambiente se tornou carente de CO2, a enzima foi inibida.</p><p>Na sequ&#234;ncia, a respira&#231;&#227;o celular vai ficar <em>mais</em> comprometida. E  isso ser&#225; um est&#237;mulo para aumentar o lactato na c&#233;lula e para esta entrar em um estado de emerg&#234;ncia, come&#231;ar a fermentar, isto &#233;, n&#227;o consegue queimar o a&#231;&#250;car de forma adequada.</p><p>Estado de emerg&#234;ncia, significa que ela n&#227;o est&#225; no seu &#243;timo de produ&#231;&#227;o de energia, est&#225; no sub&#243;timo, e nesta condi&#231;&#227;o n&#243;s temos um estado de crise, estresse ou de doen&#231;a, se se quiser.</p><p>Vimos a PDH. Agora levemos em conta outra enzima. Vamos cham&#225;-la, simplificadamente, de 11-beta.</p><p>O nome dela &#233; 11-beta-HSD1, mas para n&#243;s, doravante, fica 11-beta. Essa enzima vive <em>inativada</em> dentro da c&#233;lula, normalmente. Todas as c&#233;lulas a possuem, basicamente, s&#243; que &#233; enzima que permanece inativada, nada faz. Por&#233;m, se cair o n&#237;vel de CO2 dentro da c&#233;lula, essa enzima &#233; ativada.</p><p>A ativa&#231;&#227;o dessa enzima significa que come&#231;ar&#225; a produ&#231;&#227;o de cortisol <em>dentro </em>da c&#233;lula. Portanto, passando longe daquela ideia de que somente a suprarrenal produz cortisol.</p><p>Qualquer tecido pode produzir cortisol desde que entre em um estado de emerg&#234;ncia, ou seja, a queda do CO2, simplesmente isso, ativou a enzima, e a&#237; ela come&#231;a a produzir cortisol.</p><p>O cortisol fabrica, por sua vez, a&#231;&#250;car; a partir de que? Do &#8220;consumo&#8221; de partes da c&#233;lula dos tecidos para produzir a&#231;&#250;car.</p><p>Com esses dois exemplos, podemos come&#231;ar a tentar entender a l&#243;gica da doen&#231;a na perspectiva de Peat, que passa &#8211; dentre outras - pela seguinte ideia seminal.</p><p>O corpo vive num &#243;timo de produ&#231;&#227;o de energia. Ele n&#227;o negocia sub&#243;timo, nem inibi&#231;&#227;o da produ&#231;&#227;o de energia. Ele precisa de um fluxo permanente no corpo, na c&#233;lula, de energia, fluxo incessante, e, portanto, a produ&#231;&#227;o regular de um n&#237;vel de CO2 e de ATP. &#201; a c&#233;lula que queima o a&#231;&#250;car, produz um fluxo de energia que mant&#233;m a pr&#243;pria c&#233;lula de p&#233; e o conjunto do organismo.</p><p>Ent&#227;o n&#227;o &#233; a estrutura de um lado produzindo ATP para queimar do outro; na verdade a estrutura s&#243; se mant&#233;m de p&#233; porque continuamente est&#225; produzindo ATP.</p><p>Essa &#233; a primeira ideia que aparece naquele evento de desativa&#231;&#227;o daquela enzima respirat&#243;ria, a PDH.</p><p>Isto &#233;, se cair a produ&#231;&#227;o de energia, aquela enzima respirat&#243;ria, PDH, &#233; inativada e, nesse caso, a c&#233;lula passa n&#227;o mais a queimar preferencialmente o a&#231;&#250;car, passa a fermentar e a queimar sobretudo gordura e entra em crise, porque queimar gordura n&#227;o &#233; o melhor combust&#237;vel, sendo que ela far&#225; isso como &#250;nica forma de permanecer viva. Em estresse metab&#243;lico, sim, por&#233;m viva.</p><p>Com a outra enzima, o racioc&#237;nio &#233; bem interessante tamb&#233;m.</p><p>Com a enzima 11-beta, o que ocorre? A c&#233;lula, diante de uma crise energ&#233;tica, ou seja, caiu o g&#225;s carb&#244;nico, diminuiu a capacidade de queimar a&#231;&#250;car por alguma raz&#227;o que podemos examinar depois, e a&#237; ela entra em um estado de emerg&#234;ncia que &#233;: a c&#233;lula vai ter que sair desse estado de queda da energia oxidativa, vai precisar produzir ou dispor de a&#231;&#250;car de qualquer jeito [com a pessoa em jejum de a&#231;&#250;car], mesmo queimando parte da c&#233;lula.</p><p>As estruturas celulares v&#227;o ser <em>queimadas</em> pelo cortisol para a produ&#231;&#227;o de a&#231;&#250;car, por aquela enzima que, como sabemos, foi ativada por um estado de baixa energia.</p><p>O fato &#233; que em um estado de estresse, isto &#233;, de energia insuficiente, sempre que a c&#233;lula mergulhar nesse estado, dispara elementos de estresse que a conduzem para uma fase de <em>menor </em>produ&#231;&#227;o de energia, s&#243; que agora baseada na queima/destrui&#231;&#227;o de materiais da pr&#243;pria c&#233;lula. E, nesse minimalismo ela vai permanecer. Adaptada ao estresse energ&#233;tico. Mantendo-se em um estado de baixa energia suportada pela produ&#231;&#227;o e queima do pr&#243;prio a&#231;&#250;car por ela produzido.</p><p>Para n&#227;o morrer, ela aciona enzimas que criam cortisol, que levam &#224; destrui&#231;&#227;o de estruturas para poder entregar a&#231;&#250;car &#224; c&#233;lula. Por qu&#234;? Porque ela precisa, necessariamente, garantir o combust&#237;vel a&#231;&#250;car. De alguma maneira, ela precisa. N&#227;o h&#225; op&#231;&#227;o. Mesmo que seja for&#231;ada a queimar &#225;cidos graxos como op&#231;&#227;o imperiosa, mas continua demandando a&#231;&#250;car.</p><p>E o que ocorreu para que fosse acionada aquela enzima provedora de a&#231;&#250;car, cortisol, foi a queda de energia na c&#233;lula, ou alguma crise de hipoglicemia, falta de a&#231;&#250;car. Alguma crise de hiperventila&#231;&#227;o, ansiedade, exerc&#237;cio extenuante, todos estes levando a hipoglicemia.</p><p>Esse mesmo cortisol inibe a tireoide, ou seja, a tireoide que mant&#233;m o &#243;timo de produ&#231;&#227;o de energia, vai ser inibida pela presen&#231;a do cortisol que vai, de um lado, colocar fora de combate a tireoide e, por outro, fazer a c&#233;lula entrar em um novo regime de queima de energia agora baseado no cortisol, tamb&#233;m na gordura [beta oxida&#231;&#227;o], enfim, num esquema que n&#227;o &#233; o da melhor sa&#250;de, j&#225; n&#227;o mais ser&#225; o do &#243;timo de energia.</p><p>E isso significa que o corpo assumiu que <em>vai ficar naquele estado</em> minimalista de baixa produ&#231;&#227;o de energia; e que ele constitui uma emerg&#234;ncia, j&#225; que ele ser&#225; conduzido por horm&#244;nios de estresse, como o cortisol.</p><p>J&#225; se a c&#233;lula estiver num &#243;timo de energia, a&#231;&#250;car regular no sangue, o cortisol nem entra em cena. Entra em cena em situa&#231;&#227;o de estresse metab&#243;lico.</p><p>Nunca esquecendo que existe um mecanismo emocional que pode disparar esse mesmo processo, porque numa grande emo&#231;&#227;o a pessoa tem hipoglicemia, cai o a&#231;&#250;car, e o cortisol entrar&#225; em cena para garantir o a&#231;&#250;car e vai inibir a tireoide, e toda aquela sequ&#234;ncia citada vai acontecer.</p><p>De toda maneira, o centro da argumenta&#231;&#227;o &#233;: se a c&#233;lula tem um fluxo &#243;timo de produ&#231;&#227;o de energia, esse &#233; o estado de sa&#250;de. Porque quando esse fluxo diminui por qualquer raz&#227;o, o organismo entra em um estado de emerg&#234;ncia, que tem potencial para construir a doen&#231;a, se permanecer no tempo.</p><p>Portanto, a diferen&#231;a entre sa&#250;de e doen&#231;a tem a ver com a capacidade plena ou ent&#227;o, caso contr&#225;rio, sub&#243;tima de produ&#231;&#227;o de energia. </p><p>Na boa capacidade de produ&#231;&#227;o de energia, o cortisol, como foi argumentado, nem aparece. Aquela enzima 11-beta n&#227;o ser&#225; ativada. E a outra enzima da respira&#231;&#227;o celular, PDH, vai continuar atuando. E a c&#233;lula operando em estado de plena respira&#231;&#227;o oxidativa. Enzima respirat&#243;ria ativada, enzima do estresse/cortisol desativada.</p><p>Mas se a respira&#231;&#227;o decair por alguma raz&#227;o, aquela enzima, a PDH, vai ser inativada e entram em cena horm&#244;nios de estresse, cortisol e o pr&#243;prio &#225;cido l&#225;tico, em si mesmo, um mensageiro do estresse.</p><p>Nesse nosso plano de an&#225;lise, o que est&#225; sendo explicado &#233; que a c&#233;lula &#233; muito mais do que um conjunto de mol&#233;culas. &#201; um maquin&#225;rio de produ&#231;&#227;o incessante de energia. Se esta declina, a vida decai, estaremos em modo emerg&#234;ncia/sobreviv&#234;ncia.</p><p>De forma que o estado vivo da mat&#233;ria constitui um processo de gera&#231;&#227;o permanente em forma de <em>streaming,</em> de produ&#231;&#227;o de energia. Eis a diferen&#231;a entre uma pedra e uma c&#233;lula. Uma pedra vai continuar sendo uma pedra mesmo que se injete um fluxo de energia nela. Nela n&#227;o existe o estado incessante de produ&#231;&#227;o de energia.</p><p>No caso da a c&#233;lula, ela s&#243; existe enquanto produza e se deixe atravessar por um fluxo de energia; ou seja, a estrutura, a condi&#231;&#227;o da exist&#234;ncia da estrutura &#233; a energia. E o fluxo de energia mant&#233;m a estrutura de p&#233;.</p><p>E se o fluxo de energia n&#227;o for &#243;timo e constante, com bom n&#237;vel de CO2, a estrutura vai come&#231;ar a se decompor <em>para virar energia</em>. Entra em um estado regido por horm&#244;nios de estresse, como o cortisol. A 11-beta ser&#225; acionada para amparar esse estado.</p><p>Em tudo isso se pode ver que o CO2 nunca foi um res&#237;duo, sua presen&#231;a &#243;tima &#233;, na verdade, uma <em>evid&#234;ncia</em> de que a energia est&#225; fluindo pela c&#233;lula. Ent&#227;o, uma c&#233;lula que produz muito CO2 est&#225; em um estado metab&#243;lico est&#225;vel e organizado. Caso contr&#225;rio, ela vai acionar cortisol, mas tamb&#233;m ir&#225; produzir &#225;cido l&#225;tico, que &#233; t&#237;pico de uma c&#233;lula em crise, que come&#231;ou a fermentar.</p><p>Ent&#227;o, a perda da estrutura &#233; consequ&#234;ncia, n&#227;o &#233; causa.</p><p>A causa prim&#225;ria, ou a explica&#231;&#227;o da vida, do processo vital, n&#227;o &#233; uma cole&#231;&#227;o de estruturas que produzem energia. &#201; um fluxo de energia que consegue manter as estruturas.</p><p>Se n&#227;o h&#225; esse fluxo, se decai, teremos elementos de constru&#231;&#227;o da doen&#231;a. Esta entra em lugar do fluxo &#243;timo, teremos um fluxo minimalista, que vai se chamar doen&#231;a, que vai ser um estado defensivo, j&#225; que o &#243;timo n&#227;o est&#225; sendo poss&#237;vel.</p><p>A pessoa <em>n&#227;o</em> consegue produzir a energia para manter o conjunto das estruturas, de tal forma que esse estado sub&#243;timo &#233; o estado de doen&#231;a e, ao mesmo tempo, &#233; um regime de estresse, de emerg&#234;ncia.</p><p>A c&#233;lula n&#227;o estar&#225; vivendo, estar&#225; sobrevivendo, que &#233; o que se chama lento envelhecimento. O envelhecimento &#233; um processo cr&#244;nico, em c&#226;mera lenta, de dificuldade cada vez maior de manter as estruturas de p&#233; pela falta de uma &#243;tima produ&#231;&#227;o de energia. A dificuldade propriamente dita, ser&#225; a incapacidade de produzir plena energia para manter as estruturas, como quando a pessoa era jovem/saud&#225;vel. Isso &#233; comum no hipotireoidismo e a<span> </span>temperatura e pulso tender&#227;o a cair, haver&#225; menos calor corporal interno.</p><p>Essa <em>l&#243;gica da doen&#231;a</em> &#233; bom que ela seja entendida nessa camada mais &#237;ntima, onde se d&#225; a <em>produ&#231;&#227;o de energia</em>, incessante, e onde os processos s&#227;o qu&#237;micos, mas s&#227;o principalmente [ou mais intimamente] f&#237;sicos, eletr&#244;nicos.</p><p>O exemplo do redemoinho &#233; bem sugestivo porque ele aparece para n&#243;s, &#224; primeira vista, como uma estrutura est&#225;vel. Ali est&#225; ele. Na realidade, ele &#233; um padr&#227;o que existe <em>apenas </em>porque a &#225;gua continua fluindo. Se a &#225;gua parar, o redemoinho desaparece.  Ele n&#227;o foi destru&#237;do, ele simplesmente s&#243; existe porque est&#225; acontecendo um fluxo de energia. </p><p>&#201; a mesma l&#243;gica da c&#233;lula, que n&#227;o &#233; um saco de prote&#237;nas ou part&#237;culas, e sim, em primeiro plano, um redemoinho de energia. Ela s&#243; existe enquanto a energia flui no seu &#243;timo. Por isso que <em>manter a produ&#231;&#227;o de energia &#233; a base da sa&#250;de</em>.</p><p>E as resist&#234;ncias que vamos encontrando [estressores] para fazer com que esse processo &#243;timo continue, &#233; que geram doen&#231;a, envelhecimento e, em &#250;ltima inst&#226;ncia, um estado de emerg&#234;ncia regular, minimalista, baseado na interven&#231;&#227;o de elementos como o cortisol.</p><p>[Continua na Parte 2 de 3]</p><p>G Dantas, Bras&#237;lia, 31-7-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong><span>***</span></strong></p>]]></content:encoded></item><item><title><![CDATA[Uma introdução à catarata como um problema de produção de energia]]></title><description><![CDATA[ENSAIO [na perspectiva metab&#243;lica de Ray Peat]]]></description><link>https://outramedicina2024.substack.com/p/uma-introducao-a-catarata-como-um</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/uma-introducao-a-catarata-como-um</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Wed, 29 Jul 2026 14:16:57 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!Wfzq!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!Wfzq!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!Wfzq!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg" width="510" height="340" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:340,&quot;width&quot;:510,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:72219,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/208980550?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!Wfzq!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28a5eefc-fb22-4c43-bb00-d4d2de7bc31d_510x340.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p></p><p>Nas faculdades da &#225;rea de sa&#250;de e nos livros de biologia, nos ensinam que a c&#233;lula &#233; uma estrutura que produz ATP <em>para</em> fornecer energia para suas fun&#231;&#245;es.</p><p>Na verdade, essa abordagem simplesmente coloca a estrutura de um lado e a energia do outro. No processo real da mat&#233;ria viva, o que ocorre &#233; quase o inverso.</p><p>Ou seja, o processo celular poderia, talvez, ser melhor descrito assim: <em>porque</em> a c&#233;lula produz ATP, &#233; que ela se <em>mant&#233;m de p&#233;</em>.</p><p><em>Porque</em> produz continuamente energia, a estrutura consegue se preservar. Ou seja, &#233; a produ&#231;&#227;o em fluxo de ATP, CO2, que faz com que a estrutura continue existindo e funcional.</p><p>Basta que se reduza esse fluxo, que ele cesse e a estrutura mergulha num processo de degenera&#231;&#227;o progressiva, at&#233; chegar &#224; calcifica&#231;&#227;o, apoptose e assim por diante. Ou ent&#227;o, &#224; perda de transpar&#234;ncia, caso do cristalino. Ent&#227;o &#233; uma vis&#227;o completamente diferente, da fisiologia, e que vem a ser a explicada por Ray Peat, inspirado por Gilbert Ling, Szent Giorgy, e outros, inclusive<span> </span>Pollack.</p><p>O cristalino, aquela lente fixa dentro de cada olho, &#233; uma estrutura viva, produz energia [no seu pequeno epit&#233;lio], e serve como um dos melhores exemplos para entendimento de como funciona a nossa bioenergia, qual &#233; a rela&#231;&#227;o entre produ&#231;&#227;o de energia e estrutura.</p><p>Por qu&#234;? Porque, diferentemente da pele, ou de outros tecidos, o cristalino praticamente n&#227;o renova suas c&#233;lulas durante a vida. Ele permanece d&#233;cadas com aquela mesma estrutura<span> </span>&#8220;fixa&#8221;, que &#233; criticamente mantida pelo fluxo continuado de energia.</p><p>De tal forma que, ao longo da vida, pequenas perdas de energia, progressivas, ou cumulativas, impactam o cristalino, o que ir&#225; se expressar no desenvolvimento da perda da transpar&#234;ncia [degenera&#231;&#227;o das prote&#237;nas do cristalino], isto &#233;, catarata.</p><p>E nesta vis&#227;o, a catarata n&#227;o &#233; sujeira oxidativa que se acumula, e sim a disfun&#231;&#227;o progressiva de produ&#231;&#227;o de energia, fazendo com que aquela estrutura v&#225; colapsando lentamente, perdendo a transpar&#234;ncia.</p><p>Vejamos mais de perto esse caso do cristalino.</p><p>O cristalino &#233; como se fosse um cristal vivo. Ele possui prote&#237;nas que est&#227;o organizadas dentro de suas c&#233;lulas [&#8220;fibras&#8221;] de uma maneira extremamente precisa. A dist&#226;ncia entre elas n&#227;o pode mudar, &#233; regular, muito regular. E entre essas prote&#237;nas, a &#225;gua tamb&#233;m est&#225; estruturada de uma maneira muito bem definida, regular, na forma de <em>&#225;gua estruturada</em> - conforme nos ensina Pollak - , em torno das prote&#237;nas.</p><p>Essa arquitetura, enquanto ela permanecer intacta, a luz consegue atravessar o cristalino sem dispers&#227;o praticamente, j&#225; que conta com a transpar&#234;ncia garantida pela ordem molecular interna do cristalino e que &#233; auxiliada pela falta de vasos e organelas nas cristalinas [prote&#237;nas do cristalino].</p><p>Essa organiza&#231;&#227;o &#233; fixa em alguma medida, mas <em>n&#227;o &#233; passiva</em>, bem longe disso. Depende criticamente de um metabolismo muito eficiente, especialmente do epit&#233;lio anterior do cristalino. Quando a respira&#231;&#227;o celular funciona bem [essa &#233; a ideia de Gilbert Ling] significando que h&#225; ATP suficiente, as prote&#237;nas &#8211; chamadas cristalinas - permanecem na conforma&#231;&#227;o adequada. E, nesse caso, a &#225;gua continua fortemente estruturada e, portanto, associada &#224;s prote&#237;nas, e o cristalino mant&#233;m sua transpar&#234;ncia t&#237;pica.</p><p>Basta que o ATP v&#225; diminuindo, para que as prote&#237;nas percam parte daquela organiza&#231;&#227;o, a &#225;gua deixe de permanecer estruturada e aparecem pequenas regi&#245;es de desordem. Essas regi&#245;es, ao inv&#233;s de deixarem a luz passar atravessando diretamente sua espessura, se opacificam, passam a espalhar a luz. Isso &#233; o que &#233; percebido pela medicina como catarata.</p><p><em>Perda de transpar&#234;ncia</em></p><p>Ent&#227;o, a perda da transpar&#234;ncia para<span> </span>Peat<span> </span>&#233; consequ&#234;ncia da perda de organiza&#231;&#227;o energ&#233;tica, e n&#227;o de sujeira ou de oxida&#231;&#227;o [embora inclua oxida&#231;&#227;o], n&#227;o se trata de qualquer coisa semelhante a um dep&#243;sito de part&#237;culas sujas.</p><p>O cristalino, para Peat,<span> </span>&#233; como uma rede molecular/proteica extremamente organizada e para que ela continue perfeitamente organizada precisa de energia e fluxo constante.</p><p>A analogia pode ser com uma barraca de acampar esticada, sob tens&#227;o, e que se a energia diminuir &#8211; isto &#233;, a tens&#227;o entre as estruturas que a comp&#245;em - , a tenda come&#231;a lentamente a perder sua geometria. Ela tende a colapsar, n&#227;o porque algu&#233;m a destruiu, mas porque ela <em>deixou de ser sustentada</em> [aquela mesma ideia do redemoinho no rio]. A tens&#227;o cessou<span> </span>e a tenda perdeu sua forma espacial.</p><p>No caso do redemoinho, o rio vem e forma um redemoinho em certos lugares e segue. Basta que o rio pare seu fluxo para o redemoinho desaparecer. Novamente, ele n&#227;o foi destru&#237;do, ele perdeu a energia que o mantinha em ordem, que era o fluxo, a corrente incessante do rio.</p><p>Ent&#227;o, a catarata &#233; altera&#231;&#227;o tardia, anat&#244;mica, por conta de uma perda do fluxo energ&#233;tico, ou seja, as c&#233;lulas dali deixam de dispor de ATP na efici&#234;ncia &#243;tima, e o processo de perda de forma ocorrer&#225; em sequ&#234;ncia gradual.</p><p>Primeiro diminui a respira&#231;&#227;o celular, depois diminui o ATP. Na sequ&#234;ncia a estrutura da &#225;gua vai mudar, as suas mol&#233;culas ficam mais livres e as prote&#237;nas tendem a perder a sua conforma&#231;&#227;o. A essa altura o cristalino j&#225; perdeu sua transpar&#234;ncia.</p><p><em>Energia e estrutura</em></p><p>Peat via o organismo como um sistema no qual a energia e a estrutura s&#227;o insepar&#225;veis. Um sustenta o outro, dialeticamente.</p><p>E voltando ao in&#237;cio do texto, n&#227;o &#233; que a estrutura existe primeiro para utilizar a energia e sim que a estrutura &#233; <em>mantida de p&#233; pela energia</em>.</p><p>E <em>s&#243; existe</em> porque h&#225; um fluxo de energia. &#201; como aquela ilustra&#231;&#227;o acima: se o fluxo cessar, o redemoinho desaparece.</p><p>Ent&#227;o, a forma, neste exemplo, dependia do movimento cont&#237;nuo. Nas c&#233;lulas, nos tecidos, sempre depende.</p><p>A c&#233;lula &#233; imaginada por Ling da mesma maneira. E no caso do cristalino, n&#243;s temos um exemplo <em>redondo</em> de como essa depend&#234;ncia fica vis&#237;vel. Basta uma redu&#231;&#227;o lenta e persistente da bioenergia para que uma estrutura que permaneceu transparente por d&#233;cadas comece a perder sua forma interna, isto &#233;, sua organiza&#231;&#227;o &#243;ptica, isto &#233;, a ordem das mol&#233;culas e da &#225;gua.</p><p>Essa ideia &#233; muito profunda no sentido de que a vida n&#227;o &#233; definida principalmente pela <em>composi&#231;&#227;o qu&#237;mica</em> da c&#233;lula, mas pelo <em>estado f&#237;sico</em> dessa mat&#233;ria. Aqui a biologia e a f&#237;sica est&#227;o de m&#227;o dadas.</p><p>Duas c&#233;lulas podem conter as mesmas prote&#237;nas, lip&#237;dios, &#225;gua, e o que vai distinguir a saud&#225;vel da doente &#233; o <em>grau de organiza&#231;&#227;o</em> desses componentes. E &#233; o estado metab&#243;lico, energ&#233;tico, sustentado pela respira&#231;&#227;o, ATP, CO2, que mant&#233;m aquela organiza&#231;&#227;o.</p><p>Ent&#227;o, a biologia pensada por Peat, na sua camada mais profunda, passa muito mais pela f&#237;sica do que qu&#237;mica. E essa &#233; uma contribui&#231;&#227;o original de Peat, apoiando-se, dentre outros, em Gilbert Ling.</p><p>Sua ideia &#233; de que <em>n&#227;o</em> temos de um lado a estrutura celular e do outro o ATP. A ideia &#233;, j&#225; que o <em>ATP circula continuamente a partir da queima do a&#231;&#250;</em>car, em n&#237;veis &#243;timos, a estrutura celular existe e fica de p&#233;.</p><p>Enquanto o ATP for continuamente produzido, consumido, a estrutura celular consegue existir na forma organizada que caracteriza a vida. E o cristalino na forma organizada que caracteriza sua transpar&#234;ncia. De forma que o ATP n&#227;o &#233; apenas uma mol&#233;cula que circula, ou um combust&#237;vel fornecido de fora.</p><p>Ele &#233; continuamente produzido, consumido e regenerado. <strong>Este fluxo</strong> define e determina a vida.</p><p>Novamente: no exemplo da barraca de <em>camping</em>, ela se mant&#233;m n&#227;o por causa da estrutura, mas pela tens&#227;o entre as varetas e as cordas. Se essa tens&#227;o desaparecer, a estrutura colapsa.</p><p>A doen&#231;a, para Ray Peat, come&#231;a com a <em>perda de organiza&#231;&#227;o energ&#233;tica</em> e s&#243; mais tarde se apresenta como altera&#231;&#227;o vis&#237;vel, estrutural, ao microsc&#243;pio, ao exame de imagem ou ao exame cl&#237;nico.</p><p>G Dantas. Bras&#237;lia, 29-7-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p><strong><span>***</span></strong></p>]]></content:encoded></item><item><title><![CDATA[Teste ergométrico: um exame inocente ou um estressor agudo? ]]></title><description><![CDATA[O teste da esteira e suas contradi&#231;&#245;es]]></description><link>https://outramedicina2024.substack.com/p/teste-ergometrico-um-exame-inocente</link><guid isPermaLink="false">https://outramedicina2024.substack.com/p/teste-ergometrico-um-exame-inocente</guid><dc:creator><![CDATA[dantas2021]]></dc:creator><pubDate>Mon, 27 Jul 2026 22:16:40 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!3aEa!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="/__u/substackcdn.com/image/fetch/$s_!3aEa!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="/__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_webp, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 1456w" sizes="100vw"><img src="/__u/substackcdn.com/image/fetch/$s_!3aEa!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg" width="414" height="763" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:763,&quot;width&quot;:414,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:35018,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://outramedicina2024.substack.com/i/208753179?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="/__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_424, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 424w, /__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_848, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 848w, /__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_1272, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 1272w, /__u/substackcdn.com/image/fetch/$s_!3aEa!, /__u/outramedicina2024.substack.com/w_1456, /__u/outramedicina2024.substack.com/c_limit, /__u/outramedicina2024.substack.com/f_auto, /__u/outramedicina2024.substack.com/q_auto:good, /__u/outramedicina2024.substack.com/fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F96e83d2a-f850-4fcc-b379-ac67846abce2_414x763.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container restack-image"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button tabindex="0" type="button" class="pencraft pc-reset pencraft icon-container view-image"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>Muitos cardiologistas indicam o teste ergom&#233;trico da esteira como rotina. Os pacientes acham bom porque v&#227;o obter dados sobre sua sa&#250;de card&#237;aca.</p><p>Mas tanto nessa &#225;rea como em outras da medicina n&#227;o prevalece o consentimento informado. Isto &#233;, o doutor, frequentemente n&#227;o adverte dos riscos. S&#227;o raros sim, mas s&#227;o riscos, incluindo risco de morte.</p><p>Acontece que embora o teste ergom&#233;trico seja considerado bastante seguro quando realizado com indica&#231;&#227;o adequada e supervis&#227;o m&#233;dica, complica&#231;&#245;es graves podem ocorrer. Afinal o organismo est&#225; sendo levado, no teste, ao limite. &#201; estresse. A literatura cient&#237;fica documenta eventos como infarto agudo do mioc&#225;rdio em decorr&#234;ncia do teste. Sim, n&#227;o somente infarto mas tamb&#233;m fibrila&#231;&#227;o ventricular, bloqueios card&#237;acos graves e, mais raramente morte s&#250;bita.</p><p>&#201; considerada pelos doutores como uma taxa de eventos muito baixa, talvez por isso mesmo nem comentem com o paciente. E, evidentemente, por outro lado, a posi&#231;&#227;o respons&#225;vel n&#227;o &#233; a do cancelamento, de que nunca deva ser feito.</p><p>Mas n&#227;o custa saber das coisas quando se pretenda um envelhecimento com mais qualidade de vida, evitando riscos que s&#227;o contorn&#225;veis, sendo importante a troca de opini&#245;es do paciente com seu doutor.</p><p>Artigo de revis&#227;o de 2023 compilou grandes s&#233;ries de pacientes submetidos a testes de esfor&#231;o. A taxa de complica&#231;&#245;es maiores em testes de esteira ficou em aproximadamente 0,015% a 0,04%, ou seja, algo entre 1 e 4 eventos graves para cada 10.000 exames. E as complica&#231;&#245;es mais comuns foram arritmias ventriculares graves e infarto.</p><p>Um estudo cl&#225;ssico avaliando complica&#231;&#245;es de teste ergom&#233;trico encontrou necessidade de interven&#231;&#227;o m&#233;dica em cerca de 0,33% dos exames. Entre os eventos graves observados estavam infarto agudo do mioc&#225;rdio e taquicardia ventricular sustentada. O risco foi maior em pacientes com infarto pr&#233;vio e angina t&#237;pica.</p><p>Outro levantamento relata incid&#234;ncias aproximadas de arritmias graves em 0,3&#8211;4,8 por 10.000 exames. Algu&#233;m poderia dizer que &#233; pouco risco, mas seguramente n&#227;o est&#225; levando em conta que isso pode ocorrer com um ente querido.</p><p>De forma que a realidade parece afirmar: do ponto de vista fisiol&#243;gico, o teste n&#227;o &#233; &#8220;in&#243;cuo&#8221;. Ele foi concebido justamente para <em>aumentar</em> o trabalho card&#237;aco, o consumo de oxig&#234;nio e a <em>libera&#231;&#227;o de catecolaminas</em> [adrenalina, por exemplo]. Em indiv&#237;duos com doen&#231;a coronariana significativa ou predisposi&#231;&#227;o a arritmias, esse estresse pode precipitar eventos que talvez permanecessem latentes com a pessoa em repouso.</p><p>Descarga de adrenalina n&#227;o pode ser in&#243;cua. Peat frequentemente via a descarga de adrenalina e o aumento do estresse metab&#243;lico como potenciais fatores de risco em pessoas metabolicamente fragilizadas.</p><p>Nessa &#243;tica, um teste que leva deliberadamente o organismo ao limite poderia ser considerado um <em>desafio fisiol&#243;gico relevante</em>, especialmente em indiv&#237;duos com baixa fun&#231;&#227;o tireoidiana, baixa reserva energ&#233;tica ou doen&#231;a card&#237;aca subjacente, de acordo com o pensamento de Ray Peat.</p><p>Tanto &#233; certo de que n&#227;o se trata de um teste inocente que as diretrizes da <em>American Heart Association</em> e da <em>American College of Cardiology</em> consideram que o teste ergom&#233;trico n&#227;o deve ser realizado em situa&#231;&#245;es como arritmias graves n&#227;o controladas, estenose a&#243;rtica severa sintom&#225;tica, miocardite aguda e outras condi&#231;&#245;es que claramente aumentam substancialmente o risco de uma intercorr&#234;ncia s&#233;ria durante o esfor&#231;o. </p><p>E, sim, existe o risco &#8211; remoto &#8211; de morte s&#250;bita [n&#227;o se trata de uma opini&#227;o: as diretrizes ACC/AHA afirmam explicitamente que infarto e morte <em>podem</em> ocorrer durante o teste, embora sejam raros ambos]. &#201; comum? Certamente n&#227;o. Mas n&#227;o queremos que isso ocorra com uma pessoa querida que apenas quer saber como est&#225; seu cora&#231;&#227;o. A estimativa mais citada, como foi dito, &#233; de aproximadamente 1 morte ou evento card&#237;aco maior para cada 10.000 testes.</p><p>E isso pode ocorrer por conta de que durante o teste ocorre descarga simp&#225;tica intensa; aumento de adrenalina e noradrenalina; eleva&#231;&#227;o da press&#227;o arterial; aumento vigoroso da frequ&#234;ncia card&#237;aca.</p><p>Se houver uma placa coron&#225;ria inst&#225;vel, isquemia importante ou um foco arr&#237;tmico latente &#8211; situa&#231;&#245;es que podem ser <em>desconhecidas para a pessoa</em> - , o esfor&#231;o pode desencadear um evento cl&#237;nico que n&#227;o apareceria em repouso.</p><p>A ironia: o mesmo exame que pode precipitar uma arritmia tamb&#233;m pode revelar quem tem maior risco de morrer nos anos seguintes.</p><p>O fato &#233; que<span> </span>na perspectiva de Ray Peat, esse teste seria visto como um estressor agudo importante, n&#227;o apenas pelo aumento vigoroso da adrenalina, mas tamb&#233;m de &#225;cidos graxos circulantes, poss&#237;vel redu&#231;&#227;o do CO2 e outros problemas em pessoas com metabolismo/tireoide comprometidos.</p><p>E Peat tinha uma vis&#227;o diferente da medicina oficial sobre a adrenalina: apoiar o metabolismo na adrenalina n&#227;o &#233; sinal de sa&#250;de; da&#237; provavelmente interpretaria que &#8220;aguentar muito tempo na esteira&#8221; n&#227;o ser&#225; sempre sin&#244;nimo de boa sa&#250;de metab&#243;lica.</p><p>O <em>American College of Sports Medicine</em> [2024] resume os dados hist&#243;ricos e estima aproximadamente cerca de 6 eventos card&#237;acos por 10.000 testes em popula&#231;&#245;es mistas; a maioria dos eventos ocorre em pessoas com doen&#231;a cardiovascular conhecida ou <strong>oculta</strong>.</p><p>E mais: existe a possibilidade real de falsos-positivos e falso-negativos al&#233;m de baixa sensibilidade e especificidade do exame em alguns grupos.</p><p>E pouco se fala do seguinte fato: existem relatos de caso de pacientes que sofreram infarto ou fibrila&#231;&#227;o ventricular literalmente nos minutos finais do protocolo de Bruce, quando a inclina&#231;&#227;o e a velocidade da esteira atingem seus n&#237;veis mais elevados. Esses relatos foram justamente uma das raz&#245;es para as r&#237;gidas contraindica&#231;&#245;es atuais. E por isso, o desfibrilador e o m&#233;dico especialista treinado t&#234;m que estar por perto.</p><p>At&#233; porque j&#225; &#233; velho conhecimento da medicina sobre &#8220;evid&#234;ncias claras de que a atividade f&#237;sica aumenta de forma aguda o risco de um evento cardiovascular (CV) adverso e de morte s&#250;bita card&#237;aca (MSC) para n&#237;veis significativamente superiores aos esperados em repouso. Eventos cardiovasculares adversos durante a atividade f&#237;sica podem ser desencadeados agudamente pelo estresse fisiol&#243;gico do exerc&#237;cio&#8221; [C].</p><p>G Dantas, Bras&#237;lia, 28-7-26</p><h6><strong><span>As informa&#231;&#245;es aqui presentes n&#227;o pretendem servir para uso diagn&#243;stico, prescri&#231;&#227;o m&#233;dica, tratamento, preven&#231;&#227;o ou mitiga&#231;&#227;o de qualquer doen&#231;a humana. N&#227;o pretendem substituir a consulta ao profissional m&#233;dico ou servir como recomenda&#231;&#227;o para qualquer plano de tratamento. Trata-se de informa&#231;&#245;es com fins estritamente educativos. Nenhuma das notas aqui presentes, neste blog, conseguir&#225; atingir o contexto espec&#237;fico do paciente singular, nem doses, modo de usar etc. Este trabalho compete ao paciente com seu m&#233;dico. Isso significa que nenhuma dessas notas - necessariamente parciais - substitui essa rela&#231;&#227;o.</span></strong></h6><p></p><p><strong>Refer&#234;ncias</strong> ___________________</p><p>[A]<span> </span>GIBBONS L W MITCHELL T L, 1994. <em>The safety of exercise testing</em>. Prim Care. 1994 Sep;21(3):611-29.PMID: 9132761</p><p>Abstract</p><p>Although exercise testing is a safe activity for the vast majority of individuals being tested, complications during or soon after testing do occur, and safety is an extremely important consideration. In reviewing published rates of complications, it appears that complication rates around 5 per 10,000 tests and death rates around 0.5 per 10,000 tests might be expected. The rate of complications and deaths in our clinic is much lower than these published rates, but our population is, in general, a healthier population than those reported on in other studies. It is instructive to review the details of exercise tests in which complications have occurred, although sometimes it is impossible to predict that an untoward occurrence is imminent. Exercise testing soon after myocardial infarction or angioplasty can generally be conducted safely by knowledgeable professionals, although submaximal testing is recommended under these circumstances. Following accepted contraindications to testing and accepted indications for terminating an exercise test is still very important to ensure the safety of testing. If one desires to step outside these recognized guidelines, the anticipated benefits of testing must clearly outweigh the inherent risks. Any testing facility must have appropriate safety equipment, including a defibrillator, and personnel must be regularly drilled in responding to emergencies. In reviewing our experience at the Cooper Clinic, practical suggestions have been offered that should make exercise testing, which is already a very safe activity, even safer.</p><p>[B]<span> </span>ROCHMIS P BLACKBURN H, 1971. <em>Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests.</em> JAMA. 1971 Aug 23;217(8):1061-6. doi: 10.1001/jama.217.8.1061.  PMID: 5109427<span> </span>DOI: <a href="https://doi.org/10.1001/jama.217.8.1061">10.1001/jama.217.8.1061</a><span> </span><em>No abstract available. </em>Este estudo &#233; um cl&#225;ssico que envolve quase 200 mil testes e documenta mortes e infartos relacionados ao teste ergom&#233;trico.</p><p>[C]<span> </span>GOODMAN J M<span> </span>THOMAS S G 2011. <em>Evidence-based risk assessment and recommendations for exercise testing and physical activity clearance in apparently healthy individuals. </em>Appl Physiol Nutr Metabolismo . 2011 Jul:36 Suppl 1:S14-32. doi: 10.1139/h11-048.PMID: 21800940 DOI: <a href="https://doi.org/10.1139/h11-048">10.1139/h11-048</a>    </p><p>Abstract</p><p>Increased physical activity (PA) is associated with improved health and quality of life in the general population. A dose-response effect is evident between increasing levels of PA participation and a lower relative risk for cardiovascular disease and all-cause mortality. However, there is also clear evidence that PA acutely increases the risk of an adverse cardiovascular (CV) event and sudden cardiac death (SCD) significantly above levels expected at rest. Adverse CV events during PA may be triggered acutely by the physiological stress of exercise. This investigation will review the available literature describing the CV risks of exercise testing and PA participation in apparently healthy individuals. A systematic review of the literature was performed using electronic databases, including Medline, CINAHL, SPORT discus, EMBASE, Cochrane DSR, ACP Journal Club, and DARE; additional relevant articles were hand-picked and the final grouping was used for the review using the AGREE process to assess the impact and quality of the selected articles. Six hundred and sixteen relevant articles were reviewed with 51 being identified as describing adverse CV events during exercise and PA. Data suggests the risks of fatal and nonfatal events during maximal exercise testing in apparently healthy individuals rarely occur (approximately &lt;0.8 per 10 000 tests or 1 per 10 000 h of testing). The incidence of adverse CV events is extremely low during PA of varying types and intensities, with data limited almost exclusively to fatal CV events, as nonfatal events are rarely reported. However, this risk is reduced by 25%-50% in those individuals who have prior experience with increased levels of PA, particularly vigorous PA. Throughout a wide age range, the risk of SCD and nonfatal events during PA remain extremely low (well below 0.01 per 10 000 participant hours), but both increasing age and PA intensity are associated with greater risk. In most cases of exercise-related SCD, undetected pre-existing disease is present and SCD is typically the first clinical event. The risks of an adverse CV event during exercise testing and PA are rare and are outweighed by the health benefits. Given this risk-benefit relationship, the PAR-Q is an appropriate method to identify those at higher risk across a wide age span and should be used in conjunction with appropriate clinical guidelines for guiding individuals towards graduated PA. There are not adequate data to describe the risks of PA in those individuals considered to be at higher risk but without cardiovascular disease.<span> </span>[Evidenciam que &#61623;<span> </span>durante o teste ergom&#233;trico podem ocorrer infarto e morte s&#250;bita, embora raramente;<span> </span>em indiv&#237;duos aparentemente saud&#225;veis, o risco fatal &#233; inferior a 0,8 por 10.000 testes, mas n&#227;o &#233; zero].</p><p>[D]<span> </span>KHARABSHEH S M AL-SUGAIR A, 2006. <em>Overview of Exercise Stress Testing.</em> Ann Saudi Med. 2006 Jan-Feb;26(1):1&#8211;6. doi: <a href="https://doi.org/10.5144/0256-4947.2006.1">10.5144/0256-4947.2006.1</a>  PMCID: PMC6078558 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/16521867/">16521867</a>  Abstract  Exercise stress testing is a non-invasive, safe and affordable screening test for coronary artery disease (CAD), provided there is careful patient selection for better predictive value. Patients at moderate risk for CAD are best served with this kind of screening, with the exception of females during their reproductive period, when a high incidence of false positive results has been reported. Patients with a high pretest probability for CAD should undergo stress testing combined with cardiac imaging or cardiac catheterization directly. Data from the test, other than ECG changes, should be taken into consideration when interpreting the exercise stress test since it has a strong prognostic value, i.e. workload, heart rate rise and recovery and blood pressure changes. Only a low-level exercise stress test can be performed early post myocardial infarction (first week), and a full exercise test should be delayed 4 to 6 weeks post uncomplicated myocardial infarction. The ECG interpretation with myocardial perfusion imaging follows the same criteria, but the sensitivity is much lower and the specificity is high enough to overrule the imaging part.<span> </span>[Fica claro o motivo de o teste ser realizado com monitoriza&#231;&#227;o cont&#237;nua, desfibrilador dispon&#237;vel e equipe treinada]. Dispon&#237;vel em: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6078558/?utm_source=chatgpt.com">https://pmc.ncbi.nlm.nih.gov/articles/PMC6078558/?utm_source=chatgpt.com</a></p><p>***</p>]]></content:encoded></item></channel></rss>